0000724910-13-000009.txt : 20130501 0000724910-13-000009.hdr.sgml : 20130501 20130501163043 ACCESSION NUMBER: 0000724910-13-000009 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20130331 FILED AS OF DATE: 20130501 DATE AS OF CHANGE: 20130501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NVE CORP /NEW/ CENTRAL INDEX KEY: 0000724910 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 411424202 STATE OF INCORPORATION: MN FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-12196 FILM NUMBER: 13803614 BUSINESS ADDRESS: STREET 1: 11409 VALLEY VIEW ROAD CITY: EDEN PRAIRIE STATE: MN ZIP: 55344 BUSINESS PHONE: 9528299217 MAIL ADDRESS: STREET 1: 11409 VALLEY VIEW ROAD CITY: EDEN PRAIRIE STATE: MN ZIP: 55344 FORMER COMPANY: FORMER CONFORMED NAME: PREMIS CORP DATE OF NAME CHANGE: 19920703 10-K 1 NVE_2013_10K.htm ANNUAL REPORT FOR THE YEAR ENDED MARCH 31, 2013  
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
_______________
 
FORM 10-K
(Mark One)
     [X]  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended March 31, 2013
     [   ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____________________to____________________
Commission file number 000-12196
 NVE Logo
NVE CORPORATION
(Exact name of registrant as specified in its charter)
 
Minnesota 41-1424202
State or other jurisdiction of incorporation or organization(I.R.S.Employer Identification No.)
 
11409 Valley View Road, Eden Prairie, Minnesota55344
(Address of principal executive offices) (Zip Code)
 
Registrant’s telephone number, including area code (952) 829-9217

Securities registered pursuant to Section 12(b) of the Act:
                         Title of each class                                 
Name of each exchange on which registered
Common stock, $0.01 par value (“Common Stock”)
The NASDAQ Stock Market, LLC
 
Securities registered pursuant to Section 12(g) of the Act: None
 
 Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Yes [   ]  No [X]
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
Yes [   ]  No [X]
     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes [X]  No [   ]
     Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes [X]  No [   ]
     Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (Section 229.405 of this chapter) is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  [X]
      Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
     Large accelerated filer [   ]Accelerated filer [X]
     Non-accelerated filer [   ] (Do not check if a smaller reporting company)     Smaller reporting company [   ] 
 
     Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).
Yes [   ]  No [X]
 
     The aggregate market value of the voting stock held by non-affiliates of the Registrant, based on the closing price on September 28, 2012, the last business day of the Registrant’s most recently completed second fiscal quarter, as reported on the NASDAQ Stock Market, was approximately $176 million.
     The number of shares of the registrant’s Common Stock (par value $0.01) outstanding as of April 26, 2013 was 4,862,436.
_______________
 
DOCUMENTS INCORPORATED BY REFERENCE
       Portions of our Proxy Statement for our 2013 Annual Meeting of Stockholders are incorporated by reference into Items 10, 11, 12, 13, and 14 of Part III hereof.
 

NVE CORPORATION
INDEX TO FORM 10-K
PART I
PART II
PART III
PART IV
SIGNATURES

FINANCIAL STATEMENTS

Table of Contents
 
  
FORWARD-LOOKING STATEMENTS
     Some of the statements made in this Report or in the documents incorporated by reference in this Report and in other materials filed or to be filed by us with the Securities and Exchange Commission (“SEC”) as well as information included in verbal or written statements made by us constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to the safe harbor provisions of the reform act. Forward-looking statements may be identified by the use of the terminology such as may, will, expect, anticipate, intend, believe, estimate, should, or continue, or the negatives of these terms or other variations on these words or comparable terminology. To the extent that this Report contains forward-looking statements regarding the financial condition, operating results, business prospects or any other aspect of NVE, you should be aware that our actual financial condition, operating results and business performance may differ materially from that projected or estimated by us in the forward-looking statements. We have attempted to identify, in context, some of the factors that we currently believe may cause actual future experience and results to differ from their current expectations. These differences may be caused by a variety of factors, including but not limited to uncertainties related to the economic environments in the industries we serve, uncertainties related to direct and indirect U.S. Government funding, uncertainties relating to future revenue and growth, risks related to developing marketable products, uncertainties relating to the revenue potential of new products, risks in the enforcement of our patents, litigation risks, and other specific risks that may be alluded to in this Report or in the documents incorporated by reference in this Report. For more information regarding our risks and uncertainties, see Item 1A “Risk Factors” of this Report.

ITEM 1. BUSINESS.
In General
     NVE Corporation, referred to as NVE, we, us, or our, develops and sells devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store and transmit information. We manufacture high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. We have also licensed our spintronic magnetoresistive random access memory technology, commonly known as MRAM.

NVE History and Background
     NVE is a Minnesota corporation headquartered in a suburb of Minneapolis. We were founded in 1989 by James M. Daughton, Ph.D., a spintronics pioneer. Our common stock became publicly traded in 2000 through a reverse merger and became NASDAQ listed in 2003. Since our founding, we have been awarded more than $50 million in government research contracts, including more than 30 MRAM development contracts. These contracts have helped us build our intellectual property portfolio. Over the years our product sales have increased and we have reduced our dependence on research contracts. Fiscal years referenced in this report end March 31.

Industry Background
     Much of the electronics industry is devoted to the acquisition, storage, and transmission of information. We have focused on three applications for our spintronic technology: magnetic sensors, couplers, and memories. Sensors acquire information, couplers transmit information, and memories store information. In that sense, our technology can provide the eyes, nerves, and brains of electronic systems.

     Magnetic sensors can be used for a number of purposes including detecting the position or speed of robotics and mechanisms, or for communicating with implantable medical devices. We believe our spintronic sensors are smaller, more precise, and more reliable than competing devices.

     Couplers are widely used in factory automation, providing reliable digital communication between electronic subsystems in factories. For example, couplers are used to send data between robots and central controllers at very high speed. As manufacturing automation expands, there is a need for higher speed data and more channel density. Because of their unique properties, we believe our couplers transmit more data at higher speeds and over longer distances than conventional devices.

     Near-term potential MRAM applications include mission-critical storage such as military, industrial, and anti-tamper applications. Long term, MRAM could address the market for ubiquitous high-density memory.

Our Enabling Technology
     Our designs are generally based on either giant magnetoresistance or tunneling magnetoresistance. These structures produce a large change in electrical resistance depending on the electron spin orientation in a free layer.

     In giant magnetoresistance (GMR) devices, resistance changes due to conduction electrons scattering at interfaces within the devices. The GMR effect is only significant if the layer thicknesses are less than the mean free path of conduction electrons, which is approximately five nanometers. Our critical GMR conductor layers may be less than two nanometers, or five atomic layers, thick. Technological advances in recent years have made it practical to manufacture such small dimensions.
3
Table of Contents
 
     The second type of spintronic structure we use is based on tunneling magnetoresistance (TMR). Such devices are known as Spin-Dependent Tunnel (SDT) junctions, Magnetic Tunnel Junctions (MTJs), or Tunneling Magnetic Junctions (TMJs). SDT junctions use tunnel barriers that are so thin that electrons can “tunnel” through a normally insulating material to cause a resistance change. SDT barrier thicknesses can be in the range of one to four nanometers (less than ten molecular layers).

     In our products, the spintronic elements are connected to integrated circuitry and packaged in much the same way as conventional integrated circuits.

Our Strategy
     Our vision is to become the leading developer of practical spintronics technology and devices. We plan to do that by selling the products described below and licensing our MRAM technology. To grow product sales, we plan to broaden our sensor and coupler product lines, and longer-term to target larger markets such as consumer electronics.

Our Products and Markets
     We operate in one reportable segment. For financial information concerning this segment see “Note 8 – Segment Information” of the Financial Statements included in this report.

Sensor Products and Markets
     Our sensor products detect the strength or gradient of magnetic fields and are often used to determine position or speed. The GMR changes its electrical resistance depending on the magnetic field. In our devices, GMR is combined with conventional foundry integrated circuitry and packaged in much the same way as conventional integrated circuits. We sell standard or catalog sensors, and custom sensors designed to meet customers’ exact requirements. Our sensors are quite small, very sensitive to magnetic fields, precise, and reliable.

Standard sensors
     Our standard, or catalog, sensors are generally used to detect the presence of a magnetic or metallic material to determine position or speed. We believe our spintronic sensors are smaller, more precise, and more reliable than competing devices. Our major market for standard sensors is factory automation.

Custom and medical sensors
     Our primary custom products are sensors for medical devices, which are customized to our customers’ requirements and manufactured under stringent medical device quality standards. Most are used to replace electromechanical magnetic switches. We believe our sensors have important advantages in medical devices compared to electromechanical switches, including no moving parts for inherent reliability, and being smaller, more sensitive, and more precise. Our sensors can be customized using customer-specific integrated signal processing and design variations that can include the range and sensitivity to magnetic fields, electrical resistance, and multisensor elements configuration. Future custom sensor target markets include consumer electronics, automotive electronics, and biosensors.

Coupler Products and Markets
     Our spintronic couplers combine a GMR sensor element and an “IsoLoop” integrated microscopic coil. The coil creates a small magnetic field that is picked up by the spintronic sensor, transmitting data almost instantly. Couplers are also known as “isolators” because they electrically isolate the coupled systems. Our IsoLoop couplers are faster than the fastest optical couplers.

     We have four lines of coupler products: cost-effective IL500-Series couplers; IL600-Series passive-input couplers; IL700/IL200-Series high-speed couplers; and IL4/IL3-Series isolated network couplers.

MRAM Products and Markets
     MRAM uses spintronics to store data. It has been called the ideal or universal memory because of its potential to combine the speed of SRAM, the density of DRAM, and the nonvolatility of flash memory. Data is stored in the spin of the electrons in thin metal alloy films, and read with spin-dependent tunnel junctions. Unlike electrical charge, the spin of an electron is inherently permanent. We have invented several types of MRAM memory cells including inventions related to advanced MRAM designs and MRAM for tamper prevention or detection.

     Our strategy is to develop, manufacture, and sell low bit-density MRAM for applications such as tamper prevention and detection. For high bit-density MRAM, our strategy is to license our technology to companies with large-scale memories manufacturing capabilities.
 
4
Table of Contents
 
Product Manufacturing
     The heart of our fabrication facility is a cleanroom area with specialized equipment to deposit, pattern, etch, and process spintronic materials. Most of our products are fabricated in our facility using either raw silicon wafers or foundry wafers. Foundry wafers contain conventional electronics that perform housekeeping functions such as voltage regulation and signal conditioning in our products.

     Each wafer may include thousands of devices. We build spintronics structures on wafers in our fabrication facility. We either saw wafers to be sold in die form, or send wafers to Asia for dicing and packaging. Other production operations include wafer-level inspection and testing. Packaged parts are returned to us to be tested, inventoried, and shipped.

Sales and Product Distribution
     We rely on distributors who stock our products and sell them in more than 75 countries. Distributors of our products include Digi-Key Corporation, Premier Farnell plc companies, and Rhopoint Components Ltd. Our distributor agreements generally renew annually. In addition, Avago Technologies, a leading supplier of solid-state couplers, distributes private-branded versions of some of our couplers under an agreement that expires June 27, 2013. We may add other private-brand coupler partners in the future.

New Product Status
     In the past year we began marketing a number of new products including lines of:
           •  higher-performance network couplers;
• smaller network couplers; and
• lower-priced network couplers.
 
     Long-term product development programs in fiscal 2013 included:
           •  couplers for battery management systems and in-car networks;
• low-power couplers;
• isolated power convertors;
• current sensors for factory automation;
• low-field sensors applicable to consumer and industrial electronics; and
• high-field sensors applicable to medical devices.
 
Our Competition
Industrial Sensor Competition
     Several other companies claim to either make or have the capability to make GMR and TMR sensors. Also, several competitors make solid-state industrial magnetic sensors including silicon Hall-effect sensors and anisotropic magnetoresistive (AMR) sensors. We believe those types of sensors are not as sensitive as our GMR or TMR sensors.

Medical Sensor Competition
     Our sensors for medical devices face competition from electromechanical magnetic sensors and from other solid-state magnetic sensors. Electromechanical magnetic sensors such as reed and micro-electromechanical system (MEMS) switches have been in use for several decades. Electromechanical competitors include Hermetic Switch, Inc., Meder Electronic AG (Engen/Welschingen, Germany), and Memscap SA (Grenoble, France). Because our sensors have no moving parts, we believe they are inherently more reliable than electromechanical magnetic sensors. We also believe our sensors are smaller than the smallest electromechanical magnetic sensors, more precise in their magnetic switch points, and more sensitive. Compared to other solid-state sensors, our medical sensors may have advantages in size, sensitivity to small magnetic fields, or electrical interface simplicity.

Coupler Competition
     Competing coupler technologies include optical couplers, inductive couplers (transformers), capacitive couplers, and radio-frequency modulation couplers. In addition to being a customer, Avago is a leading producer of high-speed optical couplers. Other prominent optical coupler suppliers are Fairchild Semiconductor International, Lite-On Technology Corporation, Renesas Electronics Corporation, Toshiba Corporation, and Vishay Intertechnology.

     Our strategy is to compete based on product features rather than to compete solely on price. IsoLoop couplers are smaller and therefore require less circuit board space per channel than most competing couplers. Our other advantages over competing technologies may include less signal distortion, longer product life, and lower power consumption.

 
5
Table of Contents
 
MRAM Competition
     A number of companies compete or may compete with us for MRAM research and development or service business, or may be attempting to develop MRAM intellectual property for licensing to others. Emerging technologies that could compete with MRAM include graphene and carbon nanotubes, phase-change memory (PCM; also known as PRAM, PCRAM, chalcogenide, CRAM, or Ovonic memory), resistive RAM (ReRAM or RRAM), memory resistors (“memristors”), and conductive metal oxide (CMOx) memory. MRAM may have advantages over these technologies in either manufacturability, speed, bit density, data retention, or endurance.
 
Sources and Availability of Raw Materials
     Our principal sources of raw materials include suppliers of raw silicon and semiconductor foundry wafers that are incorporated into our products, and suppliers of device packaging services. Our wafers sources are based around the world; most of our packaging services take place in Asia.

Intellectual Property
Patents
     As of March 31, 2013 we had more than 50 issued U.S. patents assigned to us. We also have a number of foreign patents, a number of U.S. and foreign patents pending, and we have licensed patents from others. There are no patents we regard as critical to our current business owned by us or licensed to us that expire in the next 12 months.

     Much of our intellectual property has been developed with U.S. Government support. Under federal legislation, companies normally may retain the principal worldwide patent rights to any invention developed with U.S. Government support.

     Certain of our patents cover inventions we believe may be necessary for successful high-density, high-performance MRAMs. We believe U.S. patents 6,275,411 and 6,349,053, both titled “Spin Dependent Tunneling Memory,” and patent 6,538,921 titled “Circuit Selection of Magnetic Memory Cells and Related Cell Structures,” are particularly important. The 6,275,411 and 6,349,053 patents expire July 23, 2013 and the 6,538,921 patent expires August 14, 2021. The United States Patent and Trademark Office granted requests by Everspin for inter partes reexaminations of U.S. patent 6,349,053 on May 16, 2012, and of U.S. patent 6,538,921 on September 16, 2012.

     We also have patents on advanced MRAM designs that we believe are important, including patents that relate to magnetothermal MRAM, spin-momentum MRAM, and synthetic antiferromagnetic storage.

Trademarks
     “NVE” and “IsoLoop” are our registered trademarks. Other trademarks we claim include “GMR Switch” and “GT Sensor.”

Licenses
     We have licensed certain of our MRAM intellectual property to several companies, including Honeywell International Inc. and Motorola, Inc.

Agreements with Honeywell
     We have agreements and amendments to agreements with Honeywell dating approximately to our founding. Under these agreements we are not required to pay royalties to Honeywell for the use of their intellectual property, and Honeywell has intellectual property rights to certain of our earlier-developed MRAM technology.

Motorola License
     We granted Motorola a nonexclusive, nontransferable, and nonassignable license to our MRAM intellectual property and received advance payments in conjunction with the agreement. Motorola has since separated Freescale Semiconductor, Inc. Motorola and Freescale asked us to consent to Motorola’s assignment of the Patent License Option Agreement to Freescale. We have declined to provide such consent without additional consideration. We believe the Motorola agreement likely terminated in 2005 because Motorola transferred manufacturing to Freescale. Freescale later announced the formation of Everspin Technologies, Inc., an independent company that would take ownership of Freescale’s MRAM manufacturing assets. In January 2012 we filed a patent infringement lawsuit against Everspin.

Seasonality
     In some years we have observed product sales weakness for quarters ending December 31. This seasonality may have been due in part to distributor ordering patterns or customer vacations and shutdowns late in calendar years. We cannot predict whether this seasonal pattern will return in future fiscal years.
6
Table of Contents
 
Working Capital Items
     Like other companies in the electronics industry, we have historically invested in capital equipment for manufacturing and testing our products, as well as research and development equipment. We have also deployed significant capital in inventories to have finished products available from stock, to receive more favorable pricing for raw materials, and to guard against raw material shortages.

Dependence on Major Customers
     We rely on several large customers for a significant percentage of our revenue, including Avago Technologies; Phonak AG; St. Jude Medical, Inc.; certain other medical device manufacturers; and certain distributors. The loss of one or more of these customers could have a material adverse effect on us.

Firm Backlog
     As of March 31, 2013 we had $194,416 of contract research and development backlog we believed to be firm, compared to $1,059,686 as of March 31, 2012. We expect the firm backlog as of March 31, 2013 to be filled in fiscal 2014. Approximately 59% of our backlog as of March 31, 2012 was from agencies of the U.S. Government. U.S. Government orders that are not yet funded, or contracts awarded but not yet signed, are not included in firm backlog. We do not believe any material portion of our business is subject to renegotiation of profits or termination of contracts or subcontracts at the election of the U.S. Government. There can be no assurance of additional contracts or follow-on contracts for expired or completed U.S. Government or other contracts.

    Our product sales are made primarily under standard purchase orders. Only a small portion of our product order backlog is noncancelable and the dollar amount associated with the noncancelable portion is not significant, therefore product order backlog is not included in “firm backlog,” and product sales backlog as of any particular date may not be indicative of future results. We also have certain agreements that require customers to forecast purchases; however, these agreements do not generally obligate the customer to purchase any particular quantity of products. Based on semiconductor industry practice and our experience, we do not believe that such agreements are meaningful for determining backlog amounts.

Research and Development Activities
     Over the past three fiscal years our research and development activities have included development of new sensors, couplers, and memories, as well as related underlying technologies. We spent $2,304,710 for fiscal 2013, $1,887,297 for fiscal 2012, and $1,062,694 for fiscal 2011 in company-sponsored research and development activities. Additionally, we spent $2,040,640 during fiscal 2013, $3,261,191 during fiscal 2012, and $4,371,852 during fiscal 2011 on customer-sponsored research and development contract activities. These research and development contracts were with various agencies of the U.S. Government as well as non-government entities.

Environmental Matters
     We are subject to environmental laws and regulations, particularly with respect to industrial waste and emissions. Compliance with these laws and regulations has not had a material impact on our capital expenditures, earnings, or competitive position to date. Existing and future environmental laws and regulations could result in expenses related to emission abatement or remediation, but we are currently unable to estimate such expenses.

Number of Employees
     We had 54 employees as of March 31, 2013. Our employment can fluctuate due to a variety of factors. None of our employees are represented by a labor union or are subject to a collective bargaining agreement, and we believe we maintain good relations with our employees.

Financial Information About Geographic Areas
     Foreign sales accounted for approximately 56% of our revenue in fiscal 2013. More information about geographic areas is contained in “Note 8 – Segment Information” to the Financial Statements included in this report

Available Information
     All reports we file with the SEC, including our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and proxy statements and additional proxy materials on Schedule 14A, as well as any amendments to those reports and schedules, are accessible at no cost through the “Investors” section of our Website (www.nve.com). We make those filings available as soon as reasonably practicable after filing. These filings are also accessible through the SEC’s Website (www.sec.gov).
7

Table of Contents
 
ITEM 1A. RISK FACTORS.
     We caution readers that the following important factors, among others, could affect our financial condition, operating results, business prospects or any other aspect of NVE, and could cause our actual results to differ materially from that projected or estimated by us in the forward-looking statements made by us or on our behalf. Although we have attempted to list below the important factors that do or may affect our financial condition, operating results, business prospects, or any other aspect of NVE, other factors may in the future prove to be more important. New factors emerge from time to time and it is not possible for us to predict all of such factors. Similarly, we cannot necessarily assess or quantify the impact of each such factor on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in forward-looking statements.

We may lose revenue if any of our large customers cancel, postpone, or reduce their purchases.
     We rely on several large customers for a significant percentage of our revenue. These large customers include Avago Technologies; Phonak AG; St. Jude Medical, Inc.; certain other medical device manufacturers; and certain distributors. Although we have agreements with certain large customers, these agreements do not obligate customers to purchase from us and may not prevent price reductions. Furthermore, orders from our large customers can generally be reduced, postponed, or canceled. Any decreases in purchase quantities or purchase prices, or the loss of any of our large customers, could have a significant impact on our revenue and our profitability.

We risk losing business to our competitors.
     Known product competitors include Avago Technologies; Analog Devices, Inc.; Fairchild Semiconductor International; Hermetic Switch, Inc.; Linear Technology Inc.; Maxim Integrated Products, Inc.; Meder Electronic AG; Memscap SA; NEC Corporation; Sharp Corporation; Silicon Laboratories, Inc.; Texas Instruments Incorporated; Toshiba Corporation; Vishay Intertechnology; and others. Many of our competitors and potential competitors have significantly greater financial, technical, and marketing resources than us. We believe that our competition is increasing as the technology and markets mature. This has meant more competitors and more severe pricing pressure. In addition, our competitors may be narrowing or eliminating our performance advantages. We expect these trends to continue, and we may lose business to competitors or it may be necessary to significantly reduce our prices in order to acquire or retain business. These factors could cause a material adverse impact on our financial condition, revenue, gross profit margins, or income.

We are dependent on customers to integrate our products into next-level assemblies.
     We are dependent on customers to integrate our products into next-level assemblies with other components in order for some of our products to be commercially viable. There can be no assurance that such customers will manufacture appropriate assembly products or, if they do manufacture such products, that they will choose to use our products. Any integration, design, manufacturing or marketing problems encountered by such customers could adversely affect the market for our products and could have a significant impact on our revenue and our profitability.

We may lose revenue if we are unable to renew agreements with large customers.
     Our agreement with Avago Technologies, Inc., as amended, expires June 27, 2013; our Phonak AG Supply Agreement expires March 31, 2015; and our Supplier Partnering Agreement with St. Jude Medical, as amended, expires January 1, 2016. We cannot predict if any of these agreements will be renewed, or if renewed, under what terms. Although it is possible we could continue to sell products to these customers without formal agreements, an inability to agree on mutually acceptable terms or the loss of any of these large customers could have a significant adverse impact on our revenue and our profitability.

We will lose revenue if government contract funding is reduced, delayed, or eliminated.
     Although our revenue from agencies of the U.S. Government was less than 10% of our total revenue in each of the past three fiscal years, a material decrease in U.S. Government funded research or disqualification as a vendor to the U.S. Government for any reason could hamper future research and development activity and decrease related revenue. In addition to direct Government funding, certain of our non-Government customers and prospective customers depend on Government support to fund their contracts with us. Our direct and indirect Government funding depends on adequate continued funding of the agencies and their programs. Such funding is affected by Government budgets and priorities that can change and over which we have no control, and delays in such funding can occur for a number of reasons. Interruptions in the Government funding process such as federal budget delays, debt ceiling limitations, sequestration, or Department of Defense spending cuts, may impact Government contract funding. Furthermore, a significant portion of our Government funding has been through Small Business Innovation Research (SBIR) contracts. SBIR budgets, eligibility, or funding limits may be changed by legislation or by agencies such as the Department of Defense.

8
Table of Contents
 
If we were barred for any reason from U.S. government contracts there could be a significant adverse impact on our revenue and our ability to make research and development progress.
     If we were to be charged with violation of certain laws or if the U.S. Government were to determine that we are not a “presently responsible contractor,” we could be temporarily suspended or, in the event of a violation, barred for up to three years from receiving new U.S. Government contracts or government-approved subcontracts. In addition, we could expend substantial amounts in defending against such charges and in damages, fines and penalties if such charges are proven or result in negotiated settlements. Being barred for any reason from U.S. Government contracts could have a material adverse effect on our revenue, profits, and research and development efforts.

We face an uncertain economic environment in the industries we serve, which could adversely affect our business.
     We sell our products into the semiconductor market, which is highly cyclical. Additionally, effects of U.S. healthcare reform legislation could have an adverse effect on the economic environment for the medical device industries we serve. We cannot predict the timing, strength, or duration of any economic slowdown or subsequent recovery, worldwide or in the industries we serve. The economic environment could have a material adverse impact on our business and revenue.

Our reputation could be damaged and we could lose revenue if we fail to meet technical challenges required to produce marketable products.
     Our products use new technology and we are continually researching and developing product designs and production processes. Our production processes require control of dimensional, magnetic, and other parameters that are not required in conventional semiconductor processes. If we are unable to develop stable designs and production processes, we may not be able to produce products that meet our customers’ requirements, which could cause damage to our reputation and loss of revenue.

Failure to meet stringent customer requirements could result in the loss of key customers and reduce our sales.
     Some of our customers, including Avago Technologies and certain medical device manufacturers, have stringent technical and quality requirements that require our products to meet certain test and qualification criteria or to adopt and comply with specific quality standards. Certain customers also periodically audit our performance. Failure to meet technical or quality requirements or a negative customer audit could result in the loss of current sales revenue, customers, and future sales.

We could be subject to claims based on warranty, product liability, or delivery failures.
     Claims based on warranty, product liability, or delivery failures that could lead to significant expenses as we defend such claims or pay damage awards. We may also incur costs if we decide to compensate the affected customer or end consumer for such claims. In addition, if our customers recall products containing our products, we may incur costs and expenses relating to the recall. Costs or payments we may make in connection with warranty, delivery claims or product recalls may adversely affect our business and financial condition.

Some of our sensors are incorporated into medical devices, which could expose us to a risk of product liability claims and such claims could seriously harm our business and financial condition.
     Certain of our sensor products are used in medical devices, including devices that help sustain human life. We are also marketing our sensor technology to other manufacturers of cardiac pacemakers and ICDs. Although we have indemnification agreements with certain customers including provisions designed to limit our exposure to product liability claims, there can be no assurance that we will not be subject to losses, claims, damages, liabilities, or expenses resulting from bodily injury or property damage arising from the incorporation of our products in devices sold by our customers. Our indemnifying customers may not have the financial resources to cover all liability. Existing or future laws or unfavorable judicial decisions could limit or invalidate the provisions of our indemnification agreements, or the agreements may not be enforceable in all instances. A successful product liability claim could require us to pay, or contribute to payment of, substantial damage awards, which would have a significant negative effect on our business and financial condition.

Federal legislation may not protect us against liability for the use of our sensors in medical devices and a successful liability claim could seriously harm our business and financial condition.
     Although the Biomaterials Access Assurance Act of 1998 may provide us some protection against potential liability claims, that Act includes significant exceptions to supplier immunity provisions, including limitations relating to negligence or willful misconduct. A successful product liability claim could require us to pay, or contribute to payment of, substantial damage awards, which would have a significant negative effect on our business and financial condition. Any product liability claim against us, with or without merit, could result in costly litigation, divert the time, attention, and resources of our management and have a material adverse impact on our business.


9
Table of Contents
 
Any malfunction of our sensors in existing medical devices could lead to the need to recall devices incorporating our sensors from the market, which may be harmful to our reputation and cause a significant loss of revenue.
     Any malfunction of our sensors could lead to the need to recall existing medical devices incorporating our sensors from the market, which may be harmful to our reputation because it is dependent on product safety and efficacy. Even if assertions that our sensors caused or contributed to device failure do not lead to product liability or contract claims, such assertions could harm our reputation and our customer relationships. Any damage to our reputation and/or the reputation of our products, or the reputation of our customers or their products could limit the market for our and our customers’ products and harm our results of operations.

We may lose business and revenue if our critical production equipment fails.
     Our production process relies on certain critical pieces of equipment for defining, depositing, and modifying the magnetic properties of thin films. Some of this equipment was designed or customized by us, and some may no longer be in production. While we have an in-house maintenance staff, maintenance agreements for certain equipment, some critical spare parts, and back-ups for some of the equipment, we cannot be sure we could repair or replace critical manufacturing equipment were it to fail.

The loss of supply from any of our key single-source wafer suppliers could impact our ability to produce and deliver products and cause loss of revenue.
     Our critical suppliers include suppliers of certain raw silicon and semiconductor foundry wafers that are incorporated in our products. We maintain inventory of some critical wafers, but we have not identified or qualified alternate suppliers for many of the wafers now being obtained from single sources. Increased industry demand due to an economic recovery or other factors beyond our control or ability to predict could cause or exacerbate wafer supply shortages. Any wafer supply interruptions could seriously jeopardize our ability to provide products that are critical to our business and operations and may cause us to lose revenue.

The loss of supply of any critical chemicals or supplies could impact our ability to produce and deliver products and cause loss of revenue.
     There are a number of critical chemicals and supplies that we require to make products. These include certain gases, photoresists, polymers, and metals. We maintain inventory of critical chemicals and materials, but in many cases we are dependent on single sources, and some of the materials could be subject to shortages or be discontinued by their suppliers at any time. For example, there have been helium shortages in recent years. Furthermore, current and future climate change regulations could increase our costs or cause the loss of supply of critical chemicals. We use chemicals such as sulfur hexafluoride in our manufacturing process that have been identified as greenhouse gases. If such chemicals were restricted or prohibited we would need to obtain substitutes that might be more expensive or less available. Supply interruptions or shortages for any reason could seriously jeopardize our ability to provide products that are critical to our business and operations and may cause us to lose revenue.

The loss of supply from any of our packaging vendors could impact our ability to produce and deliver products and cause loss of revenue.
     We are dependent on our packaging vendors. Because of the unique materials our products use, the complexity of some of our products, and the high isolation voltage specifications of our couplers, many of our products are more challenging to package than conventional integrated circuits. Some of our products use processes or tooling unique to a particular packaging vendor, and it might be expensive, time-consuming, or impractical to convert to another vendor in the event of a supply interruption. We have alternate vendors or potential alternate vendors for the substantial majority of our product sales, but it could prove expensive, time-consuming, or technically challenging to convert certain products to an alternate vendor. We might not be able to recover work in process or finished goods in their possession if one of our packaging vendors were to become insolvent or disrupted by acts of God, including floods, typhoons, or earthquakes. Furthermore, an alternate vendor may not have sufficient capacity available to meet our requirements. One of our packaging vendors, Circuit Electronic Industries Public Co., Ltd. (“CEI”) of Ayutthaya, Thailand has been operating under voluntary debt rehabilitation under Thailand law since 2005, was shut down from October 2011 through March 2012 due to flooding of its facility, and has resumed only limited operations. CEI and certain other packaging vendors are in flood-susceptible areas. Flooding risks to such vendors may increase in the future due to possible higher ocean levels and other potential effects of climate change. Any supply interruptions or loss of inventory could seriously jeopardize our ability to provide products that are critical to our business and operations and may cause us to lose revenue.

We are subject to risks inherent in doing business in foreign countries that could impair our results of operations.
     Foreign sales were approximately 56% of our revenue for fiscal 2013, and we expect foreign sales to continue to represent a significant portion of our revenue. Furthermore, we rely on suppliers in China, India, the Philippines, Taiwan, Thailand, and other foreign countries. Risks relating to operating in foreign markets that could impair our results of operations include economic and political instability; difficulties in enforcement of contractual obligations and intellectual property rights; changes in regulatory requirements, tariffs, customs, duties, and other trade barriers; transportation delays; acts of God, including floods, typhoons, and earthquakes; and other uncertainties relating to the administration of, or changes in, or new interpretation of, the laws, regulations, and policies of jurisdictions where we do business.
10
Table of Contents
 
Our business and our reliance on intellectual property exposes us to litigation risks.
     If patent infringement claims or actions are asserted against us, we may be required to obtain a license or cross-license, modify our existing technology or design a new noninfringing technology. Such licenses or design modifications can be costly or could increase the cost of our products. In addition, we may decide to settle a claim or action against us, which settlement could be costly. We may also be liable for any past infringement, and we may be required to indemnify our customers against expenses relating to possible infringement. If there is an adverse ruling against us in an infringement lawsuit, an injunction could be issued barring production or sale of any infringing product. It could also result in a damage award equal to a reasonable royalty or lost profits or, if there is a finding of willful infringement, treble damages. Any of these results would increase our costs or harm our operating results.

We may not be able to enforce our intellectual property rights.
     We protect our proprietary technology and intellectual property by seeking patents, trademarks, and copyrights, and by maintaining trade secrets through entering into confidentiality agreements with employees, suppliers, customers, and prospective customers depending on the circumstances. We hold patents or are the licensee of others owning patented technology covering certain aspects of our products and technology. These patent rights may be challenged, rendered unenforceable, invalidated, or circumvented. Currently, two of our patents are subject to inter partes reexamination by the U.S. Patent and Trademark Office initiated by Everspin Technologies, Inc. as a defensive action in connection with our litigation against it. A final adverse decision in these or any future reexamination proceedings could invalidate some or all of the claims of those patents. Additionally, rights granted under the patents or under licensing agreements may not provide a competitive advantage to us. We have filed a patent infringement lawsuit against Everspin and at least several other companies have described designs that we believe may infringe on our patents if such designs were commercialized. Efforts to enforce patent rights can involve substantial expense and may not be successful. Furthermore, others may independently develop similar, superior, or parallel technologies to any technology developed by us, or our technology may prove to infringe on patents or rights owned by others. Thus the patents held by or licensed to us may not afford us any meaningful competitive advantage. Also, our confidentiality agreements may not provide meaningful protection of our proprietary information. Our inability to maintain our proprietary rights could have a material adverse effect on our business, financial condition, and results of operations.

We may not be able to enforce our patents against Motorola, Freescale, or Everspin.
     Our Patent License Option Agreement with Motorola provided for termination on December 31, 2005 or on the date Motorola ceases manufacturing MRAM Products, whichever is later. We believe such a termination is likely to have occurred as a result of Motorola apparently having eliminated its ability to manufacture MRAM Products through its spinoff of Freescale. In 2008 Freescale announced that it had transferred its MRAM technology and intellectual property to an independent company, Everspin Technologies, Inc. We believe we are free to negotiate a new agreement with Freescale or Everspin, or an assignment of the Motorola Patent License Option Agreement, but we have said we would do so only with amendments thereto. We have filed a patent infringement lawsuit against Everspin. There can be no assurance, however, that we can successfully enforce our patents against Motorola, Freescale, or Everspin or that any agreement will be reached with Freescale or Everspin, or that NVE would receive any value under the existing agreement with Motorola or any value under any such further agreement with Freescale or Everspin.

Our business success may be adversely affected if we are unable to attract and retain highly qualified employees.
     We have employment agreements with certain employees, including our Chief Executive Officer and Chief Financial Officer, but those agreements do not prevent employees from leaving the company. Competition for highly qualified management and technical personnel can be intense and we may not be able to attract and retain the personnel necessary for the development and operation of our business. The loss of the services of key personnel could have a material adverse effect on our business, financial condition, and results of operations.

We could incur losses on our marketable securities.
     At March 31, 2013, we held $82,751,286 in short-term and long-term marketable securities, representing approximately 86% of our total assets. A number of the securities we hold have been downgraded by Moody’s or Standard and Poor’s indicating a possible increase in default risk. Conditions and circumstances beyond our control or ability to anticipate can cause downgrades and increases in default risk. Downgrades of any of our marketable securities are possible at any time for reasons beyond our control. Additionally, the assignment of a high credit rating does not preclude the risk of default on any marketable security. We could incur losses on our marketable securities, which could have a material adverse impact on our financial condition, income, or cash flows.
11
Table of Contents
 
The price of our common stock may be adversely affected by significant price fluctuations due to a number of factors, many of which are beyond our control.
     From time to time our stock price has decreased sharply, and could decline in the future. The market price of our common stock may be significantly affected by many factors, some of which are beyond our control, including:
           •  technological innovations by us or our competitors;
• the announcement of new products, product enhancements, contracts, or license agreements by us or our competitors;
• legal proceedings involving us;
• delays in our introduction of new products or technologies or market acceptance of these products or technologies;
• changes in demand for our customers’ products;
• quarterly variations in our operating results, revenue, or revenue growth rates;
• changes in revenue estimates, earnings estimates, or market projections by market analysts;
• speculation in the press or analyst community about our business, potential revenue, or potential earnings; and
• general economic conditions or market conditions specific to industries we or our customers serve or may serve.

ITEM 2. PROPERTIES.
     Our principal executive offices and manufacturing facility are located at 11409 Valley View Road, Eden Prairie, Minnesota, 55344. The space consists of 21,362 square feet of offices, laboratories, and production areas. The space is owned by the Barbara C. Gage Revocable Trust and leased under an agreement expiring December 31, 2020. The facility is currently being utilized below maximum capacity to allow for growth, and we believe the facility is adequate to meet our current requirements. We hold no investments in real estate.

ITEM 3. LEGAL PROCEEDINGS.
     In the ordinary course of business we may become involved in litigation. Other than as set forth below, at this time we are not aware of any material pending or threatened legal proceedings or other proceedings contemplated by governmental authorities that we expect would have a material adverse impact on our future results of operation and financial condition.

     On January 3, 2012 we filed a patent infringement lawsuit against Everspin Technologies, Inc. in the U.S. District Court for the Minnesota District. The lawsuit is based on Everspin’s sale of magnetoresistive random access memory, commonly known as MRAM. The lawsuit seeks an injunction for Everspin to cease using NVE’s patented technology and provide compensation for Everspin’s past infringement. On May 24, 2012 Everspin filed an answer denying our allegations and filed counterclaims. The U.S. Patent and Trademark Office granted requests by Everspin for inter partes reexaminations of U.S. patent 6,349,053 on May 16, 2012, and of U.S. patent 6,538,921 on September 19, 2012. Both patents are assigned to us and are patents in suit. On March 8, 2013 the Court ordered all proceedings in the case stayed until June 28, 2013.

     On February 24, 2012, Everspin filed a patent infringement lawsuit against us in the U.S. District Court for the Minnesota District, alleging certain NVE products infringe on two patents purported to be owned by Everspin. The lawsuit seeks an injunction and compensation.

ITEM 4. MINE SAFETY DISCLOSURES.
     Not applicable.

  
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES.
Market Information
     Our Common Stock trades on the Capital Market tier of the NASDAQ Stock Market under the symbol NVEC. The following table shows the high and low sales prices of our Common Stock as reported on the NASDAQ for each quarter within our two most recent fiscal years:
Quarter Ended
3/31/13 12/31/12 9/30/12 6/30/12 3/31/12 12/31/11 9/30/11 6/30/11
High   $ 56.49 $ 61.47 $ 60.96 $ 57.48 $ 58.46   $ 68.93   $ 69.46   $ 62.55
Low $ 52.52 $ 47.40 $ 48.61 $ 46.35 $ 49.50   $ 53.21 $ 52.54 $ 52.36

Shareholders, Dividends, and Securities Authorized for Issuance Under Equity Compensation Plans
     We had approximately 104 shareholders of record and 6,100 total shareholders as of April 16, 2013. We have not paid or declared any cash dividends on our Common Stock in the two most recent fiscal years. We currently do not anticipate paying dividends in the foreseeable future, as we intend to retain any earnings we may generate if needed to provide for the expansion of our business, the defense of our intellectual property, or for unforeseen circumstances. Information regarding our securities authorized for issuance under equity compensation plans will be included in the section “Equity Compensation Plan Information” of our Proxy Statement for our 2013 Annual Meeting of Shareholders, and is incorporated by reference into Item 12 of this Report.
 
12
Table of Contents
 
Stock Performance Graph
     The graph below compares the performance of our Common Stock to the cumulative five-year performance of the NASDAQ Industrial Index and the SmallTimes Index of Companies Involved in Micro- and Nanotech. NVE is included in both indices. We presented the Cedrus Nanotechnology Index – Pure, which is no longer being publicly reported, in our previous year’s report on Form 10-K. The graph and table assume $100 was invested on March 31, 2008 in each of our Common Stock, the NASDAQ Industrial Index, the Cedrus Nanotechnology Index – Pure, and the SmallTimes Index, with reinvestment of dividends.
 
Stock Price Performance Graph
 
3/31/2008 3/31/2009 3/31/2010 3/31/2011 3/31/2012 3/31/2013
NVE Corporation $ 100.00 $ 116.64   $ 183.40   $ 228.10   $ 214.57   $ 228.42
SmallTimes Index $ 100.00 $ 64.16   $ 91.08   $ 99.05   $ 102.69   $ 108.11
Cedrus Nanotechnology Index – Pure $ 100.00 $ 60.93   $ 113.26   $ 131.03   $ 112.80   $ -
NASDAQ Industrial Index $ 100.00 $ 59.27   $ 98.40   $ 123.60   $ 130.31   $ 151.61
 
Stock Repurchase Program
     On January 21, 2009, we announced that our Board of Directors authorized the repurchase of up to $2,500,000 of our Common Stock. The repurchase program may be modified or discontinued at any time without notice. We did not repurchase any of our Common Stock during the past two fiscal years.

ITEM 6. SELECTED FINANCIAL DATA.
     The following balance sheet and income statement selected financial data should be read in conjunction with our financial statements and notes included in Item 8 of this Report, and with “Management’s Discussion and Analysis of Financial Condition and Results of Operation” included in Item 7 of this Report. The data are derived from our financial statements.
Balance Sheet Data as of March 31
2013 2012 2011 2010 2009
Cash, cash equivalents,
and marketable securities
 $ 85,260,969 $ 73,541,463 $ 62,179,707 $ 49,543,766 $ 34,321,811
Total assets $ 95,765,496 $ 83,126,763 $ 71,836,225 $ 57,462,914 $ 42,566,440
Total shareholders’ equity $ 93,984,608 $ 81,458,858 $ 69,970,549 $ 55,953,294 $ 41,567,571
 
Income Statement Data for Years Ended March 31
2013 2012 2011 2010 2009
Revenue
Product sales
 $ 24,434,823 $ 25,151,822 $ 26,024,823 $ 22,665,860 $ 19,715,311
Contract research and development
 2,598,596 3,427,398 5,172,240 5,481,325 3,656,958
Total revenue $ 27,033,419 $ 28,579,220 $ 31,197,063 $ 28,147,185 $ 23,372,269
 
Gross profit $ 20,008,238 $ 19,253,709 $ 21,413,365 $ 19,834,170 $ 16,648,027
Income from operations $ 15,196,854 $ 14,273,048 $ 17,669,770 $ 16,298,536 $ 13,251,590
Net cash provided by operating activities $ 12,645,302 $ 12,811,910 $ 12,808,807 $ 12,463,616 $ 9,998,114
Net income $ 11,828,838 $ 11,381,095 $ 13,360,945 $ 11,999,344 $ 9,782,895
Net income per share – diluted $ 2.43 $ 2.34 $ 2.76 $ 2.47 $ 2.04


13

Table of Contents
 
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
     You should read this discussion together with our financial statements and notes included elsewhere in this Report. In addition to historical information, the following discussion contains forward-looking information that involves risks and uncertainties. Our actual future results could differ materially from those presently anticipated due to a variety of factors, including those discussed in Item 1A of this Report.

General
     We develop and sell devices that use “spintronics,” a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. We manufacture high-performance spintronic products including sensors and couplers to revolutionize data sensing and transmission. We also receive contracts for research and development and are a licensor of spintronic magnetoresistive random access memory technology, commonly known as MRAM.

Application of Critical Accounting Policies and Estimates
     In accordance with SEC guidance, those material accounting policies that we believe are the most critical to an investor’s understanding of our financial results and condition and require complex management judgment are discussed below.

Investment Valuation
     Our investments consist primarily of corporate and municipal obligations. We have generally invested excess cash in high-quality investment grade long-term marketable securities with less than five years to maturity. We classify all of our marketable securities as available-for-sale, thus securities are recorded at fair value and any associated unrealized gain or losses, net of tax, is in included as a separate component of shareholders’ equity, “Accumulated other comprehensive income (loss).” If we judged a decline in fair value for any security to be other than temporary, the cost basis of the individual security would be written down and a charge recognized to net income. The fair values for our securities are determined based on quoted market prices as of the valuation date and observable prices for similar assets. We consider a number of factors in determining whether other-than-temporary impairment exists, including: credit market conditions; the credit ratings of the securities; historical default rates for securities of comparable credit rating; the presence of insurance of the securities and, if insured, the credit rating and financial condition of the insurer; the effect of market interest rates on the value of the securities; and the duration and extent of any unrealized losses. We also consider the likelihood that we will be required to sell the securities prior to maturity based on our financial condition and anticipated cash flows. If any of these conditions and estimates change in the future, or, if different estimates are used, the fair value of the investments may change significantly and could result in other-than-temporary decline in value, which could have an adverse impact on our results of operations.

Inventory Valuation
     Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first in, first out method. Where there is evidence that inventory could be disposed of at less than carrying value, the inventory is written down to the net realizable value in the current period. Additionally, we periodically examine our inventory in the context of inventory turnover, sales trends, competition and other market factors, and we record provisions to inventory reserve when we determine certain inventory is unlikely to be sold. If reserved inventory is subsequently sold, corresponding reductions in inventory and inventory reserves are made. Our inventory reserve was $285,000 at March 31, 2013 and $300,000 at March 31, 2012.

Deferred Tax Assets Estimation
     In determining the carrying value of our net deferred tax assets, we must assess the likelihood of sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions to realize the benefit of these assets. We evaluate the realizability of the deferred assets quarterly and assess the need for valuation allowances or reduction of existing allowances quarterly.

     As of March 31, 2013 our net deferred tax liabilities were $440,736 compared to $136,872 as of March 31, 2012. Net deferred tax liabilities included $145,592 in deferred tax assets for stock-based compensation deductions as of March 31, 2013 and $145,418 as of March 31, 2012. Utilization of certain of our deferred tax assets is subject to limitations based on Internal Revenue Code Section 382.

14
Table of Contents
 
Results of Operations
     The following table summarizes the percentage of revenue and year-to-year changes for various items for the last three fiscal years:
 
Percentage of Revenue
Year Ended March 31		   Year-to-Year Change
Years Ended March 31
2013 2012 2011 2012 to
2013		 2011 to
2012
Revenue
Product sales
 90.4 % 88.0 % 83.4 % (2.9 )% (3.4 )%
Contract research and development      
 9.6 % 12.0 % 16.6 % (24.2 )% (33.7 )%
Total revenue 100.0 % 100.0 % 100.0 % (5.4 )% (8.4 )%
Cost of sales 26.0 % 32.6 % 31.4 % (24.7 )% (4.7 )%
Gross profit 74.0 % 67.4 % 68.6 % 3.9 % (10.1 )%
Expenses
Selling, general, and administrative
 8.3 % 8.4 % 7.9 % (5.9 )% (3.8 )%
Research and development
 9.5 % 9.1 % 4.1 % (1.1 )% 104.9 %
Total expenses 17.8 % 17.5 % 12.0 % (3.4 )% 33.0 %
Income from operations 56.2 % 49.9 % 56.6 % 6.5 % (19.2 )%
Interest income 8.7 % 8.3 % 6.5 % 0.4 % 16.3 %
Income before taxes 64.9 % 58.2 % 63.1 % 5.6 % (15.6 )%
Income tax provision 21.1 % 18.4 % 20.3 % 9.3 % (17.2 )%
Net income 43.8 % 39.8 % 42.8 % 3.9 % (14.8 )%
 
     Total revenue for fiscal 2013 decreased 5% compared to fiscal 2012, and decreased 8% in fiscal 2012 compared to fiscal 2011. The decrease in fiscal 2013 was due to a 24% decrease in contract research and development revenue and a 3% decrease in product sales. The decrease in total revenue in fiscal 2012 was due to a 34% decrease in contract research and development revenue and a 3% decrease in product sales. The decreases in contract research and development revenue for fiscal 2013 compared to fiscal 2012 and for fiscal 2012 compared to fiscal 2011 were due to completion of certain contracts and contract activities and a challenging environment for government contract funding. Contract research and development activities can fluctuate for a number of reasons, some of which are beyond our control, and revenues may not continue at fiscal 2013 levels. The decreases in product sales for fiscal 2013 and fiscal 2012 was due to decreased purchase volume by existing customers.

     Gross profit margin increased to 74% of revenue for fiscal 2013 from 67% for fiscal 2012 due to a more favorable revenue mix, a more favorable product sales mix, and more efficient product manufacturing. Gross profit margin decreased to 67% of revenue for fiscal 2012 from 69% for fiscal 2011 due to decreased revenue and increased labor cost.

     Total expenses decreased 3% for fiscal 2013 compared to fiscal 2012 and increased 33% for fiscal 2012 compared to fiscal 2011. The decrease in total expenses in fiscal 2013 compared to fiscal 2012 was due to a 1% decrease in research and development expense and a 6% decrease in selling, general, and administrative expense. The decrease in selling, general, and administrative expense was primarily due to a reduction in staffing. The expense decreases in fiscal 2013 may not be representative of future periods. Research and development expense increased 105% for fiscal 2012 compared to fiscal 2011 due to increased product development activities and decreases in contract research and development activities, which caused resources to be reallocated to expensed research and development activities. Research and development expense can fluctuate significantly depending on staffing, project requirements, and contract research and development activities.

     Interest income was approximately the same for fiscal 2013 as fiscal 2012, and increased 16% in fiscal 2012 compared to fiscal 2011. For fiscal 2013, an increase in interest-bearing marketable securities was offset by a decrease in interest rates earned on reinvested funds. For fiscal 2012, the increase in interest-bearing marketable securities was partially offset by a decrease in interest rates earned on reinvested funds.

     The effective income tax rate in fiscal 2013 was 33% of income before taxes, compared to 32% for fiscal 2012 and fiscal 2011. Our effective tax rates can fluctuate due to a number of factors, including Federal and state tax rates and regulations, the mix between taxable and tax-exempt securities in our marketable securities, and other factors, some of which are outside our control.

     Net income increased 4% in fiscal 2013 compared to fiscal 2012 primarily due to increased gross profit margin and decreased expenses, partially offset by decreased revenue and increased taxes. Net income decreased 15% in fiscal 2012 compared to fiscal 2011 primarily due to decreased contract research and development revenue and increased research and development expense.

 
15
Table of Contents

     Comprehensive income increased 8% to $12.3 million in fiscal 2013 compared to fiscal 2012 due to an increase in net income and a net unrealized gain from marketable securities. Comprehensive income decreased 14% in fiscal 2012 compared to fiscal 2011 due primarily to a decrease in net income.

Liquidity and Capital Resources
     Our primary source of working capital for fiscal years 2011 through 2013 was cash provided by operating activities related to product sales and research and development contract revenue. At March 31, 2013 we had $85,260,969 in cash plus short-term and long-term marketable securities compared to $73,541,463 at March 31, 2012. All of our marketable securities were classified as available for sale. The $11,719,506 increase in cash plus marketable securities was primarily due to $12,645,302 in net cash provided by operating activities.

     The $18,594,959 increase in long-term marketable securities in fiscal 2013 was due to investment of cash flow from operations and proceeds from the maturation of short-term marketable securities in long-term securities. The $7,840,600 decrease in short-term marketable securities was due to proceeds from the maturation of short-term marketable securities being reinvested in long-term securities.

     Purchases of fixed assets were $1,824,324 in fiscal 2013 compared to $1,480,237 in fiscal 2012 and $732,800 in fiscal 2011. Purchases were primarily for capital equipment and leasehold improvements to increase our production capacity and were financed with cash provided by operating activities. Our capital expenditures can vary significantly from year to year depending on our needs, equipment purchasing opportunities, and production expansion plans.

     For the past three fiscal years, after purchasing fixed assets we invested excess cash provided by operating activities in long-term marketable securities. As of March 31, 2013 our marketable securities had remaining maturities between one day and 248 weeks (see “Note 4 – Marketable Securities” to the Financial Statements, included elsewhere in this Report for additional information). As our marketable securities mature, we currently plan to either use the proceeds to meet future capital needs or reinvest the proceeds in other marketable securities.

     The following table provides aggregate information about our contractual payment obligations and the periods in which payments are due:
 
Payments Due by Period
Contractual obligations Total <1 Year 1–3 Years 3–5 Years >5 Years
Operating lease obligations $ 2,140,639   $ 266,496   $ 541,208   $ 549,965   $ 782,970
Purchase obligations 145,698   145,698   -   -   -
Total $ 2,286,337   $ 412,194   $ 541,208   $ 549,965   $ 782,970

     Operating lease obligations are primarily for our facility lease. “Note 9 – Commitments and Contingencies” to the Financial Statements, included elsewhere in this report, provides additional information about our lease obligations. Purchase obligations as of March 31, 2013 consisted of raw materials purchase commitments and fixed asset purchase obligations. We expect to meet these contractual payment obligations from cash provided by operating activities or proceeds from maturities of marketable securities. We plan to evaluate raw materials purchases based on a variety of factors including forecasted requirements and anticipated supply leadtimes, and our obligations could vary significantly in the future. We had approximately $108,096 of fixed asset purchase obligations as of March 31, 2013 for production equipment. We plan to evaluate capital expenditures as needs and opportunities arise, and our future capital expenditures and purchase obligations could vary significantly from expenditures in the past.

     We believe our working capital and cash generated from operations will be adequate for our needs at least through fiscal 2014.

Inflation
     Inflation has not had a significant impact on our operations in any of our three most recent fiscal years. Prices for our products and for the materials and labor costs for those products are governed by market conditions. It is possible that inflation in future years could impact both materials and labor used for the production of our products.

Off-Balance-Sheet Arrangements
     Our off-balance sheet arrangements consist of purchase commitments and operating leases for our facility. We believe that our off-balance sheet arrangements do not have a material current or anticipated future effect on our profitability, cash flows, or financial position.

 
16
Table of Contents
 
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
     We are exposed to financial market risks, primarily marketable securities and, to a lesser extent, changes in currency exchange rates.

Marketable Securities
     The primary objective of our investment activities is to preserve principal while at the same time maximizing after-tax yields without significantly increasing risk. To achieve this objective, we maintain our portfolio of cash equivalents and marketable securities in securities including municipal obligations, corporate obligations, and money market funds. Short-term and long-term marketable securities are generally classified as available-for-sale and consequently are recorded on the balance sheet at fair value with unrealized gains or losses reported as a separate component of accumulated other comprehensive income or loss, net of estimated tax. Our marketable securities as of March 31, 2013 had remaining maturities between one day and 248 weeks. Marketable securities had a market value of $82,751,286 at March 31, 2013, representing approximately 86% of our total assets. We have not used derivative financial instruments in our investment portfolio.

Foreign Currency Transactions
     We have some limited revenue risks from fluctuations in values of foreign currency due to product sales abroad. Foreign sales are generally made in U.S. currency, and currency transaction gains or losses in the past three fiscal years were not significant.
 
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.
     Financial statements and accompanying notes are included in this Report beginning on page F-1.

Quarterly Summary Information
     Selected unaudited quarterly financial data for fiscal 2013 and 2012, presented as supplementary financial information, are as follows:
 
Unaudited; Quarter Ended
March 31, 2013 Dec. 31, 2012 Sept. 30, 2012 June 30, 2012
Revenue
Product sales
 $ 6,409,821 $ 5,762,925 $ 5,231,332 $ 7,030,745
Contract research and development
 812,676 762,296 591,464 432,160
Total revenue 7,222,497 6,525,221 5,822,796 7,462,905
Cost of sales 1,877,297 1,738,618 1,606,913 1,802,353
Gross profit 5,345,200 4,786,603 4,215,883 5,660,552
Expenses
Selling, general, and administrative
 526,018 570,741 607,694 536,110
Research and development
 769,212 501,325 612,258 688,026
Total expenses 1,295,230 1,072,066 1,219,952 1,224,136
Income from operations 4,049,970 3,714,537 2,995,931 4,436,416
Income before taxes 4,624,610 4,314,932 3,617,881 4,999,034
Net income $ 3,108,955 $ 2,899,342 $ 2,442,883 $ 3,377,658
Net income per share – diluted $ 0.64 $ 0.60 $ 0.50 $ 0.69
 
Unaudited; Quarter Ended
March 31, 2012 Dec. 31, 2011 Sept. 30, 2011 June 30, 2011
Revenue
Product sales
 $ 7,176,491   $ 5,394,758 $ 5,557,299 $ 7,023,274
Contract research and development
 431,808   763,768 1,041,334 1,190,488
Total revenue 7,608,299   6,158,526 6,598,633   8,213,762
Cost of sales 2,277,115   2,174,878 2,277,926 2,595,592
Gross profit 5,331,184   3,983,648 4,320,707   5,618,170
Expenses
Selling, general, and administrative
 637,882 520,044 606,847   615,830
Research and development
 774,899   718,688 611,595 494,876
Total expenses 1,412,781 1,238,732 1,218,442   1,110,706
Income from operations 3,918,403   2,744,916 3,102,265 4,507,464
Income before taxes 4,514,008   3,336,610 3,699,628 5,072,993
Net income $ 3,097,683   $ 2,289,091 $ 2,555,093 $ 3,439,228
Net income per share – diluted $ 0.63 $ 0.47 $ 0.52 $ 0.70
 
 
17
Table of Contents
 
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.
     None.

ITEM 9A. CONTROLS AND PROCEDURES.
Disclosure Controls and Procedures
     Management, with the participation of the Chief Executive Officer and Chief Financial Officer, has performed an evaluation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act) as of the end of the period covered by this Report. This evaluation included consideration of the controls, processes, and procedures that are designed to ensure that information required to be disclosed by us in the reports we file under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2013, our disclosure controls and procedures were effective.

Management’s Report on Internal Control Over Financial Reporting
     Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) under the Exchange Act. Our management, including our Chief Executive Officer and Chief Financial Officer, assessed the effectiveness of our internal control over financial reporting as of March 31, 2013. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control – Integrated Framework.

     Based on our assessment using the criteria set forth by COSO in Internal Control – Integrated Framework, management concluded that our internal control over financial reporting was effective as of March 31, 2013. Our internal control over financial reporting as of March 31, 2013 has been audited by Ernst & Young LLP, an independent registered public accounting firm, as stated in their report.

     Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within NVE have been detected. Our internal controls over financial reporting, however, are designed to provide reasonable assurance that the objectives of internal control over financial reporting are met.

Changes in Internal Controls
     During the quarter ended March 31, 2013, there was no change in our internal control over financial reporting that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
 
 
18
Table of Contents
 
  
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.
     The sections titled “Proposal 1. Election of Board of Directors” and “Certain Relationships and Related Person Transactions – Section 16(a) Beneficial Ownership Reporting Compliance” to be included in our Proxy Statement for our 2013 Annual Meeting of Shareholders set forth certain information regarding our directors and executive officers required by Item 10, the section titled “Executive Officers of the Company” sets forth information regarding our executive officers required by Item 10, and the section titled “Corporate Governance” sets forth information regarding our corporate governance and code of ethics required by Item 10. The information in these sections to be included in our Proxy Statement for our 2013 Annual Meeting of Shareholders are incorporated by reference into this section.

ITEM 11. EXECUTIVE COMPENSATION.
     The information in the sections “Executive Compensation,” “Compensation Discussion and Analysis,” “Corporate Governance – Board Committees – Compensation Committee Interlocks and Insider Participation,” “Compensation Committee Report,” and “Director Compensation” to be included in our Proxy Statement for our 2013 Annual Meeting of Shareholders is incorporated by reference into this section.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.
     The information in the sections “Equity Compensation Plan Information” and “Security Ownership” to be included in our Proxy Statement for our 2013 Annual Meeting of Shareholders is incorporated by reference into this section. Information regarding the material features of our 2000 Stock Option Plan, as amended, is contained in Note 6 to the Financial Statements included elsewhere in this Report.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.
     The information in the sections “Security Ownership – Transactions With Related Persons, Promoters, and Certain Control Persons” and “Corporate Governance – Board Composition and Independence” to be included in our Proxy Statement for our 2013 Annual Meeting of Shareholders is incorporated by reference into this section.

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.
     The information in the sections “Audit Committee Disclosure – Fees Billed to Us by Ernst & Young During Fiscal 2013 and 2012” and “Audit Committee Disclosure – Audit Committee Pre-Approval Policy” to be included in our Proxy Statement for our 2013 Annual Meeting of Shareholders is incorporated by reference into this section.


 ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES.
(a) Financial Statements and Schedules
     Financial statements are provided pursuant to Item 8 of this Report. Certain financial statement schedules have been omitted because they are not required, not applicable, or the required information is provided in other financial statements or the notes to the financial statements.

(b) Exhibits
     A list of exhibits is on the following page.
19
Table of Contents
 
Exhibit #  Description
  3.1 Amended and Restated Articles of Incorporation of the company as amended by the Board of Directors effective November 21, 2002 (incorporated by reference to the Form 10-QSB for the period ended December 31, 2002).
  3.2 Bylaws of the company as amended by the Board of Directors effective December 18, 2007 (incorporated by reference to the Form 8-K filed December 19, 2007).
  10.1 Lease dated October 1, 1998 between the company and Glenborough Properties, LP (incorporated by reference to the Form 10-QSB for the period ended September 30, 2002).
  10.2 First amendment to lease between the company and Glenborough dated September 18, 2002 (incorporated by reference to the Form 10-QSB for the period ended September 30, 2002).
  10.3 Second amendment to lease between the company and Glenborough dated December 1, 2003 (incorporated by reference to the Form 10-QSB for the period ended December 31, 2003).
  10.4 Notification from Carlson Real Estate Company, Inc. relating to change in building ownership (incorporated by reference to the Form 8-K filed October 11, 2005).
  10.5 Third amendment to lease between the company and Carlson Real Estate (incorporated by reference to the Form 8-K/A filed December 20, 2007).
  10.6 Letter from Carlson Real Estate relating to transfer of building title (incorporated by reference to the Form 8-K/A filed April 15, 2011).
  10.7 Fourth amendment to lease between the company and the Barbara C. Gage Revocable Trust (incorporated by reference to our Current Report on Form 8-K/A filed August 3, 2011).
  10.8* Employment Agreement between the company and Daniel A. Baker dated January 29, 2001 (incorporated by reference to the Form 10-KSB for the year ended March 31, 2001).
  10.9* NVE Corporation 2000 Stock Option Plan as Amended July 19, 2001 by the shareholders (incorporated by reference to our Registration Statement on Form S-8 filed July 20, 2001).
  10.10+ Agreement between the company and Agilent Technologies, Inc. dated September 27, 2001 (incorporated by reference to the Form 10-QSB for the period ended September 30, 2001).
  10.11 Amendment dated October 18, 2002 to Agreement between the company and Agilent (incorporated by reference to the Form 10-QSB for the period ended December 31, 2002).
  10.12 Report of completion of the divestiture of Agilent’s Semiconductor Products business (incorporated by reference to the Form 8-K/A filed December 6, 2005).
  10.13 Amendment No. 2 to OEM Purchase Agreement between Agilent and the company (incorporated by reference to the Form 8-K/A filed September 11, 2007).
  10.14 Amendment No. 3 to Agreement between the company and Agilent (incorporated by reference to the Form 8-K/A filed June 28, 2010).
  10.15 Indemnification Agreement by and between Pacesetter, Inc., a St. Jude Medical Company, d.b.a. St. Jude Medical Cardiac Rhythm Management Division, and the company (incorporated by reference to the Form 8-K filed September 27, 2005).
  10.16+ Supplier Partnering Agreement by and between St. Jude and the company (incorporated by reference to the Form 8-K filed January 4, 2006).
  10.17+ Amendment No. 1 to Supplier Partnering Agreement between St. Jude and the company (incorporated by reference to the Form 8-K/A filed September 10, 2007).
  10.18+ Amendment No. 2 to Supplier Partnering Agreement between St. Jude and the company (incorporated by reference to the Form 8-K/A filed December 18, 2009).
  10.19+ Amendment No. 3 to Supplier Partnering Agreement between St. Jude and the company (incorporated by reference to the Form 8-K/A filed September 16, 2010).
  10.20 Amendment No. 4 to Supplier Partnering Agreement between St. Jude and the company (incorporated by reference to the Form 8-K/A filed February 7, 2011).
  10.21 Supply Agreement by and between the company and Phonak AG (incorporated by reference to the Form 8-K filed May 6, 2009).
  10.22+ Amendment to Supply Agreement by and between the company and Phonak (incorporated by reference to the Form 8-K/A filed January 12, 2011).
  23 Consent of Ernst & Young LLP.
  31.1 Certification by Daniel A. Baker pursuant to Rule 13a-14(a)/15d-14(a).
  31.2 Certification by Curt A. Reynders pursuant to Rule 13a-14(a)/15d-14(a).
  32 Certification by Daniel A. Baker and Curt A. Reynders pursuant to 18 U.S.C. Section 1350.
101.INS XBRL Instance Document
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
101.LAB XBRL Taxonomy Extension Label Linkbase Document
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document
 
 
*Indicates a management contract or compensatory plan or arrangement.
+Confidential portions deleted and filed separately with the SEC.
 
 
20
Table of Contents
 
  
     Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

NVE CORPORATION
          (Registrant)

/s/Daniel A. Baker
by Daniel A. Baker
President and Chief Executive Officer

Date    May 1, 2013



     Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Name  Title Date 
/s/Terrence W. Glarner
Terrence W. Glarner		Director and
Chairman of the Board
 
  		May 1, 2013
/s/Daniel A. Baker
Daniel A. Baker		Director,
President & Chief Executive Officer
(Principal Executive Officer)
  		May 1, 2013
/s/Curt A. Reynders
Curt A. Reynders		 Treasurer and
Chief Financial Officer
(Principal Financial and
Accounting Officer)		 May 1, 2013
/s/James D. Hartman
James D. Hartman
 
  		Director May 1, 2013
/s/Patricia M. Hollister
Patricia M. Hollister
 
 		 Director May 1, 2013
/s/Robert H. Irish
Robert H. Irish		 Director May 1, 2013


21
Table of Contents
 
 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
The Board of Directors and Shareholders
NVE Corporation

We have audited NVE Corporation’s internal control over financial reporting as of March 31, 2013, based on criteria established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the COSO criteria). NVE Corporation’s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on NVE Corporation’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, NVE Corporation maintained, in all material respects, effective internal control over financial reporting as of March 31, 2013, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the balance sheets of NVE Corporation as of March 31, 2013 and 2012, and the related statements of income, comprehensive income, shareholders’ equity, and cash flows for each of the three years in the periods ended March 31, 2013, of NVE Corporation and our report dated May 1, 2013, expressed an unqualified opinion thereon.
 
 
/s/ Ernst & Young LLP
 
 
Minneapolis, Minnesota
May 1, 2013


F-1
Table of Contents
 
 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
The Board of Directors and Shareholders
NVE Corporation

We have audited the accompanying balance sheets of NVE Corporation as of March 31, 2013 and 2012, and the related statement of income, comprehensive income, shareholders’ equity, and cash flows for each of the three years in the period ended March 31, 2013. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of NVE Corporation at March 31, 2013 and 2012, and the results of their operations and their cash flows for each of the three years in the period ended March 31, 2013, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), NVE Corporation’s internal control over financial reporting as of March 31, 2013, based on criteria established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated May 1, 2013 expressed an unqualified opinion thereon.
 
 
/s/ Ernst & Young LLP
 
 
Minneapolis, Minnesota
May 1, 2013
F-2
Table of Contents
 
NVE CORPORATION
BALANCE SHEETS
 
March 31
2013 2012
ASSETS
Current assets
Cash and cash equivalents
 $ 2,509,683 $ 1,544,536
Marketable securities, short term
 9,711,029 17,551,629
Accounts receivable, net of allowance for uncollectible accounts of $15,000
 2,521,395 2,684,840
Inventories
 3,336,592 3,229,376
Prepaid expenses and other assets
 958,147   1,159,852  
Total current assets 19,036,846 26,170,233
Fixed assets
Machinery and equipment 
 8,417,061 7,488,211
Leasehold improvements
 1,499,454   720,882  
  9,916,515 8,209,093
Less accumulated depreciation 
 6,228,122   5,697,861  
Net fixed assets 3,688,393 2,511,232
Marketable securities, long term 73,040,257   54,445,298  
Total assets $ 95,765,496   $ 83,126,763  
 
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Accounts payable
 $ 422,092 $ 663,702
Accrued payroll and other 
 918,060 867,331
Deferred taxes
 440,736   136,872  
Total current liabilities 1,780,888 1,667,905
 
Shareholders’ equity
Common stock, $0.01 par value, 6,000,000 shares authorized; 4,862,436 issued and outstanding as of March 31, 2013 and 4,824,745 and issued and outstanding as of March 31, 2012
 48,624 48,247
Additional paid-in capital
 21,200,742 20,974,477
Accumulated other comprehensive income
1,557,726 1,087,456
Retained earnings
 71,177,516   59,348,678  
Total shareholders’ equity 93,984,608   81,458,858  
Total liabilities and shareholders’ equity $ 95,765,496   $ 83,126,763  
 

See accompanying notes.


F-3
Table of Contents
 
NVE CORPORATION
STATEMENTS OF INCOME
 
Year Ended March 31
2013 2012 2011
Revenue
Product sales
 $ 24,434,823 $ 25,151,822 $ 26,024,823
Contract research and development
 2,598,596   3,427,398   5,172,240  
Total revenue 27,033,419 28,579,220   31,197,063
Cost of sales 7,025,181   9,325,511   9,783,698  
Gross profit 20,008,238 19,253,709 21,413,365
Expenses
Selling, general, and administrative
 2,240,563 2,380,603   2,474,468
Research and development
 2,570,821   2,600,058   1,269,127  
Total expenses 4,811,384   4,980,661   3,743,595  
Income from operations 15,196,854 14,273,048   17,669,770
Interest income 2,359,603   2,350,191     2,021,426  
Income before taxes 17,556,457 16,623,239   19,691,196
Provision for income taxes 5,727,619   5,242,144   6,330,251  
Net income $ 11,828,838   $ 11,381,095   $ 13,360,945  
Net income per share – basic $ 2.44   $ 2.37   $ 2.83  
Net income per share – diluted $ 2.43   $ 2.34   $ 2.76  
Weighted average shares outstanding
Basic
 4,839,810 4,796,227 4,729,035
Diluted
 4,863,546 4,863,471 4,844,266
 
  
STATEMENTS OF COMPREHENSIVE INCOME
Year Ended March 31
2013
2012
2011
Net income $ 11,828,838 $ 11,381,095   $ 13,360,945
Unrealized gain (loss) from marketable securities, net of tax   470,270   27,018   (69,288 )
Comprehensive income $ 12,299,108   $ 11,408,113   $ 13,291,657  
 
 
See accompanying notes.
F-4
Table of Contents
 
NVE CORPORATION
STATEMENTS OF SHAREHOLDERS’ EQUITY
 
 
 
 		   Additional
Paid-In
Capital		     Accumulated
Other
Comprehen-
sive Income
(Loss)		   Retained
Earnings
  
Common Stock
Shares   Amount Total
Balance at March 31, 2010 4,700,583 $ 47,006 $ 20,169,924 $ 1,129,726 $ 34,606,638 $ 55,953,294
Exercise of stock
options and warrants
 75,615 756 417,949 - - 418,705
Comprehensive income:
Unrealized (loss) on
marketable securities,
net of tax
 -     -     -       (69,288 ) (69,288 )
Net income
 -     -     -       -       13,360,945     13,360,945
Total comprehensive income
 13,291,657
Stock-based compensation
 76,720     76,720
Tax benefit of stock-
based compensation
       230,173       230,173  
Balance at March 31, 2011 4,776,198     47,762     20,894,766       1,060,438     47,967,583     69,970,549  
Exercise of stock
options and warrants
 48,547 485 (449 )   - - 36
Comprehensive income:
Unrealized gain on
marketable securities,
net of tax
 - - - 27,018 27,018
Net income
 - - - - 11,381,095 11,381,095
Total comprehensive income
 11,408,113
Stock-based compensation
         80,160         80,160  
Balance at March 31, 2012 4,824,745 48,247 20,974,477 1,087,456 59,348,678 81,458,858
Exercise of stock
options and warrants
 37,691 377 143,811     - - 144,188
Comprehensive income:
Unrealized gain on
marketable securities,
net of tax
 - - -   470,270 470,270
Net income
 - - -   - 11,828,838 11,828,838
Total comprehensive income
 12,299,108
Stock-based compensation
 66,720 66,720
Tax benefit of stock-
based compensation
       15,734       15,734  
Balance at March 31, 2013 4,862,436 $ 48,624 $ 21,200,742   $ 1,557,726   $ 71,177,516 $ 93,984,608  
 

See accompanying notes.
F-5
Table of Contents
 
NVE CORPORATION
STATEMENTS OF CASH FLOWS
 
Year Ended March 31
2013 2012 2011
OPERATING ACTIVITIES
Net income $ 11,828,838 $ 11,381,095 $ 13,360,945
Adjustments to reconcile net income to net cash
provided by operating activities:
Depreciation
 647,163 500,121 411,547
Stock-based compensation
 66,720 80,160 76,720
Excess tax benefits
 (15,734 ) -   (230,173 )
Deferred income taxes
 51,262 (12,850 ) 294,384
Changes in operating assets and liabilities
Accounts receivable
 163,445 911,399   625,325  
Inventories
 (107,216 ) 114,481   (1,637,430 )
Prepaid expenses and other assets
 201,705 25,454   (404,012 )
Accounts payable and accrued expenses
 (190,881 ) (187,950 ) 332,334
Deferred revenue
 -   -   (20,833 )
Net cash provided by operating activities 12,645,302 12,811,910 12,808,807
 
INVESTING ACTIVITIES
Purchases of fixed assets (1,824,324 ) (1,480,237 ) (732,800 )
Purchases of marketable securities (27,209,753 ) (18,501,362 ) (14,742,032 )
Proceeds from maturities and sales of marketable securities 17,194,000   7,761,980   1,580,068  
Net cash used in investing activities (11,840,077 ) (12,219,619 ) (13,894,764 )
 
FINANCING ACTIVITIES
Net proceeds from sale of common stock 144,188 36 418,705
Excess tax benefits 15,734   -   230,173  
Net cash provided by financing activities 159,922   36   648,878  
 
Increase (decrease) in cash and cash equivalents 965,147 592,327   (437,079 )
Cash and cash equivalents at beginning of year 1,544,536   952,209   1,389,288  
 
Cash and cash equivalents at end of year $ 2,509,683   $ 1,544,536   $ 952,209  
 
Supplemental disclosures of cash flow information:
Cash paid during the year for income taxes
 $ 5,202,616 $ 5,207,565 $ 6,303,598
 

See accompanying notes.


F-6
Table of Contents
 
NVE CORPORATION
NOTES TO FINANCIAL STATEMENTS
  
NOTE 1. DESCRIPTION OF BUSINESS
     We develop and sell devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information.

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Cash and Cash Equivalents
     We consider all highly liquid investments with maturities of three months or less when purchased to be cash equivalents.

Fair Value of Financial Instruments
     The carrying amount of cash and cash equivalents, accounts receivable, and accounts payable approximates fair value because of the short maturity of these instruments. Fair values of marketable securities are based on quoted market prices.

Marketable Securities
     We classify securities with original maturities greater than three months and remaining maturities one year or less as short-term marketable securities and securities with remaining maturities greater than one year as long-term marketable securities. Securities not due at a single maturity date are classified by their average life. We classify all of our marketable securities as available-for-sale, thus securities are recorded at fair value and any associated unrealized gain or loss, net of tax, is included as a separate component of shareholders’ equity, “Accumulated other comprehensive income (loss).” We use a specific-identification cost basis to determine gains and losses. The amortized cost of marketable securities is adjusted for amortization of premiums and accretion of discounts to maturity, both of which are included in interest income.

     We consider an other-than-temporary impairment of our marketable securities to exist if we determine it is probable that we will be unable to collect all amounts due according to the contractual terms of a debt security. If we judged a decline in fair value for any security to be other than temporary, the cost basis of the individual security would be written down and a charge recognized in net income. We consider a number of factors in determining whether other-than-temporary impairment exists, including: credit market conditions; the credit ratings of the securities; historical default rates for securities of comparable credit rating; the presence of insurance of the securities and, if insured, the credit rating and financial condition of the insurer; the effect of market interest rates on the value of the securities; and the duration and extent of any unrealized losses. We also consider the likelihood that we will be required to sell the securities prior to maturity based on our financial condition and anticipated cash flows. We determined that no write-downs for other-than-temporary impairment were required on available-for-sale securities during fiscal 2013, 2012, or 2011.

Concentration of Risk and Financial Instruments
     Financial instruments potentially subject to significant concentrations of credit risk consist principally of cash equivalents, marketable securities, and accounts receivable.

     We have invested our excess cash in corporate-backed and municipal-backed bonds and other money market instruments. Our investment policy prescribes purchases of only high-grade securities, and limits the amount of credit exposure to any one issuer.

     Our customers are throughout the world. We generally do not require collateral from our customers, but we perform ongoing credit evaluations of their financial condition. More information on accounts receivable is contained in the paragraph titled “Accounts Receivable and Allowance for Doubtful Accounts” of this note.

     Additionally, we are dependent on critical suppliers including our packaging vendors and suppliers of certain raw silicon and semiconductor wafers that are incorporated in our products.

Accounts Receivable and Allowance for Doubtful Accounts
     Accounts receivable are recorded net of an allowance for doubtful accounts. We make estimates of the uncollectibility of accounts receivable. We specifically analyze accounts receivable, historical bad debts, and customer creditworthiness when evaluating the adequacy of the allowance. We had no charges or provisions to our allowance for doubtful accounts in fiscal 2013, 2012, or 2011.

Inventories
     Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first in, first out method. We record inventory reserves when we determine certain inventory is unlikely to be sold based on sales trends, turnover, competition, and other market factors.
F-7
Table of Contents
 
Product Warranty
     In general we warrant our products to be free from defects in material and workmanship for one year.

Fixed Assets
     Fixed assets are stated at cost. Depreciation of machinery and equipment, and furniture and fixtures is recorded over the estimated useful lives of the assets, generally five years, using the straight-line method. Amortization of leasehold improvements is recorded using the straight-line method over the lesser of the lease term or five-year useful life. We record losses on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets’ carrying amount. We have not identified any indicators of impairment during fiscal 2013, 2012, or 2011.

Revenue Recognition
Product Revenue Recognition
     We recognize product revenue on shipment because the terms of our sales are FOB shipping point, meaning that our customers (end users and distributors) take title and assume the risks and rewards of ownership on shipment. Our customers may return defective products for refund or replacement under warranty, and have other very limited rights of return.

     Shipping charges billed to customers are included in product sales and the related shipping costs are included in selling, general, and administrative expense. Such shipping costs were $27,386 for fiscal 2013, $40,185 for fiscal 2012, and $39,427 for fiscal 2011.

     Payments from our distributors are not contingent on resale or any other matter other than the passage of time, and delivery of products is not dependent on the number of units resold to the ultimate customer. There are no other significant acceptance criteria, pricing or payment terms that would affect revenue recognition.

Accounting for Commissions and Discounts
     We sometimes utilize independent sales representatives that provide services relating to promoting our products and facilitating product sales but do not purchase our products. We pay commissions to sales representatives based on the amount of revenue facilitated, and such commissions are recorded as selling, general, and administrative expenses.

     Our stocking distributors take title and assume the risks and rewards of product ownership. We presume consideration given to a customer is a reduction in revenue unless both of the following conditions are met: (i) we receive an identifiable benefit in exchange for the consideration and the identifiable benefit is sufficiently separable from the customer’s purchase of our products such that we could have purchased the products or services from a third party; and (ii) we can reasonably estimate the fair value of the benefit received. We recognize discounts provided to our distributors as reductions in revenue. Under certain limited circumstances, our distributors may earn commissions for activities unrelated to their purchases of our products, such as for facilitating the sale of custom products or research and development contracts with third parties. We recognize any such commissions as selling, general, and administrative expenses.

Research and Development Contract Revenue Recognition
     We recognize contract revenues pro-rata as work progresses. Our research and development contracts do not contain post-shipment obligations. Contracts may be either firm-fixed-price or cost-plus-fixed-fee. Firm-fixed-price contracts provide for a price that is not subject to any adjustment based on our cost in performing the contract.

     Cost-plus-fixed-fee contracts are cost-reimbursement contracts that also provide for payment to us of a negotiated fee that is fixed at the inception of the contract. The costs for which we earn reimbursement are the actual costs incurred and are recorded in the period in which they are incurred. We recognize the contract fees pro-rata as work progresses.

Income Taxes
     We account for income taxes using the liability method. Deferred income taxes are provided for temporary differences between the financial reporting and tax bases of assets and liabilities. We provide valuation allowances against deferred tax assets if we determine that it is less likely than not that we will be able to utilize the deferred tax assets.

Research and Development Expense Recognition
     Research and development costs are expensed as they are incurred.

Stock-Based Compensation
     We measure stock-based compensation cost at the grant date based on the fair value of the award and recognize the compensation expense over the requisite service period, which is generally the vesting period. We estimate pre-vesting option forfeitures at the time of grant by analyzing historical data and revise those estimates in subsequent periods if actual forfeitures differ from those estimates. Ultimately, the total expense recognized over the vesting period will only be for those awards that vest.
F-8
Table of Contents
 
Net Income Per Share
     Net income per basic share is computed based on the weighted-average number of common shares issued and outstanding during each year. Net income per diluted share amounts assume conversion, exercise or issuance of all potential common stock instruments (stock options and warrants). Stock options and warrants totaling 5,000 for fiscal 2013; 5,000 for fiscal 2012; and 1,000 for fiscal 2011 were not included in the computation of diluted earnings per share because the exercise prices were greater than the market price of the common stock. The following table reflects the components of common shares outstanding:

Year Ended March 31
2013 2012 2011
Weighted average common shares outstanding – basic 4,839,810 4,796,227 4,729,035
Effect of dilutive securities:
Stock options
 21,934 60,075 108,121
Warrants
 1,802 7,169 7,110
Shares used in computing net income per share – diluted 4,863,546 4,863,471 4,844,266
 
Use of Estimates
     The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Recently Issued Accounting Standards
     We have adopted all applicable recently issued accounting pronouncements.

     In January 2013, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2013-02, Reporting of Amounts Reclassified out of Accumulated Other Comprehensive Income (ASU No. 2013-02), which requires an entity to report the effect of significant reclassifications out of accumulated other comprehensive income. ASU No. 2013-02 is effective for reporting periods beginning after December 15, 2012, which will be our first quarter of fiscal 2014. The adoption of ASU No. 2013-02 will affect the presentation of comprehensive income but will not impact our financial condition or results of operations.

NOTE 3. FAIR VALUE MEASUREMENTS
     Generally accepted accounting principles establish a framework for measuring fair value, provide a definition of fair value and prescribe required disclosures about fair-value measurements. Generally accepted accounting principles define fair value as the price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement that should be determined using assumptions that market participants would use in pricing an asset or liability. Generally accepted accounting principles utilize a valuation hierarchy for disclosure of fair value measurements. The categorization within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The categories within the valuation hierarchy are described as follows:

     Level 1 – Financial instruments with quoted prices in active markets for identical assets or liabilities. Our Level 1 financial instruments consist of publicly-traded marketable corporate debt securities, which are classified as available-for-sale. On the balance sheets, these securities are included in “Marketable securities, short term” and “Marketable securities, long term.” The fair value of our Level 1 marketable securities was $75,298,160 at March 31, 2013 and $51,918,559 at March 31, 2012.

     Level 2 – Financial instruments with quoted prices in active markets for similar assets or liabilities. Level 2 fair value measurements are determined using either prices for similar instruments or inputs that are either directly or indirectly observable, such as interest rates. Our Level 2 financial instruments consist of municipal debt securities, which are classified as available-for-sale. On the balance sheets, these securities are included in “Marketable securities, short term” and “Marketable securities, long term.” The fair value of our Level 2 marketable securities was $7,453,126 at March 31, 2013 and $20,078,368 at March 31, 2012. The classification of municipal debt securities as Level 2 at March 31, 2012 has been revised to conform with the current-year classification, consistent with the Level 2 measurement principles applied to securities in all periods presented.

     Level 3 – Inputs to the fair value measurement are unobservable inputs or valuation techniques. We do not have any financial assets or liabilities being measured at fair value that are classified as Level 3 financial instruments.

 
F-9
Table of Contents
 
NOTE 4. MARKETABLE SECURITIES
     Marketable securities with remaining maturities less than one year are classified as short-term, and those with remaining maturities greater than one year are classified as long-term. The fair value of our marketable securities as of March 31, 2013, by maturity, were as follows:
Total <1 Year 1–3 Years 3–5 Years
$ 82,751,286 $ 9,711,029 $ 34,310,566 $ 38,729,691
 
     As of March 31, 2013 and 2012 our marketable securities were as follows:
As of March 31, 2013 As of March 31, 2012

Adjusted
Cost		 Gross
Unrealized
Gains		 Gross
Unrealized
Losses		 Fair
Market
Value
Adjusted
Cost		 Gross
Unrealized
Gains		 Gross
Unrealized
Losses		 Fair
Market
Value
Corporate bonds $ 72,923,502    $ 2,378,845    $ (4,187 )    $ 75,298,160    $ 50,513,389    $ 1,481,604    $ (76,434 )    $ 51,918,559
Municipal bonds   7,381,223   81,058
   (9,155 )   7,453,126 19,775,582   334,793
   (32,007 ) 20,078,368
Total $ 80,304,725   $ 2,459,903   $ (13,342 )   $ 82,751,286 $ 70,288,971   $ 1,816,397   $ (108,441 )   $ 71,996,927

     The following table shows the gross unrealized losses and fair value of our investments with unrealized losses, aggregated by investment category and length of time that individual securities had been in a continuous unrealized loss position as of March 31, 2013 and 2012:
Less Than 12 Months 12 Months or Greater Total
Fair
Market
Value		 Gross
Unrealized
Losses		 Fair
Market
Value		 Gross
Unrealized
Losses		 Fair
Market
Value		 Gross
Unrealized
Losses
As of March 31, 2013
  Corporate bonds $ 1,171,976   $ (4,187 )   $ -   $ -     $ 1,171,976   $ (4,187 )
  Municipal bonds   508,607 (9,155 ) - -   508,607 (9,155 )
  Total $ 1,680,583 $ (13,342 ) $ - $ -   $ 1,680,583 $ (13,342 )
As of March 31, 2012
Corporate bonds $ 10,387,955 $ (76,434 )     -     -     $ 10,387,955   $ (76,434 )
Municipal bonds - -   908,550 (32,007 ) 908,550 (32,007 )
Total $ 10,387,955 $ (76,434 ) $ 908,550 $ (32,007 ) $ 11,296,505 $ (108,441 )
 
     Gross unrealized losses totaled $13,342 as of March 31, 2013, and were attributed to one corporate bond and two municipal bonds out of a portfolio of 43 bonds. The gross unrealized losses were due to market-price decreases and rating downgrades after the bonds were purchased, and none had been in a continuous unrealized loss position for 12 months or greater. A substantial majority of the bonds we held were rated by Moody’s or Standard and Poor’s and had investment-grade credit ratings. For each bond with an unrealized loss, we expect to recover the entire cost basis of each security based on our consideration of factors including their credit ratings, the underlying ratings of insured bonds, and historical default rates for securities of comparable credit rating. Because we expect to recover the entire cost basis of the securities, and because we do not intend to sell the securities and it is not more likely than not that we will be required to sell the securities before recovery of the cost basis, which may be maturity, we did not consider any of our marketable securities to be other-than-temporarily impaired at March 31, 2013.
F-10
Table of Contents
 
NOTE 5. INVENTORIES
     Inventories consisted of the following:
 
March 31
2013 2012
Raw materials $ 1,312,011 $ 1,285,106
Work in process 1,533,951 1,658,467
Finished goods 775,630   585,803  
3,621,592 3,529,376
Less inventory reserve (285,000 ) (300,000 )
Total inventories $ 3,336,592   $ 3,229,376  
 
NOTE 6. STOCK-BASED COMPENSATION
Stock Option Plan
     Our 2000 Stock Option Plan, as amended, provides for issuance to employees, directors, and certain service providers of incentive stock options and nonstatutory stock options. Generally, the options may be exercised at any time prior to expiration, subject to vesting based on terms of employment. The period ranges from immediate vesting to vesting over a five-year period. The options have exercisable lives ranging from one year to ten years from the date of grant, and are generally not eligible to vest early in the event of retirement, death, disability, or change in control. Exercise prices are not less than fair market value of the underlying Common Stock at the date the options are granted. Stock-based compensation expense was $66,720 in fiscal 2013, $80,160 in fiscal 2012, and $76,720 in fiscal 2011.

Valuation assumptions
     We use the Black-Scholes standard option-pricing model to determine the fair value of stock options. The following assumptions were used to estimate the fair value of options granted:
Year Ended March 31
2013 2012 2011
Risk-free interest rate 0.7 % 1.0 % 1.6 %
Expected volatility 38 % 42 % 56 %
Expected life (years) 4.1   4.1   4.2  
Dividend yield 0 % 0 % 0 %
 
     The determination of the fair value of the awards on the date of grant using the Black-Scholes model is affected by our stock price as well as assumptions of other variables, including projected stock option exercise behaviors, risk-free interest rate, and expected volatility of our stock price in future periods. Our estimates and assumptions affect the amounts reported in the financial statements and accompanying notes.

Expected life
     We analyze historical exercise and termination data to estimate the expected life assumption. We believe historical data currently represents the best estimate of the expected life of a new option. We examined the historical pattern of option exercises to determine if there was a discernible pattern as to how different classes of optionees exercised their options. Our analysis showed that officers and directors held their stock options for a longer period of time before exercising compared to the rest of our employee population. Therefore we use different expected lives for officers and directors than we use for our general employee population for determining the fair value of options.

Risk-free interest rate
     The risk-free rate is based on the yield of U.S. Treasury securities on the grant date for maturities similar to the expected lives of the options.

Volatility
     We use historical volatility to estimate the expected volatility of our common stock.

Dividend yield
     We assume a dividend yield of zero because we do not anticipate paying dividends in the foreseeable future.

Tax effects of stock-based compensation
     Stock-based compensation increased deferred tax assets by $24,239 for fiscal 2013 and $29,122 for fiscal 2012.
F-11
Table of Contents
  
General stock option information
     We had no nonvested shares as of March 31, 2013 or 2012.
 
     The following table summarizes information about options outstanding at March 31, 2013, all of which were exercisable:
Ranges of
Exercise Prices		      Number
Outstanding		      Weighted Average
Exercise Price		      Weighted Remaining
Contractual Life (years)
$  15.08 - 16.33 27,000 $ 16.24 2.8
31.27 - 42.45 9,000 37.00 6.0
51.04 - 58.27 13,000 54.76 7.5
49,000 $ 30.27 4.6
 
     Our 2000 Stock Option Plan, as amended, provides for issuance to employees, directors, and certain service providers of incentive stock options and nonstatutory stock options. Generally, the options may be exercised at any time prior to expiration, subject to vesting based on terms of employment. The period ranges from immediate vesting to vesting over a five-year period. The options have exercisable lives ranging from one year to ten years from the date of grant. Exercise prices are not less than fair market value as determined by our Board at the date the options are granted.

     A summary of our stock options and warrants are shown in the following table:
 
Option Shares
Reserved		       Options
Outstanding		       Weighted Average
Option Exercise Price		       Warrants
Outstanding		       Weighted Average
Warrant Exercise Price
At March 31, 2010     170,230     254,500     $ 17.28   10,000     $ 16.28
Granted
 (4,000 ) 4,000 $ 42.45 - -
Exercised
 -   (83,500 ) $ 9.56 -   -
At March 31, 2011     166,230   175,000   $ 21.54 10,000   $ 16.28
Granted
 (4,000 ) 4,000 $ 58.25 -       -
Exercised
 -   (70,000 ) $ 16.93 -     -
At March 31, 2012    162,230   109,000   $ 25.85 10,000   $ 16.28
Granted
 (4,000 ) 4,000 $ 54.11 - -
Exercised
 -   (64,000 ) $ 24.23 - -
Terminated
 -   -   $ - (6,000 )     7.35
At March 31, 2013    158,230   49,000   $ 30.27 4,000   $ 29.69
 
     The remaining weighted-average exercisable life was 4.6 years at March 31, 2013; 3.7 years at March 31, 2012; and 4.3 years at March 31, 2011. All outstanding options were exercisable as of March 31, 2013, 2012, and 2011. The total intrinsic value of options exercised during fiscal 2013 was $1,881,138 based on the difference between the exercise price and stock price at the time of exercise for in-the-money options. The total intrinsic value of options outstanding March 31, 2013, based on our closing stock price for that day, was $1,290,440 all of which were exercisable. The total fair value of option grants was $66,720 in fiscal 2013. There was no unrecognized stock-based compensation at March 31, 2013.

     No warrants were issued in the past three fiscal years. Remaining weighted-average exercisable warrant life was 0.9 years at March 31, 2013; 0.9 years at March 31, 2012; and 1.9 years at March 31, 2011.
 

F-12
Table of Contents
 
NOTE 7. INCOME TAXES
     Income tax provisions for fiscal 2011 through 2013 consisted of the following:
Year Ended March 31
2013 2012 2011
Current taxes
Federal
 $ 5,314,876 $ 4,847,082 $ 5,761,632
State
 377,215 407,913 504,408
Deferred taxes
Federal
 34,718   (17,233 ) 56,996  
State
 810   4,382   7,215  
Income tax provision $ 5,727,619   $ 5,242,144   $ 6,330,251  
 
     A reconciliation of income tax provisions at the U.S. statutory rate for fiscal 2011 through 2013 is as follows:
 
Year Ended March 31
2013 2012 2011
Tax expense at U.S. statutory rate $ 6,046,264   $ 5,700,630   $ 6,809,003
State income taxes, net of Federal benefit 244,691   252,881   345,213
Domestic manufacturing deduction (460,723 ) (467,053 ) (549,123 )
Municipal interest (118,282 ) (235,470 ) (239,636 )
Other   15,669     (8,844 )   (35,206 )
Income tax provision $ 5,727,619   $ 5,242,144   $ 6,330,251  

     Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets and liabilities as of March 31, 2013 and 2012 were as follows:
 
March 31
2013 2012
Vacation accrual $ 134,214   $ 126,453  
Inventory reserve 103,540   108,990  
Depreciation (4,756 )   9,245  
Stock-based compensation deductions 145,592   145,418  
Unrealized gain on marketable securities (888,836 )   (620,500 )
Other 69,510   93,522  
Net deferred tax liabilities $ (440,736 ) $ (136,872 )

     Realizations of stock-based compensation deductions are credited to “Additional paid-in capital” and included in “Tax benefit of stock-based compensation” on our statements of shareholders’ equity. Credits of $15,734 in fiscal 2013 and $230,173 in fiscal 2011 were attributed to stock-based compensation deductions. The “Additional paid-in capital” credits also included the tax benefit of stock-based compensation deductions in those years.

     The amounts credited to “Additional paid-in capital” were the tax benefits of the deductions to the extent they exceeded the corresponding compensation expense recognized for financial reporting purposes. “Tax benefit of stock-based compensation” represented the tax benefits of deductions for stock-based compensation to the extent they exceeded the corresponding compensation expense recognized for financial reporting purposes. Cash we received from the exercise of stock options related to excess tax benefits is included in “Net proceeds from sale of common stock” in the statement of cash flows for the year in which the option was exercised and cash received.

     We had $95,184 of Federal net operating losses and $142,775 of state net operating losses at March 31, 2013, compared to $149,284 of Federal net operating losses and $155,681 of state net operating losses at March 31, 2012. These net operating losses expire in fiscal 2020 and are subject to limitation including limitation under the Internal Revenue Code.

     We had no unrecognized tax benefits as of March 31, 2013, and we do not expect any significant unrecognized tax benefits within 12 months of the reporting date. We recognize interest and penalties related to income tax matters in income tax expense. As of March 31, 2013 we had no accrued interest related to uncertain tax positions. The tax years 1999 through 2012 remain open to examination by the major taxing jurisdictions to which we are subject.

 
F-13
Table of Contents
 
NOTE 8. SEGMENT INFORMATION
     We operate in one reportable segment. We manufacture and sell spintronic products, and conduct contract research and development activities.

     The following table summarizes customers comprising 10% or more of revenue for fiscal 2013, 2012, and 2011:
 
% of Revenue for Year Ended March 31
2013 2012 2011
Customer A 16% 16% 14%
Customer B 15% 14% 11%
Customer C 14% * 11%
   
 
*Less than 10%
 
     Revenue by geographic region was as follows:
 
Year Ended March 31
2013 2012 2011
United States $ 12,006,493 $ 13,334,563 $ 14,169,952
Europe 10,666,338 10,798,146 12,009,294
Asia 3,979,862 4,130,930 4,576,270
Other 380,726 315,581 441,547
Total Revenue $ 27,033,419 $ 28,579,220 $ 31,197,063

NOTE 9. COMMITMENTS AND CONTINGENCIES
     Lease payments were $259,823 for fiscal 2013, $253,740 for fiscal 2012, and $245,220 for fiscal 2011. The operating lease for our facility expires December 31, 2020. We pay operating expenses including maintenance, utilities, real estate taxes, and insurance in addition to rental payments. We also lease a piece of office equipment under an operating lease expiring July 2014 with payments due quarterly. Our future minimum lease payments are shown in the following table:
 
Year Ending March 31
2014 2015 2016 2017 2018 2019 2020 2021 Total
$ 266,496 $ 269,269 $ 271,938 $ 272,953 $ 277,012 281,124 $ 285,396 $ 216,451 $ 2,140,639

    On February 24, 2012, Everspin filed a patent infringement lawsuit against us in the U.S. District Court for the Minnesota District alleging certain NVE products infringe on two patents purported to be owned by Everspin. The lawsuit seeks an injunction and compensation. While the ultimate results of this matter cannot be predicted with certainty, we do not expect it to have a material adverse effect on our financial statements.
 
NOTE 10. STOCK REPURCHASE PLAN
     Our authorized stock is stated as six million shares of common stock, $0.01 par value, and ten million shares of all types. Our Board may designate any series and fix any relative rights and preferences to authorized but undesignated stock. We have an outstanding authorization from our Board to purchase up to $2,500,000 of our common stock, all of which remained available as of March 31, 2013.

 NOTE 11. INFORMATION AS TO EMPLOYEE STOCK PURCHASE, SAVINGS, AND SIMILAR PLANS
     All of our employees are eligible to participate in our 401(k) savings plan the first quarter after reaching age 21. Employees may contribute up to the Internal Revenue Code maximum. We make matching contributions of 100% of the first 3% of participants’ salary deferral contributions. Our matching contributions were $105,370 for fiscal 2013, $109,126 for fiscal 2012, and $110,268 for fiscal 2011.
 
F-14
Table of Contents
 
EXHIBIT INDEX


Exhibit #  Description
 
  23 Consent of Ernst & Young LLP.
 
  31.1 Certification by Daniel A. Baker pursuant to Rule 13a-14(a)/15d-14(a).
 
  31.2 Certification by Curt A. Reynders pursuant to Rule 13a-14(a)/15d-14(a).
 
  32 Certification by Daniel A. Baker and Curt A. Reynders pursuant to 18 U.S.C. Section 1350.
 
101.INS  XBRL Instance Document
 
101.SCH XBRL Taxonomy Extension Schema Document
 
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
 
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
 
101.LAB XBRL Taxonomy Extension Label Linkbase Document
 
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document



 
EX-23 2 ex23.htm CONSENT OF ERNST & YOUNG LLP

Exhibit 23

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the NVE Corporation 2000 Stock Option Plan (as amended by the shareholders on July 19, 2001) and the NVE Corporation 2001 Employee Stock Purchase Plan of our reports dated May 1, 2013, with respect to the financial statements of NVE Corporation and the effectiveness of internal control over financial reporting of NVE Corporation, included in the Annual Report (Form 10-K) of NVE Corporation for the year ended March 31, 2013.

 

 /s/ ERNST & YOUNG LLP
 

Minneapolis, Minnesota

May 1, 2013
EX-31 3 ex31-dab.htm CERTIFICATION BY DANIEL A. BAKER PURSUANT TO RULE 13A-14(A)/15D-14(A)

Exhibit 31.1

CERTIFICATION

I, Daniel A. Baker, certify that:

1.                                        I have reviewed this Annual Report on Form 10-K of NVE Corporation;

 

2.                                        Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.                                        Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.                                        The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)                                  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)                                  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

(c)                                  Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)                                  Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.                                        The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)                                  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)                                 Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 1, 2013

 
/s/ DANIEL A. BAKER
Daniel A. Baker
President and Chief Executive Officer

EX-31 4 ex31-car.htm CERTIFICATION BY CURT A. REYNDERS PURSUANT TO RULE 13A-14(A)/15D-14(A)

Exhibit 31.2

CERTIFICATION

I, Curt A. Reynders, certify that:

1.                                        I have reviewed this Annual Report on Form 10-K of NVE Corporation;

 

2.                                        Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.                                        Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.                                        The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)                                  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)                                  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

(c)                                  Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)                                  Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.                                        The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)                                  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)                                 Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 1, 2013

 

 

/s/ CURT A. REYNDERS
Curt A. Reynders
Chief Financial Officer

EX-32 5 ex32.htm CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 32

CERTIFICATION PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)

 

The undersigned certify pursuant to 18 U.S.C. Section 1350, that to the undersigned’s knowledge:

 

1.                                       The accompanying Annual Report of NVE Corporation (the “Company”) on Form 10-K for the year ended March 31, 2013, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.                                       The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date: May 1, 2013

 

 

/s/ DANIEL A. BAKER

 

Daniel A. Baker

President and Chief Executive Officer

 

 

/s/ CURT A. REYNDERS

 

Curt A. Reynders

Chief Financial Officer

 

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 EX-101.INS 6 nvec-20130331.xml INSTANCE DOCUMENT 0000724910 us-gaap:RetainedEarningsMember 2013-03-31 0000724910 us-gaap:AdditionalPaidInCapitalMember 2013-03-31 0000724910 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-03-31 0000724910 us-gaap:RetainedEarningsMember 2012-03-31 0000724910 us-gaap:AdditionalPaidInCapitalMember 2012-03-31 0000724910 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-03-31 0000724910 us-gaap:RetainedEarningsMember 2011-03-31 0000724910 us-gaap:AdditionalPaidInCapitalMember 2011-03-31 0000724910 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-03-31 0000724910 us-gaap:RetainedEarningsMember 2010-03-31 0000724910 us-gaap:AdditionalPaidInCapitalMember 2010-03-31 0000724910 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-03-31 0000724910 us-gaap:CommonStockMember 2013-03-31 0000724910 us-gaap:CommonStockMember 2012-03-31 0000724910 us-gaap:CommonStockMember 2011-03-31 0000724910 us-gaap:CommonStockMember 2010-03-31 0000724910 nvec:RangeTwoMember 2013-03-31 0000724910 nvec:RangeThreeMember 2013-03-31 0000724910 nvec:RangeOneMember 2013-03-31 0000724910 nvec:RangeTwoMember 2012-04-01 2013-03-31 0000724910 nvec:RangeThreeMember 2012-04-01 2013-03-31 0000724910 nvec:RangeOneMember 2012-04-01 2013-03-31 0000724910 us-gaap:WarrantMember 2013-03-31 0000724910 us-gaap:StockOptionsMember 2013-03-31 0000724910 nvec:OptionSharesReservedMember 2013-03-31 0000724910 us-gaap:WarrantMember 2012-03-31 0000724910 us-gaap:StockOptionsMember 2012-03-31 0000724910 nvec:OptionSharesReservedMember 2012-03-31 0000724910 us-gaap:WarrantMember 2011-03-31 0000724910 us-gaap:StockOptionsMember 2011-03-31 0000724910 nvec:OptionSharesReservedMember 2011-03-31 0000724910 us-gaap:WarrantMember 2010-03-31 0000724910 us-gaap:StockOptionsMember 2010-03-31 0000724910 nvec:OptionSharesReservedMember 2010-03-31 0000724910 nvec:OptionSharesReservedMember 2012-04-01 2013-03-31 0000724910 nvec:OptionSharesReservedMember 2011-04-01 2012-03-31 0000724910 nvec:OptionSharesReservedMember 2010-04-01 2011-03-31 0000724910 us-gaap:OtherCreditDerivativesMember 2012-04-01 2013-03-31 0000724910 nvec:EuropeMember 2012-04-01 2013-03-31 0000724910 nvec:AsiaMember 2012-04-01 2013-03-31 0000724910 country:US 2012-04-01 2013-03-31 0000724910 us-gaap:OtherCreditDerivativesMember 2011-04-01 2012-03-31 0000724910 nvec:EuropeMember 2011-04-01 2012-03-31 0000724910 nvec:AsiaMember 2011-04-01 2012-03-31 0000724910 country:US 2011-04-01 2012-03-31 0000724910 us-gaap:OtherCreditDerivativesMember 2010-04-01 2011-03-31 0000724910 nvec:EuropeMember 2010-04-01 2011-03-31 0000724910 nvec:AsiaMember 2010-04-01 2011-03-31 0000724910 country:US 2010-04-01 2011-03-31 0000724910 us-gaap:MachineryAndEquipmentMember 2012-04-01 2013-03-31 0000724910 us-gaap:LeaseholdImprovementsMember 2012-04-01 2013-03-31 0000724910 us-gaap:FurnitureAndFixturesMember 2012-04-01 2013-03-31 0000724910 nvec:CustomerMember 2012-04-01 2013-03-31 0000724910 nvec:CustomerCMember 2012-04-01 2013-03-31 0000724910 nvec:CustomerBMember 2012-04-01 2013-03-31 0000724910 nvec:CustomerMember 2011-04-01 2012-03-31 0000724910 nvec:CustomerCMember 2011-04-01 2012-03-31 0000724910 nvec:CustomerBMember 2011-04-01 2012-03-31 0000724910 nvec:CustomerMember 2010-04-01 2011-03-31 0000724910 nvec:CustomerCMember 2010-04-01 2011-03-31 0000724910 nvec:CustomerBMember 2010-04-01 2011-03-31 0000724910 2011-03-31 0000724910 2010-03-31 0000724910 us-gaap:FairValueInputsLevel2Member 2013-03-31 0000724910 us-gaap:FairValueInputsLevel1Member 2013-03-31 0000724910 us-gaap:FairValueInputsLevel2Member 2012-03-31 0000724910 us-gaap:FairValueInputsLevel1Member 2012-03-31 0000724910 us-gaap:MunicipalBondsMember 2013-03-31 0000724910 us-gaap:CorporateBondSecuritiesMember 2013-03-31 0000724910 us-gaap:MunicipalBondsMember 2012-03-31 0000724910 us-gaap:CorporateBondSecuritiesMember 2012-03-31 0000724910 us-gaap:RetainedEarningsMember 2012-04-01 2013-03-31 0000724910 us-gaap:AdditionalPaidInCapitalMember 2012-04-01 2013-03-31 0000724910 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-04-01 2013-03-31 0000724910 us-gaap:RetainedEarningsMember 2011-04-01 2012-03-31 0000724910 us-gaap:AdditionalPaidInCapitalMember 2011-04-01 2012-03-31 0000724910 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-04-01 2012-03-31 0000724910 us-gaap:RetainedEarningsMember 2010-04-01 2011-03-31 0000724910 us-gaap:AdditionalPaidInCapitalMember 2010-04-01 2011-03-31 0000724910 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-04-01 2011-03-31 0000724910 us-gaap:CommonStockMember 2012-04-01 2013-03-31 0000724910 us-gaap:CommonStockMember 2011-04-01 2012-03-31 0000724910 us-gaap:CommonStockMember 2010-04-01 2011-03-31 0000724910 us-gaap:WarrantMember 2012-04-01 2013-03-31 0000724910 us-gaap:StockOptionsMember 2012-04-01 2013-03-31 0000724910 us-gaap:WarrantMember 2011-04-01 2012-03-31 0000724910 us-gaap:StockOptionsMember 2011-04-01 2012-03-31 0000724910 us-gaap:WarrantMember 2010-04-01 2011-03-31 0000724910 us-gaap:StockOptionsMember 2010-04-01 2011-03-31 0000724910 us-gaap:MinimumMember 2012-04-01 2013-03-31 0000724910 us-gaap:MaximumMember 2012-04-01 2013-03-31 0000724910 2011-04-01 2012-03-31 0000724910 2010-04-01 2011-03-31 0000724910 2012-03-31 0000724910 2013-03-31 0000724910 2012-09-28 0000724910 2013-04-26 0000724910 2012-04-01 2013-03-31 xbrli:pure iso4217:USD xbrli:shares iso4217:USD xbrli:shares false --03-31 FY 2013 2013-03-31 10-K 0000724910 4862436 Yes Accelerated Filer 176000000 NVE CORP /NEW/ No No 34310566 38729691 <div> <b>Concentration of Risk and Financial Instruments</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial instruments potentially subject to significant concentrations of credit risk consist principally of cash equivalents, marketable securities, and accounts receivable.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have invested our excess cash in corporate-backed and municipal-backed bonds and other money market instruments. Our investment policy prescribes purchases of only high-grade securities, and limits the amount of credit exposure to any one issuer.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our customers are throughout the world. We generally do not require collateral from our customers, but we perform ongoing credit evaluations of their financial condition. More information on accounts receivable is contained in the paragraph titled "Accounts Receivable and Allowance for Doubtful Accounts" of this note.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally, we are dependent on critical suppliers including our packaging vendors and suppliers of certain raw silicon and semiconductor wafers that are incorporated in our products. </div> 9245 -4756 145418 145592 126453 134214 <div> <table style="font-family: Times New Roman; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0" width="50%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Total</b></td> <td width="4%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>&lt;1 Year</b></td> <td width="4%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>1&#8211;3 Years</b></td> <td width="4%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>3&#8211;5 Years</b></td></tr> <tr><td width="1%">$</td> <td width="12%" align="right">82,751,286</td> <td> </td> <td width="1%">$</td> <td width="12%" align="right">9,711,029</td> <td> </td> <td width="1%">$</td> <td width="12%" align="right">34,310,566</td> <td width="2%"> </td> <td width="1%">$</td> <td width="12%" align="right">38,729,691</td></tr></table> </div> <div> <b>Fixed Assets</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fixed assets are stated at cost. Depreciation of machinery and equipment, and furniture and fixtures is recorded over the estimated useful lives of the assets, generally&nbsp;<font class="_mt">five</font> years, using the straight-line method. Amortization of leasehold improvements is recorded using the straight-line method over the lesser of the lease term or <font class="_mt">five</font>-year useful life. We record losses on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets' carrying amount. We have not identified any indicators of impairment during fiscal 2013, 2012, or 2011.<br /> </div> 549123 467053 460723 239636 235470 118282 108121 60075 21934 7110 7169 1802 149284 95184 155681 142775 216451 285396 281124 P1Y <div> <b><i>Research and Development Contract Revenue Recognition</i></b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We recognize contract revenues pro-rata as work progresses. Our research and development contracts do not contain post-shipment obligations. Contracts may be either firm-fixed-price or cost-plus-fixed-fee. Firm-fixed-price contracts provide for a price that is not subject to any adjustment based on our cost in performing the contract.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost-plus-fixed-fee contracts are cost-reimbursement contracts that also provide for payment to us of a negotiated fee that is fixed at the inception of the contract. The costs for which we earn reimbursement are the actual costs incurred and are recorded in the period in which they are incurred. We recognize the contract fees pro-rata as work progresses.<br /> </div> P10Y P1Y 66720 P4Y3M18D P1Y10M24D P3Y8M12D P10M24D P4Y7M6D P10M24D 10000000 75615 48547 37691 418705 0 417949 756 0 36 0 -449 485 0 144188 0 143811 377 0 <div> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="100%"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Option&nbsp;Shares<br />Reserved</b></td> <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Options<br />Outstanding</b></td> <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Weighted Average<br />Option&nbsp;Exercise&nbsp;Price</b></td> <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Warrants<br />Outstanding</b></td> <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Weighted Average<br />Warrant&nbsp;Exercise&nbsp;Price</b></td></tr> <tr><td valign="top">At&nbsp;March&nbsp;31,&nbsp;2010&nbsp;&nbsp;&nbsp;&nbsp;</td> <td valign="top" width="14%" align="right">170,230</td> <td width="1%">&nbsp;</td> <td>&nbsp;</td> <td valign="top" align="right">254,500</td> <td valign="top" width="1%">&nbsp;</td> <td>&nbsp;</td> <td valign="top" width="1%">$</td> <td valign="top" width="18%" align="right">17.28</td> <td>&nbsp;</td> <td valign="top" width="12%" align="right">10,000</td> <td width="1%">&nbsp;</td> <td>&nbsp;</td> <td valign="top" width="1%">$</td> <td valign="top" width="18%" align="right">16.28</td></tr> <tr><td bgcolor="#ccdaef"> <div style="margin-left: 9pt;">Granted</div></td> <td bgcolor="#ccdaef" align="right">(4,000</td> <td bgcolor="#ccdaef">)</td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef" align="right">4,000</td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef">$</td> <td bgcolor="#ccdaef" align="right">42.45</td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef" align="right">-</td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef" align="right">-</td></tr> <tr><td> <div style="margin-left: 9pt;">Exercised</div></td> <td style="border-bottom: black 1px solid;" align="right">-</td> <td style="border-bottom: black 1px solid;">&nbsp;</td> <td> </td> <td style="border-bottom: black 1px solid;" align="right">(83,500</td> <td style="border-bottom: black 1px solid;">)</td> <td> </td> <td style="border-bottom: black 1px solid;">$</td> <td style="border-bottom: black 1px solid;" align="right">9.56</td> <td> </td> <td style="border-bottom: black 1px solid;" align="right">-</td> <td style="border-bottom: black 1px solid;">&nbsp;</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">-</td></tr> <tr><td bgcolor="#ccdaef" valign="top">At&nbsp;March&nbsp;31,&nbsp;2011&nbsp;&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">166,230</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">175,000</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">21.54</td> <td bgcolor="#ccdaef"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">10,000</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">16.28</td></tr> <tr><td> <div style="margin-left: 9pt;">Granted</div></td> <td align="right">(4,000</td> <td>)</td> <td> </td> <td align="right">4,000</td> <td> </td> <td> </td> <td>$</td> <td align="right">58.25</td> <td> </td> <td align="right">-</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">-</td></tr> <tr><td bgcolor="#ccdaef"> <div style="margin-left: 9pt;">Exercised</div></td> <td style="border-bottom: black 1px solid;" bgcolor="#ccdaef" align="right">-</td> <td style="border-bottom: black 1px solid;" bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef"> </td> <td style="border-bottom: black 1px solid;" bgcolor="#ccdaef" align="right">(70,000</td> <td style="border-bottom: black 1px solid;" bgcolor="#ccdaef">)</td> <td bgcolor="#ccdaef"> </td> <td style="border-bottom: black 1px solid;" bgcolor="#ccdaef">$</td> <td style="border-bottom: black 1px solid;" bgcolor="#ccdaef" align="right">16.93</td> <td bgcolor="#ccdaef"> </td> <td style="border-bottom: black 1px solid;" bgcolor="#ccdaef" align="right">-</td> <td style="border-bottom: black 1px solid;" bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef">&nbsp;</td> <td style="border-bottom: black 1px solid;" bgcolor="#ccdaef" colspan="2" align="right">-</td></tr> <tr><td valign="top">At&nbsp;March&nbsp;31,&nbsp;2012&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 3px double;" valign="top" align="right">162,230</td> <td style="border-bottom: black 3px double;">&nbsp;</td> <td> </td> <td style="border-bottom: black 3px double;" valign="top" align="right">109,000</td> <td style="border-bottom: black 3px double;">&nbsp;</td> <td> </td> <td style="border-bottom: black 3px double;" valign="top">$</td> <td style="border-bottom: black 3px double;" valign="top" align="right">25.85</td> <td> </td> <td style="border-bottom: black 3px double;" valign="top" align="right">10,000</td> <td style="border-bottom: black 3px double;">&nbsp;</td> <td> </td> <td style="border-bottom: black 3px double;" valign="top">$</td> <td style="border-bottom: black 3px double;" valign="top" align="right">16.28</td></tr> <tr bgcolor="#ccdaef"><td> <div style="margin-left: 9pt;">Granted</div></td> <td align="right">(4,000</td> <td>)</td> <td> </td> <td align="right">4,000</td> <td> </td> <td> </td> <td>$</td> <td align="right">54.11</td> <td> </td> <td align="right">-</td> <td> </td> <td> </td> <td> </td> <td align="right">-</td></tr> <tr><td> <div style="margin-left: 9pt;">Exercised</div></td> <td align="right">-</td> <td>&nbsp;</td> <td> </td> <td align="right">(64,000</td> <td>)</td> <td> </td> <td>$</td> <td align="right">24.23</td> <td> </td> <td align="right">-</td> <td> </td> <td> </td> <td colspan="2" align="right">-</td></tr> <tr bgcolor="#ccdaef"><td valign="top"> <div style="margin-left: 9pt;">Terminated</div></td> <td style="border-bottom: black 1px solid;" valign="top" align="right">-</td> <td style="border-bottom: black 1px solid;" valign="top">&nbsp;</td> <td> </td> <td style="border-bottom: black 1px solid;" valign="top" align="right">-</td> <td style="border-bottom: black 1px solid;" valign="top">&nbsp;</td> <td> </td> <td style="border-bottom: black 1px solid;" valign="top">$</td> <td style="border-bottom: black 1px solid;" valign="top" align="right">-</td> <td> </td> <td style="border-bottom: black 1px solid;" valign="top" align="right">(6,000</td> <td style="border-bottom: black 1px solid;">)</td> <td>&nbsp;</td> <td style="border-bottom: black 1px solid;" valign="top">&nbsp;</td> <td style="border-bottom: black 1px solid;" valign="top" align="right">7.35</td></tr> <tr><td valign="top">At&nbsp;March&nbsp;31,&nbsp;2013&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 3px double;" valign="top" align="right">158,230</td> <td style="border-bottom: black 3px double;" valign="top">&nbsp;</td> <td> </td> <td style="border-bottom: black 3px double;" valign="top" align="right">49,000</td> <td style="border-bottom: black 3px double;">&nbsp;</td> <td> </td> <td style="border-bottom: black 3px double;" valign="top">$</td> <td style="border-bottom: black 3px double;" valign="top" align="right">30.27</td> <td> </td> <td style="border-bottom: black 3px double;" valign="top" align="right">4,000</td> <td style="border-bottom: black 3px double;">&nbsp;</td> <td> </td> <td style="border-bottom: black 3px double;" valign="top">$</td> <td style="border-bottom: black 3px double;" valign="top" align="right">29.69</td></tr></table> </div> 663702 422092 2684840 2521395 5697861 6228122 1087456 1557726 20974477 21200742 76720 0 76720 0 0 80160 80160 66720 66720 230173 230173 15734 15734 15000 15000 1000 5000 5000 83126763 95765496 26170233 19036846 70288971 50513389 19775582 80304725 72923502 7381223 32007 32007 108441 76434 32007 13342 4187 9155 11296505 10387955 908550 1680583 1171976 508607 76434 76434 13342 4187 9155 10387955 10387955 1680583 1171976 508607 908550 908550 9711029 71996927 51918559 51918559 20078368 20078368 82751286 75298160 75298160 7453126 7453126 1816397 1481604 334793 2459903 2378845 81058 108441 76434 32007 13342 4187 9155 <div> <p><font size="2" class="_mt"><strong>NOTE 1. DESCRIPTION OF BUSINESS</strong> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We develop and sell devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. </font><br /><br /></p> </div> 1389288 952209 1544536 2509683 -437079 592327 965147 <div> <b>Cash and Cash Equivalents</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We consider all highly liquid investments with maturities of three months or less when purchased to be cash equivalents. </div> <div> <font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><b>NOTE 9. COMMITMENTS AND CONTINGENCIES</b><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lease payments were $<font class="_mt">259,823</font> for fiscal 2013, $<font class="_mt">253,740</font> for fiscal 2012, and $<font class="_mt">245,220</font> for fiscal 2011. The operating lease for our facility expires December&nbsp;31, 2020. We pay operating expenses including maintenance, utilities, real estate taxes, and insurance in addition to rental payments. We also lease a piece of office equipment under an operating lease expiring July&nbsp;2014 with payments due quarterly. Our future minimum lease payments are shown in the following table:<br />&nbsp;<br /></font> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="100%"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="23" align="center"><b>Year Ending March 31</b></td> <td colspan="3"> </td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2014</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2015</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2016</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2017</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2018</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2019</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2020</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2021</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Total</b></td></tr> <tr bgcolor="#ccdaef"><td width="1%">$</td> <td width="6%" align="right">266,496</td> <td> </td> <td width="1%">$</td> <td width="6%" align="right">269,269</td> <td> </td> <td width="1%">$</td> <td width="6%" align="right">271,938</td> <td> </td> <td width="1%">$</td> <td width="6%" align="right">272,953</td> <td> </td> <td width="1%">$</td> <td width="6%" align="right">277,012</td> <td> </td> <td width="1%"> </td> <td width="6%" align="right">281,124</td> <td> </td> <td width="1%">$</td> <td width="6%" align="right">285,396</td> <td> </td> <td width="1%">$</td> <td width="6%" align="right">216,451</td> <td> </td> <td width="1%">$</td> <td width="6%" align="right">2,140,639</td></tr></table><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><br />&nbsp;&nbsp;&nbsp;&nbsp;On February 24, 2012, Everspin filed a patent infringement lawsuit against us in the U.S. District Court for the Minnesota District alleging certain NVE products infringe on two patents purported to be owned by Everspin. The lawsuit seeks an injunction and compensation. While the ultimate results of this matter cannot be predicted with certainty, we do not expect it to have a material adverse effect on our financial statements. <br /></font> </div> 0.01 0.01 6000000 6000000 4824745 4862436 4824745 4862436 48247 48624 13291657 11408113 12299108 5172240 3427398 2598596 9783698 9325511 7025181 5761632 4847082 5314876 504408 407913 377215 56996 -17233 34718 294384 -12850 51262 7215 4382 810 108990 103540 -136872 -440736 93522 69510 29122 24239 136872 440736 620500 888836 110268 109126 105370 1.00 0.03 411547 500121 647163 <div> <font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><b>NOTE 6. STOCK-BASED COMPENSATION<br />Stock Option Plan</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our 2000 Stock Option Plan, as amended, provides for issuance to employees, directors, and certain service providers of incentive stock options and nonstatutory stock options. Generally, the options may be exercised at any time prior to expiration, subject to vesting based on terms of employment. The period ranges from immediate vesting to vesting over a <font class="_mt">five</font>-year period. The options have exercisable lives ranging from&nbsp;<font class="_mt">one</font> year to&nbsp;<font class="_mt">ten</font> years from the date of grant, and are generally not eligible to vest early in the event of retirement, death, disability, or change in control. Exercise prices are not less than fair market value of the underlying Common Stock at the date the options are granted. Stock-based compensation expense was $<font class="_mt">66,720</font> in fiscal 2013; $<font class="_mt">80,160</font> in fiscal 2012; and $<font class="_mt">76,720</font> in fiscal 2011.<br /><br /><b>Valuation assumptions</b><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We use the Black-Scholes standard option-pricing model to determine the fair value of stock options. The following assumptions were used to estimate the fair value of options granted:<br /><br /></font> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="50%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="8" align="center"><b>Year Ended March 31</b></td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2013</b></td> <td width="4%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2012</b></td> <td width="4%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2011</b></td></tr> <tr bgcolor="#ccdaef"><td>Risk-free interest rate</td> <td width="11%" align="right">0.7</td> <td width="2%">%</td> <td> </td> <td width="11%" align="right">1.0</td> <td width="2%">%</td> <td> </td> <td width="11%" align="right">1.6</td> <td width="2%">%</td></tr> <tr><td>Expected volatility</td> <td align="right">38</td> <td>%</td> <td> </td> <td align="right">42</td> <td>%</td> <td> </td> <td align="right">56</td> <td>%</td></tr> <tr bgcolor="#ccdaef"><td>Expected life (years)</td> <td align="right">4.1</td> <td>&nbsp;</td> <td> </td> <td align="right">4.1</td> <td>&nbsp;</td> <td> </td> <td align="right">4.2</td> <td>&nbsp;</td></tr> <tr><td>Dividend yield</td> <td align="right">0</td> <td>%</td> <td> </td> <td align="right">0</td> <td>%</td> <td> </td> <td align="right">0</td> <td>%</td></tr></table><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt">&nbsp;<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The determination of the fair value of the awards on the date of grant using the Black-Scholes model is affected by our stock price as well as assumptions of other variables, including projected stock option exercise behaviors, risk-free interest rate, and expected volatility of our stock price in future periods. Our estimates and assumptions affect the amounts reported in the financial statements and accompanying notes.<br /><br /><b><i>Expected life</i></b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We analyze historical exercise and termination data to estimate the expected life assumption. We believe historical data currently represents the best estimate of the expected life of a new option. We examined the historical pattern of option exercises to determine if there was a discernible pattern as to how different classes of optionees exercised their options. Our analysis showed that officers and directors held their stock options for a longer period of time before exercising compared to the rest of our employee population. Therefore we use different expected lives for officers and directors than we use for our general employee population for determining the fair value of options. <br /><br /><b><i>Risk-free interest rate</i></b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The risk-free rate is based on the yield of U.S. Treasury securities on the grant date for maturities similar to the expected lives of the options. <br /><br /><b><i>Volatility</i></b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We use historical volatility to estimate the expected volatility of our common stock.<br /><br /><b><i>Dividend yield</i></b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We assume a dividend yield of&nbsp;<font class="_mt">zero</font> because we do not anticipate paying dividends in the foreseeable future.<br /><br /><b>Tax effects of stock-based compensation</b><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation increased deferred tax assets by $<font class="_mt">24,239</font> for fiscal 2013 and $<font class="_mt">29,122</font> for fiscal 2012.<br /></font><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt">&nbsp;<br /></font><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><b>General stock option information</b><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We had no nonvested shares as of March&nbsp;31, 2013 or 2012.<br />&nbsp; <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes information about options outstanding at March&nbsp;31, 2013, all of which were exercisable:<br /><br /></font> <table style="font-family: Times New Roman; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0" width="67%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td style="border-bottom: black 1px solid;" valign="bottom" align="center"><b>Ranges of<br />Exercise&nbsp;Prices</b></td> <td width="4%">&nbsp;&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 1px solid;" valign="bottom" align="center"><b>Number<br />Outstanding</b></td> <td width="4%">&nbsp;&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 1px solid;" valign="bottom" colspan="2" align="center"><b>Weighted&nbsp;Average<br />Exercise&nbsp;Price</b></td> <td width="4%">&nbsp;&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 1px solid;" valign="bottom" align="center"><b>Weighted&nbsp;Remaining<br />Contractual&nbsp;Life&nbsp;(years)</b></td></tr> <tr bgcolor="#ccdaef"><td width="10%" align="right">$&nbsp;&nbsp;<font class="_mt">15.08</font>&nbsp;-&nbsp;<font class="_mt">16.33</font></td> <td> </td> <td width="10%" align="right">27,000</td> <td> </td> <td width="1%">$</td> <td width="9%" align="right">16.24</td> <td> </td> <td width="10%" align="right">2.8</td></tr> <tr><td align="right"><font class="_mt">31.27</font>&nbsp;-&nbsp;<font class="_mt">42.45</font></td> <td> </td> <td align="right">9,000</td> <td> </td> <td> </td> <td align="right">37.00</td> <td> </td> <td align="right">6.0</td></tr> <tr bgcolor="#ccdaef"><td align="right"><font class="_mt">51.04</font>&nbsp;-&nbsp;<font class="_mt">58.27</font></td> <td> </td> <td style="border-bottom: black 1px solid;" align="right">13,000</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">54.76</td> <td> </td> <td style="border-bottom: black 1px solid;" align="right">7.5</td></tr> <tr><td> </td> <td> </td> <td style="border-bottom: black 3px double;" valign="top" align="right">49,000</td> <td> </td> <td valign="top">$</td> <td valign="top" align="right">30.27</td> <td> </td> <td style="border-bottom: rgb(255,255,255) 3px solid;" valign="top" align="right">4.6</td></tr></table><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt">&nbsp;<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our 2000 Stock Option Plan, as amended, provides for issuance to employees, directors, and certain service providers of incentive stock options and nonstatutory stock options. Generally, the options may be exercised at any time prior to expiration, subject to vesting based on terms of employment. The period ranges from immediate vesting to vesting over a five-year period. The options have exercisable lives ranging from one year to ten years from the date of grant. Exercise prices are not less than fair market value as determined by our Board at the date the options are granted.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A summary of our stock options and warrants are shown in the following table:<br />&nbsp;<br /></font> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="100%"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Option&nbsp;Shares<br />Reserved</b></td> <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Options<br />Outstanding</b></td> <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Weighted Average<br />Option&nbsp;Exercise&nbsp;Price</b></td> <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Warrants<br />Outstanding</b></td> <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Weighted Average<br />Warrant&nbsp;Exercise&nbsp;Price</b></td></tr> <tr><td valign="top">At&nbsp;March&nbsp;31,&nbsp;2010&nbsp;&nbsp;&nbsp;&nbsp;</td> <td valign="top" width="14%" align="right">170,230</td> <td width="1%">&nbsp;</td> <td>&nbsp;</td> <td valign="top" align="right">254,500</td> <td valign="top" width="1%">&nbsp;</td> <td>&nbsp;</td> <td valign="top" width="1%">$</td> <td valign="top" width="18%" align="right">17.28</td> <td>&nbsp;</td> <td valign="top" width="12%" align="right">10,000</td> <td width="1%">&nbsp;</td> <td>&nbsp;</td> <td valign="top" width="1%">$</td> <td valign="top" width="18%" align="right">16.28</td></tr> <tr><td bgcolor="#ccdaef"> <div style="margin-left: 9pt;">Granted</div></td> <td bgcolor="#ccdaef" align="right">(4,000</td> <td bgcolor="#ccdaef">)</td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef" align="right">4,000</td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef">$</td> <td bgcolor="#ccdaef" align="right">42.45</td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef" align="right">-</td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef" align="right">-</td></tr> <tr><td> <div style="margin-left: 9pt;">Exercised</div></td> <td style="border-bottom: black 1px solid;" align="right">-</td> <td style="border-bottom: black 1px solid;">&nbsp;</td> <td> </td> <td style="border-bottom: black 1px solid;" align="right">(83,500</td> <td style="border-bottom: black 1px solid;">)</td> <td> </td> <td style="border-bottom: black 1px solid;">$</td> <td style="border-bottom: black 1px solid;" align="right">9.56</td> <td> </td> <td style="border-bottom: black 1px solid;" align="right">-</td> <td style="border-bottom: black 1px solid;">&nbsp;</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">-</td></tr> <tr><td bgcolor="#ccdaef" valign="top">At&nbsp;March&nbsp;31,&nbsp;2011&nbsp;&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">166,230</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">175,000</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">21.54</td> <td bgcolor="#ccdaef"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">10,000</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">16.28</td></tr> <tr><td> <div style="margin-left: 9pt;">Granted</div></td> <td align="right">(4,000</td> <td>)</td> <td> </td> <td align="right">4,000</td> <td> </td> <td> </td> <td>$</td> <td align="right">58.25</td> <td> </td> <td align="right">-</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td align="right">-</td></tr> <tr><td bgcolor="#ccdaef"> <div style="margin-left: 9pt;">Exercised</div></td> <td style="border-bottom: black 1px solid;" bgcolor="#ccdaef" align="right">-</td> <td style="border-bottom: black 1px solid;" bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef"> </td> <td style="border-bottom: black 1px solid;" bgcolor="#ccdaef" align="right">(70,000</td> <td style="border-bottom: black 1px solid;" bgcolor="#ccdaef">)</td> <td bgcolor="#ccdaef"> </td> <td style="border-bottom: black 1px solid;" bgcolor="#ccdaef">$</td> <td style="border-bottom: black 1px solid;" bgcolor="#ccdaef" align="right">16.93</td> <td bgcolor="#ccdaef"> </td> <td style="border-bottom: black 1px solid;" bgcolor="#ccdaef" align="right">-</td> <td style="border-bottom: black 1px solid;" bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef">&nbsp;</td> <td style="border-bottom: black 1px solid;" bgcolor="#ccdaef" colspan="2" align="right">-</td></tr> <tr><td valign="top">At&nbsp;March&nbsp;31,&nbsp;2012&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 3px double;" valign="top" align="right">162,230</td> <td style="border-bottom: black 3px double;">&nbsp;</td> <td> </td> <td style="border-bottom: black 3px double;" valign="top" align="right">109,000</td> <td style="border-bottom: black 3px double;">&nbsp;</td> <td> </td> <td style="border-bottom: black 3px double;" valign="top">$</td> <td style="border-bottom: black 3px double;" valign="top" align="right">25.85</td> <td> </td> <td style="border-bottom: black 3px double;" valign="top" align="right">10,000</td> <td style="border-bottom: black 3px double;">&nbsp;</td> <td> </td> <td style="border-bottom: black 3px double;" valign="top">$</td> <td style="border-bottom: black 3px double;" valign="top" align="right">16.28</td></tr> <tr bgcolor="#ccdaef"><td> <div style="margin-left: 9pt;">Granted</div></td> <td align="right">(4,000</td> <td>)</td> <td> </td> <td align="right">4,000</td> <td> </td> <td> </td> <td>$</td> <td align="right">54.11</td> <td> </td> <td align="right">-</td> <td> </td> <td> </td> <td> </td> <td align="right">-</td></tr> <tr><td> <div style="margin-left: 9pt;">Exercised</div></td> <td align="right">-</td> <td>&nbsp;</td> <td> </td> <td align="right">(64,000</td> <td>)</td> <td> </td> <td>$</td> <td align="right">24.23</td> <td> </td> <td align="right">-</td> <td> </td> <td> </td> <td colspan="2" align="right">-</td></tr> <tr bgcolor="#ccdaef"><td valign="top"> <div style="margin-left: 9pt;">Terminated</div></td> <td style="border-bottom: black 1px solid;" valign="top" align="right">-</td> <td style="border-bottom: black 1px solid;" valign="top">&nbsp;</td> <td> </td> <td style="border-bottom: black 1px solid;" valign="top" align="right">-</td> <td style="border-bottom: black 1px solid;" valign="top">&nbsp;</td> <td> </td> <td style="border-bottom: black 1px solid;" valign="top">$</td> <td style="border-bottom: black 1px solid;" valign="top" align="right">-</td> <td> </td> <td style="border-bottom: black 1px solid;" valign="top" align="right">(6,000</td> <td style="border-bottom: black 1px solid;">)</td> <td>&nbsp;</td> <td style="border-bottom: black 1px solid;" valign="top">&nbsp;</td> <td style="border-bottom: black 1px solid;" valign="top" align="right">7.35</td></tr> <tr><td valign="top">At&nbsp;March&nbsp;31,&nbsp;2013&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 3px double;" valign="top" align="right">158,230</td> <td style="border-bottom: black 3px double;" valign="top">&nbsp;</td> <td> </td> <td style="border-bottom: black 3px double;" valign="top" align="right">49,000</td> <td style="border-bottom: black 3px double;">&nbsp;</td> <td> </td> <td style="border-bottom: black 3px double;" valign="top">$</td> <td style="border-bottom: black 3px double;" valign="top" align="right">30.27</td> <td> </td> <td style="border-bottom: black 3px double;" valign="top" align="right">4,000</td> <td style="border-bottom: black 3px double;">&nbsp;</td> <td> </td> <td style="border-bottom: black 3px double;" valign="top">$</td> <td style="border-bottom: black 3px double;" valign="top" align="right">29.69</td></tr></table><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt">&nbsp; <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The remaining weighted-average exercisable life was&nbsp;<font class="_mt">4.6</font>&nbsp;years at March&nbsp;31, 2013;&nbsp;<font class="_mt">3.7</font>&nbsp;years at March&nbsp;31, 2012; and&nbsp;<font class="_mt">4.3</font>&nbsp;years at March&nbsp;31, 2011. All outstanding options were exercisable as of March&nbsp;31, 2013, 2012, and 2011. The total intrinsic value of options exercised during fiscal 2013 was $<font class="_mt">1,881,138</font> based on the difference between the exercise price and stock price at the time of exercise for in-the-money options. The total intrinsic value of options outstanding March&nbsp;31, 2013, based on our closing stock price for that day, was $<font class="_mt">1,290,440</font> all of which were exercisable. The total fair value of option grants was $<font class="_mt">66,720</font> in fiscal 2013. There was no unrecognized stock-based compensation at March&nbsp;31, 2013.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No warrants were issued in the past three fiscal years. Remaining weighted-average exercisable warrant life was&nbsp;<font class="_mt">0.9</font>&nbsp;years at March&nbsp;31, 2013;&nbsp;<font class="_mt">0.9</font>&nbsp;years at March&nbsp;31, 2012; and&nbsp;<font class="_mt">1.9</font>&nbsp;years at March&nbsp;31, 2011.<br /></font> </div> 2.83 2.37 2.44 2.76 2.34 2.43 <div> <div class="MetaData"><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><b>Net Income Per Share</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income per basic share is computed based on the weighted-average number of common shares issued and outstanding during each year. Net income per diluted share amounts assume conversion, exercise or issuance of all potential common stock instruments (stock options and warrants). Stock options and warrants totaling&nbsp;<font class="_mt">5,000</font> for fiscal 2013;&nbsp;<font class="_mt">5,000</font> for fiscal 2012; and&nbsp;<font class="_mt">1,000</font> for fiscal 2011 were not included in the computation of diluted earnings per share because the exercise prices were greater than the market price of the common stock. The following table reflects the components of common shares outstanding:</font><br /><br /> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="5" align="center"><b>Year Ended March 31</b></td></tr> <tr><td style="border-bottom: black 1px solid;" width="11%" align="center"><b>2013</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" width="11%" align="center"><b>2012</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" width="11%" align="center"><b>2011</b></td></tr> <tr bgcolor="#ccdaef"><td>Weighted average common shares outstanding &#8211; basic</td> <td width="11%" align="right">4,839,810</td> <td colspan="2" align="right">4,796,227</td> <td colspan="2" align="right">4,729,035</td></tr> <tr><td colspan="6">Effect of dilutive securities:</td></tr> <tr bgcolor="#ccdaef"><td> <div style="margin-left: 9pt;">Stock options</div></td> <td align="right">21,934</td> <td colspan="2" align="right">60,075</td> <td colspan="2" align="right">108,121</td></tr> <tr><td> <div style="margin-left: 9pt;">Warrants</div></td> <td style="border-bottom: black 1px solid;" align="right">1,802</td> <td> </td> <td style="border-bottom: black 1px solid;" align="right">7,169</td> <td> </td> <td style="border-bottom: black 1px solid;" align="right">7,110</td></tr> <tr valign="top" bgcolor="#ccdaef"><td>Shares used in computing net income per share &#8211; diluted</td> <td style="border-bottom: black 3px double;" align="right">4,863,546</td> <td> </td> <td style="border-bottom: black 3px double;" align="right">4,863,471</td> <td> </td> <td style="border-bottom: black 3px double;" align="right">4,844,266</td></tr></table><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt">&nbsp;<br /></font></div> </div> 867331 918060 0.11 0.11 0.14 0.14 0.16 0.15 0.14 0.16 230173 0 15734 230173 0 15734 <div> <p><font size="2" class="_mt"><strong>NOTE 3. FAIR VALUE MEASUREMENTS</strong> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Generally accepted accounting principles establish a framework for measuring fair value, provide a definition of fair value and prescribe required disclosures about fair-value measurements. Generally accepted accounting principles define fair value as the price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement that should be determined using assumptions that market participants would use in pricing an asset or liability. Generally accepted accounting principles utilize a valuation hierarchy for disclosure of fair value measurements. The categorization within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The categories within the valuation hierarchy are described as follows: <br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Level 1 &#8211; Financial instruments with quoted prices in active markets for identical assets or liabilities. Our Level&nbsp;1 financial instruments consist of publicly-traded marketable corporate&nbsp;debt securities, which are classified as available-for-sale. On the balance sheets, these securities are included in "Marketable securities, short term" and "Marketable securities, long term." The fair value of our Level&nbsp;1 marketable securities was $<font class="_mt">75,298,160</font> at March&nbsp;31, 2013 and $<font class="_mt">51,918,559</font> at March&nbsp;31, 2012.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Level 2 &#8211; Financial instruments with quoted prices in active markets for similar assets or liabilities. Level&nbsp;2 fair value measurements are determined using either prices for similar instruments or inputs that are either directly or indirectly observable, such as interest rates. Our Level&nbsp;2 financial instruments consist of municipal debt securities, which are classified as available-for-sale. On the balance sheets, these securities are included in "Marketable securities, short term" and "Marketable securities, long term." The fair value of our Level&nbsp;2 marketable securities was $<font class="_mt">7,453,126</font> at March&nbsp;31, 2013 and $<font class="_mt">20,078,368</font> at March&nbsp;31, 2012. The classification of municipal debt securities as Level 2 at March&nbsp;31, 2012 has been revised to conform with the current-year classification, consistent with the Level&nbsp;2 measurement principles applied to securities in all periods presented.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Level 3 &#8211; Inputs to the fair value measurement are unobservable inputs or valuation techniques. We do not have any financial assets or liabilities being measured at fair value that are classified as Level&nbsp;3 financial instruments.</font><br /></p> </div> <div> <b>Fair Value of Financial Instruments</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The carrying amount of cash and cash equivalents, accounts receivable, and accounts payable approximates fair value because of the short maturity of these instruments. Fair values of marketable securities are based on quoted market prices. </div> 21413365 19253709 20008238 19691196 16623239 17556457 <div> <font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><b>NOTE 7. INCOME TAXES</b><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax provisions for fiscal 2011 through 2013 consisted of the following:<br /><br /></font> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="67%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="11" align="center"><b>Year Ended March 31</b></td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>2013</b></td> <td width="3%"> </td> <td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>2012</b></td> <td width="3%"> </td> <td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>2011</b></td></tr> <tr><td bgcolor="#ccdaef" colspan="12">Current taxes</td></tr> <tr><td> <div style="margin-left: 9pt;">Federal</div></td> <td width="1%">$</td> <td width="16%" align="right">5,314,876</td> <td width="1%"> </td> <td width="3%"> </td> <td width="1%">$</td> <td width="16%" align="right">4,847,082</td> <td width="1%"> </td> <td width="3%"> </td> <td width="1%">$</td> <td width="16%" align="right">5,761,632</td> <td width="1%"> </td></tr> <tr bgcolor="#ccdaef"><td> <div style="margin-left: 9pt;">State</div></td> <td colspan="2" align="right">377,215</td> <td> </td> <td> </td> <td colspan="2" align="right">407,913</td> <td> </td> <td> </td> <td colspan="2" align="right">504,408</td> <td> </td></tr> <tr><td colspan="12">Deferred taxes</td></tr> <tr bgcolor="#ccdaef"><td> <div style="margin-left: 9pt;">Federal</div></td> <td colspan="2" align="right">34,718</td> <td>&nbsp;</td> <td> </td> <td colspan="2" align="right">(17,233</td> <td>)</td> <td> </td> <td colspan="2" align="right">56,996</td> <td>&nbsp;</td></tr> <tr><td> <div style="margin-left: 9pt;">State</div></td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">810</td> <td style="border-bottom: black 1px solid;">&nbsp;</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">4,382</td> <td style="border-bottom: black 1px solid;">&nbsp;</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">7,215</td> <td style="border-bottom: black 1px solid;">&nbsp;</td></tr> <tr valign="top" bgcolor="#ccdaef"><td>Income tax provision</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">5,727,619</td> <td style="border-bottom: black 3px double;">&nbsp;</td> <td> </td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">5,242,144</td> <td style="border-bottom: black 3px double;">&nbsp;</td> <td> </td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">6,330,251</td> <td style="border-bottom: black 3px double;">&nbsp;</td></tr></table><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt">&nbsp;<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A reconciliation of income tax provisions at the U.S. statutory rate for fiscal 2011 through 2013 is as follows:<br />&nbsp;<br /></font> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="11" align="center"><b>Year Ended March 31</b></td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>2013</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>2012</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>2011</b></td></tr> <tr bgcolor="#ccdaef"><td>Tax expense at U.S. statutory rate</td> <td width="1%">$</td> <td width="11%" align="right">6,046,264</td> <td width="1%">&nbsp;</td> <td> </td> <td width="1%">$</td> <td width="11%" align="right">5,700,630</td> <td width="1%">&nbsp;</td> <td> </td> <td width="1%">$</td> <td width="11%" align="right">6,809,003</td> <td width="1%"> </td></tr> <tr><td>State income taxes, net of Federal benefit</td> <td> </td> <td align="right">244,691</td> <td>&nbsp;</td> <td> </td> <td> </td> <td align="right">252,881</td> <td>&nbsp;</td> <td> </td> <td> </td> <td align="right">345,213</td> <td> </td></tr> <tr bgcolor="#ccdaef"><td>Domestic manufacturing deduction</td> <td> </td> <td align="right">(460,723</td> <td>)</td> <td> </td> <td> </td> <td align="right">(467,053</td> <td>)</td> <td> </td> <td> </td> <td align="right">(549,123</td> <td>)</td></tr> <tr><td>Municipal interest</td> <td> </td> <td align="right">(118,282</td> <td>)</td> <td> </td> <td> </td> <td align="right">(235,470</td> <td>)</td> <td> </td> <td> </td> <td align="right">(239,636</td> <td>)</td></tr> <tr bgcolor="#ccdaef"><td>Other</td> <td style="border-bottom: black 1px solid;">&nbsp;</td> <td style="border-bottom: black 1px solid;" align="right">15,669</td> <td style="border-bottom: black 1px solid;">&nbsp;</td> <td> </td> <td style="border-bottom: black 1px solid;">&nbsp;</td> <td style="border-bottom: black 1px solid;" align="right">(8,844</td> <td style="border-bottom: black 1px solid;">)</td> <td> </td> <td style="border-bottom: black 1px solid;">&nbsp;</td> <td style="border-bottom: black 1px solid;" align="right">(35,206</td> <td style="border-bottom: black 1px solid;">)</td></tr> <tr valign="top"><td>Income tax provision</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">5,727,619</td> <td style="border-bottom: black 3px double;">&nbsp;</td> <td style="border-bottom: black 3px double;"> </td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">5,242,144</td> <td style="border-bottom: black 3px double;">&nbsp;</td> <td style="border-bottom: black 3px double;"> </td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">6,330,251</td> <td style="border-bottom: black 3px double;">&nbsp;</td></tr></table><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets and liabilities as of March&nbsp;31, 2013 and 2012 were as follows:<br />&nbsp;<br /></font> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="67%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="7" align="center"><b>March 31</b></td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>2013</b></td> <td width="3%"> </td> <td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>2012</b></td></tr> <tr><td>Vacation accrual</td> <td width="1%">$</td> <td width="16%" align="right">134,214</td> <td width="1%"> </td> <td align="right">&nbsp;</td> <td width="1%">$</td> <td width="16%" align="right">126,453</td> <td width="1%">&nbsp;</td></tr> <tr bgcolor="#ccdaef"><td>Inventory reserve</td> <td colspan="2" align="right">103,540</td> <td> </td> <td align="right">&nbsp;</td> <td colspan="2" align="right">108,990</td> <td>&nbsp;</td></tr> <tr><td>Depreciation</td> <td colspan="2" align="right">(4,756</td> <td>)</td> <td align="right">&nbsp;</td> <td colspan="2" align="right">9,245</td> <td>&nbsp;</td></tr> <tr bgcolor="#ccdaef"><td>Stock-based compensation deductions</td> <td colspan="2" align="right">145,592</td> <td> </td> <td align="right">&nbsp;</td> <td colspan="2" align="right">145,418</td> <td>&nbsp;</td></tr> <tr><td>Unrealized gain on marketable securities</td> <td colspan="2" align="right">(888,836</td> <td>)</td> <td align="right">&nbsp;</td> <td colspan="2" align="right">(620,500</td> <td>)</td></tr> <tr bgcolor="#ccdaef"><td>Other</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">69,510</td> <td style="border-bottom: black 1px solid;">&nbsp;</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">93,522</td> <td style="border-bottom: black 1px solid;">&nbsp;</td></tr> <tr><td>Net deferred tax liabilities</td> <td style="border-bottom: black 3px double;" width="1%">$</td> <td style="border-bottom: black 3px double;" align="right">(440,736</td> <td style="border-bottom: black 3px double;">)</td> <td> </td> <td style="border-bottom: black 3px double;" width="1%">$</td> <td style="border-bottom: black 3px double;" align="right">(136,872</td> <td style="border-bottom: black 3px double;">)</td></tr></table><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Realizations of stock-based compensation deductions are credited to "Additional paid-in capital" and included in "Tax benefit of stock-based compensation" on our statements of shareholders' equity. Credits of $<font class="_mt">15,734</font> in fiscal 2013 and $<font class="_mt">230,173</font> in fiscal 2011 were attributed to stock-based compensation deductions. The "Additional paid-in capital" credits also included the tax benefit of stock-based compensation deductions in those years.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The amounts credited to "Additional paid-in capital" were the tax benefits of the deductions to the extent they exceeded the corresponding compensation expense recognized for financial reporting purposes. "Tax benefit of stock-based compensation" represented the tax benefits of deductions for stock-based compensation to the extent they exceeded the corresponding compensation expense recognized for financial reporting purposes. Cash we received from the exercise of stock options related to excess tax benefits is included in "Net proceeds from sale of common stock" in the statement of cash flows for the year in which the option was exercised and cash received. <br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We had $<font class="_mt">95,184</font> of Federal net operating losses and $<font class="_mt">142,775</font> of state net operating losses at March&nbsp;31, 2013, compared to $<font class="_mt">149,284</font> of Federal net operating losses and $<font class="_mt">155,681</font> of state net operating losses at March&nbsp;31, 2012. These net operating losses expire in fiscal 2020 and are subject to limitation including limitation under the Internal Revenue Code. <br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We had no unrecognized tax benefits as of March&nbsp;31, 2013, and we do not expect any significant unrecognized tax benefits within 12&nbsp;months of the reporting date. We recognize interest and penalties related to income tax matters in income tax expense. As of March&nbsp;31, 2013 we had no accrued interest related to uncertain tax positions. The tax years 1999 through 2012 remain open to examination by the major taxing jurisdictions to which we are subject.<br /></font> </div> 6303598 5207565 5202616 6330251 5242144 5727619 6330251 5242144 5727619 <div> <b>Income Taxes</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We account for income taxes using the liability method. Deferred income taxes are provided for temporary differences between the financial reporting and tax bases of assets and liabilities. We provide valuation allowances against deferred tax assets if we determine that it is less likely than not that we will be able to utilize the deferred tax assets.<br /> </div> 6809003 5700630 6046264 -35206 -8844 15669 345213 252881 244691 332334 -187950 -190881 -625325 -911399 -163445 -20833 0 0 1637430 -114481 107216 404012 -25454 -201705 300000 285000 <div> <font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><b>NOTE 5. INVENTORIES</b><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories consisted of the following:<br />&nbsp;<br /></font> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="50%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="7" align="center"><b>March 31</b></td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>2013</b></td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>2012</b></td></tr> <tr bgcolor="#ccdaef"><td>Raw materials</td> <td width="1%">$</td> <td width="22%" align="right">1,312,011</td> <td width="1%"> </td> <td width="4%"> </td> <td width="1%">$</td> <td width="22%" align="right">1,285,106</td> <td width="1%"> </td></tr> <tr><td>Work in process</td> <td> </td> <td align="right">1,533,951</td> <td> </td> <td> </td> <td> </td> <td align="right">1,658,467</td> <td> </td></tr> <tr bgcolor="#ccdaef"><td>Finished goods</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">775,630</td> <td style="border-bottom: black 1px solid;">&nbsp;</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">585,803</td> <td style="border-bottom: black 1px solid;">&nbsp;</td></tr> <tr><td> </td> <td> </td> <td align="right">3,621,592</td> <td> </td> <td> </td> <td> </td> <td align="right">3,529,376</td> <td> </td></tr> <tr bgcolor="#ccdaef"><td>Less inventory reserve</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">(285,000</td> <td style="border-bottom: black 1px solid;">)</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">(300,000</td> <td style="border-bottom: black 1px solid;">)</td></tr> <tr valign="top"><td>Total inventories</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">3,336,592</td> <td style="border-bottom: black 3px double;">&nbsp;</td> <td> </td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">3,229,376</td> <td style="border-bottom: black 3px double;">&nbsp;</td></tr></table><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><br /></font> </div> 585803 775630 3529376 3621592 3229376 3336592 <div> <b>Inventories</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first in, first out method. We record inventory reserves when we determine certain inventory is unlikely to be sold based on sales trends, turnover, competition, and other market factors. </div> 1285106 1312011 1658467 1533951 2021426 2350191 2359603 <div> <font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><b>NOTE 4. MARKETABLE SECURITIES</b><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Marketable securities with remaining maturities less than one year are classified as short-term, and those with remaining maturities greater than one year are classified as long-term. The fair value of our marketable securities as of March&nbsp;31, 2013, by maturity, were as follows:<br /><br /></font> <table style="font-family: Times New Roman; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0" width="50%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Total</b></td> <td width="4%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>&lt;1 Year</b></td> <td width="4%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>1&#8211;3 Years</b></td> <td width="4%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>3&#8211;5 Years</b></td></tr> <tr><td width="1%">$</td> <td width="12%" align="right">82,751,286</td> <td> </td> <td width="1%">$</td> <td width="12%" align="right">9,711,029</td> <td> </td> <td width="1%">$</td> <td width="12%" align="right">34,310,566</td> <td width="2%"> </td> <td width="1%">$</td> <td width="12%" align="right">38,729,691</td></tr></table><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt">&nbsp; <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of March&nbsp;31, 2013 and 2012 our marketable securities were as follows:<br /><br /></font> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="100%"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="12" align="center"><b>As of March&nbsp;31, 2013</b></td> <td style="border-bottom: black 1px solid;" rowspan="2" width="1"> </td> <td style="border-bottom: black 1px solid;" colspan="12" align="center"><b>As of March&nbsp;31, 2012</b></td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="2" align="center"><b><br />Adjusted<br />Cost</b></td> <td width="1"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Gross<br />Unrealized<br />Gains</b></td> <td width="1"> </td> <td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>Gross<br />Unrealized<br />Losses</b></td> <td width="1"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Fair<br />Market<br />Value</b></td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b><br />Adjusted<br />Cost</b></td> <td width="1"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Gross<br />Unrealized<br />Gains</b></td> <td width="1"> </td> <td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>Gross<br />Unrealized<br />Losses</b></td> <td width="1"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Fair<br />Market<br />Value</b></td></tr> <tr><td valign="bottom">Corporate&nbsp;bonds</td> <td>$</td> <td valign="bottom" align="right">72,923,502</td> <td>&nbsp;&nbsp;</td> <td>$</td> <td valign="bottom" align="right">2,378,845</td> <td>&nbsp;&nbsp;</td> <td>$</td> <td valign="bottom" align="right">(4,187</td> <td valign="bottom">)</td> <td>&nbsp;&nbsp;</td> <td>$</td> <td valign="bottom" align="right">75,298,160</td> <td>&nbsp;&nbsp;</td> <td>$</td> <td valign="bottom" align="right">50,513,389</td> <td>&nbsp;&nbsp;</td> <td>$</td> <td valign="bottom" align="right">1,481,604</td> <td>&nbsp;&nbsp;</td> <td>$</td> <td valign="bottom" align="right">(76,434</td> <td valign="bottom">)</td> <td>&nbsp;&nbsp;</td> <td>$</td> <td valign="bottom" align="right">51,918,559</td></tr> <tr bgcolor="#ccdaef"><td valign="bottom">Municipal&nbsp;bonds&nbsp;&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">7,381,223</td> <td>&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">81,058<br /></td> <td>&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">(9,155</td> <td style="border-bottom: black 1px solid; valign: ;" valign="bottom">)</td> <td>&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">7,453,126</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">19,775,582</td> <td>&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">334,793<br /></td> <td>&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">(32,007</td> <td style="border-bottom: black 1px solid; valign: ;" valign="bottom">)</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">20,078,368</td></tr> <tr><td valign="top">Total</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">80,304,725</td> <td>&nbsp;</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">2,459,903</td> <td>&nbsp;</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">(13,342</td> <td style="border-bottom: black 3px double;">)</td> <td>&nbsp;</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">82,751,286</td> <td> </td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">70,288,971</td> <td>&nbsp;</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">1,816,397</td> <td>&nbsp;</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">(108,441</td> <td style="border-bottom: black 3px double;">)</td> <td>&nbsp;</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">71,996,927</td></tr></table><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table shows the gross unrealized losses and fair value of our investments with unrealized losses, aggregated by investment category and length of time that individual securities had been in a continuous unrealized loss position as of March&nbsp;31, 2013 and 2012:<br /><br /></font> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td rowspan="2" colspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="6" align="center"><b>Less Than 12 Months</b></td> <td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="6" align="center"><b>12 Months or Greater</b></td> <td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="6" align="center"><b>Total</b></td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Fair<br />Market<br />Value</b></td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>Gross<br />Unrealized<br />Losses</b></td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Fair<br />Market<br />Value</b></td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>Gross<br />Unrealized<br />Losses</b></td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Fair<br />Market<br />Value</b></td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>Gross<br />Unrealized<br />Losses</b></td></tr> <tr><td colspan="22">As of March 31, 2013</td></tr> <tr><td bgcolor="#ccdaef" width="12">&nbsp;</td> <td bgcolor="#ccdaef">Corporate bonds</td> <td bgcolor="#ccdaef" width="1%">$</td> <td bgcolor="#ccdaef" width="9%" align="right">1,171,976</td> <td bgcolor="#ccdaef" width="2%">&nbsp;</td> <td bgcolor="#ccdaef" width="1%">$</td> <td bgcolor="#ccdaef" width="8%" align="right">(4,187</td> <td bgcolor="#ccdaef" width="1%">)</td> <td bgcolor="#ccdaef" width="4%">&nbsp;</td> <td bgcolor="#ccdaef" width="1%">$</td> <td bgcolor="#ccdaef" width="9%" align="right">-</td> <td bgcolor="#ccdaef" width="2%">&nbsp;</td> <td bgcolor="#ccdaef" width="1%">$</td> <td bgcolor="#ccdaef" width="8%" align="right">-</td> <td bgcolor="#ccdaef" width="1%">&nbsp;</td> <td bgcolor="#ccdaef" width="4%">&nbsp;</td> <td bgcolor="#ccdaef" width="1%">$</td> <td bgcolor="#ccdaef" width="9%" align="right">1,171,976</td> <td bgcolor="#ccdaef" width="2%">&nbsp;</td> <td bgcolor="#ccdaef" width="1%">$</td> <td bgcolor="#ccdaef" width="8%" align="right">(4,187</td> <td bgcolor="#ccdaef" width="1%">)</td></tr> <tr><td>&nbsp;</td> <td>Municipal&nbsp;bonds&nbsp;&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">508,607</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">(9,155</td> <td style="border-bottom: black 1px solid;">)</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">-</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">-</td> <td style="border-bottom: black 1px solid;">&nbsp;</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">508,607</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">(9,155</td> <td style="border-bottom: black 1px solid;">)</td></tr> <tr><td bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef" valign="top">Total</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">1,680,583</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">(13,342</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">)</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">-</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">-</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">&nbsp;</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">1,680,583</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">(13,342</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">)</td></tr> <tr><td colspan="22">As of March 31, 2012</td></tr> <tr><td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef">Corporate bonds</td> <td bgcolor="#ccdaef">$</td> <td bgcolor="#ccdaef" align="right">10,387,955</td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef">$</td> <td bgcolor="#ccdaef" align="right">(76,434</td> <td bgcolor="#ccdaef">)</td> <td bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef" align="right">-</td> <td bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef" align="right">-</td> <td bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef">$</td> <td bgcolor="#ccdaef" align="right">10,387,955</td> <td bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef">$</td> <td bgcolor="#ccdaef" align="right">(76,434</td> <td bgcolor="#ccdaef">)</td></tr> <tr><td> </td> <td width="122">Municipal bonds</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">-</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">-</td> <td style="border-bottom: black 1px solid; valign: ;">&nbsp;</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">908,550</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">(32,007</td> <td style="border-bottom: black 1px solid; valign: ;">)</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">908,550</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">(32,007</td> <td style="border-bottom: black 1px solid; valign: ;">)</td></tr> <tr><td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef" valign="top" width="122">Total</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">10,387,955</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">(76,434</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">)</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">908,550</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">(32,007</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">)</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">11,296,505</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">(108,441</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">)</td></tr></table><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt">&nbsp;<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross unrealized losses totaled $13,342 as of March&nbsp;31, 2013, and were attributed to one corporate bond and two municipal bonds out of a portfolio of 43 bonds. The gross unrealized losses were due to market-price decreases and rating downgrades after the bonds were purchased, and none had been in a continuous unrealized loss position for 12 months or greater. A substantial majority of the bonds we held were rated by Moody's or Standard and Poor's and had investment-grade credit ratings. For each bond with an unrealized loss, we expect to recover the entire cost basis of each security based on our consideration of factors including their credit ratings, the underlying ratings of insured bonds, and historical default rates for securities of comparable credit rating. Because we expect to recover the entire cost basis of the securities, and because we do not intend to sell the securities and it is not more likely than not that we will be required to sell the securities before recovery of the cost basis, which may be maturity, we did not consider any of our marketable securities to be other-than-temporarily impaired at March&nbsp;31, 2013.<br /></font> </div> 720882 1499454 83126763 95765496 1667905 1780888 7488211 8417061 17551629 9711029 54445298 73040257 <div> <b>Marketable Securities</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We classify securities with original maturities greater than three months and remaining maturities one year or less as short-term marketable securities and securities with remaining maturities greater than one year as long-term marketable securities. Securities not due at a single maturity date are classified by their average life. We classify all of our marketable securities as available-for-sale, thus securities are recorded at fair value and any associated unrealized gain or loss, net of tax, is included as a separate component of shareholders' equity, "Accumulated other comprehensive income (loss)." We use a specific-identification cost basis to determine gains and losses. The amortized cost of marketable securities is adjusted for amortization of premiums and accretion of discounts to maturity, both of which are included in interest income.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We consider an other-than-temporary impairment of our marketable securities to exist if we determine it is probable that we will be unable to collect all amounts due according to the contractual terms of a debt security. If we judged a decline in fair value for any security to be other than temporary, the cost basis of the individual security would be written down and a charge recognized in net income. We consider a number of factors in determining whether other-than-temporary impairment exists, including: credit market conditions; the credit ratings of the securities; historical default rates for securities of comparable credit rating; the presence of insurance of the securities and, if insured, the credit rating and financial condition of the insurer; the effect of market interest rates on the value of the securities; and the duration and extent of any unrealized losses. We also consider the likelihood that we will be required to sell the securities prior to maturity based on our financial condition and anticipated cash flows. We determined that no write-downs for other-than-temporary impairment were required on available-for-sale securities during fiscal 2013, 2012, or 2011. </div> 648878 36 159922 -13894764 -12219619 -11840077 12808807 12811910 12645302 13360945 13360945 11381095 0 0 0 11381095 11828838 0 0 0 11828838 3743595 4980661 4811384 17669770 14273048 15196854 2140639 266496 277012 272953 271938 269269 -69288 -69288 0 0 0 27018 27018 0 0 470270 470270 0 0 245220 253740 259823 14742032 18501362 27209753 732800 1480237 1824324 <div> <p><font size="2" class="_mt"><strong>NOTE 11. INFORMATION AS TO EMPLOYEE STOCK PURCHASE, SAVINGS, AND SIMILAR PLANS</strong> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All of our employees are eligible to participate in our 401(k) savings plan the first quarter after reaching age&nbsp;21. Employees may contribute up to the Internal Revenue Code maximum. We make matching contributions of <font class="_mt">100</font>% of the first <font class="_mt">3</font>% of participants' salary deferral contributions. Our matching contributions were $<font class="_mt">105,370</font> for fiscal 2013, $<font class="_mt">109,126</font> for fiscal 2012, and $<font class="_mt">110,268</font> for fiscal 2011.<br />&nbsp;</font><br /></p> </div> 1159852 958147 418705 36 144188 1580068 7761980 17194000 8209093 9916515 2511232 3688393 P5Y P5Y P5Y <div> <b>Accounts Receivable and Allowance for Doubtful Accounts</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable are recorded net of an allowance for doubtful accounts. We make estimates of the uncollectibility of accounts receivable. We specifically analyze accounts receivable, historical bad debts, and customer creditworthiness when evaluating the adequacy of the allowance. We had no charges or provisions to our allowance for doubtful accounts in fiscal 2013, 2012, or 2011. </div> 1269127 2600058 2570821 <div> <b>Research and Development Expense Recognition</b><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development costs are expensed as they are incurred.<br /> </div> 59348678 71177516 <div> <b>Revenue Recognition</b><br /><b><i>Product Revenue Recognition</i></b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We recognize product revenue on shipment because the terms of our sales are FOB shipping point, meaning that our customers (end users and distributors) take title and assume the risks and rewards of ownership on shipment. Our customers may return defective products for refund or replacement under warranty, and have other very limited rights of return.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shipping charges billed to customers are included in product sales and the related shipping costs are included in selling, general, and administrative expense. Such shipping costs were $<font class="_mt">27,386</font> for fiscal 2013, $<font class="_mt">40,185</font> for fiscal 2012, and $<font class="_mt">39,427</font> for fiscal 2011. <br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments from our distributors are not contingent on resale or any other matter other than the passage of time, and delivery of products is not dependent on the number of units resold to the ultimate customer. There are no other significant acceptance criteria, pricing or payment terms that would affect revenue recognition.<br /><br /> </div> <div> <b><i>Accounting for Commissions and Discounts</i></b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We sometimes utilize independent sales representatives that provide services relating to promoting our products and facilitating product sales but do not purchase our products. We pay commissions to sales representatives based on the amount of revenue facilitated, and such commissions are recorded as selling, general, and administrative expenses.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our stocking distributors take title and assume the risks and rewards of product ownership. We presume consideration given to a customer is a reduction in revenue unless both of the following conditions are met: (i)&nbsp;we receive an identifiable benefit in exchange for the consideration and the identifiable benefit is sufficiently separable from the customer's purchase of our products such that we could have purchased the products or services from a third party; and (ii)&nbsp;we can reasonably estimate the fair value of the benefit received. We recognize discounts provided to our distributors as reductions in revenue. Under certain limited circumstances, our distributors may earn commissions for activities unrelated to their purchases of our products, such as for facilitating the sale of custom products or research and development contracts with third parties. We recognize any such commissions as selling, general, and administrative expenses.<br /> </div> 31197063 14169952 4576270 12009294 441547 28579220 13334563 4130930 10798146 315581 27033419 12006493 3979862 10666338 380726 26024823 25151822 24434823 <div> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="100%"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="12" align="center"><b>As of March&nbsp;31, 2013</b></td> <td style="border-bottom: black 1px solid;" rowspan="2" width="1"> </td> <td style="border-bottom: black 1px solid;" colspan="12" align="center"><b>As of March&nbsp;31, 2012</b></td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="2" align="center"><b><br />Adjusted<br />Cost</b></td> <td width="1"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Gross<br />Unrealized<br />Gains</b></td> <td width="1"> </td> <td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>Gross<br />Unrealized<br />Losses</b></td> <td width="1"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Fair<br />Market<br />Value</b></td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b><br />Adjusted<br />Cost</b></td> <td width="1"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Gross<br />Unrealized<br />Gains</b></td> <td width="1"> </td> <td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>Gross<br />Unrealized<br />Losses</b></td> <td width="1"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Fair<br />Market<br />Value</b></td></tr> <tr><td valign="bottom">Corporate&nbsp;bonds</td> <td>$</td> <td valign="bottom" align="right">72,923,502</td> <td>&nbsp;&nbsp;</td> <td>$</td> <td valign="bottom" align="right">2,378,845</td> <td>&nbsp;&nbsp;</td> <td>$</td> <td valign="bottom" align="right">(4,187</td> <td valign="bottom">)</td> <td>&nbsp;&nbsp;</td> <td>$</td> <td valign="bottom" align="right">75,298,160</td> <td>&nbsp;&nbsp;</td> <td>$</td> <td valign="bottom" align="right">50,513,389</td> <td>&nbsp;&nbsp;</td> <td>$</td> <td valign="bottom" align="right">1,481,604</td> <td>&nbsp;&nbsp;</td> <td>$</td> <td valign="bottom" align="right">(76,434</td> <td valign="bottom">)</td> <td>&nbsp;&nbsp;</td> <td>$</td> <td valign="bottom" align="right">51,918,559</td></tr> <tr bgcolor="#ccdaef"><td valign="bottom">Municipal&nbsp;bonds&nbsp;&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">7,381,223</td> <td>&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">81,058<br /></td> <td>&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">(9,155</td> <td style="border-bottom: black 1px solid; valign: ;" valign="bottom">)</td> <td>&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">7,453,126</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">19,775,582</td> <td>&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">334,793<br /></td> <td>&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">(32,007</td> <td style="border-bottom: black 1px solid; valign: ;" valign="bottom">)</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">20,078,368</td></tr> <tr><td valign="top">Total</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">80,304,725</td> <td>&nbsp;</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">2,459,903</td> <td>&nbsp;</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">(13,342</td> <td style="border-bottom: black 3px double;">)</td> <td>&nbsp;</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">82,751,286</td> <td> </td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">70,288,971</td> <td>&nbsp;</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">1,816,397</td> <td>&nbsp;</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">(108,441</td> <td style="border-bottom: black 3px double;">)</td> <td>&nbsp;</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">71,996,927</td></tr></table> </div> <div> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="100%"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="23" align="center"><b>Year Ending March 31</b></td> <td colspan="3"> </td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2014</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2015</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2016</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2017</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2018</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2019</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2020</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2021</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Total</b></td></tr> <tr bgcolor="#ccdaef"><td width="1%">$</td> <td width="6%" align="right">266,496</td> <td> </td> <td width="1%">$</td> <td width="6%" align="right">269,269</td> <td> </td> <td width="1%">$</td> <td width="6%" align="right">271,938</td> <td> </td> <td width="1%">$</td> <td width="6%" align="right">272,953</td> <td> </td> <td width="1%">$</td> <td width="6%" align="right">277,012</td> <td> </td> <td width="1%"> </td> <td width="6%" align="right">281,124</td> <td> </td> <td width="1%">$</td> <td width="6%" align="right">285,396</td> <td> </td> <td width="1%">$</td> <td width="6%" align="right">216,451</td> <td> </td> <td width="1%">$</td> <td width="6%" align="right">2,140,639</td></tr></table> </div> <div> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="50%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="7" align="center"><b>March 31</b></td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>2013</b></td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>2012</b></td></tr> <tr bgcolor="#ccdaef"><td>Raw materials</td> <td width="1%">$</td> <td width="22%" align="right">1,312,011</td> <td width="1%"> </td> <td width="4%"> </td> <td width="1%">$</td> <td width="22%" align="right">1,285,106</td> <td width="1%"> </td></tr> <tr><td>Work in process</td> <td> </td> <td align="right">1,533,951</td> <td> </td> <td> </td> <td> </td> <td align="right">1,658,467</td> <td> </td></tr> <tr bgcolor="#ccdaef"><td>Finished goods</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">775,630</td> <td style="border-bottom: black 1px solid;">&nbsp;</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">585,803</td> <td style="border-bottom: black 1px solid;">&nbsp;</td></tr> <tr><td> </td> <td> </td> <td align="right">3,621,592</td> <td> </td> <td> </td> <td> </td> <td align="right">3,529,376</td> <td> </td></tr> <tr bgcolor="#ccdaef"><td>Less inventory reserve</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">(285,000</td> <td style="border-bottom: black 1px solid;">)</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">(300,000</td> <td style="border-bottom: black 1px solid;">)</td></tr> <tr valign="top"><td>Total inventories</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">3,336,592</td> <td style="border-bottom: black 3px double;">&nbsp;</td> <td> </td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">3,229,376</td> <td style="border-bottom: black 3px double;">&nbsp;</td></tr></table> </div> <div> <div class="MetaData"> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="50%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="5" align="center"><b><font style="white-space: nowrap;" class="_mt">% of Revenue for Year Ended March 31</font></b></td></tr> <tr><td style="border-bottom: black 1px solid;" align="center"><b>2013</b></td> <td width="4%"> </td> <td style="border-bottom: black 1px solid;" align="center"><b>2012</b></td> <td width="4%"> </td> <td style="border-bottom: black 1px solid;" align="center"><b>2011</b></td></tr> <tr bgcolor="#ccdaef"><td>Customer A</td> <td width="11%" align="center">16%</td> <td> </td> <td width="11%" align="center">16%</td> <td> </td> <td width="11%" align="center">14%</td></tr> <tr><td>Customer B</td> <td width="12%" align="center">15%</td> <td> </td> <td width="12%" align="center">14%</td> <td> </td> <td width="12%" align="center">11%</td></tr> <tr><td bgcolor="#ccdaef">Customer C</td> <td bgcolor="#ccdaef" width="11%" align="center">14%</td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef" width="11%" align="center">*</td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef" width="11%" align="center">11%</td></tr></table> <table style="font-size: 4pt;" border="0" cellspacing="0" cellpadding="0" width="50%" align="center"> <tr><td style="border-bottom: windowtext 1pt solid; border-left: medium none; padding-bottom: 0pt; padding-left: 0pt; padding-right: 0.7pt; border-top: medium none; border-right: medium none; padding-top: 0pt;" width="85">&nbsp;</td> <td rowspan="2">&nbsp;</td></tr> <tr><td style="padding-bottom: 0pt; padding-left: 0pt; padding-right: 0.7pt; padding-top: 0pt;">&nbsp;</td></tr></table> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="50%" align="center"> <tr><td>*<font class="_mt">Less than 10%</font></td></tr></table></div> </div> <div> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="67%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" width="40%" colspan="8" align="center"><b>Year Ended March 31</b></td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2013</b></td> <td width="3%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2012</b></td> <td width="3%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2011</b></td></tr> <tr bgcolor="#ccdaef"><td bgcolor="#ccdaef">United States</td> <td width="1%">$</td> <td width="16%" align="right">12,006,493</td> <td> </td> <td width="1%">$</td> <td width="16%" align="right">13,334,563</td> <td> </td> <td width="1%">$</td> <td width="16%" align="right">14,169,952</td></tr> <tr><td>Europe</td> <td> </td> <td align="right">10,666,338</td> <td> </td> <td> </td> <td align="right">10,798,146</td> <td> </td> <td> </td> <td align="right">12,009,294</td></tr> <tr bgcolor="#ccdaef"><td>Asia</td> <td> </td> <td align="right">3,979,862</td> <td> </td> <td> </td> <td align="right">4,130,930</td> <td> </td> <td> </td> <td align="right">4,576,270</td></tr> <tr><td>Other</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">380,726</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">315,581</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">441,547</td></tr> <tr valign="top" bgcolor="#ccdaef"><td>Total Revenue</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">27,033,419</td> <td> </td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">28,579,220</td> <td> </td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">31,197,063</td></tr></table> </div> <div> <table style="font-family: Times New Roman; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0" width="67%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td style="border-bottom: black 1px solid;" valign="bottom" align="center"><b>Ranges of<br />Exercise&nbsp;Prices</b></td> <td width="4%">&nbsp;&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 1px solid;" valign="bottom" align="center"><b>Number<br />Outstanding</b></td> <td width="4%">&nbsp;&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 1px solid;" valign="bottom" colspan="2" align="center"><b>Weighted&nbsp;Average<br />Exercise&nbsp;Price</b></td> <td width="4%">&nbsp;&nbsp;&nbsp;&nbsp;</td> <td style="border-bottom: black 1px solid;" valign="bottom" align="center"><b>Weighted&nbsp;Remaining<br />Contractual&nbsp;Life&nbsp;(years)</b></td></tr> <tr bgcolor="#ccdaef"><td width="10%" align="right">$&nbsp;&nbsp;<font class="_mt">15.08</font>&nbsp;-&nbsp;<font class="_mt">16.33</font></td> <td> </td> <td width="10%" align="right">27,000</td> <td> </td> <td width="1%">$</td> <td width="9%" align="right">16.24</td> <td> </td> <td width="10%" align="right">2.8</td></tr> <tr><td align="right"><font class="_mt">31.27</font>&nbsp;-&nbsp;<font class="_mt">42.45</font></td> <td> </td> <td align="right">9,000</td> <td> </td> <td> </td> <td align="right">37.00</td> <td> </td> <td align="right">6.0</td></tr> <tr bgcolor="#ccdaef"><td align="right"><font class="_mt">51.04</font>&nbsp;-&nbsp;<font class="_mt">58.27</font></td> <td> </td> <td style="border-bottom: black 1px solid;" align="right">13,000</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">54.76</td> <td> </td> <td style="border-bottom: black 1px solid;" align="right">7.5</td></tr> <tr><td> </td> <td> </td> <td style="border-bottom: black 3px double;" valign="top" align="right">49,000</td> <td> </td> <td valign="top">$</td> <td valign="top" align="right">30.27</td> <td> </td> <td style="border-bottom: rgb(255,255,255) 3px solid;" valign="top" align="right">4.6</td></tr></table> </div> <div> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="50%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="8" align="center"><b>Year Ended March 31</b></td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2013</b></td> <td width="4%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2012</b></td> <td width="4%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2011</b></td></tr> <tr bgcolor="#ccdaef"><td>Risk-free interest rate</td> <td width="11%" align="right">0.7</td> <td width="2%">%</td> <td> </td> <td width="11%" align="right">1.0</td> <td width="2%">%</td> <td> </td> <td width="11%" align="right">1.6</td> <td width="2%">%</td></tr> <tr><td>Expected volatility</td> <td align="right">38</td> <td>%</td> <td> </td> <td align="right">42</td> <td>%</td> <td> </td> <td align="right">56</td> <td>%</td></tr> <tr bgcolor="#ccdaef"><td>Expected life (years)</td> <td align="right">4.1</td> <td>&nbsp;</td> <td> </td> <td align="right">4.1</td> <td>&nbsp;</td> <td> </td> <td align="right">4.2</td> <td>&nbsp;</td></tr> <tr><td>Dividend yield</td> <td align="right">0</td> <td>%</td> <td> </td> <td align="right">0</td> <td>%</td> <td> </td> <td align="right">0</td> <td>%</td></tr></table> </div> <div> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td rowspan="2" colspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="6" align="center"><b>Less Than 12 Months</b></td> <td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="6" align="center"><b>12 Months or Greater</b></td> <td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="6" align="center"><b>Total</b></td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Fair<br />Market<br />Value</b></td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>Gross<br />Unrealized<br />Losses</b></td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Fair<br />Market<br />Value</b></td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>Gross<br />Unrealized<br />Losses</b></td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>Fair<br />Market<br />Value</b></td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="3" align="center"><b>Gross<br />Unrealized<br />Losses</b></td></tr> <tr><td colspan="22">As of March 31, 2013</td></tr> <tr><td bgcolor="#ccdaef" width="12">&nbsp;</td> <td bgcolor="#ccdaef">Corporate bonds</td> <td bgcolor="#ccdaef" width="1%">$</td> <td bgcolor="#ccdaef" width="9%" align="right">1,171,976</td> <td bgcolor="#ccdaef" width="2%">&nbsp;</td> <td bgcolor="#ccdaef" width="1%">$</td> <td bgcolor="#ccdaef" width="8%" align="right">(4,187</td> <td bgcolor="#ccdaef" width="1%">)</td> <td bgcolor="#ccdaef" width="4%">&nbsp;</td> <td bgcolor="#ccdaef" width="1%">$</td> <td bgcolor="#ccdaef" width="9%" align="right">-</td> <td bgcolor="#ccdaef" width="2%">&nbsp;</td> <td bgcolor="#ccdaef" width="1%">$</td> <td bgcolor="#ccdaef" width="8%" align="right">-</td> <td bgcolor="#ccdaef" width="1%">&nbsp;</td> <td bgcolor="#ccdaef" width="4%">&nbsp;</td> <td bgcolor="#ccdaef" width="1%">$</td> <td bgcolor="#ccdaef" width="9%" align="right">1,171,976</td> <td bgcolor="#ccdaef" width="2%">&nbsp;</td> <td bgcolor="#ccdaef" width="1%">$</td> <td bgcolor="#ccdaef" width="8%" align="right">(4,187</td> <td bgcolor="#ccdaef" width="1%">)</td></tr> <tr><td>&nbsp;</td> <td>Municipal&nbsp;bonds&nbsp;&nbsp;</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">508,607</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">(9,155</td> <td style="border-bottom: black 1px solid;">)</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">-</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">-</td> <td style="border-bottom: black 1px solid;">&nbsp;</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">508,607</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">(9,155</td> <td style="border-bottom: black 1px solid;">)</td></tr> <tr><td bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef" valign="top">Total</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">1,680,583</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">(13,342</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">)</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">-</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">-</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">&nbsp;</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">1,680,583</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">(13,342</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">)</td></tr> <tr><td colspan="22">As of March 31, 2012</td></tr> <tr><td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef">Corporate bonds</td> <td bgcolor="#ccdaef">$</td> <td bgcolor="#ccdaef" align="right">10,387,955</td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef">$</td> <td bgcolor="#ccdaef" align="right">(76,434</td> <td bgcolor="#ccdaef">)</td> <td bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef" align="right">-</td> <td bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef" align="right">-</td> <td bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef">$</td> <td bgcolor="#ccdaef" align="right">10,387,955</td> <td bgcolor="#ccdaef">&nbsp;</td> <td bgcolor="#ccdaef">$</td> <td bgcolor="#ccdaef" align="right">(76,434</td> <td bgcolor="#ccdaef">)</td></tr> <tr><td> </td> <td width="122">Municipal bonds</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">-</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">-</td> <td style="border-bottom: black 1px solid; valign: ;">&nbsp;</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">908,550</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">(32,007</td> <td style="border-bottom: black 1px solid; valign: ;">)</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">908,550</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">(32,007</td> <td style="border-bottom: black 1px solid; valign: ;">)</td></tr> <tr><td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef" valign="top" width="122">Total</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">10,387,955</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">(76,434</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">)</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">908,550</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">(32,007</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">)</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">11,296,505</td> <td bgcolor="#ccdaef" valign="top"> </td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">$</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top" align="right">(108,441</td> <td style="border-bottom: black 3px double;" bgcolor="#ccdaef" valign="top">)</td></tr></table> </div> <div> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="5" align="center"><b>Year Ended March 31</b></td></tr> <tr><td style="border-bottom: black 1px solid;" width="11%" align="center"><b>2013</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" width="11%" align="center"><b>2012</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" width="11%" align="center"><b>2011</b></td></tr> <tr bgcolor="#ccdaef"><td>Weighted average common shares outstanding &#8211; basic</td> <td width="11%" align="right">4,839,810</td> <td colspan="2" align="right">4,796,227</td> <td colspan="2" align="right">4,729,035</td></tr> <tr><td colspan="6">Effect of dilutive securities:</td></tr> <tr bgcolor="#ccdaef"><td> <div style="margin-left: 9pt;">Stock options</div></td> <td align="right">21,934</td> <td colspan="2" align="right">60,075</td> <td colspan="2" align="right">108,121</td></tr> <tr><td> <div style="margin-left: 9pt;">Warrants</div></td> <td style="border-bottom: black 1px solid;" align="right">1,802</td> <td> </td> <td style="border-bottom: black 1px solid;" align="right">7,169</td> <td> </td> <td style="border-bottom: black 1px solid;" align="right">7,110</td></tr> <tr valign="top" bgcolor="#ccdaef"><td>Shares used in computing net income per share &#8211; diluted</td> <td style="border-bottom: black 3px double;" align="right">4,863,546</td> <td> </td> <td style="border-bottom: black 3px double;" align="right">4,863,471</td> <td> </td> <td style="border-bottom: black 3px double;" align="right">4,844,266</td></tr></table> </div> <div> <font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><b>NOTE 8. SEGMENT INFORMATION</b><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We operate in one reportable segment. We manufacture and sell spintronic products, and conduct contract research and development activities.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes customers comprising 10% or more of revenue for fiscal 2013, 2012, and 2011:<br />&nbsp;<br /></font> <div class="MetaData"> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="50%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="5" align="center"><b><font style="white-space: nowrap;" class="_mt">% of Revenue for Year Ended March 31</font></b></td></tr> <tr><td style="border-bottom: black 1px solid;" align="center"><b>2013</b></td> <td width="4%"> </td> <td style="border-bottom: black 1px solid;" align="center"><b>2012</b></td> <td width="4%"> </td> <td style="border-bottom: black 1px solid;" align="center"><b>2011</b></td></tr> <tr bgcolor="#ccdaef"><td>Customer A</td> <td width="11%" align="center">16%</td> <td> </td> <td width="11%" align="center">16%</td> <td> </td> <td width="11%" align="center">14%</td></tr> <tr><td>Customer B</td> <td width="12%" align="center">15%</td> <td> </td> <td width="12%" align="center">14%</td> <td> </td> <td width="12%" align="center">11%</td></tr> <tr><td bgcolor="#ccdaef">Customer C</td> <td bgcolor="#ccdaef" width="11%" align="center">14%</td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef" width="11%" align="center">*</td> <td bgcolor="#ccdaef"> </td> <td bgcolor="#ccdaef" width="11%" align="center">11%</td></tr></table> <table style="font-size: 4pt;" border="0" cellspacing="0" cellpadding="0" width="50%" align="center"> <tr><td style="border-bottom: windowtext 1pt solid; border-left: medium none; padding-bottom: 0pt; padding-left: 0pt; padding-right: 0.7pt; border-top: medium none; border-right: medium none; padding-top: 0pt;" width="85">&nbsp;</td> <td rowspan="2">&nbsp;</td></tr> <tr><td style="padding-bottom: 0pt; padding-left: 0pt; padding-right: 0.7pt; padding-top: 0pt;">&nbsp;</td></tr></table> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="50%" align="center"> <tr><td>*<font class="_mt">Less than 10%</font></td></tr></table></div><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt">&nbsp;<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Revenue by geographic region was as follows:<br />&nbsp;<br /></font> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="67%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" width="40%" colspan="8" align="center"><b>Year Ended March 31</b></td></tr> <tr><td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2013</b></td> <td width="3%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2012</b></td> <td width="3%"> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="center"><b>2011</b></td></tr> <tr bgcolor="#ccdaef"><td bgcolor="#ccdaef">United States</td> <td width="1%">$</td> <td width="16%" align="right">12,006,493</td> <td> </td> <td width="1%">$</td> <td width="16%" align="right">13,334,563</td> <td> </td> <td width="1%">$</td> <td width="16%" align="right">14,169,952</td></tr> <tr><td>Europe</td> <td> </td> <td align="right">10,666,338</td> <td> </td> <td> </td> <td align="right">10,798,146</td> <td> </td> <td> </td> <td align="right">12,009,294</td></tr> <tr bgcolor="#ccdaef"><td>Asia</td> <td> </td> <td align="right">3,979,862</td> <td> </td> <td> </td> <td align="right">4,130,930</td> <td> </td> <td> </td> <td align="right">4,576,270</td></tr> <tr><td>Other</td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">380,726</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">315,581</td> <td> </td> <td style="border-bottom: black 1px solid;" colspan="2" align="right">441,547</td></tr> <tr valign="top" bgcolor="#ccdaef"><td>Total Revenue</td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">27,033,419</td> <td> </td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">28,579,220</td> <td> </td> <td style="border-bottom: black 3px double;">$</td> <td style="border-bottom: black 3px double;" align="right">31,197,063</td></tr></table><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><br /></font> </div> 2474468 2380603 2240563 76720 80160 66720 P5Y 0.00 0.00 0.00 P4Y2M12D P4Y1M6D P4Y1M6D 0.56 0.42 0.38 0.016 0.010 0.007 1881138 6000 7.35 -4000 4000 -4000 4000 -4000 4000 1290440 170230 254500 10000 166230 175000 10000 162230 109000 10000 158230 49000 4000 17.28 16.28 21.54 16.28 25.85 16.28 30.27 29.69 9.56 16.93 24.23 42.45 58.25 54.11 <div> <b>Stock-Based Compensation</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We measure stock-based compensation cost at the grant date based on the fair value of the award and recognize the compensation expense over the requisite service period, which is generally the vesting period. We estimate pre-vesting option forfeitures at the time of grant by analyzing historical data and revise those estimates in subsequent periods if actual forfeitures differ from those estimates. Ultimately, the total expense recognized over the vesting period will only be for those awards that vest.<br /> </div> 15.08 51.04 31.27 49000 27000 13000 9000 30.27 16.24 54.76 37.00 P4Y7M6D P2Y9M18D P7Y6M P6Y 16.33 58.27 42.45 4700583 4776198 4824745 4862436 39427 40185 27386 <div> <font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><b>NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&nbsp;<br /><font class="_mt"><b>Cash and Cash Equivalents</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We consider all highly liquid investments with maturities of three months or less when purchased to be cash equivalents.</font></b>&nbsp;<br /><br /><font class="_mt"><b>Fair Value of Financial Instruments</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The carrying amount of cash and cash equivalents, accounts receivable, and accounts payable approximates fair value because of the short maturity of these instruments. Fair values of marketable securities are based on quoted market prices.</font> <br /><br /><font class="_mt"><b>Marketable Securities</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We classify securities with original maturities greater than three months and remaining maturities one year or less as short-term marketable securities and securities with remaining maturities greater than one year as long-term marketable securities. Securities not due at a single maturity date are classified by their average life. We classify all of our marketable securities as available-for-sale, thus securities are recorded at fair value and any associated unrealized gain or loss, net of tax, is included as a separate component of shareholders' equity, "Accumulated other comprehensive income (loss)." We use a specific-identification cost basis to determine gains and losses. The amortized cost of marketable securities is adjusted for amortization of premiums and accretion of discounts to maturity, both of which are included in interest income.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We consider an other-than-temporary impairment of our marketable securities to exist if we determine it is probable that we will be unable to collect all amounts due according to the contractual terms of a debt security. If we judged a decline in fair value for any security to be other than temporary, the cost basis of the individual security would be written down and a charge recognized in net income. We consider a number of factors in determining whether other-than-temporary impairment exists, including: credit market conditions; the credit ratings of the securities; historical default rates for securities of comparable credit rating; the presence of insurance of the securities and, if insured, the credit rating and financial condition of the insurer; the effect of market interest rates on the value of the securities; and the duration and extent of any unrealized losses. We also consider the likelihood that we will be required to sell the securities prior to maturity based on our financial condition and anticipated cash flows. We determined that no write-downs for other-than-temporary impairment were required on available-for-sale securities during fiscal 2013, 2012, or 2011.</font><br /><br /><font class="_mt"><b>Concentration of Risk and Financial Instruments</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Financial instruments potentially subject to significant concentrations of credit risk consist principally of cash equivalents, marketable securities, and accounts receivable.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have invested our excess cash in corporate-backed and municipal-backed bonds and other money market instruments. Our investment policy prescribes purchases of only high-grade securities, and limits the amount of credit exposure to any one issuer.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our customers are throughout the world. We generally do not require collateral from our customers, but we perform ongoing credit evaluations of their financial condition. More information on accounts receivable is contained in the paragraph titled "Accounts Receivable and Allowance for Doubtful Accounts" of this note.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additionally, we are dependent on critical suppliers including our packaging vendors and suppliers of certain raw silicon and semiconductor wafers that are incorporated in our products.</font><br /><br /><font class="_mt"><b>Accounts Receivable and Allowance for Doubtful Accounts</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable are recorded net of an allowance for doubtful accounts. We make estimates of the uncollectibility of accounts receivable. We specifically analyze accounts receivable, historical bad debts, and customer creditworthiness when evaluating the adequacy of the allowance. We had no charges or provisions to our allowance for doubtful accounts in fiscal 2013, 2012, or 2011.</font><br /><br /><font class="_mt"><b>Inventories</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first in, first out method. We record inventory reserves when we determine certain inventory is unlikely to be sold based on sales trends, turnover, competition, and other market factors.</font><br /></font><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt">&nbsp;<br /><font class="_mt"><b>Product Warranty</b><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In general we warrant our products to be free from defects in material and workmanship for&nbsp;<font class="_mt">one</font> year.<br /></font><br /><font class="_mt"><b>Fixed Assets</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fixed assets are stated at cost. Depreciation of machinery and equipment, and furniture and fixtures is recorded over the estimated useful lives of the assets, generally&nbsp;<font class="_mt">five</font> years, using the straight-line method. Amortization of leasehold improvements is recorded using the straight-line method over the lesser of the lease term or <font class="_mt">five</font>-year useful life. We record losses on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets' carrying amount. We have not identified any indicators of impairment during fiscal 2013, 2012, or 2011.<br /></font><br /><font class="_mt"><b>Revenue Recognition</b><br /><b><i>Product Revenue Recognition</i></b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We recognize product revenue on shipment because the terms of our sales are FOB shipping point, meaning that our customers (end users and distributors) take title and assume the risks and rewards of ownership on shipment. Our customers may return defective products for refund or replacement under warranty, and have other very limited rights of return.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shipping charges billed to customers are included in product sales and the related shipping costs are included in selling, general, and administrative expense. Such shipping costs were $<font class="_mt">27,386</font> for fiscal 2013, $<font class="_mt">40,185</font> for fiscal 2012, and $<font class="_mt">39,427</font> for fiscal 2011. <br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments from our distributors are not contingent on resale or any other matter other than the passage of time, and delivery of products is not dependent on the number of units resold to the ultimate customer. There are no other significant acceptance criteria, pricing or payment terms that would affect revenue recognition.<br /><br /></font><font class="_mt"><b><i>Accounting for Commissions and Discounts</i></b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We sometimes utilize independent sales representatives that provide services relating to promoting our products and facilitating product sales but do not purchase our products. We pay commissions to sales representatives based on the amount of revenue facilitated, and such commissions are recorded as selling, general, and administrative expenses.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our stocking distributors take title and assume the risks and rewards of product ownership. We presume consideration given to a customer is a reduction in revenue unless both of the following conditions are met: (i)&nbsp;we receive an identifiable benefit in exchange for the consideration and the identifiable benefit is sufficiently separable from the customer's purchase of our products such that we could have purchased the products or services from a third party; and (ii)&nbsp;we can reasonably estimate the fair value of the benefit received. We recognize discounts provided to our distributors as reductions in revenue. Under certain limited circumstances, our distributors may earn commissions for activities unrelated to their purchases of our products, such as for facilitating the sale of custom products or research and development contracts with third parties. We recognize any such commissions as selling, general, and administrative expenses.<br /></font><br /><font class="_mt"><b><i>Research and Development Contract Revenue Recognition</i></b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We recognize contract revenues pro-rata as work progresses. Our research and development contracts do not contain post-shipment obligations. Contracts may be either firm-fixed-price or cost-plus-fixed-fee. Firm-fixed-price contracts provide for a price that is not subject to any adjustment based on our cost in performing the contract.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost-plus-fixed-fee contracts are cost-reimbursement contracts that also provide for payment to us of a negotiated fee that is fixed at the inception of the contract. The costs for which we earn reimbursement are the actual costs incurred and are recorded in the period in which they are incurred. We recognize the contract fees pro-rata as work progresses.<br /></font><br /><font class="_mt"><b>Income Taxes</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We account for income taxes using the liability method. Deferred income taxes are provided for temporary differences between the financial reporting and tax bases of assets and liabilities. We provide valuation allowances against deferred tax assets if we determine that it is less likely than not that we will be able to utilize the deferred tax assets.<br /></font><br /><font class="_mt"><b>Research and Development Expense Recognition</b><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development costs are expensed as they are incurred.<br /></font><br /><font class="_mt"><b>Stock-Based Compensation</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We measure stock-based compensation cost at the grant date based on the fair value of the award and recognize the compensation expense over the requisite service period, which is generally the vesting period. We estimate pre-vesting option forfeitures at the time of grant by analyzing historical data and revise those estimates in subsequent periods if actual forfeitures differ from those estimates. Ultimately, the total expense recognized over the vesting period will only be for those awards that vest.<br /></font></font><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt">&nbsp; </font> <div class="MetaData"><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><b>Net Income Per Share</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income per basic share is computed based on the weighted-average number of common shares issued and outstanding during each year. Net income per diluted share amounts assume conversion, exercise or issuance of all potential common stock instruments (stock options and warrants). Stock options and warrants totaling&nbsp;<font class="_mt">5,000</font> for fiscal 2013;&nbsp;<font class="_mt">5,000</font> for fiscal 2012; and&nbsp;<font class="_mt">1,000</font> for fiscal 2011 were not included in the computation of diluted earnings per share because the exercise prices were greater than the market price of the common stock. The following table reflects the components of common shares outstanding:</font><br /><br /> <table style="font-family: Times New Roman; font-size: 10pt;" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr><td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr><td rowspan="2"> </td> <td style="border-bottom: black 1px solid;" colspan="5" align="center"><b>Year Ended March 31</b></td></tr> <tr><td style="border-bottom: black 1px solid;" width="11%" align="center"><b>2013</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" width="11%" align="center"><b>2012</b></td> <td width="2%"> </td> <td style="border-bottom: black 1px solid;" width="11%" align="center"><b>2011</b></td></tr> <tr bgcolor="#ccdaef"><td>Weighted average common shares outstanding &#8211; basic</td> <td width="11%" align="right">4,839,810</td> <td colspan="2" align="right">4,796,227</td> <td colspan="2" align="right">4,729,035</td></tr> <tr><td colspan="6">Effect of dilutive securities:</td></tr> <tr bgcolor="#ccdaef"><td> <div style="margin-left: 9pt;">Stock options</div></td> <td align="right">21,934</td> <td colspan="2" align="right">60,075</td> <td colspan="2" align="right">108,121</td></tr> <tr><td> <div style="margin-left: 9pt;">Warrants</div></td> <td style="border-bottom: black 1px solid;" align="right">1,802</td> <td> </td> <td style="border-bottom: black 1px solid;" align="right">7,169</td> <td> </td> <td style="border-bottom: black 1px solid;" align="right">7,110</td></tr> <tr valign="top" bgcolor="#ccdaef"><td>Shares used in computing net income per share &#8211; diluted</td> <td style="border-bottom: black 3px double;" align="right">4,863,546</td> <td> </td> <td style="border-bottom: black 3px double;" align="right">4,863,471</td> <td> </td> <td style="border-bottom: black 3px double;" align="right">4,844,266</td></tr></table><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt">&nbsp;<br /></font></div><br /><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><font class="_mt"><font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><b>Use of Estimates</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.<br /></font></font><br /><b>Recently Issued Accounting Standards</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We have adopted all applicable recently issued accounting pronouncements.<br /><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In January 2013, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2013-02, <i>Reporting of Amounts Reclassified out of Accumulated Other Comprehensive Income</i> (ASU No. 2013-02), which requires an entity to report the effect of significant reclassifications out of accumulated other comprehensive income. ASU No. 2013-02 is effective for reporting periods beginning after December&nbsp;15, 2012, which will be our first quarter of fiscal 2014. The adoption of ASU No. 2013-02 will affect the presentation of comprehensive income but will not impact our financial condition or results of operations.<br /></font> </div> <div> <b>Product Warranty</b><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In general we warrant our products to be free from defects in material and workmanship for&nbsp;<font class="_mt">one</font> year.<br /> </div> 81458858 93984608 55953294 1129726 20169924 47006 34606638 69970549 1060438 20894766 47762 47967583 81458858 1087456 20974477 48247 59348678 93984608 1557726 21200742 48624 71177516 <div> <p><font size="2" class="_mt"><strong>NOTE 10. STOCK REPURCHASE PLAN<br /></strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our authorized stock is stated as&nbsp;<font class="_mt">six</font> million shares of common stock, $<font class="_mt">0.01</font> par value, and&nbsp;<font class="_mt">ten</font> million shares of all types. Our Board may designate any series and fix any relative rights and preferences to authorized but undesignated stock. We have an outstanding authorization from our Board to purchase up to $<font class="_mt">2,500,000</font> of our common stock, all of which remained available as of March&nbsp;31, 2013.</font><br /></p> </div> 83500 70000 64000 2500000 <div> <font style="font-family: Times New Roman; font-size: 10pt;" class="_mt"><b>Use of Estimates</b> <br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.<br /></font> </div> 4844266 4863471 4863546 4729035 4796227 4839810 Less than 10% EX-101.SCH 7 nvec-20130331.xsd SCHEMA DOCUMENT 00100 - Statement - Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Statements of Income link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 00500 - Statement - Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - Summary of Significant Accounting Policies (Schedule Of Weighted Average Number Of Shares) (Details) link:presentationLink link:calculationLink link:definitionLink 40403 - Disclosure - Marketable Securities (Amortized Cost And Approximate Fair Values Of Marketable Securities) (Details) link:presentationLink link:calculationLink link:definitionLink 40404 - Disclosure - Marketable Securities (Gross Unrealized Losses And Fair Values Of Investments By Investment Category And Length Of Time) (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 40702 - Disclosure - Income Taxes (Schedule Of Income Tax Provisions) (Details) link:presentationLink link:calculationLink link:definitionLink 40703 - Disclosure - Income Taxes (Schedule Of Reconciliation Of Income Tax Provisions) (Details) link:presentationLink link:calculationLink link:definitionLink 40704 - Disclosure - Income Taxes (Schedule Of Deferred Tax Assets And Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Statements of Shareholders Equity link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - Description of Business link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - Stock Repurchase Plan link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - Information as to Employee Stock Purchase, Savings, And Similar Plans link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - Summary of Significant Accounting Policies (Policy) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - Marketable Securities (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - Marketable Securities (Fair Value Of Marketable Securities By Maturity) (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - Stock-Based Compensation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - Stock-Based Compensation (Schedule Of Valuation Assumptions) (Details) link:presentationLink link:calculationLink link:definitionLink 40604 - Disclosure - Stock-Based Compensation (Summary Of Options Outstanding) (Details) link:presentationLink link:calculationLink link:definitionLink 40605 - Disclosure - Stock-Based Compensation (Summary Of Stock Options And Warrants) (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - Income Taxes (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - Segment Information (Schedule Of Revenue By Major Customers) (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - Segment Information (Schedule Of Revenue By Geographic Region) (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - Stock Repurchase Plan (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - Information as to Employee Stock Purchase, Savings, And Similar Plans (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 nvec-20130331_cal.xml CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 nvec-20130331_def.xml DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 nvec-20130331_lab.xml LABELS LINKBASE DOCUMENT EX-101.PRE 11 nvec-20130331_pre.xml PRESENTATION LINKBASE DOCUMENT GRAPHIC 12 logo-10k.gif NVE LOGO begin 644 logo-10k.gif M1TE&.#EAA``:`+,``,[8[][G]P!&K5*"QEJ)SM;@[S]XPF*1SIVZX/#U_'*? MU<78[];G]\[@[________R'Y!`$```\`+`````"$`!H```3_T,D9FK5A:IH\20%HD%";#IQ"LGM2:U: MK2[-@3C@*8A&`G%W=`Q_M<#U21ZLWW#G348327X42D>;.A-U.`.RL[2T ME@NUN;J[O+VU9!JMJ1J4`!I-/*@Y71*8:&70T=+3TWE->Q);SQ/6.%D:W883 MI#C8U.?HZ1M5P&:9&\+M$N25Q$26ZOGZT0U5S!SW-E#"]PJ,!C$_Y.U;R)!2 M.!?T1($@0D`@$8GN$B[8R+'C1E,-_SR*'$FRI$F/)+0)"CB)"(,-SLIIB"G` MG!I$IE2"VJF'!*PEL(HX0)C#IT$)\2P6^N>`I],41(R5H#A" MV!I\-Y_RQ-CC(L!,8:&0J"J!J+<1X=8`\RH6T1UX1%SHK#2&!+TH?QDU(4"X ML.'"61`H6,RXL>/'D"-+=FR*V[N)/]R*$_RC2U`2_2XS'+V09D7+3\QI",K6 M!DO2L-6%%F3O2=0-FE=A'1:[-S5*\JB0G4`WQUTZ1`KX7BYM;V4^;([0^W%[ M`DT!!;)KW[[=2`/NX,.+'T^>N]&>,)\\UY#VZ(CI;^X&K;MT1'N"$_;6A/9D M.-)/$K1'7TDA9+6V`0!-X`?7-67$M08SE`P8AT(/\<`:-%XI)!4BEC@HX1KK F(7#`B".N%R")(RI7Q@(H'J`@>RW&*..(9(@XXXTXYHBC@A$``#L_ ` end GRAPHIC 13 stkgraph.gif STOCK PRICE PERFORMANCE GRAPH begin 644 stkgraph.gif M1TE&.#EA^`&W`-4``````/____8+#O'+U[Q)<9@G5;,I9K`56\53AM%UGMB- MK^*OQN_O\-S?[P!&K1!1L2!?6IK*I"2&-SEF/%IE*E)23_7T M\VA4399!)*HF$O\``.8A'O]`0/Q86/]^?OZ:F?ZOK_^_O]_?W\_/S[^_OZ^O MKY^?GX^/CW]_?W!P<&!@8$!`0"HJ*A`0$"P`````^`&W```&_\"`<$@L&H_( MI'+);#J?T*AT2JU:K]BL=LOM>K]*&GA,+IO/Z+1ZS6Z[CPQ<;E<+['P[X:W7 M$^=L.6^"@X2%AH>(B6XZ-S8,-HX!)W4Z0S65.76*FYR=GI^@H5KK[.WN[_#Q\O/K5-6PT*]#.@PU@3J:D@!0 M1K"@P8.T!DZ1,X?!'CXV;OP1$^!/+R4*$6KK`@5FUG,BV?`R#1@GIB!!@N&_@]`^MMO`0H3+H"]7 MGI#X`F,4FY>@8&PA<64(H6,[>."X;NK;11I0^*SW@>'%DRO+-OR@,H7$C&MW MC8PAN`3?PQU`J)QX<6/>LY6_T8P;*@8*L/5.N-`@[X4DJS%<2#Q!`O;ATR4< MMZ[=9?KU%2J_EST:.6/5G]%V5G>#H7#!!-#-1@$&J`WQU7E4,-<:91*$%UT$ MU%5@&H/),.?_7(*RQ3=?&BET@N2),NKT7@07U(>(C>\)%-YMQ_D6)A%R`)3%C MC586AV,%)`HUU9)6?6>A`^-I.19KKKEGY6$96M>@7WL)P5AS%0`YYY"E&9F( MDEL0BN9&!E*08%D<P6M%KK+.H:=@$4(I5V*Z\G@DL M2HDN2L$%#:K%%K+)5A%-H_>HMD?-M!@0PV.^)!*'CO\:X=(2+A;[QO"ZB5!L0<;I!D.S03` MP+4`X>",#3A8_,HN`C5LS&J*]C9>M!X7Q)T.K!!123##L&P#,1V7/,NVH+[H MK^-&%PWDX86'-;C!*.TN!1,*[X$?%V:_;C,BE+.63@&5;VY2XY_H3G!Y-< M1,)MX\CDA#S;T1Z!PJEX1B$[][[5O/VNDV6\????*Z_;B!JO?SSYLV-PZ@2]VP]4^P4SW@4L-"__)06`4ID="BH0 MG@=40'L&_!_^"/>]MD#``A",H`0-@<"KF,^"U-+@43I8!!)Z)W[]$^$!)U@R M_?TEA2I<(0?S-L"_3"Z&&QP0SA;8P`?BD"LF'$(0$2(R*$IGH$O@I#(91K`IW_-$W/0R!!D$3@[X(%L!LN7`N6,SB4QBP@0T` M``=MC,(-&J&N&OC_8`@X4!<#`.:W,L:JAG.YH1J/`@(.&-*0'HA"#J81`(KT M0`@,T(4>3#''Y*&)AXCSX2#34LA#@?$(T`$&,7PH!()74V/1NDX.EM44"4)0E3N0P31)<\Y`= M\,`';(E-13["%0'H92.C88H]VJ&/"=S,&=V21G6F!`6T!($'1/!.#L13`R"( M(Q$Z>>41:ZJ1-H+@`SE]YTY'L`&`7F&*0:7` M^8A:$#:.0*$,?6<\YRG1(\'4*0.5'U4_=M*4:M4#+'7I&J#*E0NU@,@8*I3.;%8I.@&.K"D&P,FRUH$7#:7$%UH0[<: M4XQ`VO>,=[``,0P+S(7?_`:+WBW#9>-;I(12E*54K? M:X*VI=4"JD_<:L-#=?>WP34`>2=[W.0.P`;AY8%R`7M<`0_8`.9-@`*6*X3V M/C>Z\IUN?3<,SPR#-KIWW4!6#VE;C93V)H`L"TFYLF`%-'C`!RCPA"EXR)TQ%$)P3>INF`0E.(&0R3OD$[B9!XRPL!HLO($M'^/$ M'2D/$4X+0CL'I=#%VFMA-T*6\#G1>57I+8#_CROH2BO@TIE6S09&@-0E5_D*#+@T@P,]8`*8^M)^ MEJ%^'04=#%T1*:+^[G!K?6M,7^&D9D;D!YB*T&NJ`=`PMK6E!Y!K]EU95I'J MJT9\2^,D_/>[DQZOM$]-[2P@6ZD0;:H1&`!BZ!("VL2>=K5/LNECP*D]:U(8 MEH=]@`000;FC#K=X9:Q<+AQ:`XGN\%V5`6_RCAO71I!L>;N]D7J+(C+KH4R0 M9.,ZC4B\M0@0>'$)3G$L()354S;D5O%[D@4'E]_B#O/'RSOO6E@<$3."%*IP MM!C',"\['8%Y>,%LX#&1LDTZ<*#:#R_4/=("&%Y!V&``B8= M;@/4?`D'3[E#[_MJM@0`'\-@#8`["` M0".@Y%,X.5*3O?+""P8%M#;`VD,Q@!FX_O4Q@('L9^^"VMO>!2S(?>YC,(4X MB(1@@-/'3Z^0'BI1ZD42R'I!D=)YXB)@]5L8NR?1JG1@#>`%:7@][&<_^Q?< MOO:Z#[_XQT]^\K=`"AUEF1V'(#>Y>2D#E8>3QJ]>=]F)90!IGRP!%O#W&M=2 MMI\548F')B_``J`W!*VG?3+`?;+G?=\G`.47@1(H?O\"\'TN\`(,"`,RH'VN M%P`M$'Z\!P4ZX`J:8$JPD$U6$? MP'*R@`("``-=@(3:IX2T9X&V%X6$6(@LT(3?EX%6R($'Z`8)J'U2$$FI)`1A MN$ICN&=HJ!<9L(FK<`+/](E.$US$I0+E8&8:=DUH5@*@B`X)D``%N(>`Z("" M:(BT2(LK<(NXF(N`N(5Z4P7_-L`#O6!*>=0S&2,,-\`Q1/!SFG@"!Z`".Y`# MK)0M,U=I4>!..@5:%P$*?[B$M=B-C">(M0>(LN//@$JR9X'H"':Z!]L1>(@^B-+%"!$*A[ M5,B`&^B',X"%;)"!^>@1F@$(.=`+8/0UD,"1['($+W``;9$!+6``'F`"*["0 MNG>/%\=:FM>(1,``(7!+J&@"AB2'7D&0W.>$"'F(M\=]B]B!1*"'X8=] M&J0B/<@$K6/1'AZS4=9"0!]2D"5B19/(\`` M*:4"_RS@3CII!$>X?0;I`EA9B[?7D!H(B58@`Q8H0O5&D]5D`BKPA"NI@1+Y M$@LPC?S'!/^(31%%!!M@`Q!8DB\@BW#YDW/)?0\9E7&5)'K%62)``GX)F%DI MF%RVCP30CTK`E]35`7<8+0.P@"X`FE!8F;.G?3*9F5IQ95-Y2Y[YE^*GE8-9 M52_IE8TXE1^0FAH0`MQ'8`C`PE)AIFZ(@=4B0F+L)F[YY$RBP`&[8 MB)PU91[`5*T'`]XW?A7XG#`@?K4IG:1U;4>P`57)`=?9FZ*)$EU)8&`YDR-0 MAR+P`3BPG'%YB!@8G4(@F2X0@NQY6XX':S6)2_-IC\^YGO_%H(.L59H0E)NI MZ9?E.7[W:(4)FE\IX@6)*9]^68^ZUP(O$`,2RES[J'FCQ9F'M)LI:9Y:N:(? M>F?N"07$:5@E*GXHJJ*W<'G=:00C:@(E&J`7B(^_Z1$+I$WY(@3ZTI&:``G\ MTI%+V1W4F06H>4@]NH4I:J.#<)\Q!I:Y:94JL`*P&9H>:BR?T25)4`,_H`D[ MT`\`<"V-D$]0JH++DJ5<`*-<>J8^^J6<4)B3MG\D$P(XL`-G&J`HJH%@BBO8 MX:9(L`K10`PG@"[L"$E7BAM\Z@48ZDE=>J*"^FXM:IH!H)P&8*+VF*(1J1:) M\:JONA]$`JL:8@1!DTK$8`./Y!#_E/@,'M.I8\``^YE+GQFH0+H&;0B38#>> M&QI^YWFL?#$G_&&K`=`#T`A,-'`#O@0)T9@MP&H&\)EH#ZI[`C"J8["=M$99 M&#B9%#B@CUH5M!JKEW$IM$HME1!))X!'<#8$IK2IG)JC9_"IAU0"?AF7Y0JM M6D"HD]4"+1"@++`"*E":IKR M.(E(3'6C_VA"M8;@IX:$9LR8M>9GGBV@`B9@C8;4GQ-KMIN!MH@@L&L;M`?` ML`;+L')+MPYUG$N*MUH$L)X@K%.69FBI>R:`9)Y$EE`;-F#Z"!/3!$]J"E%* MI>72>Y!`1GB40R%J4O$IGUBY`H-.@"N7R")CPN5-P M`WEP!+;[$WHK"E.I`[EXBZOI/[B'H$PP@EY$`X_02)I``YK`,KLZ#!+32%`J MO0%0`Q2AO=L;";YPKPR0"I"DJU"JL]RC!:+;.#;E;,9#F47@A?RPO0K<=H"M0[!"_C"X^T2/C[!X^4+XS0-\,8O@P`9[G02'WS`_^O`$8^HPLL MDQ*$$@=S4`R+@$^G(M_,+-4_"D3*`OZ/>11<"K3@K0 M7!"\\>P%`W!<"6!G.J".^6H$O^L$.W,MDWA1WL9(3#"[4:!/1^##]T;#`Y6L)/Y,O8C`Q MY"LQ4TH,0=U(QMRKV*O"YVM*W*NYE6`##TT$WMO4[+N@)!VPP75<6AURX65K M6UU@11#20M`W_X^$40SP`PQP`K4<-&DMR@F<+CW`O__$`]+;#(Y\NSNP+ZP0 MI7G`#SUP"<'02PQ\1_F<2O_K,W)PQ"-H1Z;``QO;2,V``ZF4->:KK?D[T;9\ M!%4<-/Q`R3K0`W1MV4=]SMMQU<_F=$YG`$70`\$7RHZMPRU,QC8LTXX0IT_= MUE2,"I5``_G:R)#0![N]PEJ_08,,&G^%L51K=<.L4>/'-L`<]T2`=_/<,9VX`Q=O-ZFG$^F MG$JFP`K\XM_#[0QY$.#1\(Y$D`-1C>"]:L)GS+W[LB_>1`3W_0HC?M][7 MG%<7;H2`E9]*X`^0P$\_W,OW>\K%G9%SA,N0E#'7\C9RD$>P#`T8@RY9L\*3 M\`J1+,L2@0.\_`=U(`?C>\71P..C)`9\0P27X#-J@PHUP`.2K2]J?,3"O6ZN M/`3`>,5TSN9K;$D6_N0X`T;9N^?V,M*2CAMSD+.\K<_3B>F9;K8&'>H?.NJD M7@9Q@"ZFW+'!I[_&^`=94P0J"`D=JP<`@03_&2."!+/"`8'%W,SK"0'JISYF M[7:W$@,`Z`(SD93+]PK;Y5+1R\Y^=9#6JYT$1Z[9\6NKP5?D*L/DGF#JP]X$ M<>@$)V#",+-(NV!'T5""P*0)Z"X$-1#5&7G@V7H).?TR`%$'3XHQ@$#7^Q(( MNQ`1E;KMWUOBC035\=TWCR#DG0#NX3X$3`Q=IACQ(6"K#0XSI`3&>QPQ2`T, MEAI)SQ#A/;ZK_I+8E;#5OWP6+!D#651WV0'^]HS>"2N>UGFM]8]D,84,PV3,"*J4O]A;+ARM6&>/]DDP[DS@ M3Q(#P370NTO$+[V0!^L-XMNK^0!0!XXM,:0T!"`/\KSKXHD*\M!XIXX]"?,;#,X@$37@,XVP[H\@#!OE#V;]D50:NNH""+$. M"!/C"!\%^<1?_!Q!R_4,%PYO_[(`!+7`D%@T'I%)Y9+9=#ZA1$`TRJ`&IO]7 M[9;;]7[!8?&87#:?T>EDEGS+Z6@!V[S)5M_Q>?V>W_?_`=?*:7.YN[V_P:_+XFQN M9$4);7NW6M>=VMT;X[7@YY'JM61M%A7[U>V?X`-81.!`+`8#(JQCI@8.*T-F M+50H;R+%BO1(HDX1`@#(408,>W_]'0J$:=0ETJJ\9&&E:U% MHG8-\)7I1[)C5P:Z2D0(C:@!WK8-^W9NI;-BLS(P"[%(5KJ5UDIU"[:(7*A_ MAPRF=-=*WKUR^A(>$IB)CAT]B."@H>-$K;$^BN#8=R(1C1P,:IE&/?8TCTDX M7CT4!=N'%=2>`XC:\2J.#@8Y>O^.QPTN4(>8[L2G,1/00(L^"G!`2 M$ADY34(BA('PJ1WF.%$T'HN8+Q(3+* MW")RSDPFE.ONH1SZHY"($XE(Q#E9]K2!@1YRH"H2&AZDH3]"B8@3KCJS\ZP' M11]]T$I(Z#1Q,AX^XG*R6IQS#E(JVRNT/T7/E)-)U&;Y=$M+*@T`3P,SO=,J M3D$EM1/0& M'VIQ]EK/%*WV1$@_/>$&'(Q\1%DK=JSAA/F&@S M1Z;Z>W`1D1'IRH>W(*$!,SP36]C2%6?LA(<8;=RWDHXM+(*]>5F^X:D'@U04 M:(%7#LTS83;^K;M9Q@75:4IP?FMGYWK^>8B@AB\SZ/N1!&;!KQM2[(U8NWNNB.D M-;T>%)IQP$XC5NM2TY9Y#LW08\3*224IO(C#"<9!<5AK[G9TNR,O8G)A*C?P MX.G[J-U$B4BX_^Z'_/[7_,17/=DH*7S%.U[SVC<9$"%/?B6:P_V8IK^D3)""%;3@ )!3&8P3\$`0`[ ` end XML 14 R39.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes (Schedule Of Income Tax Provisions) (Details) (USD $)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Income Taxes [Abstract]      
Current, Federal $ 5,314,876 $ 4,847,082 $ 5,761,632
Current, State 377,215 407,913 504,408
Deferred, Federal 34,718 (17,233) 56,996
Deferred, State 810 4,382 7,215
Income tax provision $ 5,727,619 $ 5,242,144 $ 6,330,251
XML 15 R46.htm IDEA: XBRL DOCUMENT v2.4.0.6
Information as to Employee Stock Purchase, Savings, And Similar Plans (Details) (USD $)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Information as to Employee Stock Purchase, Savings, And Similar Plans [Abstract]      
Percentage of employer matching contributions 100.00%    
Percentage of participants' salary 3.00%    
Employer matching contributions $ 105,370 $ 109,126 $ 110,268
XML 16 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
Inventories (Details) (USD $)
Mar. 31, 2013
Mar. 31, 2012
Inventories [Abstract]    
Raw materials $ 1,312,011 $ 1,285,106
Work in process 1,533,951 1,658,467
Finished goods 775,630 585,803
Inventory, Gross, Total 3,621,592 3,529,376
Less inventory reserve (285,000) (300,000)
Inventory, Net, Total $ 3,336,592 $ 3,229,376
XML 17 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 18 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Commitments and Contingencies (Tables)
 12 Months Ended
Mar. 31, 2013
Commitments and Contingencies [Abstract]  
Schedule Of Future Minimum Lease Payments
Year Ending March 31
2014 2015 2016 2017 2018 2019 2020 2021 Total
$ 266,496 $ 269,269 $ 271,938 $ 272,953 $ 277,012 281,124 $ 285,396 $ 216,451 $ 2,140,639
XML 19 R42.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Schedule Of Revenue By Major Customers) (Details)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Customer A [Member]
      
Revenue, Major Customer [Line Items]      
Percentage of Revenue 16.00% 16.00% 14.00%
Customer B [Member]
      
Revenue, Major Customer [Line Items]      
Percentage of Revenue 15.00% 14.00% 11.00%
Customer C [Member]
      
Revenue, Major Customer [Line Items]      
Percentage of Revenue 14.00%    [1] 11.00%
[1] Less than 10%
XML 20 R37.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Summary Of Stock Options And Warrants) (Details) (USD $)
 12 Months Ended
Mar. 31, 2013
Option Shares Reserved [Member]
Mar. 31, 2012
Option Shares Reserved [Member]
Mar. 31, 2011
Option Shares Reserved [Member]
Mar. 31, 2013
Options [Member]
Mar. 31, 2012
Options [Member]
Mar. 31, 2011
Options [Member]
Mar. 31, 2013
Warrants [Member]
Mar. 31, 2011
Warrants [Member]
Mar. 31, 2010
Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Options Outstanding, Beginning 162,230 166,230 170,230 109,000 175,000 254,500 10,000 10,000 10,000
Granted (4,000) (4,000) (4,000) 4,000 4,000 4,000      
Exercised       (64,000) (70,000) (83,500)      
Terminated             (6,000)    
Options Outstanding, Ending 158,230 162,230 166,230 49,000 109,000 175,000 4,000 10,000 10,000
Weighted Average Option Exercise Price, Beginning       $ 25.85 $ 21.54 $ 17.28 $ 16.28 $ 16.28 $ 16.28
Granted       $ 54.11 $ 58.25 $ 42.45      
Exercised       $ 24.23 $ 16.93 $ 9.56      
Terminated             $ 7.35    
Weighted Average Option Exercise Price, Ending       $ 30.27 $ 25.85 $ 21.54 $ 29.69 $ 16.28 $ 16.28
XML 21 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies
 12 Months Ended
Mar. 31, 2013
Summary of Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES 
Cash and Cash Equivalents
     We consider all highly liquid investments with maturities of three months or less when purchased to be cash equivalents. 

Fair Value of Financial Instruments
     The carrying amount of cash and cash equivalents, accounts receivable, and accounts payable approximates fair value because of the short maturity of these instruments. Fair values of marketable securities are based on quoted market prices.

Marketable Securities
     We classify securities with original maturities greater than three months and remaining maturities one year or less as short-term marketable securities and securities with remaining maturities greater than one year as long-term marketable securities. Securities not due at a single maturity date are classified by their average life. We classify all of our marketable securities as available-for-sale, thus securities are recorded at fair value and any associated unrealized gain or loss, net of tax, is included as a separate component of shareholders' equity, "Accumulated other comprehensive income (loss)." We use a specific-identification cost basis to determine gains and losses. The amortized cost of marketable securities is adjusted for amortization of premiums and accretion of discounts to maturity, both of which are included in interest income.

     We consider an other-than-temporary impairment of our marketable securities to exist if we determine it is probable that we will be unable to collect all amounts due according to the contractual terms of a debt security. If we judged a decline in fair value for any security to be other than temporary, the cost basis of the individual security would be written down and a charge recognized in net income. We consider a number of factors in determining whether other-than-temporary impairment exists, including: credit market conditions; the credit ratings of the securities; historical default rates for securities of comparable credit rating; the presence of insurance of the securities and, if insured, the credit rating and financial condition of the insurer; the effect of market interest rates on the value of the securities; and the duration and extent of any unrealized losses. We also consider the likelihood that we will be required to sell the securities prior to maturity based on our financial condition and anticipated cash flows. We determined that no write-downs for other-than-temporary impairment were required on available-for-sale securities during fiscal 2013, 2012, or 2011.

Concentration of Risk and Financial Instruments
     Financial instruments potentially subject to significant concentrations of credit risk consist principally of cash equivalents, marketable securities, and accounts receivable.

     We have invested our excess cash in corporate-backed and municipal-backed bonds and other money market instruments. Our investment policy prescribes purchases of only high-grade securities, and limits the amount of credit exposure to any one issuer.

     Our customers are throughout the world. We generally do not require collateral from our customers, but we perform ongoing credit evaluations of their financial condition. More information on accounts receivable is contained in the paragraph titled "Accounts Receivable and Allowance for Doubtful Accounts" of this note.

     Additionally, we are dependent on critical suppliers including our packaging vendors and suppliers of certain raw silicon and semiconductor wafers that are incorporated in our products.

Accounts Receivable and Allowance for Doubtful Accounts
     Accounts receivable are recorded net of an allowance for doubtful accounts. We make estimates of the uncollectibility of accounts receivable. We specifically analyze accounts receivable, historical bad debts, and customer creditworthiness when evaluating the adequacy of the allowance. We had no charges or provisions to our allowance for doubtful accounts in fiscal 2013, 2012, or 2011.

Inventories
     Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first in, first out method. We record inventory reserves when we determine certain inventory is unlikely to be sold based on sales trends, turnover, competition, and other market factors.
 
Product Warranty
     In general we warrant our products to be free from defects in material and workmanship for one year.

Fixed Assets
     Fixed assets are stated at cost. Depreciation of machinery and equipment, and furniture and fixtures is recorded over the estimated useful lives of the assets, generally five years, using the straight-line method. Amortization of leasehold improvements is recorded using the straight-line method over the lesser of the lease term or five-year useful life. We record losses on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets' carrying amount. We have not identified any indicators of impairment during fiscal 2013, 2012, or 2011.

Revenue Recognition
Product Revenue Recognition
     We recognize product revenue on shipment because the terms of our sales are FOB shipping point, meaning that our customers (end users and distributors) take title and assume the risks and rewards of ownership on shipment. Our customers may return defective products for refund or replacement under warranty, and have other very limited rights of return.

     Shipping charges billed to customers are included in product sales and the related shipping costs are included in selling, general, and administrative expense. Such shipping costs were $27,386 for fiscal 2013, $40,185 for fiscal 2012, and $39,427 for fiscal 2011.

     Payments from our distributors are not contingent on resale or any other matter other than the passage of time, and delivery of products is not dependent on the number of units resold to the ultimate customer. There are no other significant acceptance criteria, pricing or payment terms that would affect revenue recognition.

Accounting for Commissions and Discounts
     We sometimes utilize independent sales representatives that provide services relating to promoting our products and facilitating product sales but do not purchase our products. We pay commissions to sales representatives based on the amount of revenue facilitated, and such commissions are recorded as selling, general, and administrative expenses.

     Our stocking distributors take title and assume the risks and rewards of product ownership. We presume consideration given to a customer is a reduction in revenue unless both of the following conditions are met: (i) we receive an identifiable benefit in exchange for the consideration and the identifiable benefit is sufficiently separable from the customer's purchase of our products such that we could have purchased the products or services from a third party; and (ii) we can reasonably estimate the fair value of the benefit received. We recognize discounts provided to our distributors as reductions in revenue. Under certain limited circumstances, our distributors may earn commissions for activities unrelated to their purchases of our products, such as for facilitating the sale of custom products or research and development contracts with third parties. We recognize any such commissions as selling, general, and administrative expenses.

Research and Development Contract Revenue Recognition
     We recognize contract revenues pro-rata as work progresses. Our research and development contracts do not contain post-shipment obligations. Contracts may be either firm-fixed-price or cost-plus-fixed-fee. Firm-fixed-price contracts provide for a price that is not subject to any adjustment based on our cost in performing the contract.

     Cost-plus-fixed-fee contracts are cost-reimbursement contracts that also provide for payment to us of a negotiated fee that is fixed at the inception of the contract. The costs for which we earn reimbursement are the actual costs incurred and are recorded in the period in which they are incurred. We recognize the contract fees pro-rata as work progresses.

Income Taxes
     We account for income taxes using the liability method. Deferred income taxes are provided for temporary differences between the financial reporting and tax bases of assets and liabilities. We provide valuation allowances against deferred tax assets if we determine that it is less likely than not that we will be able to utilize the deferred tax assets.

Research and Development Expense Recognition
     Research and development costs are expensed as they are incurred.

Stock-Based Compensation
     We measure stock-based compensation cost at the grant date based on the fair value of the award and recognize the compensation expense over the requisite service period, which is generally the vesting period. We estimate pre-vesting option forfeitures at the time of grant by analyzing historical data and revise those estimates in subsequent periods if actual forfeitures differ from those estimates. Ultimately, the total expense recognized over the vesting period will only be for those awards that vest.
 
Net Income Per Share
     Net income per basic share is computed based on the weighted-average number of common shares issued and outstanding during each year. Net income per diluted share amounts assume conversion, exercise or issuance of all potential common stock instruments (stock options and warrants). Stock options and warrants totaling 5,000 for fiscal 2013; 5,000 for fiscal 2012; and 1,000 for fiscal 2011 were not included in the computation of diluted earnings per share because the exercise prices were greater than the market price of the common stock. The following table reflects the components of common shares outstanding:

Year Ended March 31
2013 2012 2011
Weighted average common shares outstanding – basic 4,839,810 4,796,227 4,729,035
Effect of dilutive securities:
Stock options
 21,934 60,075 108,121
Warrants
 1,802 7,169 7,110
Shares used in computing net income per share – diluted 4,863,546 4,863,471 4,844,266
 

Use of Estimates
     The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Recently Issued Accounting Standards
     We have adopted all applicable recently issued accounting pronouncements.

     In January 2013, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2013-02, Reporting of Amounts Reclassified out of Accumulated Other Comprehensive Income (ASU No. 2013-02), which requires an entity to report the effect of significant reclassifications out of accumulated other comprehensive income. ASU No. 2013-02 is effective for reporting periods beginning after December 15, 2012, which will be our first quarter of fiscal 2014. The adoption of ASU No. 2013-02 will affect the presentation of comprehensive income but will not impact our financial condition or results of operations.
EXCEL 22 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\V9#-D,#AC-E\Q9F%B7S0T.35?.64Q,%\R,C(V M-3$R8F8X93$B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/E-U;6UA#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D9A:7)?5F%L=65?365A#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN8V]M95]487AE#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E-E9VUE;G1?26YF;W)M871I;VX\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K7U)E<'5R8VAA#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/DEN9F]R;6%T:6]N7V%S7W1O7T5M M<&QO>65E7U-T;SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/E-U;6UA#I7;W)K#I%>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN=F5N=&]R:65S7U1A M8FQE#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T M;V-K0F%S961?0V]M<&5N#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E-E9VUE;G1?26YF;W)M871I;VY?5&%B M;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O5]O9E]3:6=N:69I8V%N=%]! M8V-O=6YT,SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E-U;6UA#I7;W)K#I7;W)K#I7;W)K#I7;W)KF4\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E M;%=O#I%>&-E;%=O#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN8V]M95]487AE#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN8V]M95]487AE#I. M86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN8V]M95]487AE#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-E9VUE;G1?26YF;W)M871I;VY?4V-H961U;&5? M3S$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV M95-H965T/@T*("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^9F%L'0^36%R(#,Q+`T*"0DR,#$S/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!296=I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$"!+97D\+W1D/@T*("`@ M("`@("`\=&0@8VQA2!&:6QE3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^06-C96QE2!#;VUM;VX@4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!0=6)L:6,@1FQO870\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^3F\\2!7 M96QL+6MN;W=N(%-E87-O;F5D($ES'0^3F\\'1087)T7S9D,V0P.&,V7S%F86)?-#0Y-5\Y93$P7S(R,C8U,3)B9CAE M,0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\V9#-D,#AC-E\Q9F%B M7S0T.35?.64Q,%\R,C(V-3$R8F8X93$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'!E M;G-E&5D(&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA M7)O;&P@86YD M(&]T:&5R/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY,3@L,#8P M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V M9#-D,#AC-E\Q9F%B7S0T.35?.64Q,%\R,C(V-3$R8F8X93$-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F0S9#`X8S9?,69A8E\T-#DU7SEE,3!? M,C(R-C4Q,F)F.&4Q+U=O'0O:'1M;#L@8VAAF5D/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XV+#`P,"PP,#`\3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\V9#-D,#AC-E\Q9F%B7S0T.35?.64Q,%\R,C(V-3$R M8F8X93$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F0S9#`X8S9? M,69A8E\T-#DU7SEE,3!?,C(R-C4Q,F)F.&4Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-RPU-38L-#4W M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V9#-D,#AC-E\Q9F%B7S0T.35? M.64Q,%\R,C(V-3$R8F8X93$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-F0S9#`X8S9?,69A8E\T-#DU7SEE,3!?,C(R-C4Q,F)F.&4Q+U=O'0O:'1M;#L@ M8VAA#PO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\V9#-D,#AC-E\Q9F%B7S0T.35?.64Q,%\R,C(V-3$R8F8X M93$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F0S9#`X8S9?,69A M8E\T-#DU7SEE,3!?,C(R-C4Q,F)F.&4Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$&5R8VES92!O9B!S=&]C:R!O<'1I;VYS(&%N9"!W87)R86YT'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F5D("AL;W-S*2!O;B!M M87)K971A8FQE('-E8W5R:71I97,L(&YE="!O9B!T87@\+W1D/@T*("`@("`@ M("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F5D("AL;W-S*2!O M;B!M87)K971A8FQE('-E8W5R:71I97,L(&YE="!O9B!T87@\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S&5R8VES92!O9B!S=&]C:R!O<'1I;VYS(&%N9"!W M87)R86YT#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S"!B96YE9FET(&]F('-T M;V-K+6)A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'!E;G-E6%B;&4@86YD(&%C8W)U960@97AP96YS97,\+W1D/@T*("`@("`@ M("`\=&0@8VQA2!O<&5R871I;F<@ M86-T:79I=&EE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG M(%!O;&EC:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV M/B`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`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA2!A8V-E<'1E9"!A8V-O M=6YT:6YG('!R:6YC:7!L97,@9&5F:6YE(&9A:7(@=F%L=64@87,@=&AE('!R M:6-E('1H870@=V]U;&0@8F4@2X@1V5N97)A;&QY(&%C8V5P=&5D(&%C8V]U;G1I;F<@<')I;F-I<&QE M2!F;W(@9&ES8VQOF%T M:6]N('=I=&AI;B!T:&4@=F%L=6%T:6]N(&AI97)A2!I2!A2!O3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V9#-D,#AC-E\Q9F%B7S0T M.35?.64Q,%\R,C(V-3$R8F8X93$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-F0S9#`X8S9?,69A8E\T-#DU7SEE,3!?,C(R-C4Q,F)F.&4Q+U=O M'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`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`S<'@@9&]U8FQE.R<@86QI9VX],T1R M:6=H=#XW,"PR.#@L.36QE/3-$)V)O"!D;W5B;&4[)SXD/"]T M9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`S<'@@9&]U M8FQE.R<@86QI9VX],T1R:6=H=#XQ+#@Q-BPS.3<\+W1D/@T*/'1D/B9N8G-P M.SPO=&0^#0H\=&0@6QE/3-$)V)O"!D;W5B;&4[)R!A;&EG;CTS1')I9VAT/B@Q,#@L-#0Q/"]T M9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`S<'@@9&]U M8FQE.R<^*3PO=&0^#0H\=&0^)FYB6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF5D(&QO6QE/3-$)V)O M"!S;VQI9#LG(&-O;'-P86X],T0V(&%L M:6=N/3-$8V5N=&5R/CQB/C$R($UO;G1H6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)V)O"!S;VQI9#LG/BD\+W1D/@T*/'1D/B`\+W1D/@T* M/'1D('-T>6QE/3-$)V)O"!S;VQI9#LG M(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)V)O"!S;VQI9#LG/BD\+W1D/CPO='(^#0H\='(^/'1D(&)G M8V]L;W(],T0C8V-D865F/B9N8G-P.SPO=&0^#0H\=&0@8F=C;VQO6QE/3-$)V)O"!D;W5B;&4[)R!B9V-O;&]R/3-$(V-C9&%E M9B!V86QI9VX],T1T;W`@86QI9VX],T1R:6=H=#XQ+#8X,"PU.#,\+W1D/@T* M/'1D(&)G8V]L;W(],T0C8V-D865F('9A;&EG;CTS1'1O<#X@/"]T9#X-"CQT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`S<'@@9&]U8FQE.R<@ M8F=C;VQO6QE/3-$)V)O"!D;W5B;&4[)R!B9V-O M;&]R/3-$(V-C9&%E9B!V86QI9VX],T1T;W`@86QI9VX],T1R:6=H=#XH,3,L M,S0R/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`S M<'@@9&]U8FQE.R<@8F=C;VQO6QE/3-$)V)O"!D;W5B;&4[ M)R!B9V-O;&]R/3-$(V-C9&%E9B!V86QI9VX],T1T;W`@86QI9VX],T1R:6=H M=#XM/"]T9#X-"CQT9"!B9V-O;&]R/3-$(V-C9&%E9B!V86QI9VX],T1T;W`^ M(#PO=&0^#0H\=&0@6QE/3-$)V)O"!D;W5B;&4[)R!B9V-O;&]R/3-$(V-C9&%E9B!V86QI9VX],T1T;W`@86QI M9VX],T1R:6=H=#XQ+#8X,"PU.#,\+W1D/@T*/'1D(&)G8V]L;W(],T0C8V-D M865F('9A;&EG;CTS1'1O<#X@/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`S<'@@9&]U8FQE.R<@8F=C;VQO6QE/3-$)V)O"!D;W5B;&4[)R!B9V-O;&]R/3-$(V-C9&%E9B!V86QI M9VX],T1T;W`@86QI9VX],T1R:6=H=#XH,3,L,S0R/"]T9#X-"CQT9"!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`S<'@@9&]U8FQE.R<@8F=C;VQO M6QE/3-$)V)O"!S;VQI9#L@=F%L:6=N.B`[)SXF;F)S<#L\+W1D M/@T*/'1D/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)V)O"!S;VQI9#L@=F%L:6=N.B`[)SXI/"]T9#X\+W1R/@T*/'1R/CQT9"!B9V-O M;&]R/3-$(V-C9&%E9CX@/"]T9#X-"CQT9"!B9V-O;&]R/3-$(V-C9&%E9B!V M86QI9VX],T1T;W`@=VED=&@],T0Q,C(^5&]T86P\+W1D/@T*/'1D('-T>6QE M/3-$)V)O"!D;W5B;&4[)R!B9V-O;&]R M/3-$(V-C9&%E9B!V86QI9VX],T1T;W`^)#PO=&0^#0H\=&0@6QE/3-$)V)O"!D;W5B;&4[ M)R!B9V-O;&]R/3-$(V-C9&%E9B!V86QI9VX],T1T;W`@86QI9VX],T1R:6=H M=#XH-S8L-#,T/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`S<'@@9&]U8FQE.R<@8F=C;VQO6QE/3-$)V)O"!D M;W5B;&4[)R!B9V-O;&]R/3-$(V-C9&%E9B!V86QI9VX],T1T;W`@86QI9VX] M,T1R:6=H=#XY,#@L-34P/"]T9#X-"CQT9"!B9V-O;&]R/3-$(V-C9&%E9B!V M86QI9VX],T1T;W`^(#PO=&0^#0H\=&0@6QE/3-$)V)O"!D;W5B;&4[)R!B9V-O M;&]R/3-$(V-C9&%E9B!V86QI9VX],T1T;W`^)#PO=&0^#0H\=&0@3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C;&%SF5D(&QO2!O9B!T:&4@8F]N9',@=V4@:&5L M9"!W97)E(')A=&5D(&)Y($UO;V1Y)W,@;W(@4W1A;F1AF5D(&QO6EN M9R!R871I;F=S(&]F(&EN2!I;7!A M:7)E9"!A="!-87)C:"9N8G-P.S,Q+"`R,#$S+CQB3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V M9#-D,#AC-E\Q9F%B7S0T.35?.64Q,%\R,C(V-3$R8F8X93$-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F0S9#`X8S9?,69A8E\T-#DU7SEE,3!? M,C(R-C4Q,F)F.&4Q+U=O'0O:'1M;#L@8VAA6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)V)O"!S;VQI9#LG/BD\+W1D/@T*/'1D/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O M"!S;VQI9#LG(&-O;'-P86X],T0R(&%L M:6=N/3-$6QE/3-$)V)O"!S;VQI9#LG/BD\+W1D/CPO='(^#0H\='(@ M=F%L:6=N/3-$=&]P/CQT9#Y4;W1A;"!I;G9E;G1O6QE/3-$)V)O"!D M;W5B;&4[)R!A;&EG;CTS1')I9VAT/C,L,S,V+#4Y,CPO=&0^#0H\=&0@6QE/3-$)V)O M"!D;W5B;&4[)R!A;&EG;CTS1')I9VAT M/C,L,C(Y+#,W-CPO=&0^#0H\=&0@6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V M9#-D,#AC-E\Q9F%B7S0T.35?.64Q,%\R,C(V-3$R8F8X93$-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F0S9#`X8S9?,69A8E\T-#DU7SEE,3!? M,C(R-C4Q,F)F.&4Q+U=O'0O:'1M;#L@8VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UE2!T:6UE('!R:6]R('1O(&5X<&ER871I;VXL('-U8FIE8W0@=&\@ M=F5S=&EN9R!B87-E9"!O;B!T97)M65A M65A'!E8W1E9"!V;VQA=&EL:71Y/"]T9#X-"CQT9"!A;&EG;CTS M1')I9VAT/C,X/"]T9#X-"CQT9#XE/"]T9#X-"CQT9#X@/"]T9#X-"CQT9"!A M;&EG;CTS1')I9VAT/C0R/"]T9#X-"CQT9#XE/"]T9#X-"CQT9#X@/"]T9#X- M"CQT9"!A;&EG;CTS1')I9VAT/C4V/"]T9#X-"CQT9#XE/"]T9#X\+W1R/@T* M/'1R(&)G8V]L;W(],T0C8V-D865F/CQT9#Y%>'!E8W1E9"!L:69E("AY96%R M2!O M=7(@'!E8W1E9"!V;VQA=&EL:71Y(&]F(&]U7IE(&AI&%M:6YE9"!T:&4@:&ES=&]R:6-A;"!P871T97)N(&]F(&]P=&EO;B!E>&5R M8VES97,@=&\@9&5T97)M:6YE(&EF('1H97)E('=A65E('!O<'5L871I;VX@ M9F]R(&1E=&5R;6EN:6YG('1H92!F86ER('9A;'5E(&]F(&]P=&EO;G,N(#QB M'!E8W1E9"!V M;VQA=&EL:71Y(&]F(&]U6EE;&0\+VD^/"]B/B`\8G(@+SXF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#M792!A"!E9F9E8W1S M(&]F('-T;V-K+6)A"!A6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UE3H@5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C;&%S6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE6QE/3-$ M)V)O"!S;VQI9#LG('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1&-E;G1E6QE/3-$)V)O"!D;W5B;&4[)R!V86QI9VX],T1T;W`@86QI9VX],T1R:6=H=#XT.2PP,#`\ M+W1D/@T*/'1D/B`\+W1D/@T*/'1D('9A;&EG;CTS1'1O<#XD/"]T9#X-"CQT M9"!V86QI9VX],T1T;W`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`\+W1D M/@T*/'1D('-T>6QE/3-$)V)O"!D;W5B M;&4[)R!B9V-O;&]R/3-$(V-C9&%E9B!V86QI9VX],T1T;W`@86QI9VX],T1R M:6=H=#XQ-S4L,#`P/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!B;&%C:R`S<'@@9&]U8FQE.R<@8F=C;VQO6QE/3-$ M)V)O"!D;W5B;&4[)R!B9V-O;&]R/3-$ M(V-C9&%E9B!V86QI9VX],T1T;W`@86QI9VX],T1R:6=H=#XR,2XU-#PO=&0^ M#0H\=&0@8F=C;VQO6QE/3-$)VUA6QE/3-$)VUA&5R8VES960\+V1I=CX\ M+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S M;VQI9#LG(&)G8V]L;W(],T0C8V-D865F(&%L:6=N/3-$6QE/3-$)V)O"!S;VQI9#LG(&)G8V]L;W(],T0C8V-D865F/BD\+W1D M/@T*/'1D(&)G8V]L;W(],T0C8V-D865F/B`\+W1D/@T*/'1D('-T>6QE/3-$ M)V)O"!S;VQI9#LG(&)G8V]L;W(],T0C M8V-D865F/B0\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S;VQI9#LG(&)G8V]L;W(],T0C8V-D865F(&%L:6=N/3-$6QE/3-$)V)O"!S;VQI9#LG M(&)G8V]L;W(],T0C8V-D865F(&%L:6=N/3-$6QE/3-$)V)O"!S;VQI9#LG(&)G8V]L;W(],T0C8V-D865F(&-O;'-P86X] M,T0R(&%L:6=N/3-$6QE/3-$)V)O"!D;W5B;&4[)SXF M;F)S<#L\+W1D/@T*/'1D/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!D;W5B;&4[)R!V86QI9VX],T1T;W`^)#PO=&0^ M#0H\=&0@6QE/3-$)V)O"!D;W5B;&4[)R!V86QI9VX],T1T;W`@86QI9VX],T1R:6=H=#XQ-BXR M.#PO=&0^/"]T6QE/3-$)V)O"!S;VQI M9#LG('9A;&EG;CTS1'1O<"!A;&EG;CTS1')I9VAT/BT\+W1D/@T*/'1D/B`\ M+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S M;VQI9#LG('9A;&EG;CTS1'1O<"!A;&EG;CTS1')I9VAT/B@V+#`P,#PO=&0^ M#0H\=&0@6QE/3-$)V)O"!D;W5B;&4[)R!V M86QI9VX],T1T;W`@86QI9VX],T1R:6=H=#XQ-3@L,C,P/"]T9#X-"CQT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`S<'@@9&]U8FQE.R<@=F%L M:6=N/3-$=&]P/B9N8G-P.SPO=&0^#0H\=&0^(#PO=&0^#0H\=&0@6QE/3-$)V)O"!D;W5B;&4[ M)R!V86QI9VX],T1T;W`@86QI9VX],T1R:6=H=#XT+#`P,#PO=&0^#0H\=&0@ M3H@5&EM97,@3F5W M(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C;&%S2P@=V%S("0\9F]N="!C;&%S65A'0O:F%V87-C3X- M"B`@("`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`\+W1D M/@T*/'1D('-T>6QE/3-$)V)O"!S;VQI M9#LG/B9N8G-P.SPO=&0^#0H\=&0@"!P6QE/3-$)V)O"!D;W5B;&4[)SXD/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`S<'@@9&]U8FQE.R<@86QI9VX],T1R:6=H=#XU M+#6QE/3-$)V)O"!D;W5B;&4[)SXF;F)S<#L\+W1D/@T*/'1D('-T>6QE/3-$)V)O M"!D;W5B;&4[)SX@/"]T9#X-"CQT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`S<'@@9&]U8FQE.R<^)#PO M=&0^#0H\=&0@6QE/3-$)V)O"!D;W5B;&4[)R!A;&EG;CTS1')I9VAT/C8L M,S,P+#(U,3PO=&0^#0H\=&0@6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0S(&%L:6=N/3-$8V5N=&5R/CQB/C(P M,3,\+V(^/"]T9#X-"CQT9"!W:61T:#TS1#,E/B`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`X M8S9?,69A8E\T-#DU7SEE,3!?,C(R-C4Q,F)F.&4Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R6QE/3-$)V9O;G0M9F%M:6QY M.B!4:6UE3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C96QL6QE/3-$)V)O M"!S;VQI9#LG(&%L:6=N/3-$8V5N=&5R M/CQB/C(P,3,\+V(^/"]T9#X-"CQT9"!W:61T:#TS1#0E/B`\+W1D/@T*/'1D M('-T>6QE/3-$)V)O"!S;VQI9#LG(&%L M:6=N/3-$8V5N=&5R/CQB/C(P,3(\+V(^/"]T9#X-"CQT9"!W:61T:#TS1#0E M/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S;VQI9#LG(&%L:6=N/3-$8V5N=&5R/CQB/C(P,3$\+V(^/"]T9#X\+W1R M/@T*/'1R(&)G8V]L;W(],T0C8V-D865F/CQT9#Y#=7-T;VUE6QE/3-$)V)O'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@;65D:75M(&YO;F4[('!A M9&1I;F6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UE6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R M/CQB/C(P,3,\+V(^/"]T9#X-"CQT9"!W:61T:#TS1#,E/B`\+W1D/@T*/'1D M('-T>6QE/3-$)V)O"!S;VQI9#LG(&-O M;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/C(P,3(\+V(^/"]T9#X-"CQT M9"!W:61T:#TS1#,E/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N M=&5R/CQB/C(P,3$\+V(^/"]T9#X\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-D M865F/CQT9"!B9V-O;&]R/3-$(V-C9&%E9CY5;FET960@4W1A=&5S/"]T9#X- M"CQT9"!W:61T:#TS1#$E/B0\+W1D/@T*/'1D('=I9'1H/3-$,38E(&%L:6=N M/3-$6QE/3-$ M)V)O"!S;VQI9#LG(&-O;'-P86X],T0R M(&%L:6=N/3-$6QE/3-$)V)O"!D;W5B;&4[)R!A;&EG;CTS1')I9VAT/C(W+#`S,RPT M,3D\+W1D/@T*/'1D/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!D;W5B;&4[)SXD/"]T9#X-"CQT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`S<'@@9&]U8FQE.R<@86QI9VX],T1R:6=H M=#XR."PU-SDL,C(P/"]T9#X-"CQT9#X@/"]T9#X-"CQT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`S<'@@9&]U8FQE.R<^)#PO=&0^#0H\=&0@ M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V9#-D M,#AC-E\Q9F%B7S0T.35?.64Q,%\R,C(V-3$R8F8X93$-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-F0S9#`X8S9?,69A8E\T-#DU7SEE,3!?,C(R M-C4Q,F)F.&4Q+U=O'0O:'1M;#L@8VAA6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UE6UE;G1S+B!792!A;'-O(&QE87-E(&$@<&EE8V4@;V8@;V9F:6-E M(&5Q=6EP;65N="!U;F1E29N8G-P.S(P,30@=VET:"!P87EM96YT6QE M/3-$)V)O"!S;VQI9#LG(&-O;'-P86X] M,T0R,R!A;&EG;CTS1&-E;G1E6QE/3-$)V)O"!S;VQI9#LG(&-O M;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/C(P,30\+V(^/"]T9#X-"CQT M9"!W:61T:#TS1#(E/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N M=&5R/CQB/C(P,34\+V(^/"]T9#X-"CQT9"!W:61T:#TS1#(E/B`\+W1D/@T* M/'1D('-T>6QE/3-$)V)O"!S;VQI9#LG M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/C(P,38\+V(^/"]T9#X- M"CQT9"!W:61T:#TS1#(E/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$ M8V5N=&5R/CQB/C(P,3<\+V(^/"]T9#X-"CQT9"!W:61T:#TS1#(E/B`\+W1D M/@T*/'1D('-T>6QE/3-$)V)O"!S;VQI M9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/C(P,3@\+V(^/"]T M9#X-"CQT9"!W:61T:#TS1#(E/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N M/3-$8V5N=&5R/CQB/C(P,3D\+V(^/"]T9#X-"CQT9"!W:61T:#TS1#(E/B`\ M+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S M;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/C(P,C`\+V(^ M/"]T9#X-"CQT9"!W:61T:#TS1#(E/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O M"!S;VQI9#LG(&-O;'-P86X],T0R(&%L M:6=N/3-$8V5N=&5R/CQB/C(P,C$\+V(^/"]T9#X-"CQT9"!W:61T:#TS1#(E M/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/E1O=&%L M/"]B/CPO=&0^/"]T'!E8W0@:70@ M=&\@:&%V92!A(&UA=&5R:6%L(&%D=F5R'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/&1I=CX@/'`^ M/&9O;G0@2!S97)I97,@86YD(&9I M>"!A;GD@F5D(&)U="!U;F1E3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\V9#-D,#AC-E\Q9F%B7S0T.35?.64Q,%\R,C(V-3$R8F8X M93$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F0S9#`X8S9?,69A M8E\T-#DU7SEE,3!?,C(R-C4Q,F)F.&4Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R65E(%-T;V-K(%!U'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$F4],T0R M(&-L87-S/3-$7VUT/CQS=')O;F<^3D]412`Q,2X@24Y&3U)-051)3TX@05,@ M5$\@14U03$]9144@4U1/0TL@4%520TA!4T4L(%-!5DE.1U,L($%.1"!324U) M3$%2(%!,04Y3/"]S=')O;F<^(#QB2!C;VYT'1087)T7S9D,V0P.&,V7S%F86)? M-#0Y-5\Y93$P7S(R,C8U,3)B9CAE,0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL M93HO+R]#.B\V9#-D,#AC-E\Q9F%B7S0T.35?.64Q,%\R,C(V-3$R8F8X93$O M5V]R:W-H965T'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA2D\8G(^/"]S=')O;F<^/"]T:#X-"B`@ M("`@("`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`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#X\9&EV/B`\8CY);F-O;64@5&%X97,\+V(^(#QB&5S(&%R92!P"!B87-E2!T:&%N(&YO="!T:&%T('=E('=I;&P@8F4@86)L92!T;R!U=&EL:7IE('1H M92!D969E'0^/&1I=CX@/&(^4W1O8VLM0F%S M960@0V]M<&5N2!T:&4@=F5S=&EN9R!P97)I;V0N(%=E(&5S M=&EM871E('!R92UV97-T:6YG(&]P=&EO;B!F;W)F96ET=7)E2!A;F%L>7II;F<@:&ES=&]R:6-A;"!D871A(&%N M9"!R979IF5D(&]V97(@=&AE('9E2!B92!F;W(@ M=&AO'0^ M/&1I=CX@/&1I=B!C;&%S6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)O M"!S;VQI9#LG('=I9'1H/3-$,3$E(&%L M:6=N/3-$8V5N=&5R/CQB/C(P,3,\+V(^/"]T9#X-"CQT9"!W:61T:#TS1#(E M/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S;VQI9#LG('=I9'1H/3-$,3$E(&%L:6=N/3-$8V5N=&5R/CQB/C(P,3(\ M+V(^/"]T9#X-"CQT9"!W:61T:#TS1#(E/B`\+W1D/@T*/'1D('-T>6QE/3-$ M)V)O"!S;VQI9#LG('=I9'1H/3-$,3$E M(&%L:6=N/3-$8V5N=&5R/CQB/C(P,3$\+V(^/"]T9#X\+W1R/@T*/'1R(&)G M8V]L;W(],T0C8V-D865F/CQT9#Y796EG:'1E9"!A=F5R86=E(&-O;6UO;B!S M:&%R97,@;W5T6QE/3-$)VUA6QE/3-$)V)O"!D;W5B;&4[)R!A;&EG;CTS1')I9VAT/C0L.#8S+#4T-CPO M=&0^#0H\=&0^(#PO=&0^#0H\=&0@3H@5&EM M97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z(#$P<'0[)R!C;&%S'0^/&1I=CX@/&9O M;G0@'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^/&1I=CX@/'1A8FQE('-T>6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE6QE/3-$)VUA M6QE/3-$)V)O"!D;W5B;&4[)R!A M;&EG;CTS1')I9VAT/C0L.#0T+#(V-CPO=&0^/"]T'1087)T7S9D M,V0P.&,V7S%F86)?-#0Y-5\Y93$P7S(R,C8U,3)B9CAE,0T*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B\V9#-D,#AC-E\Q9F%B7S0T.35?.64Q,%\R M,C(V-3$R8F8X93$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!">2!-871U3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/&1I=CX@/'1A8FQE M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)O M"!S;VQI9#LG(&-O;'-P86X],T0R(&%L M:6=N/3-$8V5N=&5R/CQB/B9L=#LQ(%EE87(\+V(^/"]T9#X-"CQT9"!W:61T M:#TS1#0E/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB M/C$F(S@R,3$[,R!996%RF5D($-O&EM871E($9A M:7(@5F%L=65S($]F($UA'0^/&1I=CX@/'1A8FQE('-T>6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UE6QE/3-$)V)O"!S;VQI9#LG(')O=W-P86X],T0R('=I9'1H/3-$,3X@/"]T9#X- M"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'@@6QE/3-$ M)V)O"!S;VQI9#LG(&-O;'-P86X],T0R M(&%L:6=N/3-$8V5N=&5R/CQB/CQB6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N M=&5R/CQB/D=R;W-S/&)R("\^56YR96%L:7IE9#QB6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0S(&%L:6=N M/3-$8V5N=&5R/CQB/D=R;W-S/&)R("\^56YR96%L:7IE9#QB6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N M/3-$6QE/3-$)V)O"!S;VQI9#LG M(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)V)O"!S;VQI9#LG M(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)V)O"!D;W5B;&4[)SXD/"]T9#X-"CQT9"!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`S<'@@9&]U8FQE.R<@86QI9VX],T1R:6=H M=#XH,3,L,S0R/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`S<'@@9&]U8FQE.R<^*3PO=&0^#0H\=&0^)FYB6QE/3-$)V)O"!D;W5B;&4[)R!A;&EG;CTS1')I9VAT/C6QE/3-$ M)V)O"!D;W5B;&4[)R!A;&EG;CTS1')I M9VAT/C$L.#$V+#,Y-SPO=&0^#0H\=&0^)FYB6QE/3-$ M)V)O"!D;W5B;&4[)SXI/"]T9#X-"CQT M9#XF;F)S<#L\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!D;W5B;&4[)SXD/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`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`^)#PO=&0^#0H\=&0@6QE/3-$)V)O"!D;W5B;&4[ M)R!B9V-O;&]R/3-$(V-C9&%E9B!V86QI9VX],T1T;W`^)FYB6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$6QE M/3-$)V)O"!S;VQI9#LG(&-O;'-P86X] M,T0R(&%L:6=N/3-$6QE/3-$)V)O"!D;W5B;&4[)R!B9V-O;&]R/3-$(V-C9&%E9B!V86QI9VX] M,T1T;W`@86QI9VX],T1R:6=H=#XQ,"PS.#6QE/3-$)V)O"!D M;W5B;&4[)R!B9V-O;&]R/3-$(V-C9&%E9B!V86QI9VX],T1T;W`^)#PO=&0^ M#0H\=&0@6QE/3-$)V)O"!D;W5B;&4[)R!B9V-O;&]R/3-$(V-C9&%E9B!V86QI9VX] M,T1T;W`^*3PO=&0^#0H\=&0@8F=C;VQO6QE/3-$)V)O"!D;W5B;&4[)R!B9V-O;&]R/3-$(V-C9&%E9B!V86QI9VX],T1T;W`^ M)#PO=&0^#0H\=&0@6QE/3-$)V)O"!D;W5B;&4[)R!B9V-O;&]R/3-$(V-C9&%E9B!V86QI M9VX],T1T;W`@86QI9VX],T1R:6=H=#XH,3`X+#0T,3PO=&0^#0H\=&0@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)V)O"!S;VQI9#LG/BD\+W1D/@T*/'1D/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O M"!S;VQI9#LG(&-O;'-P86X],T0R(&%L M:6=N/3-$6QE/3-$)V)O"!S;VQI9#LG/BD\+W1D/CPO='(^#0H\='(@ M=F%L:6=N/3-$=&]P/CQT9#Y4;W1A;"!I;G9E;G1O6QE/3-$)V)O"!D M;W5B;&4[)R!A;&EG;CTS1')I9VAT/C,L,S,V+#4Y,CPO=&0^#0H\=&0@6QE/3-$)V)O M"!D;W5B;&4[)R!A;&EG;CTS1')I9VAT M/C,L,C(Y+#,W-CPO=&0^#0H\=&0@'1087)T M7S9D,V0P.&,V7S%F86)?-#0Y-5\Y93$P7S(R,C8U,3)B9CAE,0T*0V]N=&5N M="U,;V-A=&EO;CH@9FEL93HO+R]#.B\V9#-D,#AC-E\Q9F%B7S0T.35?.64Q M,%\R,C(V-3$R8F8X93$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/&1I=CX@/'1A8FQE('-T M>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE M/3-$)V)O"!S;VQI9#LG(&-O;'-P86X] M,T0X(&%L:6=N/3-$8V5N=&5R/CQB/EEE87(@16YD960@36%R8V@@,S$\+V(^ M/"]T9#X\+W1R/@T*/'1R/CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`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`@86QI9VX],T1R:6=H M=#XQ-C8L,C,P/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`S<'@@9&]U8FQE.R<@8F=C;VQO6QE/3-$)V)O"!D;W5B;&4[)R!B9V-O;&]R/3-$(V-C9&%E9B!V86QI9VX] M,T1T;W`@86QI9VX],T1R:6=H=#XQ,"PP,#`\+W1D/@T*/'1D('-T>6QE/3-$ M)V)O"!D;W5B;&4[)R!B9V-O;&]R/3-$ M(V-C9&%E9CXF;F)S<#L\+W1D/@T*/'1D(&)G8V]L;W(],T0C8V-D865F/B`\ M+W1D/@T*/'1D('-T>6QE/3-$)V)O"!D M;W5B;&4[)R!B9V-O;&]R/3-$(V-C9&%E9B!V86QI9VX],T1T;W`^)#PO=&0^ M#0H\=&0@6QE/3-$ M)V)O"!S;VQI9#LG(&)G8V]L;W(],T0C M8V-D865F/B9N8G-P.SPO=&0^#0H\=&0@8F=C;VQO6QE/3-$)V)O"!S;VQI9#LG(&)G8V]L;W(],T0C8V-D865F M/B9N8G-P.SPO=&0^#0H\=&0@8F=C;VQO6QE/3-$)V)O"!D;W5B M;&4[)SXF;F)S<#L\+W1D/@T*/'1D/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O M"!D;W5B;&4[)R!V86QI9VX],T1T;W`@ M86QI9VX],T1R:6=H=#XQ,#DL,#`P/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`S<'@@9&]U8FQE.R<^)FYB6QE/3-$ M)V)O"!D;W5B;&4[)R!V86QI9VX],T1T M;W`@86QI9VX],T1R:6=H=#XR-2XX-3PO=&0^#0H\=&0^(#PO=&0^#0H\=&0@ M6QE/3-$)VUA M6QE M/3-$)VUA&5R8VES960\+V1I=CX\+W1D/@T* M/'1D(&%L:6=N/3-$6QE/3-$)V)O"!S;VQI9#LG('9A M;&EG;CTS1'1O<"!A;&EG;CTS1')I9VAT/BT\+W1D/@T*/'1D('-T>6QE/3-$ M)V)O"!S;VQI9#LG('9A;&EG;CTS1'1O M<#XF;F)S<#L\+W1D/@T*/'1D/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S;VQI9#LG('9A;&EG;CTS1'1O<"!A;&EG M;CTS1')I9VAT/BT\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S;VQI9#LG('9A;&EG;CTS1'1O<#XF;F)S<#L\+W1D/@T* M/'1D/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S;VQI9#LG('9A;&EG;CTS1'1O<#XD/"]T9#X-"CQT9"!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'@@6QE/3-$ M)V)O"!S;VQI9#LG/BD\+W1D/@T*/'1D M/B9N8G-P.SPO=&0^#0H\=&0@6QE/3-$)V)O"!D;W5B;&4[)R!V86QI9VX],T1T;W`@86QI9VX],T1R M:6=H=#XT.2PP,#`\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!D;W5B;&4[)SXF;F)S<#L\+W1D/@T*/'1D/B`\+W1D/@T* M/'1D('-T>6QE/3-$)V)O"!D;W5B;&4[ M)R!V86QI9VX],T1T;W`^)#PO=&0^#0H\=&0@6QE/3-$)V)O"!D;W5B;&4[)SXF;F)S<#L\+W1D/@T*/'1D M/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!D;W5B;&4[)R!V86QI9VX],T1T;W`^)#PO=&0^#0H\=&0@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/&1I=CX@/&1I=B!C;&%S6QE M/3-$)V9O;G0M6QE/3-$)V)O"!S;VQI9#LG M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/C(P,3,\+V(^/"]T9#X- M"CQT9"!W:61T:#TS1#,E/B`\+W1D/@T*/'1D('-T>6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$ M8V5N=&5R/CQB/C(P,3(\+V(^/"]T9#X-"CQT9"!W:61T:#TS1#,E/B`\+W1D M/@T*/'1D('-T>6QE/3-$)V)O"!S;VQI M9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/C(P,3$\+V(^/"]T M9#X\+W1R/@T*/'1R(&)G8V]L;W(],T0C8V-D865F/CQT9"!B9V-O;&]R/3-$ M(V-C9&%E9CY5;FET960@4W1A=&5S/"]T9#X-"CQT9"!W:61T:#TS1#$E/B0\ M+W1D/@T*/'1D('=I9'1H/3-$,38E(&%L:6=N/3-$6QE/3-$)V)O"!S;VQI9#LG(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)V)O"!D;W5B M;&4[)R!A;&EG;CTS1')I9VAT/C(W+#`S,RPT,3D\+W1D/@T*/'1D/B`\+W1D M/@T*/'1D('-T>6QE/3-$)V)O"!D;W5B M;&4[)SXD/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`S<'@@9&]U8FQE.R<@86QI9VX],T1R:6=H=#XR."PU-SDL,C(P/"]T9#X- M"CQT9#X@/"]T9#X-"CQT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`S<'@@9&]U8FQE.R<^)#PO=&0^#0H\=&0@'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/&1I=CX@/'1A8FQE('-T>6QE M/3-$)V9O;G0M9F%M:6QY.B!4:6UE'1087)T7S9D,V0P.&,V7S%F86)?-#0Y-5\Y93$P7S(R,C8U,3)B9CAE,0T* M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\V9#-D,#AC-E\Q9F%B7S0T M.35?.64Q,%\R,C(V-3$R8F8X93$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2P@<&QA;G0@86YD(&5Q=6EP;65N="!U'0^-2!Y96%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2P@<&QA;G0@86YD(&5Q=6EP;65N="!U'0^-2!Y96%R M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2P@<&QA;G0@86YD(&5Q M=6EP;65N="!U'0^-2!Y96%R7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\V9#-D,#AC-E\Q9F%B7S0T.35?.64Q,%\R,C(V M-3$R8F8X93$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F0S9#`X M8S9?,69A8E\T-#DU7SEE,3!?,C(R-C4Q,F)F.&4Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V9#-D,#AC-E\Q9F%B7S0T M.35?.64Q,%\R,C(V-3$R8F8X93$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-F0S9#`X8S9?,69A8E\T-#DU7SEE,3!?,C(R-C4Q,F)F.&4Q+U=O M'0O:'1M M;#L@8VAA2!-871U2D@*$1E M=&%I;',I("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H M(&-L87-S/3-$=&@^36%R+B`S,2P@,C`Q,SQB65A'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@ M(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V9#-D,#AC M-E\Q9F%B7S0T.35?.64Q,%\R,C(V-3$R8F8X93$-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO-F0S9#`X8S9?,69A8E\T-#DU7SEE,3!?,C(R-C4Q M,F)F.&4Q+U=O'0O:'1M;#L@8VAAF5D($QO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$F5D M($=A:6YS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,2PP-3@\ MF5D($QO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879AF5D($QOF5D M($QOF5D($QO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%SF5D($QOF5D($QOF5D M($QOF5D($QO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!R97-E3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\V9#-D,#AC-E\Q9F%B7S0T.35?.64Q,%\R,C(V-3$R M8F8X93$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F0S9#`X8S9? M,69A8E\T-#DU7SEE,3!?,C(R-C4Q,F)F.&4Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M65A"!A'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES86)L M92!L:79E'0^,2!Y96%R M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^-"!Y96%R7,\7,\7,\'0^,3`@;6]N=&AS M(#(T(&1A>7,\65A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA65A'0^ M-"!Y96%R65A6EE;&0\+W1D/@T*("`@("`@("`\=&0@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M2!/9B!/<'1I;VYS M($]U='-T86YD:6YG*2`H1&5T86EL&5R8VES M92!0&5R8VES92!0'0^,B!Y M96%R&5R8VES92!0'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\V9#-D,#AC-E\Q9F%B7S0T.35?.64Q,%\R,C(V M-3$R8F8X93$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F0S9#`X M8S9?,69A8E\T-#DU7SEE,3!?,C(R-C4Q,F)F.&4Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R6UE;G0@07=A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V9#-D,#AC-E\Q M9F%B7S0T.35?.64Q,%\R,C(V-3$R8F8X93$-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO-F0S9#`X8S9?,69A8E\T-#DU7SEE,3!?,C(R-C4Q,F)F M.&4Q+U=O'0O:'1M;#L@8VAA&5S("A.87)R871I=F4I M("A$971A:6QS*2`H55-$("0I/&)R/CPO'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A"!0&5S(%M!8G-T"!P7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA"!0&5S(%M!8G-T"!P M7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!R97-EF5D(&=A:6X@;VX@;6%R:V5T86)L92!S96-U"!L:6%B:6QI=&EE'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\V9#-D,#AC-E\Q9F%B7S0T.35?.64Q,%\R,C(V-3$R8F8X93$-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F0S9#`X8S9?,69A8E\T-#DU7SEE M,3!?,C(R-C4Q,F)F.&4Q+U=O'0O:'1M;#L@8VAA2!'96]G7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(U M.2PX,C,\'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F5D/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XV+#`P,"PP,#`\7!EF5D/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ,"PP,#`L,#`P/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F5D(&-O;6UO;B!S=&]C:R!F;W(@'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA65E(%-T M;V-K(%!U3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S65R(&UA=&-H:6YG M(&-O;G1R:6)U=&EO;G,\+W1D/@T*("`@("`@("`\=&0@8VQA7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M M87,M;6EC XML 23 R43.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Schedule Of Revenue By Geographic Region) (Details) (USD $)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Revenue $ 27,033,419 $ 28,579,220 $ 31,197,063
United States [Member]
      
Revenue 12,006,493 13,334,563 14,169,952
Europe [Member]
      
Revenue 10,666,338 10,798,146 12,009,294
Asia [Member]
      
Revenue 3,979,862 4,130,930 4,576,270
Other Credit Derivatives [Member]
      
Revenue $ 380,726 $ 315,581 $ 441,547
XML 24 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
Marketable Securities (Narrative) (Details) (USD $)
Mar. 31, 2013
Mar. 31, 2012
Marketable Securities [Abstract]    
Gross unrealized losses $ 13,342 $ 108,441
XML 25 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measurements (Details) (USD $)
Mar. 31, 2013
Mar. 31, 2012
Marketable securities, fair value $ 82,751,286 $ 71,996,927
Level 1 [Member]
    
Marketable securities, fair value 75,298,160 51,918,559
Level 2 [Member]
    
Marketable securities, fair value $ 7,453,126 $ 20,078,368
XML 26 R44.htm IDEA: XBRL DOCUMENT v2.4.0.6
Commitments and Contingencies (Details) (USD $)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Commitments and Contingencies [Abstract]      
Lease payments $ 259,823 $ 253,740 $ 245,220
2014 266,496    
2015 269,269    
2016 271,938    
2017 272,953    
2018 277,012    
2019 281,124    
2020 285,396    
2021 216,451    
Total $ 2,140,639    
XML 27 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Marketable Securities (Fair Value Of Marketable Securities By Maturity) (Details) (USD $)
Mar. 31, 2013
Mar. 31, 2012
Marketable Securities [Abstract]    
Marketable securities, Total, fair value $ 82,751,286 $ 71,996,927
Marketable securities, debt maturities due within one year, fair value 9,711,029  
Marketable securities, debt maturities due after one year through three years, fair value 34,310,566  
Marketable securities, debt maturities due after three years through five years, fair value $ 38,729,691  
XML 28 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
Marketable Securities (Amortized Cost And Approximate Fair Values Of Marketable Securities) (Details) (USD $)
Mar. 31, 2013
Mar. 31, 2012
Schedule of Investments [Line Items]    
Adjusted Cost $ 80,304,725 $ 70,288,971
Gross Unrealized Gains 2,459,903 1,816,397
Gross Unrealized Losses (13,342) (108,441)
Fair Market Value 82,751,286 71,996,927
Corporate Bonds [Member]
    
Schedule of Investments [Line Items]    
Adjusted Cost 72,923,502 50,513,389
Gross Unrealized Gains 2,378,845 1,481,604
Gross Unrealized Losses (4,187) (76,434)
Fair Market Value 75,298,160 51,918,559
Municipal Bonds [Member]
    
Schedule of Investments [Line Items]    
Adjusted Cost 7,381,223 19,775,582
Gross Unrealized Gains 81,058 334,793
Gross Unrealized Losses (9,155) (32,007)
Fair Market Value $ 7,453,126 $ 20,078,368
XML 29 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Description of Business
 12 Months Ended
Mar. 31, 2013
Description of Business [Abstract]  
Description of Business

NOTE 1. DESCRIPTION OF BUSINESS
     We develop and sell devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information.

XML 30 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Marketable Securities (Gross Unrealized Losses And Fair Values Of Investments By Investment Category And Length Of Time) (Details) (USD $)
Mar. 31, 2013
Mar. 31, 2012
Schedule of Investments [Line Items]    
Marketable Securities, Continuous Unrealized Loss Position, Less than 12 Months, Fair Market Value $ 1,680,583 $ 10,387,955
Marketable Securities, Continuous Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses (13,342) (76,434)
Marketable Securities, Continuous Unrealized Loss Position, 12 Months or Greater, Fair Market Value   908,550
Marketable Securities, Continuous Unrealized Loss Position, 12 Months or Greater, Gross Unrealized Losses   (32,007)
Marketable Securities, Continuous Unrealized Loss Position, Fair Market Value, Total 1,680,583 11,296,505
Marketable Securities, Continuous Unrealized Loss Position, Gross Unrealized Losses, Total (13,342) (108,441)
Corporate Bonds [Member]
    
Schedule of Investments [Line Items]    
Marketable Securities, Continuous Unrealized Loss Position, Less than 12 Months, Fair Market Value 1,171,976 10,387,955
Marketable Securities, Continuous Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses (4,187) (76,434)
Marketable Securities, Continuous Unrealized Loss Position, 12 Months or Greater, Fair Market Value     
Marketable Securities, Continuous Unrealized Loss Position, 12 Months or Greater, Gross Unrealized Losses     
Marketable Securities, Continuous Unrealized Loss Position, Fair Market Value, Total 1,171,976 10,387,955
Marketable Securities, Continuous Unrealized Loss Position, Gross Unrealized Losses, Total (4,187) (76,434)
Municipal Bonds [Member]
    
Schedule of Investments [Line Items]    
Marketable Securities, Continuous Unrealized Loss Position, Less than 12 Months, Fair Market Value 508,607  
Marketable Securities, Continuous Unrealized Loss Position, Less than 12 Months, Gross Unrealized Losses (9,155)  
Marketable Securities, Continuous Unrealized Loss Position, 12 Months or Greater, Fair Market Value   908,550
Marketable Securities, Continuous Unrealized Loss Position, 12 Months or Greater, Gross Unrealized Losses   (32,007)
Marketable Securities, Continuous Unrealized Loss Position, Fair Market Value, Total 508,607 908,550
Marketable Securities, Continuous Unrealized Loss Position, Gross Unrealized Losses, Total $ (9,155) $ (32,007)
ZIP 31 0000724910-13-000009-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000724910-13-000009-xbrl.zip M4$L#!!0````(`.:#H4)^(&3TJ((``#(7!0`1`!P`;G9E8RTR,#$S,#,S,2YX M;6Q55`D``X][@5&/>X%1=7@+``$$)0X```0Y`0``[%U;^9$6#(@='.W>\/77<>TVP[;,[/]Y$!0DFH:@;8`V9I??S(+$.@N!+H@,P\] M,A25ER\K,^O^^9_O?9,,*7>8;9V7Y(I4(M32;8-9W?.2YY0U1V>L],\O?_W+ MY[^5R_^Y?/I*#%OW^M1RBW"L>R3E"THMO]*)%=)XTR2SJH*N;CW"[ZWN4E`/LLY+\4(XN.*S;OPD50] M99;C:I9.2W[),Y-9/Y84Q]=MX"LL_CY3_JTJ2LNM5NM4O!T7A8H,-BX;K[=^ MZK\,BQITJIQ#]4K7'I[""Y15*4MRN2K':V8)9&2.K2IR8]D7?HGP`VM(]8G2 M\`"A$GJ7JA$G8#%=31N,RW8TIRUJ#5[,8]YA\_0';,BG_[G_^JSW:%\K3XN@ MVY[E\M%\+04OX\3`'@CYC'"<.:+&)]HA`IXS=S2@YR6']0]3CMG)=0 M['(H8N7=,4KDU*\(;="V7/H.5DYU%XQ;F!R\T8/'S#@O73BO#YW7ZFM5?L5: M7@,EO#Z[8+W8A&[^ZS%W=&7W![8%?SH7[\P9EWJBKL8L:MQHW(+FZ-S3?IMR M7Q(@!.7AV^`O^)L9^*3#*"="0CJAU5`U5W>_E+Y(\%]#45NR]/DT^BRJRJ%= MY&[\`![Y]GE&WPX7U'Y9JH(A?#X-GX4UQ+[Y?!J@ES64%X;!T$@T\U%C MQIUUI0V8JYE'A>A2&8\66!UBH6=B,'IP>Y1C,4Y[J,(AO8-`VJ?'!?*Z\N8% M<*5PRGMTRLH^H2R<\K$"6SCEG3OE3`&7"Z>\1ZS:^H^C`G9&KF,=?RH` MS'E?M0`PYWEM`>#AQL">QJE8-8!"@AXTS.C$4^?"K,)$)/1RN@5Q[7,C\JKX&N?J+742=8XLZ M8!G@:J&4)+"9Z.BY(+2,L-C:L\%D>#:N(5MN/5A_5N(HHM^4HMP?# M6I0O7;QIW'@9#>A$-_EWC7,(N?FP@@D1HB[QA`R'FZ8=(^$]?(M\#/5&'\B$U MB)T&68Z#7'2YM@VRO![(2K8@2W&0BW1SVR!+ZX$L[V:N+ES!]R]J=[DVZ#%= M,R-P>Y&7:=3'F MHM7'92D`#@"^<)AV'/!&DA3@.J_!<56OOS[G&-=`B+-?GX\0T@49=A&7]Q67 M]Y.#)S:#(BY_!("+N'R[9IW/4'W!Z*YI63S"V182R1LS",>89QZW&+N1ZG M4.Z6O>.O8[2+Q6)^'+.XU_ZP^97GN':?%'BVP"P9/"T><[P'4#6$M'/&1`ELXXD,'=L%H6>&(\SUB MMB&LA2,^4F`+1WQHP$YM^-PZ,GO;'7E(DFWIH-A;C?'?--.CEZ/QSW\#@QK7 M>Z.O=$@G5PN,R]Q9`\]U1`$E'PUT/4ECHXN+1?+B?M<"[,KF`QOZ0Q0%?*:ZQYG+\C(KNPRYI8+E!4*E:'/YU>JG@`DZFI3*"XC+$PB.(2QWU_U\(!J[HWR\'B[._Q$F M2.L#J;WG&\@X_T<(Y&1BM/=-:@>73QR61O:Q)W/_1K&UW1&')%DF:]!;KTKS M$#%KE95F.LG45Z5^B)BI9:6^G37,>Q=T1]'I;^7RKQ9SR3/541GELO_8PV>H M)7PIJV-M]*GF>)Q^P4C,S@;P\_-I^,RO';^<5T>D48,-01N1`%CNF]>G`(<= M1?,8,>;8JB(WSGY]OIZDY@LW_WM1[36U[#ZS%E7L2^&(>]@6U3Q;Q>?3F`2+ M!59FE+90CL65+%#\/);CE0"J+][`I-.PPO,;4\P(3+\Q*#N[@!<&OKPUM2X) MS.2)=E:WE8YF.F`),Y5$=5]YG.-#YNB:^9UJ_,8WT41DRJ%]+ZLQHGEMZUY_ M7.11M(%;>.8D(GK[W:>WL+9%!)&GY.3PWWD$Q[7-DO-YV42A<9^QL,99@MA_ M3D0'4J=?)BE@%5'%-\(57L%SKIEWED'??Z&C1!3BOG9AC3,$HXDO_S+&!\_% M4&(P:]+^IZ,@P:8FWOBME!A49WUH!.>ENV^WI2]JLZZHU?H$*TMHS?#EF_83 M'=CUA5XS3=6V92?@60=VV>3/T7NDY-],#4(**6./&):J=I M/GIMZ,S=FK;FSE%YE%)-J5R)Z[QDTR=]LT[,@@/L*28;G-SM.9ZJF:4*_4]/\ MQ;+?K&>(#[9%C3O'\2!AV9S@@AI]POYQ_D.-F5K;I+V98N?"B:RD/GB3D_Q!'-EF;I#!TK M6+OPY\ZC#2UMY/_[`B)=FN#I$EG)8X8=I!C7=Q90S@R#F\=\!!DP)DE=NQ"15A$Q8Q:+;40;;ZX2;D\&$;-R.+5S8N+"00_B"H M^X+%M5HA#T""C7?)@I;1B$!'U-$Y:U/0N\?UGN90H4_;`J7U6+=7[G+-F-6/ MR?H,M`,TB=9'3<5`H.\#&S-F1$VS0/<62"I<688J1''T\/PPHB$UOZG9GBO8 M>K.Y:50(J+I++8B::`6&32P;K`2M@*-C,'%-)KPC'6[W!0KC.D](&VIZHP3Z M=1V;PUNK:XN<)9`2S,B+#!!(,DXZ8XL&(_07!%?(O2<+B M)9])H`$:R-*6HX7/YN@$]858&'0`/12T,Y!51\.![!I:\V!@,L0+&J;IB0P0 M=3X`6]:Z^-<0OK*Y;]!1:30MRE$QA&MOX`G`=%&'6(CV\;?AZ=!W)&]:!\N[ M/A$%(:BEJ+>!V*8T,>%D9'LMJHU9/RXQ(UR_!\1BX=HY:COCB MFB)*HG6E4):LUE2YN8C#592WQ/5*M0+7M9:R#:Y_TW11&KP"]WPOM;%JE;I: MJRYB.NQ/>D9D:>!^*D'0YP;E*#'X M1=-TP'^"\QS_/=`,(_S[C1EN[[Q4DWXJ$_"%YX&`5< M8\S@J?\[*/%AGOL_^7SEA'CY^B^W;1=2A3/2-B%^$7GP3AP(!P8`!(D%@`*Z M5N9I?9QWO]BN9D;9]!SV0OS4GTJ+),B:*1'9X0^98(?ET+B3!7M_;RJR_*DJ M.'0.C<5JC,7:$A:7FUK`M^SS_3]+1).5J&USR-A=\453.6G4Y!.E64_0&E)3 M;9TT9/E$4EJ[)%I53ZJR=%*KSQ,U_%198@"I&6B>-)362;TESX?7_XD>/V)A M,N_<*`#%`QA[IX8?Y;8T1B`H$)]$A@,`6*DF*A4)N^.*5%T,4SINA4PDJM`- MZ(>7WHGDGX;77?E]TDYXP97_5W#%%7:KH`YLW-!)'D(?&?M5T`V&M`%I>0[% M?I*)%]T&';F`HY.HYQAC'@3&B$QT$TJ=EU[[O@UTX'NA%WPI5#/"EG\"]6/' M!FO%04NTF;()(I`^=7LV=%`O^CA:_.=81#.\OHVPV/UM$U(LKS(2TJ0@!P^% M$A43<%?0E>5D;3G**$>DI0X5?6J?%V+:CA@PL."7U2VC$L=XPB=^IVM`PX&: MMQZUX)$!O4'7]CMV("38OAB20`/`\0CQ&Q!$ICTH[(@>+%0FAD8ZT,UU8OBY M-FF'?7S\NSV"#VV'QLT*%8&]0BN&[O]"=9R/4)/^"(:02PS+X!C!>"[9$&,8 M"YDVH&%"%1TQ?T2P`9W@O\H)*AD7JDQTM>>V_15M-];,_:VBD-!"WQ]ZJM`/ MGLK]K^$U:$:_URROH^FN8&[\>JD7F%H4M"+3KJDM60FS_Y1L[4C`J75@*P14 MZPVIEB\!I_SX2@&EQNX0')^>>(<)$U25H2TJU5:]6E\NR0S]K%E.9EU*M:8V MI#VSG,Q>9+FI-)54+',1RS0SF*85,[07KLM9VQ,)SXL=7R*>PD*F69>:LB)' MK"?C8VLR+#>9*1GJDM2H'9P(RTUHVNCE5E7=E0C!%I(,K0AZ-E(2[D,.ML)Y M(MMIR/76P7">R&3DIJ2DY/P;=1_\#-3J?H5T]98:8L8GU:AR2VF&EKR@_E0< MK'3&K9J<@@&Q93V5`FJU>E->0%_4GH+Z&L/C2F/L"U=1CUYB]\>Y];!3&.Q= M>=1&HG-UC0?@WV`_2HS6I.%-D>MJ+=3,!K0WX?R9#JF5GO-F#?*HI)Q'M#?B MG+UGP+N M):9.GZ#/BU ME\.(R1'6Y83S_\$L.QG8CEMV>OX8$K';)NOZ`Q65L>P.Z6LC'&"@3*ROZ$"W MO]S!'GMYP)E.L9>/0U7E@>DYP8L.I15R.UTPX@)'=9CAS]-KQ'\KIJS]R?GX MHA<<>M",/[Q@T48;9_UPM$6L5`"R.+X2K$\(AX1".AE.\5_-"A@31Q,K*:`$ MIZS?]KA#I[3N3\>;CCTA^C<)F!^'(\,N;;<)P[%&BY#:\:)LK$;<3 MX"B2')3L04_L7R+#OK."U?ESEUFF&VJHUQN*E%8#R[G-0A]/M`]1!/SN[Q3S M-VI<#"'[Z-()W7>6*R;U20"/ZO?JO=R\3JNN-87)I=ZFCL2`YB5+]XKZT726 M^H28Q^KWYKVL%'I+8FL?T=)2GQL&7JUQ7R_4EA=#2_ M1D;#@&+CD13N.UI!,\X8VI780F-3/X;AA(.8*WC,^X'+5 M1K=&K2Z'PUVIA-J)-J]:%L[+'V%RJ0/H:VE=PVL-*I&2VU]!#6M]"73JHDV>ARU M7A;<5G(D+2O9(I5J7A#?T45&1VD$NW2O934WSG6[6>Q,W&GF)9/9QCV"1]*N M$BZG4R&#;>92M,+!;E-;:1RLK%:;\HH.WW&H*;&+K396C!(`U=B\"$UEFY% MW6SMS<[DFQ`H=FY:/F4*IR](,'\Q(=P4GJ$+BYX\XIJLG`H>^-@/@V8@\&9P M+M^#/0Q85UY%?U;ED^@/'(1*H[TXW7$04N?M/)8;THE2E59O M:EY*<&6!28YFN%!JZDE-FLO%7%&R9VF-'=QSRS?G*[6B-+/C:>Z6<5DZD>9K M+"]*JD\J:7E+:G>AI=O\O/1W73S:S6#\W:UO)6J=+UV=;G#:?(]>1M9!!FFLW8 M\*RT&27_*5)]98L)_JHHK*1-Y[?3.TLB@]1*FZ/M6(;TV=:JD?-*,U'PSPR) M`HBD2>X"7U>DO9NEO6I%EE/QO"CMS6(=PL$-Z6:7]*\G[L_UK(QM?9-0U(HR M+Y/:K4FDRC*6^8@9?[:VE>`!0G@[9G8=GN7.,%42.2WE=L>#CU*0C8)=.JUL M&8B?ZRG[EF*(K4VY"*ZF^\;=3/0B%)OJDU5FF5F'J%, M6%I][F9-D:NMVH8LA3N"XA=\P&^3BG-*+"-^*\8CQRLDW-&C":8([V[":S_2 M:+16;S6:=7F"_4R8VKFHJX]34Y2FK"@[%'71/B\\H!]5>K-1I*9HS/WRL6VQN5RN=(K8:JXK:I]>EER-\:1RTKDM10 ME33\A2>K.B_V@H_%9H_V]$E*3WCUD,-<^DSYD.G4WR<5.YMS]9&(R8X[:?A' M(NZ*\X/5TQ[WGA:ZW^%.UL+>=W.L2Z'CW1T1\P$5G>S`F:8DUPL][?9,EH^K M\XW.I/[P>MJE;1Z\SJ%'=M/I4-V]Y79__IFKF=YS)\F-:C)]K,'AOL7>I44= MC0H3'C94:^#-:TANA^4U+#@SEBV7&[OPF"Q@]%NC39D0]$TVWD9I.9W)2.I M+2E4',LR#%L].H6-T\"6-5FW5./XF$ZN=I;JJ)HAGX!0IE([2\/]8VTL`N_# M*"Z]A%?6><$FW,2_!1%U?7P?=ST_A3%SK!7U"IY8QC?1QS!XH-'YPT-$'T!< M^!"-U2'V4<--1`%EHR-Y"LR82D&^/29^C;VW@>?__"J)-O35<]N7'\>B<\R9 MHLBVKHO\B,%8'8/:Z9<%4R]E#+YY;AW5<)P`DYI#`TW315["BR1V\OF#%_S\ MG9C59_HXBB'RL*?BT8&WUS2N^'+8KNN.HCJF(;<*)5HC]*P43CY7%%FS+4>H M"]\0BWK-$-DV#/G%\J5Y33%MV;!;A6:G2>#T8Q M`X2>/.R\DF1P;I^H_T@YK'&"B!$]Y%HDC\Z)%Q5LG#0KG]/Y/FU&O"0G_>5S M\KC._+/PKSAXM@".OI#S4IC@)3LI7TCD!V_MZ[;?[QOST:83^B[4?Z2/T2*_)G+H/U)HG9 M`\IW1G!&J"UK&&39LC73/E%&C+P@G22USB3XZXL?:-7X1A(^XP]N+WG>;V`MH''^@\3SR6!/8\V#QSHV]^.;^ M4T1C0)I5IN:=8+O4R?XS[76?]Z!=9[UI[V$0$@-:K.?^W'=CH.V/59(WSX^3 M*`P>\*_KF]L+HLS(AXLO[S]??KJ]O+DF-[^0=[]]N;R^^/*%M;;=/,=?9&+&<-RFO<^_[@6=`#N+_ZR^KQWXR6\ M@/]@(X9'T#_LP9"\=Z-HZP4/38ELN=FJV8YJ%UR&5A#'1;*Q2XMC8-_@H^+8 MH@&$#J&J>50D6S08EAVSN+L^&I*\_<]E,`=K&-,/E/\[8J>>,UVS9*M1"<1X M3$1!MU9LAJ-JQ;V6$R"@6\L;QS04?4H"0M^;;\=9"._P$X[/3#S[4(#$C/7= M.,L98!E["UAS7%C*EM[#TM\2WP-8"UA0,K\D)D]>LB2K?!^0A/>P2$64DA7; M:25A1'Q8*,C3D@9DO8E@S8KI`M>L.X"!^-,=_K.*Y:857_=$$:Y@[6,XXIML M<_B!!G/>OWU+;KT5<.2:/I'/X MWA)%QBM[1![,7>Z\.#/R_N;JZO+VZN+Z]@LYO_X`?U_?7E[_>G']_O+BRT[< MPZ3]D4VHM;M-14HC2OZ14[:'HFHXDIU>OI3Y$4!81.Z!K:Y/D$=2W>N:9.ER MW>LJ]U^JA]`-"1;.NB'`[;M=4H+-R%T4/.@@DH@/A1MXT)U[OI=L"?VZ!KS\PW>5U]!UCZB/E:=+&7:4JZ8W98DH9#="2U M=)G8Y!`M17(T^UDAJI)C=+IN=C!$2\(;Y'M#K'M$#-%6)$75GY-&VY"TY]55 M!6:'T>DFZ:$0)467)5-K==D>_C5V*J%C2N`F(+_0NPA"P"U1=2D-QB\>:<0V M(>X]GRXP"(5P-F#["AA7LG;*Q'>?XHV7$/#%2>3- M$_(>XN^$!>+XVY47!#0&\[E[P/5]^H`^ZIQ&>'L&N?[7!5E'X6(S3^(<)NZ0 M)$]ABDJ,F:5U"(%KEEF"F!0^WVUSY'E"(,,RIO2O&(-E+_AS$\Q9^(V!^;S0 M<1F"[R40S/#<^(FWPB`^HC%\3M-<7HR9+U@.R-P-@C!!P.N(+H`,NN"Q=4I$ MLI7($R6+D.!CF$``2@$/0';I/F)@CZ-''L3^[@(QAK"=-81&.EG&PL/D`OX> M9QVLTVR9,)"NRJ-U2HH=)M32^V(^N=%-Q#II+U@B/>LYVV6?02LF82^O?WGU M3WDF*V54&\"-B=]!DGA*_-BO\?DF6881[K!VX=L!6J;,_A-BM@]H#(QJNQB? MF:,B=!G'FX'LT6U5MXK'I"J`#,6DEBTI)J:JEW;2>F%RLTG`!/`P?EK&%""- M@M,8+&J#T^`]3\8:(1*B?OZ`NN_OQ,DM,?\(6JV%PGL#: M>K=AKL9M>!T&B&,4^CX\\/!(@U%OUS042U7UTNI6AC4`DV[*I>FJ MI3GV))ATDZYJ.+;AF.TQB4'0XXO&P>JO,D,*@/KBT$THCJ8:AJ*,C$,W<5BR M:BAV2QSX70._T`6-^#TT?'/S'0WHO3?FHF!8IF)JA9.F#:#'P[.;!'5;MV3[ M&'AVD[*A*;I=[(/1!T\6M4`H^#&<3RQ]6==+YK\-_+%1[J@(LN64ENYCH-Q- M)S3+4A5C$,H?Z#V%EQ:I&O&5>5+-,)WBTM$._N@X=U.-,W`"BK?%'`GICLJA M6XH]#L[3:X7JZ)JM'V([.9I=%4&UBSU0G@W-CFN%HIKJ0"Q+1F1Z!2@;LBY( M3(1^Q\5#LP4,/R+ZW13&5@1*W1][>(Q?;845+4$21MN!976.(\#O$,H(V#2' MMK)FZ&-@\]%S[]*#@Q`)#V'0F:*9MB70OPI88R'6R*LS<`(M3;#:]T/LAM7$ M#&D!IAEJ'9L8@(%(-%\7[1BBV=8)"?B0?9?.Q^+=H5B:PZ=G++Y<=.C-<:JC MU/)Q!/2.RH`6)>BJYAR)`84I\WZ$"U^K3<T/7X MW?9BM?;#[9Y5';@EHH=-Q%DI]0IYJBH=TS[RX9FR6.A7GP6 MW\T>OG*3^1+TK?0[C>;[5J<;+7J1%A5HF$@9%8%N ML\S4+<746B&0'_*YN2_Z%Y^ICZ=7T,TH>""?TC*?$Z^2,V?DR^W-^_\]>W?^ MY0(KY*X^75Q_.<=Z_^+Y*+:-3FY8K3I!1=X=V!U8+(EU4JHLR^0`A$30%.,N\1*Z40<,@`Q^S%`#Y`N+YAT6WIYQGY%EPU3&#%\Q+*VG0KM MZ<(]T%\Z^G:VQ3H7#B6K`N0$LI-V*7FLP,R'=V.&"0)"5,HU:B)X85`&1QBX M)&Q^,Z'!X9LI!U`."V0`,.P!$$JX^/',VD,F+7YTT/<>/,0]Y1"!,>"G]*@E M[O`E.$9$$U`D9#JH%'63)6I6S#TV$#N(A8U]*Q`Z MPF3UNZSSQ+WK1:`GT5\T(8_LL`L[!TEY\:&/E?6$'UI)YP*H4$Y:4=<884@G M!1FQ1\^XYA0/8&:%EN0)9E%E-:AI2M9^,2@[JYI7H_Y4_;(M2XI9][+Z4WTM MJM4$79GM'](L?<8/>+:'$PQ#;U:<1>5R@D&5W-AZ!)G_#NL;SK[,ER%(E+!C M5&ZT2&5RAD)GI:SA@OJH7@N*1D/@GVT]ZB]:H2":>\.5Y7BC%GC$/TY53B;NWM'9 M'T57,?,LN=.;AA!E?Q"_<9_`/66]\`["(X+]YQX$7BWW7CV(,%CY%*\!PP(J M[K&RR`:#\B=LT(?!><%713>4;>8]NI&';(0@?-?B!4+O/_F(1>R1>F'A,1P^M)X.\AR,&$;SW"@]E8]Z/)7.A>91?Q)X3S!FW"C=8%!?1 MM"8NZ\XB*"+CX\PQ[H)@'PG%IH1Q<]2"'[P#@\9TT,NU<:1>5&[@^MO_4++T ML+^AAZ%5SG?6ZK"@3J`G[D&P04M&=\`+9F-83!+@S*B8O+<9C' M($4\('8QHI_#>RP=D(WALE>6X1/\"@K!=]YP)O/67'Q\"G_LTCPP),R\/)9# M+6/\CF$687,?]HB;I!V'(JXQ>9Z*+,'RIF.4TU"8Y7*)SRY:RK(^R"M,)]UA MY^8\&UF963Z`Z/W;<$`B:REW. M#GYF*RD2PLIV;[')W093B+O]Q/1!;H>954:N%%K`Q1XL,BPIMC\Q'K,&<;0/ MG_Y5=C='MS*H!(5I6;#/E>;DT(;/>?J+384.1E3@R8QO1='L468XBL``\^;D MY7]H%#)<\BS7'9V[R+%=63/H`^M)G+`.83@],D#QKC\8VE'*\C5\>6OFT:W[ M-2V&CO/4DR!;6(XJ^S.J,AOII:T?P7ZDV^#8T@VY2@$S<#-J&M9):MH#H*IC M7D/'.T=25+5N`/6`CZ4FO],[@E-"S#0AW;@H.V"%[L9CJ0#,E:6+>RBXC8)9 M=G3Z6/DIKJ^@@RSOM-\K$(081@)9Y(^-8+SW^NL1F-`K%RNIXR(?B'L7;I)\ M(0X+U;FPCE<@+[%>#^/0=+0T'4V0;13GD^L9VB\KRK3S*VUGO!2!/0>;UA;3\+ M1!8JS$^=KI8YU]\I9A3H8H?$^2/8T0?:0K:GSH).9'^FV*%:KNG'] M0D=<#&7SOXI)NK$Z?,FB7.T_JM@E<@H48R;;Y74W?^>LQ>OF3"MW\>V2JZHE M0[4D6:Y*7@WLL^0(<]SFK%_O*C'Z,[M>P`5Q'KQDOK M`$NGHX#:CZQ9LVZB/QC!+.V/=)U?K05B*#-9[R\0PSZ09P>BVYJ[0TW7NDZM M`1MXA[PZ]"_$D5)O3:B4M'*21YVGTOK?] M4U20)S="L-\;[7__?ORTP10>@R@.XZ:VD&!EF;2B:GZF:#HI3WM7!9O])MFS MT5[?1IHIP?W$66M?#KS>\P*4PR3T M[@\L`1K"O9(;FRU"NC!O8,F2JM4=QU,.4EN-M,$\3^A-R9^SH_)F#*P;7=C6TR!;V!HG0N_>URFGK8.U"9Y6T\[P1P>X.LI4WG*I91N/DHMXRJ5?6;HKR7D1G$6569&:)MRI.0>J5'_5WH`PU) M!T]_"K^^O1??>3EO[8]7C5#WO5!,ASN3]DP5^='M<1:MV*U6XH'!Y9CK[W$= MX;Z!2._QG\NP="3RC=7+B#:2.C".'@1[D!O>@F=@'AW1U7K'D>!)J.DXN>%# M:D=R_@>X^NJ$#G[3*JP.=>>GBUM-F?.9W6GQ'TT2WP71 MU!*5&.1EU)[LW;=GK;7D-JT.'R_@J3>&@YS(?2JGS0=_DX3T6NR&<65B0;PQ M!\:5=59GW,*<5N(>B2W63&M]6'Q(V*(=+VPQ[,&[$--/Q#'.SO]=/>>1SO5W M%\1W.92])V=F.F)CPC].7M\P1F^/K,"1/*5'_LYLATZ+L+*WY M."R1X@?SJ\O)6Q0P:K.J@KB&P7E3UC;8:_T`*#-RCL7PA<+YL-C0M,C,VHX` M'%U>)L+'13$E8>+ZV.PE\H+8FQ]V0=V5=RPV$:N-*'2*J.V&JTBVK4B*5BX, M+;=XR1KES+$/3_)$:=H\N%1,P5`N-00"=:D:.%NI28.J8XLZ?I>T][:Y@=%6D3M M?GAU2#RT47':U(@-$X1D$T1T'CX$>+-&9=N3FBDX8JW*=;BK16',\=A5]5DU MRMJ-43NPJ5!*#IM@,_*YG4%*Q^Y@F.29,YUAZCUX6\.D]`5PV$UZITO%X+9P M&<"PEO_E^P,NW`B%&7^B4?8.S.G^=SEH>Q=0J#.[<(^!$-I0A.KO=CA$2+,F M1JC^KH=#A'1]$$(?/'^3,!LRGM"*MQ!7P!N.5&?!U?!I-*0Z"Z]&O5LA]0D" MX_EVG!LY,'&6&J8KFK@?W,1]-86'ZV>]5FA"^+61!,@AC!YFM.YRE`:L4#"X MQP=?P^!W;-ZQIDW8X@Y73";,DB-TL"8%K!L,KNM9&S?>]2E=[=`E*OHKJ7-& M77`9T'#/R!X6BU2%.!Y96\ZT#]L<>TM%,2O2S;VI8M$Q]I`$KV0=)EA!#(MJ ML;<<@(F3:,-[>+ZI+AW](;U?05Q7REP:K&MJ7+)V9P*K6IBU6%@;!VF]@#8- MI'`W!8N!>0O7G;/"=2'O/9O)B*8SC0F."RQK<7?H':=>T$-$81&->*DQ/I56 M&G.G-.UT6.H(2$1=O")Z[[/V=AEZX$<'O-M=60\+RO>V[$!4>'K/7N?[HKIP MU2<,)[G:P#BAJPT$;>,'76V@CG"-0'N^K MP"];8M=ZH9O#&KJ7G5+NVQ3-1NH"=:6NE%T76153DPQ]M+*K-N!TJ].AF$'@ M=%U2S1-JB;3O#_Y8C/4.$T,-D>5>&)HV/TJS1N->.6V;EJ85+M!L!#8>;HUW M:SJ*+9MR?]P@<$NVOWL+>.&1!AMZY?X91N\W$`RL:)1>D\K7][;IF#_2L?\H M#16??_7B/R"@G/^1??7NBF(TVWSIJU+D?4N$3X?,]W\/,EM3J9\$E>5LW00Z M^WQD?HV]MX'GPR(<;>@KXBU^?G69T-69+,O*JRF84*W1/YZ.I%H+RCP)?2SG M0B?01^,ED]G>AIZ&=>E)YC/J[-/;_V_O;9O;-I)&T>^GZOP'7.V3BG,* M8O#^DIS=*MF6\^@^EN62Y.S=3UL0.920@``#@)*UO_YV]PS>2``$2)"B;&XE M68H$9GIZ>GKZO;VOHM7]ASB:%5ZVLA_N`^_)%-Z?C4&)Y0U4AFN.KNF*:I=] M#MO`M:\E]FN_KKRRU?7K[:Z:=L61]1(KO`*MT4L/CT1KX-K7$O=`HB^XNCV1 MZ-H5?O#\&)MCLR*((1G&]3FOJN6@;)/1K,9SF:1Q%-Z3^_+J]ES21]*'LXMK MZ?>SCU_.I7YY]N;TC++I[>TIV9E__%WGQL3J;@\1C]A[P7H0]G M>XX-#UF"9@8_><#RN[$W8T]1_"?OR$6MNRAZ+`]9RNL;8Q4K!4O'@=]`1#I86:Q[U@ MW(-&(5U/T2*82`3)F/F/O$5<0OT;0]Y]";VF<\_GO>-B+TRF5(TX$,KY,^Q9 M,0'VAA1^.A%.58*=SY@\9%.6*@7SCI/ECHOT;.;Q\V+>_(HBI.AU]!SZH93U M52\#6X*L,ZH6V&?L/[AQCWF_^`#+/>*"Z`F;U`4@$`6\QO5\(5"'/0/]^]"?^F,,Z!(MX.IA MJ8*"/M5V,-!L.1%DB;TOA1\U^:6YAUSO<_>1UJ16S*,?\K:999\[`BO]M8AP MQX1/&&#WQN2*X%0ABHA/T'V/?FG1*JQ$`+!JWG&1YBW`4$N].LN3`L]+?-X8 M<;Z`8S\.GD^!XM%AR*;!C'J??H M^0&.<@JPGR8>!C]>\3VY\P**2T@>&"R#ZI(G9:\+C5;VMI]<%C"5YX;S%:=4 M?/R$F$W3<]@[DAX;G7"_>37TL@YML[J1VN,R;5/67$=6K>6(T,80PO9F;:8J MNZHCFZ;;<;S5WFW;TJ\V)/UF[1P;J'=I"[0FQB..[Q(_93YUW!4`E*/U`4P<,]`;P10A4&.2,EE#7R%U917I)(2B*`-Y\' M?B;_Y)#CJ<4P,=XF6A*=B@=M5<`QHU>XRH4XD&TW/)'O(BQ.8W:,H[ATPZ=L M_!#Z?RWP4/XS[R9*W2*PM45Q)&LY$.P',A(Q*S5Q*`&3\XOJD5S"N%Y_[D>M M,58_SUN\:ZVJ2X.66,YDW$4(^Y]Q9:W+Z8>X]\WR;.:@P M7T43]-).9\%Z(NJ.,T31E?A9?$L2>;&]);6`@NWJ.1U%`F;BK[@PRW%^HH=Q M"PVT;6R5%GZ+HR3Y'$>@-P]I8E$-5=>MDHFZ-,]F`/0S@*BN9NJVX@X(0#\; M!7;^<33=Z0``CU#^"+^BY0*[`_KA`NA86"N`?;^EMN/\N5OO*TLN_3!"*KL0 M$L99.*F.<@ZDGCY?LO0A@E^P:4XN5PRTQ:IKN2K\IUC@'M=QF`CL2:*6I>F: M[AX1N*D9T#9-RS#M@T$@#%A2%8%F17LD77QZ=W5Y+MV>_7_G-]4P MTLWO89%M@6W*R>Z7D-UJ.5(^?8BCQ?T#%\0S^7227:1YL/H>.T`?VSY_LP'P M>)4=3`1\#I4^3`2\/D"T>7>8ND7`[Q>F37:KI5*ERDDO"^1+\8[H.FZ9&ZV- M8/[`)FB&+POR+3CMT*=8M>I"[4U95PW9J>VENC1X6]_BMCW=%D2,;+5ED)8/ M%T13MBU5MO2>(-90RX"9`&AN7T,]K?'YNFW+FMJGFF4C?MLS+Q1;=M4^A>(V MF\=4#-E0FAI!=;^%EGG!>S9E,1IZ.C"#P;:W(WMHWV!#MM6-&F-MM@%O5"`H MO6FC>Q6\;-]H2W;=IBC_VG4-Q[8[';M!FJ,TI$>]CLXNAJS7\_/7`7X38]P: M_#J6T2?EIDZ_Z@OGNZ(FMF72[4]BLO'1K^\<`[OY^A3R$*QW[@YWY`O]8P(DIS;CW=984`L@"$"*(EN#='G>"8"6 M[%!CC]HN.+VL&55Z(-VH=--A^`^F@J/WGZNSTAT/T>ZSVIJR\X9LN4UIUQNA MM,?DIH8%+U]F=BU)_;$$-_YBZHU3'LH-;'XQ3NO5C.Z0 MOS$L!?2"(6P#O2:U9<7<\Z2FX?!8%DJX'6BJZLA:K5Z^0WQH MNBD;]E"=*3I/Z@(';K(1K=F$=2?E"@-!M[BKUW**+1%S`JED8QKBF;86X0:(1%&?BD4@>^)G!7 M!%YC/&XY\IH;Q;)`XIC!P#QK;1'/HX3Q%W#(K/(IU:;B!>,+/B4>'DDWI<2Q M:A5,S$N8E/Q^30"UUN+/BO!KO';GZ[#8??,A3JU2]VX,:G:K2>85&M$.(>QH MK?;TNR?2<+SQ.%X(7_KFII3:P!!5-T`C[V"*ZJ:WM%^?6P.K69@FM7[HSJ[+ MM=[*1]A1,@8R3,BIM0>NJ2&)%?WZ=+KLB]2U)2Q=MVGZS4(-WK-YS,;<,]0; MH#>&;)M=U-J=H,,%,;$I7F@HFKEI:CN2&Z*2_MMHF++I]BKG.2@5P?1&OT"< MM53T)8R9%U"CEGO/#S%3J#:9J#^%.0ZHT9U,)SM!UAM+4V2S4R?3#:AK6]/- MFD*YKFR^YJ@=%YBMMI.PG;7TC'T,*@)W2MP:6ZN%+XQ#$6V:P]+ M+YUP,*/3'I>NZI;LV+VII6WI)2KA'P]2"[XFQNN);F+3YD99Q8W%$X*!M/V4 M9U.?G('BA3^!&HN%9$ZQ?K(W]U,OX.GTE11\=+0*SUG;A"=9PS)TPHH:"/@X MUD)ZB`+8B^1'2H+%,C#O"!IZH+ESF0G$S87;A@9B:]+H=456;;UE`-$UPTO3 MV+];".1T0"A/MV_%XE@LT`N2J$`G=93KAL[R_E&1F"AAHLU8A8"V(J;;DK&B M,X$0SI96DF3I4R6H1:H\^YKR2D/L&3Z/&A!JS/*J`;4+*2V"2G0T;=&^5_@.\\B?2I6AIG$TJ[9KR=:=][^)>>5F MA)51J;+J:OVD>M@_49IWA(M(^/!8P*/DV M*8B2S-+7S+@,3;9%RX+RB(2LAO$:2X7(1#=>S+>P94Y0CX9=A6G*EH@UV'85 MO$!)TO`:G`6?ZKX4K%E3>#4$^#I9W/U!!MX(I+*9+SH9<:*E08HO%^&$<;JC MA%KD7J**J?0NFK`=$-5RV\K*V5K3*I4Z4^7U/Y`AP"JQ`DBYHECSZ*)ZF*H5 M8\/Y3!]R5EQPD`GL&-4:R<*7NZK"5[Q3I.JZ;CD851,] M@)&H0L[C0"X+.3G*I3;@]7W_TR-+7<97-G'^E(2GK,"B*,=*%5D#U'("_T\6//-6E2A? M\=JZ#,2F``.!);)4H^`AZLQRY75EGHHHL.[V;^TIE#]U74G/::#4LU1([C=9 M2'OQ/LK?`_(N1W$51:]9SA"`OA0.>O(_6U%`?OK&<-"/AUJ*86E6W1VP-QR0 M?R3_*KS'OC-#7M.G.@B%=1)A!S!VM(!^='KJ.+6W],O!W[=VOF75W=)#P4\Y M(&?AY&,TQMJ#N;P_(`WIAJFIZ[EE$R2[6T8_2M),S7'J!-:77D;/0H>&8;D# M+B-F(+.\9_S_+\(S48WS,R_&"2.<<1M&J1'>D+2E:[I>/=\;`+3S1?7D6:IC MNZ9R\*OJ1WBGJJLL'Z`=KNHZ+Q,[Y'5H:::NF5W64,P_,,0]:$8A0M>`*(=GX MC)M`AJ,!0S%@N6VP=P%HYXOJ232::9BMTM1!+*KG?0(/V4KK?;+)JD2D]-GD MCT5=J>2>':YU!?]7AG%U_*T@6*\7..:F$+R:(LHF%E'^_?S3[=7UQ9`UE"O, ML5-QY,/*(3*_]:(_K>&LQQRB6BB&#V$>+G%H7=CXM?>$(1@L]H&]U<'>/35' MTVI32L-D__3"+QB#%(#=PF$(&ERVI]KOD656/^B>TCJ6UAA,%Q?2BF M!D93UV6W-DEW*%Y0-ZME.K)AV9MQCG7$]\$/_>0!$SVB:-([&+Y[S4O;;"I: M]#JR%TP@3Z>^J-'.TQ>VK.LC6YK:,T-IB%E-S97UVM+@`Y#M1_0!^UTR``?9 M_3?(G93:O*&7+O^Q!G"0U0<&O&ZWFDMXW$8I51C*I*,I MUZ\3&^/5KK-YRAV$PE6Y_1"1<&6[!85RIQ1:+FH<8POOF&>Q)-22'!,1>`XS M622H*>)(>H>_^DFY;Z\((I_Z,?X4RN(3]H//@NE$8'T\614X$NGI@8752+4L MT+UX&&9&<)2GW=:Q>BZ MB)H$BVZ-6$4QBAO;-39M;P,1@!)ZF>F@V]"\"I*2JM31?'F&[8!8;ZL'?1?4 MW!C==*UE$:(/9`EZ)>^P$6'149LW M(;S)JSK`C^\X#[N-/;2^_YME*U,"9M^K%7RA>F0*5HU"D3*ZV<*8&OZ=XA\BBSA@F!#@^W M6TK9<.WC8H=T&G;4T""]H4MP>VX;W)I9+V*YO?Y8DW@^B,>`JR>YL^#H/-B7 M$V(+VT2=-9V,!-7CN8$->F"@B.[A#U7"G@2'!IU::EZO$X3)H8&HET`T6T!L M)[4>=Z6"(WJ896.ZLKVZHJ*UI=6=B=3:H;LJXJLFFU>5': MVD%L#8`CVYJ[5#]_;Y:@_)[:4M5LSW?.RVXV7YXO=R'V:9QSO/>.WQ^J?+&; MSD/MUU7KL6^_6[N"4EI6?A0/8X$;5$$=7-XJ<48>QL4FY>_0>-=)Q!D2I>T@ MD^VX#&-1.+'\[6^8YKIWT-L#6#J"_I%*N!P8VC^`$EL&DBODY6]^1PUWF#-[ MI-XC]1X,];8SY,P+ST$\X6078X9_R@J.?Q>%M8$^^+E6Y%\:MB:X1Y-=39=- MI2G$I%;>'A("3=9M[,_2H7[P;@!X8\BJ4Q>B5;C<0F*">JKJL.TV*\!@8XBZPH0CM:K&\,A M0*[!:7=EMS9,^Z`!?X,RD3%HN?-7L>[-G#,O"+"M`+".[-H;->E]2;\D@.%O`WV"?',+9NC??J#H<-$KAK@6I=WK+2]<(_'F07@]MR,JDD7%H/ M6#D<@RWO*9IW4329*=6K7@U0\8O@)1X/L_*B+'GW]S&[IXC0N^?2&](8OKO' M&$PJ3LC">W@?DUW]6592,)SXC_YDX05E#QY6-+[#&HA^*'D4Y>2'BVBQ`G1> MR;ACK[X#=04>(V*.WW?^OEW`+;NX2L+S<(*XU6I!K;8TCJWM15M=^7721ZC9@=ZJLN99L*D=V=S], ME/+F9@;^<>>%=7#@S8."?VL(^TU1$H`__XL;:M;5GL-86EYA)TUC_VZ!0;]I M1#7PQA5S!J^C]Q1)LZHV0L5=L6VYA!W-IR`>1?BGH?.?>:&\IAAEFGFRH-[B MO/K/Z3SVQU@`EC=HXF',6`HQO(>=?0KO8V^"WTYYN3YA:N$#S1>P2"P#RY<5 MXB+ZQQYC*W=5DV9Y4*$H#CB2SJ1D<9>D'HP!JY]Y?T18LB]K]Y,!(CVP0.`T MSF*H+Z-H\OPCC78#[T^\F./S M^('O",5O>^'R4K"&H,2^SMDX1;QBM=U'@2P8V<>BAEBY]\Y+?*(-&E"$:S\7 M=70Q6IQZ&F&C:L(,/"O*Y`*DXV`QH7#T!^;'2X#*--DBA#>#9WQ(?(\C^"$6 MO9QP=/&->O`3K$4\!J1.V-1;!#002V@K2G'D5)%X-O=BWG:R/.5(>LO&W@*+ M//9:._Y0S,#!N2M&FD1`11C6GK*0SD7"@F#I)7K'ITK(^.PL@DFR\L08.HM? M4G#\$U:@A-?OL`+R7PL_9HU#WK$I#B/`STFL@!WV^,&';9MYSSA>N7RD-/$G M-&FV>0#@HAGR+,IRF;X=&/@<=)/F"<8(4E-+"14865(??L4#=^ M%R54JX5:/R('>8B"R<5L'@,B:;ZM:Z[;FN(XI9K@S;,,`,WZ>L2&ZU8:]W4& MI^BK"_B]20%[^!:+$X[^;5#DZ*IFV5:ILNZZV0:#;2W"7-.V3,.U!H#MW2*. M*2UFFZK6ENV6.Q2N#K_%].NIQW:`F)WNTU_"7>&'P)(`4XB=.9+7]D?*<+"N M90%&\S0#@+,6*XZAVHJU$3@9"RN8UQ!$8INF:FEN&:#&B8:`:/TALE55&0R@ M3U$XWAY+IF$8IN8Z[4`5)4NGM8G"ZL.^* M!S=64/Z9%\]^7JGL#=+>O1^2$%U?@SM]B!G+9'!2`>K*=N>5ND%.I+K@E=+? M3<6X8;1.E<8;BH*7JH#7SS`J89,$,51P0'CRI`1F"`II39J@'%RZ M*V6+>J3PP51)$HU]4F-*6L8]=N1`G).V@=U!4$#UOLHH!'/5@-=+AR4SE-=3 M1I([(#&D9Y,'F%MGT0DB!05UF`4$?D#?^!3D71#SX1/76$K"/LBX15<17`"G!*Z(H0[*N/4$ZK'5RX M:@2RZ!V]LJP*+4+^=80NFP#U-B1O0"FAB8[.&$F4=,U(J$%A&H,BBFG&.$O" M[0\3T"-R/78D71`X6\(Q&FGR-16[A6_&?%HV MG2+!Y0>].&I\&5%(C^4)],OKYZTET((E+"3X!5S)XK`@8:W8O&A_03:(BDVF MGDMH,?`?HFC2VU@PCWU`=XFA5&TX=0_4E,<"O<8N M":3=@=@)\/WZ]NC6P0#>KZV/:KJNINT,>&Z[VA7)G*JZXQJV9:R%OP:.G<#? MCVI.54U374MU#P;^?L1SJJJ.H2BVO3/XK^:,7U4[H1]50XN.LA[\&C!V`GX_ M\@'P5=55E8,!OR?KT2S#U)7US*<+^+P'V<=E8]:6]*'KEN(:9@7"8J9A@/BW M&.#?-]A7$N4!;DE]E^F`R1D(H_E3UPQM^VQR[L4HT2:7#$7>%UI)3WH%=JTJ M[FZ!Z(G.DA9]A5+:N[(.S0'HAF'EH%8UX;*K%WSV?#A![[RYGWK!*UP)?#V+ M0O(SO$+H-SRLNSDG/;FSZFB.HSL[!>);.:S;K>J0#NM6*WGQP[H5])L>UA[G M))=DSK_.@6H'%69UV]#-,M-8F6P;6/K=](;K*%;9*3@H+/T8F>$@/S7ZP[(; MD=*V+->VE1IPUA+-;H0R0T.GF[-#@/I:)$`E=LRZ#5L+$,5S)!\6Z2)FEW[H MSQ:SS]XS176\7[!M').::BB6[M8`U3[G1H`.X'36+*L2M]%OYHV@1BO1(Z-F MFUM!#J=#U7I#7II]4^BC13P`])IKZIM`G\V^(?2WZ`0>`'S5U>MX0??I-X7_ M*=H>>LN%?S:!7DR^!'N#C%D4M/OO*$#G$/:I0JYT%9;B\&(?/=COR5;_F<5^ M-`'!X&IZZWT=T@(**RZ').T*Y(-#S$MI#D>$[U>I.>)W>%7KB-,A%<#O`['] ME`H-1+CO@TD>AO'YB._CI70`^#U>2D/8JVQ%L[]'Q+P4\SPB_,@]#P&_A\\] M,YO)ARC^'$=CQB;)ASB:?8R\$+/!N)5E0.N&9IB:5EIEI_F'!KFGY&OJMO'2 M(/>[<#33=31]$)!OH[,Q1;'619H.Z44Q;$-3=&T5Z%8(A@:ZIZ?%,6$WK)<& MNB=QV)KBVF8->6P#--#5G,7I\^?`"]-RGN"`-&+KFJ/4G,3U0.P$^+Y>.4?1 M=/M@H._IPG,T0]>,`:#'NRP*X0&ZX#Y'28KY03%=IF]9R*9^;6K[5NE^\VHA M$[@\>4NQU2Z%`$T4WN-?GZYNSR4,O+_X].'J^O+L]N+JDW1V(]U>2>>7GS]> M_>O\7+JYO7KW/]+G+]?O_OOLYER6;LY^O_CTVXTLG7UZ+]U<7%Y\/+N6/G\\ M^W1#T?O%X%OF%IX5&7!L-@^B9R;2V5C@W_LBGVCNQ5F&`^;,X,.&HK[Y\R>#S#8^K'22K]M8`W,.F&BHO$C+)^[R7OGA4S:X"0\WQ*++]`V4A4 M.45:S+,4I0M,),$$QVOVR,(%D]Y%$TS\^XI^&LJQF'E_4B8@GR,?!--O<&GY M9BWMD:HHE0(+/V1Y*7P)3:_IJR_EZ`$B_A%0$F`&QX1-61SS7)$"H)%T17E? MMSH3IVN9+#VKF'!'7SU)Z]@MGSSC4`I\X@ MH-YX`:,:,SQ#[FJZ:VG>!$'-:H"]$S"[7$L_:K%M2W4=Y4#7TI.D;-4U%&70 MQ=1+?5L717%`2U%)[NJ9:KFP&!]8EO=9)JIJEI%=VZ9:!"0 MUN))MQQ'[[1]W4'ZDK#I(OCH3]DF)KO&8=\^WS[/6<5P]V$1PZ)`,H'G/OA? M\5/F._['9_-?'595P'IPBZLMD?7-K*ZV6-$PJ[MF8^8_(CL4.=;#:*=4;>9L M+"IC%).07'^&?>^I'`#*[.^CQ5T*L$G9XX.5J\GGCTOSEPNDB#(GH#%Z%9`F M&4B>&*%0[S`_=,8K"4Q%2411Y,*G*EM4EL];G9A&R&J:P&S/,*L7//^'U3TL ME\LPW'D3JH,A2AF.%_#+C&7U&9^B.$7:@!O@Z8&%$L/*!KQL`D+G31BHP..\ MW&"^3H('"U2&D2A?0:4L\?#X"2F!6#(45,0UF*'B&[U3_)NI;IDZ$X;U"8&2 MWX/6'41$RT)9%UG)5S2X#V#+Q4##VM-E;(.28SIYA[&NDMQ5'4X>'<:CZ M6-DD=)1*TT@9+JYY#1<$;8N/CL5&`)CNES5C`(%>!) MQ9+1>*#6(F\9V]4HLI*?^CT#%N5O5[C-U0W'LBO$NFZ^`>%;7\!-56W;5*UM MX",C8(E<4--(KJ:_1=&DEWK31*C'K,W\(./'T`&F"S&J=0TA)^;NP:J M"9?7/<+K@Z:.Q=11*"4/PG"?U>#%:R@O\80W#!:.XGZ.U]<\\L-4 MEF;,"_EMYJ6\@+&X`!/I#5;PA2%C7I9K`GDBQF M?/+83_[,*M`]>?&$`_($\A7.78:9&TF+"=$V'#.0G$.RJF*>?[YF7D,G!BD+ M!J9/\\`;DR#*RR9+,%<,4MFSJ)#L/69%J:@><.#/?*S;0Q73"20^TX"UP6XR MU&87/D@L`2]"5*QQN519MJ5BET1YI)CQDF[Y;A6\K/PRUC:"7V7IG@%ZO8`O MW9M@G2O8+(\0*)C?2+I98-7JZHCMIFC-EG6GU93<9HDV%%EUS&T,T;HK&YK= M;H>6AMO`S$$E3>-H1H>A3/.$?5$E&@5`*ED5PE919291%8U3'$BP:59?+*O. M")0,:\/RA"@K^C,FBPLK\+."U3FIB\+8$P8[-Q'SX`A%93/DORC2)J"391Z4 M1S(6Q\(:/R2N^F[(.;U0 M!2.NIBB^:\ M<@IP!XXB(L0JOZ'D]9MC.KTF.4,`:OE;M*7`/BPD1N5ZAK&)]31@/Q\!'_#!'YB*D M,J]9O4SR>T:HOM%>N/_5"SPB0FU&9MTB^1 M2%8&<$P\BB2`O,&%*)HH'J=BB^)TT#P>_.['$W+Q/O,RA6_\)4P`RT07=Q)A M_S-']!(1M92(M?X^=]?;M9[ M(57+=LAWS1@_W[TR!M$&]HQPRR! M//6"A\&TM6NM.O4V!:6TK/PH'L8"M=H%MF]2;_C:P2N;3\Y$DY_R=^^B)&W? MAAV@M!UDBK,LPUADR):_Q3399.^@ZT.`_I$ZIQP8VC]X?EP&DL<*E[_Y'2VH MPYS9(_4>J?=@J+>=(6=-UCF()YSL1"?Q@N-3^^>&&[JVU_S2L*L]XVU-=C5= M-A6M8=A:[]>0$&BR;CNR8Y@O!<`;0U8=N\.K^-M/+P6E;F^;1YS-U5UF)E55[:!WYI.ATMQ M5S#HNB';KGX@1*9KLJ+4WI$[I;+=;;&FR`J(';I(<>\CHJ71G(:XC5+@A#T! MU`%`S/`(V*\GC0R^ZP`UG$F1=04(1^L@31T6Y!J<=E=VE>'9^HX!?X,RD5'' M*7I!-3RCW36I:;(-@H;F#,:?=PRPK0"PCNS:ZFM#M2H[JB7K;AT#/FC`WZB* M(QM&'<*_[<-A@P3N6J!:E[>L=+WPC^@N*D[*2L39MKZL)L]8I?W!-<;D!J52 M;TN]$H[NL>/WQ^^'O.7F?49-=L,C?L M9D9;SL(U-IJQ[9'Z&1U55K4F=\E.UNB8H*CNE59!-3;,)IU^)S/*JJ'(EM[@ M7>$?.^MV6VAC30K>1?@(KT?QLRCO^,IT.%/YH8XQ?SL:7 M=:V*0SNT`T>'K`W8&PXE:P'I'%C7=OGCIVOO">L!8&Y]4!>^T8,A:5H=1U)E M7=7@;JDUM'6_0XSUCVP!(EX-JE)W-;2`V$I\^.F?4?RG**(Q9DE3<$SMDFI@ M-'4=A((^ETG?[^MFM4Q'-JPFZ^X:=*PCO@^8\`HW@W2/`?.#G)Q:;ZUMPI58 M%YS2=7P">UU`Q.X\@B:0IU/K?MIZ`6N)>#L"TF5+`])U^TB60\QJ:JZLVUUD MO0W(]B.6+/`S0892Q>-'MK/=?X/<25&VI=_].[+?Z(HR,.!UN[7L_"Z61FIR MOE,^Z\UB=NR*T65=MQI.1R^XAN=-.U^YUGA"MU]YB4KXQ\X:3[MZTJ34B+2O MM\^7WA]1_"ZKIO7V^9K-HQA5I!MVSYN+#*?NP.>L(-4E2[WW7NH)740@\J@. M'81Z8ZX-\.<]7/BX3P]^RDX1];`98?04>_-?5_JZ4+N/K,`?5C;)/"T@2E7T MI7*KBQTI3]LH3%V$^V'@J->7]@]'9S5VG0R2,1GIK&4]JEI[/%7KAS[7Q#X' M,W[H2J`5)+QMFTJKG\K<".Z&P8PA!U,[(Z&>2G*TO*N;?.657GO2/$SC:OM. M^'_V.UTCNJNB0_.URB].@^Y-SA[R*W/(*[2!`SWYX21Z0BD"V%":Q;2*AP(V M37^19FSB+V9PFX3L5TF`D+^/]WW^)7^^\A7);/#=R,9OQ;@@:B\-*WX03]?. M2"]Q\4*LW3'72Z_+EW)_+39#W'8K7UU%?_'S8$6S_Y.+(4N2!JFZ5")457Y8 M%2G6K+@R/).+*FFNTHVV=/HI5 MQ;8"1)==VY4=:PA/P>KH0!RZ(KNU3J`A1C=M2]9LI1V'58Q1I;"!>5@)G0[0 MS0OD)^HJ)B?V"GD99%[#4&73:$AIJ'45K*-H[CP04F1?N'>=D6;+BJ[+AMHK M#NXE`7;@B`";T?HY-4BQ6KU2&*'OJZ.*LT_&?(X-BDU2GQDL7?/.NSMH:.@ MU[*OV/(-&G_Q4BXN>@G.1&5BGT?Q7$[KJ M#'6J.5*X`I(;Z/)W3CN\;HUTO?IZCWNZ=1DHJ]3&@*P=;KTJZ-9J@M9HL[CR M>O!'WB=--&&V(Z*_NY`P6HSM+2\V@-$XYHC#J%UFV_0'MDMN_^YL)< M=]V@HC2N*IY]3\]*O%IK(:WZ275EI'6)R5VSV/C^[HUFFK+X]R=:]_+EVK#L MD56_,_QC9\5H5PK+>@5)9+*<89>KTM#)[[R%85Q MCV(XD9Y]%DPZ@=`D5FY'+"\W:@E'_.,&8N+F8EN32%@4^<;"WEY6)*^W]`+0J&MVSMK17$$8M'++XP%MN/>8$RSI)* M'9VD2J>J+H,UIU^TQ._GF*O/9\FZC4A-349:9FUQ(C6^5.]6DE4L!%6?LMHX ME+;B#=TY]$X=],V=1-9-7JOO-;ZTZOU]F=TZ?96[U`]J=2NH#V6GCN>J@_%@ MK4WC(/J?F(HC6[6]&(:[*G?1:*21S^T6[+K3OO\97TL-G&^%MGJ*3YMPN<'; M@7288[OXV_;Q:PM3.8IL.K4UD=8#NUU`P*$A8X`V'QW6U%$._+91W5%`^PZ1 M,.!JMF5WWQ:VCZSN15E=^W7=P732.1]QFQH7^.LF9I(>6E!=9J+NV+);+QUM MN9A-@6II@UD[3[=;;0.NM`DCV_"Z.4*W=T+>(W3;4'0KOVD\D+G!EO.TW+30 MS%>^/W6XU#7RA15C5\%VNON/`A^R\683)SYBKB_F=B9A5`6S)1;Q#1H8^MT) MW[K8W7P''2T,PZ*ZF2E]=ZC8D$\>J6X#=J?*FFO)IG)D=_?#](;=W,S`/W8. MC>TZ\Q!^W MF15J,W\,V=%=V5%K!9_VRD^R#3>75IL/N_9-S945O7..<3G>%K\]GT[9.$6+ M[\0/%JG_".PM;W_]RW;8SVK%8IE_020S+[[W0U&JULU*T%(2A!3QC(?R95&' MCQ4<:-C;L%:P;T6=IL93AOF92UQ58Z%,TC0L-TB(!MN&'R#'F"RS=*X4LA2_@;R;-6?;J6+3Q^N MKB_/;B^N/E6OSRRXNG,YH_S3/QDP94;^.#@)4,FBW&:R/0K8!+_(HQBI2)J/T5R&OXZ88\L MB.8XM@0_^H]T%8TJ*]EJ5;R*-LYIV=/1C/\&G M5.4'S(Z91;!`N"OC4N.2*="*%U"$.7>6\D6B&/-+`Z!+2\DKKI0OBF-?G->N MA2P?_&-?G.VN_!>ON;`GI>78%^?^V!?GV!=GB/4=^^(<^^(<^^+LNB_.T!I. MO:#<6\[/I*B[9^D^+T4-HOL]*&[2DY=(\`_7`Y)-!?5C3YQO0J`_]L09)C[H MV!,'?SOVQ!ERUF-/G(V&/_;$&6+T8T^<8T^<8T^<[[8G#OXUM.NF3IUH[+4$VD!P@P] MB%*-"D=TPL;^S`L25%'^H1FV85A.&>0N$`P.M5J&6EL+-7!12]%?'.HEK^$Z MJ#5#`>%K2ZAK:Y4/2!&V96M*"<;:^;:&J=]^.XIJ[1ZF?KMI#86G,PP9N6?( M*-X^U]<8I?_\SA+D(9]9[$<3M9$5$=&<+A(>IN_71W?::[9?&L MG=$LG;E_?#;^I5VJVOLE/.P$L(-`P-)90@2HE];WL_Z5F^9%US_T>?L]K]<_ M^.UC6COF%578#PM9?6\@0_N.D=7W%M*=;P59V*_D0\S8A>A6,N0AU.G"5G=U M"NM`/R1,]3B!`E.[DFT.'5,]CA_'E&*_+*8VN6ROLA-.O@:3Q'Z8^&." MHBH$G"7_OIIVUY15QU'5%:ZT$S`'(APQSX\;I4@I`I;W> MGO"M+]VI]D@W]XCP-@P,NQF_4;)2-B^5>.]QOS:@.'QDXW_S"7C>QC5+6/S( M)IV(^]08E+IK5O@*4)A]6^XMU`E[WSCRJE++D?YVA<(C_6UQQ1SI;[!;^ENG MOZLB?;TJR&XE;FNN8A@#HJ$1RITA@^=]MB!!V#.+ZBPT/8QB=- M,PUSR+/VBG#51U=3E4$YT@%A:3?BOVI9W^H1'%S85VWS>R.NXQ$L8VDW&I!J M:=_J$1Q'Y(Z>P.& M5G>6?0"J/=*&<*SW6^)KPVLOMXIJ'5$ZA%JPC%=-'9G&$:]'4AT:I=N+SRND M:HZ<`5VKWRA>CZ3:&Z7;BYG+>-65D39$9,^WC==>I*JY(\L]=)0F:V;-QMX^ M@&7@T(!E;+O]8HX'7??!XGQ@=W@-,W;U(])WZP->82O&2/M6D%YU01\J:S&T MD=%'C!MNU8>)[AUS%=,9:4=T[XV?F,9(50\6W7S0LW!R$6*E)/^1?0Z\,/D< M!?[X>:N:UU1;B=!U2K-*Y6F+ZDM2I2K")B6J9\S#F@A20G/=T5SC:M9VDDI> M*J4/3+I'[$D3:C%+3\+O^/W4\ZF.R(+J.^,W'N*<2CG';!S=A_Y_&'U?&9J) M-/\(T$^_QNROA9_X*=;'CA^1].:T3[+T]."/'R0_D>YYPG[P3"\\\HQH\1A5 MT\9O9@CA/&:GV>^\.P*6!,["?[,EP<,$-%_:W3/`[`7/_\&7'GQ`"I""%^"2 M/;&:1R`0>#-*BJD2+/"=+.X2`!_(0$`#WTZQ!O<"WB]///&G4UCO-(YFR^., MI"\!_Q@\RQP\*KB2(2K'Y:3`614%TI,?!+`M@)\[7@*93T'[014+4WJC4A&\ MJ8)&?YKOHW:P]QS\?F0=-$JV$2&%]`DQW<3E.CC`!X>EE^;IRQ&9]G%7#H*S+P=S MZ,=].0#^OK0KA\+"[@::='6R-L7R+;OWPQ">?>O!<.-^^;U=/",'LJS7B?"7 MOECJ7(K+HNF!H/&XP0-I'\;(7O8.'0@BCUL\B#ICKY8G.Q`TON0&7[.9YR,P M[T0KNX478'4IK6_5*[M#U:N]+^*U8W;O%^$_/FO_/S[; M_[(NCSOY2GSTL MT]HV,.M[@-G2#'W9+M$`LS^?PSW]WW";8U.%LW!R&\.QH&[G>$C>14G:IS37 MNC(KNFM4.6F7^0>'N5\?!4-1J^D6+P)SSZX9MNY86\+LWX?^U!][87HV'D>+ MD#H88+"(SY*\$\M6L5)#-YG!#Y^N;L\E;23=?+F\/+O^EW3U0;JY^.W3Q8>+ M=V>?;J6S=^^NOGRZO?CTF_3YZN/%NXOSF^;&EW7]0_.)WGG)`T46T0<\PX]> M@,=WR"`OP&[BP[TE>4$@/8"0'3Q+@0]S320_Q'`@"IV3GOST09IYZ2+V4]@= M'LL%XHT$K"-]@+]C*<"^IT\/+)3FBWC\0$%@:82Q1F.$GQ7PCRI->DH-`QOQ MU!EG6*!5^CT+-_O@AUXX]KU`N@B3-%[,!L7>+0:M>7'\C#%6W@P)&"<=9]NV MO&Q9\CB9)QBMQ>#KNX#)]&C^P]Q[IM:GWGP>1U]%"%DIANZ.C;U%DL?2)2!Z MI-F^/(MOX6>_6.Y(^I"_3OLV\^(_F6BPRL;9A@(#+P+W_EI$V&F1/RG-4719 MVC1IXQVZ+*:_R:;_>"D7SD#ZA M9E9(/V32,W8IS6C>2_@^G,)`LR;TPFC+\-2.7@$HGPJF""+LI-PXPZB$32F, M4FD"U.*EDB93`40H9';;4^RIC[*%.\QZ>$MP#BF;^8)1D_B5GVR\1/!'1=$%P_+&8W",MHL@4 M$#AAFHN`GL9K$M!:H@V\BN$@`R/`K:Z,RZ>"$Y.P<$R7*9Q,$"W%']49$8,R$A@] MPR;R*IR$Y&DN;.1K*G8+WXSYM&PZ18++#WIQU/@R1.!\)6:^O'Z<"[^;"%F8 MO@`!61P6)*P2U\Q8#>POB.Y1L$XNUC+L(E#+Y;0@H( M!1A!7C"40GK`XUJ'#,[>4Q#OY\1L23Z:8IMX`B\_O`*8,")"9J=(QGQWUU'; M$XM+D..4*Q=2>0V`0=R\*?!'`!0U"!G_J\EXS:`6MRJH;B3RO(LH'C[.>36V M#"!T[%9`+48OR8/2/$)2\2E1(EG<_8'$B)M<:&.X9P7`_"0)$G@+27C8*^;!HZL;-1@D!2!)]G6,TAJ!Z>,M'2,!`7W= M>>,_&<](F8'22TO*OKP#ZN57*N?.(!RRY^+@EJ3L*YBBT)@`RY3H@SQF'/MW M>&*$5D3XI#0,5+=.[V-OLHJ?`$V#"<^7*30+O@GLZYR:E>*NX6E'*=%'VTL\ M(`IQ.6.0-N!RB+G0!M)QM+A_B!8\.^8IB@.>5E/DW4PB$CW%":2[%859S'+! ME):H/"8((`OB.',6P^&$7\/["(]CMDID@`4!OBS=Q1\X"X%1T0R`G>A\M[M+I M(I"RQT\XD#X)WT/2\MF$KQ,1+".^<"\F;,[""7%\H&0D'.1@R6(^#WP6)\5U M2SB?`RU[]_C7([R%MSFI(_G32%HL1L3`%?0$G`!(5_#K!(1*1/4"I0#IR9OB M\\2>A<"8G2+"*$T61_ATC9*_$>_<<#L&XZ%G-81446&$(@)"FU*=1(\#S`T7-5KXX"3F!0P67Q"UCL#N5ND,W(2I$L'@7B68E[,4.QB M11_*SG?Q,,RX"$D`S/2/)$+U(9/B4%B"#8R!8P#5@(P78EZAS-,T4V))B4!?:]ZSRPY`FVLWLK)\YQY)$D93GDD%R2^K(KD82K/GH%1XI$#]%LQ/= MD*#0L#$_$,@@8KSI$,=P0O\$'"0/_AR/4'6A=8L#F:!JKT,STLJMU+A#[396 M_RN0R!GH%8/*JE_)>H.#+ITE/#XCZ3T#60JM0D*&GGECY%GQ,]=_0.*8H^#% M:7(*Y$HYM4(S^\KS:_VDX-MYEFS&C2=HUD&V%/B/!6OF$,F%D+,>]U-X?Q7Y M,,8BR5@J]A+'@)93L@YD9_ILR:03,#B,:+!"'0>8*D]CKZRB?V1=0!R\4.20`KIZGN;Z["#-#5D5W+.T?/TU\I]*,C5**ANZN3VY^^:`0]?,)2(T)B#^&Q@6=D;^,$O ML[JF(?RJ0V9[8WR1XB]X'J;)T]1XQ3SP,YM[-2BM/;.M(:/DEQ#NVX>KM_3\ MG!+:05&`DSYC7LC)WTNKRH7T!JXM)#LAZP+EI*"%+7#7?I)2%,)(WN>Z*/;R MXY.C?IN9_GE:/`+R!`1%K+<$,U?XB@EG'MZ_>$T*)HZFXYS/H]@3P['!ZQ(_ MS0-O3*<9J9K%V>7PS+D741Z_5A^1P9$R"-07X_DFD/A,`VH9F?\VE^-`$`WX MD:IJ@64;<;:E8I?$.8T9MZ7GNS4FU_/RRVA4@E]SSBKL`A,T,"9D>@`DB.H& M(^EF,7Y8'I&L/?_5=%PT6]8=J\J'<1LJQ[/Q;4.15<=L>UOC`#>.H+NRH=EM M(ZBC9B]:[PT4!4V20M,NTSQA'WD9*L"`0:$Y`H=%DY@P1V>"7)IFAMV"4@7P@L$Y#*^]@E#+A\_<_>#('5?N)_*&BJ.4)B4,;``KS"2-X5U?2&*6^34 M1LZ1F`G`!3AE&Q4H#VR>DE*!"C#*2C*Y*DGK1:67$"+X"3=ODH'%G]F8B5N6CIM`$^EOD[S02L)/M'"%P(^S*,TM"]FNDYCEC5%[Y8]6>0.: M>H1Q*#.#58T%>.'"CJ%VD>,(C9*U4%8*S!3FL6Q'>UY1678SJ\JCE#`&KZ6V?RY8'D/BPG)=EC8`="Y"./A M&/@(&H($,D%'1(DI1"U*D M_=X!JJ?HIL-B/T`1P)1$49IE@+.+I?YUV+W%=(HQ0V&*%FV6>7Q$%9V"I?R8 ME(AO6J5?(I',!S(F/D&W<"F4Y:%TGY.G29P.FL=#VQ](P3!Y^LQ]-&_\)4P` MVT+U/XG0^?A<5".J+Y.4+5#@KU#YN3A5.'7%<9UDQI8JWT^*;4U*^SJ2*%HU MMPMD(L;8C\>+64)\%326E?%0S`$E(*P<)_)GHL3#W2KH?0HR@9S;;:NV[Q+B M98YYCP]2X2"DU-#U-!5;6,$_<@0O'C^(F^B1!1$7)C-'K8BR*/;%%WZP`HGD MA%UA#MOR@\VD^OS6N"XO['UI85FNPTM([QE2,_HALCN-J?950N8)_.(^9MS; MB(RMPP:)*T%8Y4&L3]+37"F([@+_GFN+HWSMG`)!RV,^2013T+U.IV@[.*4P M):0,E`Y/Y\$B$3],&9#[A^4'"RBR^X[(F$<[<58@1)F2DXRB4R@*@^LM99G<'EE>?R4@1Z M$X]M"-D]7/5TDG&*#"=3;JI)A6L;Q;"2KSM?+T6W<$D=Q^=A)L`&B7U48>/N M)9:51.,OP%DS^(N/#=\]9VH&O;ETVLO0X8+::7B84WW! M@X=NO:_#!KD)TSEA5@0HI3A'R2`4P$7)O0F9?>D]**:$T#T(XPNY,WDH&0<.*.[W,57 M>`C@!8J32DF-)FAQ5#'8C&K*HGTPBICB*U7D& M,]0TQP?1#%;+X@^WKY(#V)#-W3+(2X,/B,*<.(#Y#P4!5^P*(BSS>SGC,/ M#@LYJZ0E*"9^L.!V180CB]44FC'53BH][PKR)1.XO<;]P\F_PTDFX:?^0$#VM8[R$R94516DV3OPXPB$9ZZ/J! MU'4#J=S42KZ0D@4W8XJ+-/=897N$,A[%;^+&\0TKV_CS'>*I!7SXI5!\5DD_ M**3+8M>XA%E8(WBD6"&$C[87M$=8=).T"8.N^6='K?=-V+5D3/J.> M;VJNK.AF9ZK.A[-H@/,\))T8.%JWBH#47[;#?L8U44`21`*,_=X/3P,V37^1 M7&2+NT9X'KG`Q!SE$ M6!5*N6Q39AM"!.J[.AU6AX&1`:M;'G`52Y=-PQH*F5VF,VQU;],9AJQ95OT& M\H\H=.U4KVM7*TL'<<4(,IQJUV13V84&^86[P0V?-E]'-J&0GX3Y^EJ>+<,`QY9E(E=CJ MW&\J=#5N]N8W7>$X3H0)LU!I:F'-?)RB!$@IO.`&!1@TDPRVB5D`G#>)^`Y@?B0F#(R%EB5@ MR;3Y\@9%(7SF\4U#>LLO0NG_]<(%&J9Y]`[N5I'C5(<.Z6V$QCR_&6'2ESD9 M!=^DB3H0_7YO)37E'^"(9-.!$C]/& MG$7N:*:SC9[K/'ZU^1PW=8?VTA'U=W'<-2MIK_(DLW^XR\ M(0K/4AXQ@E?%;?0I"LGM&E%0Q466[=Q2W6P=S*;IFKKF&FTP;P+3OM?9LU)7 MZ7JAVZ5RN?"[I;Z"US+^5%5S;B&*1VXKF7IK8SW%2!K;44^.#:V8AKN M:U_GBS%KQ5*,UT\F^V76CFO8UFOG0X-73%UEUK:E?6=(VHQ9&[9KV=5ZN*\1 M68-H(Z]AG2_'K!W;,%\[X^F-ONV8M6L;P(F^,YSU9]98*?H[0])FS-IT=<.Q M[-?.Q`8QW;R&=;X8LS9-^_6;07JC;RMFK6J*8ANO76@O<_TO7YYR_7[_[[[.9<^OSQ[-.*FZEX<;-T8R]O5Y*%/B=YJ9UD MO7\E\;]6_2LS'[!>"J8KHFQQ])8*"\I(4:M#S3V1B2%WBUM.6;@.%O1:I\_S M+"61>X,Q@W#"T&U*E;"I$&^<%>F>^E_I*Y[S_LBRHAOX&]PR>3H4)@,6J$27 M(E;R$(-.L@#EW(L>5L(,LS>YGS*OV,#!PR3[+$UY,<<_FVMWG&RR#F!5(Q&0A^IDC9`O6Z2IY;?4T]KWFK8ZWCR:LYL#S0X3UE M!GPF=S./RRHUVL.]T M[=5F)$.O'=O;'^[:&]I,#;1VRQA^[=T,K&89IK'CW5AY MZRUE2`Y'4K;F*KJY=A'U<.QJ"?W(R78MK=R)[2"6T).4=-=1E:V6\/^HK_S]A!HZ3-CD1'P+VBU\^Y"F M\U]^_OGIZ6GT]2X.1E%\_[.F*/K/^///^.`)#9X-#W)U953X&RM79H,^Q+CV MOUT`8S^%2U_-O@>-@`5_/\F__W=P%YQ(/U>&SB`_BZM3@`*1#0,?UX`MGO@9 MRP:?9B-FK^.5L0*$F"KZ^TF&UU.$FY(._GZB-D%9`1%+SX&HPOK@=ADX@:(* M$%]G`7R/B9PL//UR<_*/CWFQ457YX?_^7(&($\'/*U0`W__?GQ$`^/#_`U!+ M`P04````"`#F@Z%"!O(1)=D/``"-X0``%0`<`&YV96,M,C`Q,S`S,S%?8V%L M+GAM;%54"0`#CWN!48][@5%U>`L``00E#@``!#D!``#M7=USHS@2?[^J^Q^X M[,ON@^//)..IF=MRDLE$'4PL3\?#8\'1QJR#6)B>_'YR'-ZNF-@?/3S M/__^MT__Z/7^.'^XT4QB>"MDNYI!D>XB4WO%[E*[H,1QYI@B[7FC/>`7Y&J/ M9.Z^ZO!-(%\[.3XY'HXFQP-MZ;KKC_W^Z^OK,65EG:#HL4%6O5[0VKGN@'2H MQYL='0^WOUP$+1/[HS;ICP?]T6`XULX^#@8?3P;:['9;\!:0S+&PI(7MOYZA M-0VL83N?CV+JO3U3ZYC0!50 MMAU7MXVH%A.35F\XG4[[_%F&Q'ONJ-QSU MQL/C-\<\`AMHVB=*+/2`YAI7X*.[6://1PY>K2VF./]N2='\\Y']@HP>L^-@ M[-?_X=$%=S!.G.L6`_JX1.#3(XU)_/7A.J$XU&9>[K/?^ED5^Y5IM/W'N9M? M`[-7J(A::;7KT>V"K-84+9'M0'_83]%4435IK3O+*XN\%O)UAH"]-;S$CF$1 MQZ/HT5NM=+JYFS_BA0T#@*';[LPPB&>[,+#=$PL;&#FL=YJ>A>[FOR.\6,*` M,H.12E^@7[S5,Z)0>PE#DG.)7!U;,@CK5J!""]WJ]"\0^VRA1V1X%+N@SFQ% MJ(O_A\P+XK@SVYRMUY2\X15XZTK']#?=\A"X+*UJ&1O5I4+-5OK*)KI?;9B! M+*;H#7P"O6TSKM\U"'5<3O'S3?3A`F`L"-U`Z1MD+]SEW?P)KU!5QJM1LPIM MRAJU74)+LB:M>J7:L>'R27^+]\[ME_>4O&`6RI14O:#LNG$]((/8!K8P#R_J MQ5FDK;IQ7Z(YHA29\/4,^HC+.LD-UI]!N[*#V5[M5(@7YOX5]OLW-'9!^'P# M$7U)6#+B`NT-W3(\BWOW!G0--&;RBH=_<0N@-Q?9)C*WWV*7B80(>S#0>MI6 M!/P?2-$",5POT,PB1D*BQ>)I0I-5D0?-<=YYYY`P+H(6NK]FB8=1'ENN$ MWS#SCWJ#81!`_Q!\_:?OYE"RI3\CBR^C$C_V&U/LP@,ZVFZN?D&9/T_')X/1 M=#`:3*;CT6AT.CR-:1YS]HPF0>C4".7#OSO^3ZY*@A)]A\5+3%H/@S?#^G-* M5KOF"QHC110GU$04UK='FN>`/F3-VM*M(^V5!U[\ES7%,*VXF\]'HV9\Q&)A MULO@SY?_>OA%MWB_@\F9T@WT.SZ'9_A.JF[2-./6^#3/<[O>+@]5"1:$`<[F M%Y354>-%NN%3(:+`=:-6NRXM*,\?M]G^PD^/`F@;!_`/DAF%+$%OE5.F&QPLC M#%Q]TFI7IXU?O\!"MO"H'E5*&F,"QCAKA;MEAV\!$B5FZGM*UHBZFWN+;:3&Z0[ M:$DL\WJUIN3%?[J9Y_OL"@KY/5O?7<\7!*S$5LVM;BRQC?AC,ZD>GUVAHUXO M"%B-OAX]P0%4CRXQ_F*\1M1A"-U-5H\75FL83/X"=K=@PH/CP>AT-&B8LK*> M28Q+D)``J(1W8T^3I7MM M;IT.^;HX3B6FFB^KM44V"#T@OKJ2=KNP7H=<7PZK$IL:TK'%;L%6.UAZ]*05-B#G]@ M:9(V,K_HU,;VPDELEL^Q@;-B.''%#OF[)-B2V0*?^N^252O(8$T[*12W>68: MZV@GC342I9&Y%@AK@+HPE4;S:@9+WY5I)F$N;/\*R.CG*'M`HKLUHMR9SCF: MDT2*]BVV.2>N;1=1Q$^:)*7XY+U%[I*8L2,3F?EXWTR#9#<8M:#/I[(DF=O7 MK'64"/HB$#[0$'E.!FA:\?;1HVGOI_&Q@.V4($]@2WLA'*Y32GZGC)@RLF93 M8G7!'[_=4S+/##UC)=K'#EE?['I1!$N)OLX.QK+3="_(SED8QLJTSX,B/Z0M M!T6`U$@3"A!DC<[ASUUP62X6)<;)1]U"3@#C*R&FDYT;FE:T?4[,=4G*YKLL MJ&+CYKBI<=-VJ6ZXCFCH3!93WHM2@)3HC]N)/SA4(HQQPW+M\V'Y&$8.G-"? M+9D-'0168XD%Y;M>KG+2.&,PSDA1#NR!5XGQ?+M\#Y"<`]#L-6E&Z?:Y M6W(_5`Y)V8&\[B<,23WN&`L>=R0D-_CP(P5AF%H`GRS/Y/=X44XMUZ7X MV>/'Y)X(.Q['8B[">Z]@'[?B5GP.P8@R/AV,IX.3Z8>F8K6,#(WH=JI_$8N! M^ZICFW64.SMV"1C%#OQT"1\!/0)VFX*LF+J::]_H\BT(DQ)U?DO[*A')%'XV M^IU*LD8I&;S4/N5%-U5*370GHHD.Y&F^P-;<->3W3O`/9:>U+I'_-VON*B2B MH4[*M.,WS(&+SC>_.@A4N\*V;AM`W9D!@30?H[)[L*2`%G;O$AY^UU'WP:[$ M*`[@#(1,_H3PVG$\=GL<#VX%F9;">NVCPY[NW.5'.1L4H\6DH6,7;P9R')@' M@Z49@\BOXN4WDK-Y$R9-;G#YH60OF0=`I^KMH\0F2(8=_12%/::H%`'M(U%- M4Y0L=B4(,CX1&8&V"C]YN>L:4JF;OMHL:=;4Z:JTG90(ZU@!U_1ZVWD M!1PB6XH90XUG;_'HC3WH!UBWNLNZPB;]>GV)2%A*3M)F$[#9N',$JL0F2IQN MR;#=]I%7V?`E14#[B%-3^"*+70F"A`?SBSWL$]1J'Q7V=.4N-\I80(DM%_EU MGOP@LI?,`R!3]?91(\AY/PA?V^_NA&%)%89!O<2U$=D)""6$'0"[*C2,$E-: M-M[HZN/"'(JJ'C1C!&80GO=-#CL-I1KOP@MG\_S<8V&]@Z2&C`V4N$I\%UKL M76;2E(C5.4@ZB/`'5#A5;8@(7I@0LCWUQ0G2))$1=I#L*6V8@%9G[:;5GEE) MG22!&&_@VP^MGCW2UVM9J?*IA0_`V06`!UZ?MMKK\?OT,_?*HB))H"==]+`0 M;K@+-F@N?[#N]T#'/9>1?S@!HXRTGA:IPA(0?6U8]F%,'RU22`LUTGX,==+N MYEJHE1:HI?EZL9]\S7[2?@R4^ZF)9,8,JUUBRX-O?17O/-=Q=9LEM69TI()2 M@'R3Z8>SLP_3#R?3,R#L]$/1,6+W1:[L&S]L8<\7M]?9\;:32;@\Q>J.<_O] M3%].2/O&CBH<$@T@%5JEYHWV?6CQNTZIOGM357$!W^D@91$E+!2BI0AJ.5V8OT#13 MZ8I0EB`2*;:U:62(C/Y82$9(Y^GIY.QL#$N^=G^Z)P]\.,%LL*%H`,-\@H\+31/$&VC55BO0?CFZAQ-*Y MHS?$7B!:N\%$#2:'BE,8*B9M&4`K8Y_<=%R+)16/_$0VN6%YCDM]:YO:Z2QJ M\#N=:[6DXJ&HR";;2*-P="HM.1'QG0Q/!\.!:E8*F?/TBJP7Y+.G/LOEMM;B M[EXQ18HL"JHWJ5K36&&#Q`T13N_U,3JWM>^,_C8F;?[6HVBA&J%MNS(:D1$"_Q7'%[N-=(I-?CR_R8Z)PB_V9 M[9P$CHV7[9I?A=C4ZK"_$_H7.P5`V(%8D5\3 MA;OF6#&X-J6FQ%[U%27+;K_DV<4.2][:;(^C(UWE(R"3;Z18O::_C! M2,;M`&FO3,L^.R0OH9'WMGB4`F.OD,ENP9>]0$)0*\GWLU9TYL*>3+SEI01> M)2;D`!B_.I<]3(66BI(@OVY7J5`"M1)3>7AT+Z!ZN7ME\BMWCA)[P%;B1H80 M7X+SY9@A(Z*S_"@-OOGWL`M"Q0=D$-O`EG]NK)+0<2==.3MT3+;^/9@L$4QF MGXGQ6TR:^!),;_!V+N%GQ\7&K6Y[<]UP^4LHMC]GG)+91V1G!H?:C*'*'FTJ M\@QCSL+0FPVA'EM?1_5A3!7UERK:Z`SQOIUU:@YXBXU9MYZ-#;QF$V_J*Z,* MU>T,&?9'73;-N!7##;^69/N5O;@&^PIG7PD1G>%'9>!+AK"M8$EZW)YWJ501 M*8?"E4+X2]XX]NU6/.&:#K[VKS5BR*+K%XNN=G9.(F2O=L*6^>K&;]L_4A"U MWO!*9\$KL:^_` MVCZ8DV7?MH+2/BX)3ZFMZBTF'HW(^I<7[J9OLZ'5O-TL.^;^IAN^5=FUQ:QY MB6'W71VE/5<>H1)A=`Q9S`;)D\_.G?U$=79YA_`=*&7%*4V16L`+H^H]U^JR M_9_?`+5SC6"TZRDU((B$*.W^"B$+;^S]ADLI=@L4]O.+V9M=^()R@6RC\(II MNIL)'Y.MZ3:[O28FO=D%T?8ZQAMV3:YSY;GL2#RV\2)=NY$W MT:1_8* MD_UGFDA,)SA0*?B:WP2S-P/P6P7^#X0D#3`]"._G02^YD&SIC/$$K5839D22 M.L&8JO$+7^VB%FU>236D">0<*&7RT)=\7TS:AM6G/M/Q&92!#_\'4$L#!!0` M```(`.:#H4("@PIF_A```*('`0`5`!P`;G9E8RTR,#$S,#,S,5]D968N>&UL M550)``./>X%1CWN!475X"P`!!"4.```$.0$``.U=67/C-A)^WZK]#USG9?(@ MZ_`QL6MF4Y+MF:C*'KED3Y*W%$U"$A*2T`*D+.77+\!+I,0#%`^U%#W9D@#T M\36`[D83_/3STC24!:(,$^OS6?>\Z;<4<+8!%.DO*V4,5X@6WDA$_M=Y=_X MXRM7YU?GW=[E>4>9V?;\MMU^?W\_IZ(M\YN>:\1LM7QJ`Y7QT7D_EVSOO!O^ MZ%\O&VT[F]ZBC]I[#A$Y=D@G-;&MCZZXU34[@V+/;Y M+,+>\HT:YX1.>.:UO%TR'&O]?A&T[;9_?WI\T6;(5%O88K9J:>M> M8IBD?MV;FYNV^VO8E)/7[;!ME)NKMOKV6A?=\R73S[BZ%.43)08:HXGB\GIKK^;H\QG#YMP0,KK?S2B:?#ZS M%DAK"95W+KS^/[S8'#EA/N$_;#1YF7'L9\30N:$\_,_!]NI,$22^CXV]$CMLCS?8Z89A#D4O3BFJ=(5IX.G%KZ`*.7Y2Z5]\ MV#<#O2#-H=CF*NJ;A-KX;Z3?$6;W+;T_GU.RQ"8WEI`O;C%)77>1M2X6:M;2 M5[%N?[?X@FH(1A_Y)\ZWI4?Y&_)!F>V"-UBM/]QQ,::$KGCK1V1-[=EH\HK- MG8R^8PNZ8Z#19(P6R'+0 M8/6D_DGHG<-L8O*]!2Y!I6MJOB$RI.I]A;8RFO$EM\J82\B56J28K=(K# M%OB!PE.[I;PO<\4GU!4MG`4;-EMWK3MMVDG#E`CPR&5 MEDY,%1?D=KMW,ZRBB>H8]LZ\!MWK9-;51\M$YANB!1F-=ZV12=4PBK'F=O`9 MXEK$%A9S[Y&3]AD0K2J(&Z(2HJ6-+!WIX;?8%C0ZGF4]5=2ZBV5X;&38+OA&+8J_5 MZ?KAV@_^UW^$3+T*)RN@8*AOR'#C_,1&[7TRZNE*;)W$$LKL+S'+XSNY3RC& MVECZ-"X0-ZU@;-_*=EPD">5`?S[K!J--*#'3%>RS0*1%<1AGC+A.@VKL!Z`- MQN[])3<1F)2V-0&RO0](HI%E:E%P4L0Y!E#^N+ZXZO1N.KW.YV`30"6*"``[SJ;)74<1#CSYNVTB;@GMZ@(HOO=G@Y-I>E%0$O@'H/V^ MKF./_K.*]:%UI\ZQK1J92.3T:1257DE40NRB(G+Q<`%,JD_0#MMA.=*%])WM#WU[X>:L1R^9!W8/A M-N4AK)?,6?]N$(;TSV<4$\I[NU8*82Z+!`,;,N:LLQ.; M8,>:0-CD)"&+\5V=XK>SQ^(;ST(\:O<.%7:!.$G=/6M*R=8_+!'5,-O2?`7C M0=CKLF&J0,A]8>I95H6@R@[8**I75:,J*R6T-3+-/Q9GRM^0/9J\JDM/0OX] M12I#]\C[VW]C-E6UM&VTBH$;-8GK,NMQ%=(>BFFL"P]^X3X#GP%?N3:%H",K M4M]!,1/GU)$I$NBAH,&4)P\'M@W M!(6&58*\@:P5QFF54X'@_==C+Y6K"IK%]?4_';_8[96DY&U=#^UML^AHC'C` MR["-7A!=8`UYRATCC4P]$W#=]=1L=]UD&[7)CV4\H/IU<8A&QV?8PV2"-/L+ M5ZDK_E;96PG;DAJ]41/ZJ6X3DA(YWU(^M>/E,3N7S)2O3H\"D5)+<]GA)JBT ME#4Q44SCT7,K:=84E35)):"I?`BI_JA\\`G_>*JUR6#TF9(YHO;JV1`H6KI( MB\X%3X/5*Z>=47$CU?.0ZFZD!`*P'*?R*;C,+/N0Z@FD,J>`84J!&!7QV$&, ME;E<7_:N+SMP*GGJ`S91;`!8/ZG:C+L#[K,H(=N9A]^9/2!D>0J8;Q3$3+D` M(/7%H5RAW.T0SQCAI?@ONTHAJP.$M,R..&6)!0"F1Y$'$.>X0Q[NDX57:9V) M4V8/"/F0'8'*E`L`4J,*#?AV>H1+9"1D8&4[7Q(24A9F0`LK(GS:9OI MS&16P3&`Y":+66TBO'+R_A-1CF?QKF`E+QM"/E$'D(QA:/%-GKD"=[,39%D] M(&0R=[+O1&"3)`2*6:\P9CU(63FZ'D>E!E/:KR(61)$3PI MG"DEPE4D`&7*:)(\R+ZK8<([L2*7]66&IAD=]C'5UUSD%,4D-004?N;B$)W" M2;(`V!OC;/G7/.*_W8Q3IELCTQ%(@)EN;^D`)0MTW(#%XZ1K'B=UX<2*58&8 M*"0`7.\(G1/*&1X02U_O-3D7V&3V@1`0RIMK_,F#3,$`P/7D6%C#<]40'&:C ME-P4@O.Y&SC)\@#`)'%#SHWY%4,-.Z=7X$@G)3-^E9*;/Y519LZIXO+HIOXTT M7X1A9;"*?%0"GMU>'M>B@^#[E`8\I0%/:@.'.!O>ZS-AGG^,&'N=J=;K.S(6Z(FWGJU=\<*12DEJ$*9[E3%-276` MC7*WLC*R@G9[GI#]Z92B*5]*O>"DEV=H-1`\ML18>8V`-;?"\RHZGT;TD5A3 M1.M;U'*H'5M.KJ0ZP%I9X1D5S*1`R-H7M7R"!YX4K$$C8,VM\+RJ;P';UV*5 M=HEP@XO542Y,M2]$>UYXTJY>;'#AV66AJ>,:/<6G\[M*]9R4_T8;0-G^W&=.-U@'L'XFWW?9%W=]3)%_2K=N\ZRNQ'>N M&&M9+%W<-O%--;.O4ZN'%)`#A$3#W7J]2N72GRRH+*EXS>]-[_KR`DYA\UZL M*E$C$`PM\B:4S%.2I(80#K#JG"E;+]_:D!\`?OX-4IG0;;0!D>IN"+4-T0$` M-A829CABD=_WX(3E/329ZH1%V(:BY.SW6!L(&W>"`<7OVHUQ#$'/7%.Y>HZW@;#5YNDYSC$`/9]N MCSB$LH_3FWQJ](Y/;_+9+2N2&33\BI@=OD$O[<&7:DF`J/20?U%Q97+7_U+< M7=GU7_$J%M]'O$";6TO5@X.HP)!X66YU$A_-FA&>S_89+HB2BWI7%WEE0+.[>S1!E"+]55URWI&H\UT&WPD)+(9B MNK#T`;(XCC9+5E;&,]?UD`)1CR%E7?7(#WH<<>35@2T!2DY%-B6^&U3XE&P[(8"#BV;8HMAS5V:,UWI MF@@>SLLRZ]0"2!/;95+YLHX*:5J=9+JME<>J?Y'2]/`8#*#\-W^V[;=M&"Q*U+#](+$H,W M_(XFBD]7B1`^52F6V3S<;UG?L6?BR5>D?^=PT4@MAB@!8(.5OTNB9XHUE'?$ M7@NE0ZJ8K$4!8/T/*;FVI=JA:*XD)2!E"#5.Q(J,,%V%)R,L1RE6X_"QV[N^ MO(13J'&XAIFHUCH<:I?FR$HNS$EL`:$4I,8I$[J_FW+7'MNX!%_?20X4D18@ MCIZ;@B(B=T-0\"9Y\R+6!L3A;6-P1"4'EU-J[+Q8/ MK#0*C-[^V88?UG:(.SBHJMF.:KPB:J9=8P*&N\.IU0*C,HBGEM%GC/N6[C^\ M6O#-C->=JYV.+MU&X0&FN'T]H+_O$\SP4A7@R3DIOV%EQO`QPCAN@"Z>E9ZJS6<$]RJKO7(5<)X!S8@[E? M9<\W=9SN5ZG_W.B?<+_*SF6.N6=+%0R\Q[.HRM22_$*#TN[;<1U[[51^[64D MZZ]U#^@Q2>[%]A+5!<[ZA+Y MJ;%6HHM1A_56R0&(&P7V8\%5JO'HK#B0;Z^&7)`)$/<6P+3E@IH\.',NZT'M MP,:I6DAA!+5DHC&[_O>EMH`-N:./X;36+, M99:=9+0'4CN2;H91.#+D."94X@\F7_6N+Z_A/.]=$JE$V>HHX0G(II?M;+:` M4*J3:T-AO-Z_0N7Z=WD"I9BNOT#FHMV):_ M$),JK_Y$NO?^BDP*"IA<25+"JSK4&I)LO?&(4./\\C!P)\N(=H>P2)8P$GE! MX4;(7Q&94G4^P]H837F3HC%RKTR,O":N>-3W'24?S.5T`0]K#:I&UA5SZ>T! M1;+Y%\6EBP%@/_4M/\I;]B,1Z>V!Q*:Y9A8#)UV<8P(G'L9=\S#N(YP0M1K` M$D6L#$.&M/,I6;0UXE@V77D0^A\VT?.__N/[RP9,T1\@1*^YYB44'V6ZCICJ MP:%DGG&G5/QW",Z7E-H2>*\]/.TSK*8K,OHKA*!47HU1SJ'%HR-[QJ-EBG1L MWR.*%]QW7*#LIY2RNX`HS)2!1DX<`!"=;CX[@/#=#[!2W^@<_@QB!Y""9LWS M3I'TI[8845SSP#_\'U!+`P04````"`#F@Z%"Q:C_9C]%``"B5P0`%0`<`&YV M96,M,C`Q,S`S,S%?;&%B+GAM;%54"0`#CWN!48][@5%U>`L``00E#@``!#D! M``#M?7MOY#B2Y_\'W'?@]2XPW4#6L^>QW3>SA_2KQEB[[+-=W3LH'`9R)M/6 MM%+*T<-ESZ<_DGI1*;XD40QF=0,[VRZ;$8Q?*"(8)(/DG__/\S9"3SC-PB3^ MRS?O7K_]!N%XE:S#^.$OWQ39JR!;A>$W_^<__^?_^//_>O7JOX]N+M`Z615; M'.=HE>(@QVOT)[] M[U^_18]YOOOQS9LO7[Z\3FG;K&KZ>I5L7[VJ>CL*,L*=T+%NW[]^U_SEN.HY MB7]$OW_S_=LW[]^^^Q[]Z<>W;W_\PUNTO&P:7A(DFU#;,@KC7^Y);XAH(\[^ M\@TGWO-]&KU.T@="^/;[-W7#;\J6/SYG8:?UE^_KMN_>_/?EQ>WJ$6^#5V&< MY4&\:JDH&Q'=NQ]^^.$-^RMIFH4_9HS^(ED%.?L^6KF0M`7]UZNZV2OZJU?O MWK_Z_MWKYVS]#=$!0G].DPC?X`UB`OR8O^SP7[[)PNTNHH*SWSVF>".6(DK3 M-Y3^38P?Z*>A/?Q`>WCW1]K#OU6_O@CN,*66;K#H,(VHD2=K5 M0?R$5Z^HQ;_]OOS2_T9_\_>3RH.7\?HTSL/\Y3S>).F6&=GR/LO38)77C)CX M)2=#NC>-B)1TF7;E#-)5S9K\J(%=M7BS2HCW[/)74:G9DGR3)MM!@E5B)`.( M_A[=1_N(.G!2G"5%NL)#OF,=0%E/8_5<2D;B":&DL1K'KS[=?O.?-2D*XC4J MB1%'C3[7]/_OSV]8EW:A=3X0."03%ZGP,"R;(+MG@,C`]Q`$.SI8O'^#HSRK M?T.=Z?VKM^^JP/EOU:__?DL^)J9"W@7W;2"J%"!KY-91U*)2KQ"WF,4%1':B MZKYG%$TC])DU\^';DR"/S\F/F0X8UQ#8!GHB"^V@:05G"WLBJ.R!-D6L[62C MR/#J]4/R]&:-P](>R`_[9D!^U42W.\)V#TG_SVX_N4P\^J'W_^;L\XH[ED=^ MVL;5MUR2'M>TU[,H>!#(O?=W]U]3*&#].3M_=/H]!3WW/FC3!M%&KKWS&J=A M0M*/]0F)%0J+W&L'YZ]"@?<=M],(Q(,%$LA=N6Q,\K@UHLU=V\!9F*V"J!3B MC/QN?ZS6M(6S!:G@^_;0:PAB$Q(IY'91$M3FP4A@;.-O.$C-+(-K"6T7/:'% M5M$T`[2)/1FT%D';N[6'7"-S]_GN-``Q`*(', M`JK&B+5&I+DK&S@NTK03K^0YH[RI>TO0B5T;@ZR=4WM0"]$SB:IY9U!PG4.6 M9GD61C@])MT^)*D\,.RU@@H+0F&[0:'3!"`D"/J7!036%-5M'8\(R7:;Q+=Y MLOKE]C$@:K@J%.200V5AA`V1LX%!00HXA6'.F0PB@1(UV@DAAQ MU(YMJ@QJ-WB7I#GIG2YB"N<=ZN9@=J04?\^"A&TA;$RB3T`#HFH:D,8")*"61F0HE>O4+I4(U&2KI/-B6OMJ.O:`)9P,UM!![>]K16J9WE'041+"DD.BW$^.3:--[-EEI'^ M-0:UWPC&=,2B\D;2;>'<'$3=]_=06:.Y"[ER,N#AB\FRWMZ>WMW"&>=QD#TN MXS7]S^D_B_`IB(BO9,MW(C0N>$/D*J_ M,DB(6&D@^X$C7Z`@1S4'Q%C,XBJ[>OM;Y2Y6$*[H#[@EIP`Q^7VR0:40,^(C M0U6:@R"\QP]A'--O."].;$\4+@R=%"'6R!6$3\+R">?#%WP]EE MD/Z"HM714K21)Q5:U,2!2@I8(8N`Q#\@*5H[GR8TLK2,Z*6`K4DBWI! M$2:,34*1<2BRQR3-$>EO"Q/$;'\.2;!R.)=:K9*"1)@;O,(DVA`Q/^)<[>!J M$J!YE@&,SJQ+T=[]'$PK3'^64Y&@EF:!"!6PGT]!DG)(8IS3S"N(HN0+6W+8 M)"DJXE4217B5A]29@IJ.M/OW=W]8O'W[%B8DS/'UP,/">?Q$Q$C2%R*5!'>W M"8S;B\3DW9S_NW.W[G?>,X2F"?O\,#X[0$PR#HP7))F#%G"D`6,',;W'7PI\&AA$A>\B`!:7X?U:A.K<.*EVJ310%!FDVA5 M%0*)7=#E@);L<)J_7!,9V9'Z?Q;ACNXCDM%6LQ5G1@HUI)G#ZHYI>CJ`0^`_T$B/I:I.< M`&HE50>ANY`J:PVPCJH61;!N5Q'LNP(C@EI&G00"UR10:Z=6/P%XTG:!@PP_ M)M'Z?+M+DR=65).IW%E%`./.>@B\.\M;.W=GG2@]6VH($$\!ZLT3,(0I8%29U!3^)/ZJ0Q*D_3-YQM&]2NS05K08WRT7J`J:(0L89D1Y%%3 MQ#(G3H/UFQ$(V=_0QHNT?;E:%=LBHGDCG M7^SW4KSR_2-+[,&V7JVJ9V^;U@IOB"U=BX*+-A!K]HCGOT!-#RPH\'V08-$- M&XMNW(`+]`>H+)^&D(-4GZ/!R:!@84[=76`RB@6<`M=<)V#E"H=G+>";N?*5 MQQ&+E=Y-Z+7F3N.4OX$4C4U&=+X_. M+\[OSD]OT?+C";K]Z_+F]*]7%R>G-[>_0Z?_]]/YW=_@#^]0'/*K6GAS+&2;[KFP->ZIFFKK!$Z[3[2Y*7C"^ MP6Q)C(M&:FC6.!A@8F#A@!X6.`DL"Y_QM(TW\E MH*)!A,@COY\$)0^>^V?Z0.:):A_PQ_#-K-T#$SFK(O]QB)WC\9$+1GD MW8<#%SG\6]88MI#AT=+%X&D]3_"[>JEBF>=I>%^4"[AY0B83S+J@5S"&@Z-7 MC#?@,",!O`^OO3A=>?5=KQG0+7<2<3L7VNVU<7]WG5"`_G52W,WS@-?0#1=V M4=_DQ2ZT7?NTK6T#C2>U3\.@9"64?W_[^NT[,E=,T5,)ZH_TYA7Z/Y253QL$ M1?Z8I.&_\/I_H]\O_N./[Q>___Z/*&38R\EE^_8!"MC]+9?$01_1]^\6B#X< MSAH1RO>_7_SI]W\80/D>Z&(["R8!>V6="T/XTY_^N'CWPW^H/^X]3 M]/U;UJ3S?=\!KK2OU^R&Y""Z#L+U>7P<[$+RQ3C-R=8Q#0B!5N"-(756X[54 M[E?F#47JKWPUA(A2HC!&%>T"^3%VS@[-IZ'5`5A/1EX;2.G-)J\(TE5)Z\7Q M&':Y"D&Q(_,/'&?A$SZ/5\D67R19]A'G5YN[X%F^WS.,"_AAER%@)6=:3%A` M'ETQET]9!U[>N=/A@TI&Z%O*ZKOR?@DR_A-^7AQ#@0#N52B&5H4O@=JZ'LK[ MM%8=/82,$?AQ$)@O#;PA=X/S((SQ^C1(J;EEG>,QFW`5RI9O30AAQBAS2/RP MI*=R/A*9BM0SQYH0U93HV^ZY)$;\'=Q0,S;`%-WWK#2X^SX'&IY@\#SY/SN89@RNK"#*OMDMU M]>KZR@D)&7BUC!+.D!,2WIV,&'0B`KRR9@B$TD.B/2!^>L]J#:YRR^C5]J8*<$KQR M3`=*4DPF(X.L+U/+I"ER(<2(F%])7I:\(,(`,0[@14_CH+'RE[;NQ0LG8F)G MRZ;>1H^]3P'N-#(0$F?9;P[I)&)9-,Y1$J&6"MPAAL&HZL!ZQ5X>>41976<* MO&[MB2=TA5=Z0=D4W@-X.8RLORZ`],3T3>0OXW]6B1_.*/Z`NM.)Z@=?F>]! MN6I+0TW1=T@\\6$!#*4C<^WAO;DGC*%-<71>G#JPAL:GF?,\^#R9%H\'UXW. MB=P273ZE2FM?V#R#7A"H.14H;0WUP*I2^.Y;J\*F`,^N*N00;'!5[=CY@W-A M)9;+:J0G'!0&K*8(( M9Y44'Y)DGD!DE^G MR;I8Y2BC)$`E`Q;T[,$D*F8!HP8B3:[VFT%-EL3B=B=(W38`DR*1`(+LLVJ& M)&'95=X\2%I$A,#L@"7=U5\3FB@1/@7B/@'2C(W0"8\JT0%+<#2)#511J5*X MLL`DG=%I#,X_FRD0,K!G^=5&%]4[;:!"ND#0;CSG&@`$\U[O@MB8L;,IP''< M7%#`K&F$/L&3)/:P',DX-]*#/9T6,'XD$)+W(N[/SGVHU[?DZ;ZR"8Q=FLJX M$\KHSA:O=C@-\C!^.'W>X3C3+OLHVL/8J18`;[72QLYM6"-)SUJ:]J@F`%\D M&@JA;@:X7(0CPO/A`XZ)Y!%]96R]#>.02IV'3[@24#8_-R0&6E(:!*VSR&1$ MZ7[9:8!8_062DGB!*O+RN;<.@]J/@):FK*![J-"5;]4%'19`BUB.OAIX#G=3 M+5L0B"?MHH4Z@FAHH)83#(!TUQ@4!``+#UII!)-I;LF)HX(-"9.1*!;/7*VS MV/\6X([>RW),LR%O$F*C1!@^`39.?&&,VU3>ZC;SM!2HZ9'Q+8-OM M"RVTWK89G/WNRZ"PX,X5-,!FK!6[$I9^()245$D,:-#G\1/. M=8ZWU?.ZM*`A80L8,P<]W1#OC?(KU0*_ M[]/`K!+W(QQC^8/8XETZOPWM@Z^\?,2Y=NZZUP;&286"\J[9:>#<(06] M]PR!WH;:'3(=7H>F=4E3!)"7V$Z3T>%KL-7]B/5-`T=!%JXDF"1M@5Y]50G> M>>E5U-#]ZZYR*?H[X_6=E.M M-A0//OCMHS@)HR*7WB,@;>V'J^X)KW+6JBFXNW;D,+*;BL(/EU6++W':]9P( MAKKMZ`\`[KH_X_#AD0BR?"+S[0?\L:"/25UM>J>(-95VP]G`./M8N'P4&,K# M>7@8)V#/;&LVJ.*#2D;LV;'R#IO.4?C*HL$K_6RC#RKTU;T]7AR1-\6HRI<' M\O#;7Z7Y]2`&WGJJ*BT/@-U6-$J M>1OP4YSB(*+7OOXUB:@7?PC"F.["7,6W>%6DY8L3:9B1/YV0?\8/U^Q^.\UK ML/-U!U1;.[/Z.@6Z,_7EOLIW5B`]W[L,TE]PN>7:LEF@MC=$^YFU@%A[ZM.M M1CCHWT9L8YK,<;:MFC).37'YI&<^TP.^^MIJCXT%>,8+:#4/A.-WB-I.608X MV'B<7D&\KZ`:*/E75%`%72XX:PF1GQ&HQ-_B!V M^0QM=>7PU:;_$)]F8]J0%NJQV@'`NN_7&A`"/&EK+)7\6FFVHBIX1-4#\RL% MH;Z1Q/1`P?(YE)7Z:FB`S4T%1&AF(@(X\Y)+(S>K17UHIB5#GRDAX!K1'HZ3 M9$NR?UG%D;@M4,F<2O!.P9RHH?MR.;D4_5JM/2M!G\OF0,4LLX@.\DS-)::[ M&?*L9K\=^(,T78$EK]"4C2"?GN$E4+Y@@CZ738$LV:K(#A]+7J]#FDP'T740 MKL_CXV`7DDF)TIHU-$"/(9L`Z3Q^K")P_]BQ7IK^0Z\-#:)$9(:.*C)@7[`` MYI4!&(=>LEH5VR*B+X/*%D_5'F-.#^0]0P%V/,F4V+U7#9-,])1R38\8`R3> MD(7U-C<@JZ.(\,YX@W.2]>%U?>Q`Z7FRQE#W^ZE$[U[L)VH)<*.?7`S!]7%E M8]0<"(%UC)F$=[DRL[_*9''GR19SJ+4>FZKI+@K9X`RP>F1/;,$R4W_!TKO@!XL/OUEQ@=DW^"G'@U>._?AB7/=N^:@CYD;/*'MX,URLZBF M%[7RW?J97]`8-4#:3"CMA-IMYNEEWWP)TT]!5&#VMZL=NY5K&:]_#M(TB//L M]!FGJS#K>9(%?@#5WS84T)2'3V$&4S\^76+QX%'%`%0R1277!6)\%]5J;\6: MW:Y=,T<-=[>EZ+\R/4CGBG,IH_X[>Y&+H4XXU%\J+O,'MC+86HQLI@S]"6W# M5*"+;6;Y-5U_G,PX>WKU<2H`#=)'681;DH*-^]));J<79<6ENH@ MOT]QD.$37/Y7]_J:!<9^G3X:KA*30%M3X8GD;+2]P?\LPBS,\2U.G\(5+K5Q M@U?)0\RXL%Q1NAT^=[=0)1=NU-FMVIBW3X#"#Q>`!.463;=T(7._E"1LJB^J MW.85ZQ[Q_2]0(P&J1*CR(<0)83>B_5`J-,8/=+M:78,"HM?3S0:O\B8GJM2V MXMC3,Y/QS/?CZ@MT0)1S*U$)S(["U^YYP*=,/;.Q^A4PO[,/>E<\BR#TG8?Z MQMRN=B:HVXB[O[G$`.4,31D,6'N9&1C+/24,<0\35.\1E(>W9>')WS%MO+HH M^/L*O&)P]^`4U]7F.,@>SZ+DB^[Y>#4)^)%!*0S)2<%>>\@#@A)AY`>X,FI6 ME`HQ,M"7/J@8["V5-5X?O7PB1GX>-V\5+E=Y^%1>!:$VKS&,P-X,&0EY[V&1 M@5P@7A\9):+PTG)FK#4K=/^"OOU4WLGV'6I?V6PY@J]R60-_=7UZL[P[__@! M+8_OSG\ZOSL_O?4DK:1)4NL>/1\W3E0<)I66W2[--2/["IJ%40 MNKRTZ0SU7T4B?SZT&`2GR+11)'=/)OD]_=>*:G'':3%I=!;5 MV&`-N`OR)WA'/F"H6@#H-H$)JB(Q^6#(_]UY$.MWWK\3F&L"8^X#A?2CTMAT MCB<8]"6:F<@3Z&(:&XKH7&`SA:'[BVZF2RLH8Z,\S1>W%\*)!514 MG5$C>;OB/=/SR=K+@6#`NU>S74G)+%M5VI68Y=@@#F)@P'"(?'LRIG4>* MH:+U3+1F@+ZM67Q']]S;W**Y_`AXQ7(RTN-'\B^<473M0R@ M,OD)X!H4Z4PHQL<*FQ@@@\%Y_(1CTIM\/4%#XXO["X"H_9XC\,#A>]*8>CI' MZ(^'FZ"92>SQ+NV!T+I9PSQVX^&$X3K%NR!ZU\$+37,)>O*;M"`^TQC,ZZ'L!I-Y@O0&``,Z7T*T!)`Z&N\1>1!XA1*9VF.S?U11^Q-+S6`U\J=S MR#\^0MJ1WL>C4!(5#&'@^]$G420PI_;XJ).](TXP([05I$9'`+SS1+HZE]DX ME*ADY)5G&D`V\%`%%U\\52OB4(]M&/IT(,@:^/.//YW>>G,HD23R]4G\U3^+ M,,4$(`DH^%:EJOF%(ZTG`5`%3QDH1(7R8E$ME9)8M.6KIO0F,0\#Q M,63;HLIF0C4Z.!X`IL$!<@XCA`^):;+">)VQ`R`!6W*^#'(JW+4Y3K;;)&;7I1CDBQ(Z^.F9$I!L M.B8D`IU^*232Y-\U);N_EM&6KV#!3ZZ&8*+A8M?!16=0%-.JQ)2),/EX!8X@ M6DAT-9&G[U?@*!0Q[@H<`4./K\"12FOA"AS1Z.G['3&#]>'''3'F.<'DI,+_ MY'9:4NMQ,FLOB?4]O?UT*ME*ZGLQ\X+HOZC2E!U3Q,U+&`ME/X M7\$*X])5J1+8#[AE#A-^+`!M/]J:/^I@#-3AE<+%;A>Q-U&"J'Y&Y3S>).F6 MY7&Z1VU,J8$N'1X&KG,+L1FI^VN)A\C5OW26HV[?OT$<`_!E.8L`UV&VBI*L M2,O-6>9T&XHW;/G!WH)57K.',_INED0?O59@9]=$PNZ=5..;0)Q+Z_BWQ.:*F&2QWR%V^G[-'I5'^2-&NS)'(-:LO#[2X?OO MZ4,0A_]BKG6O2;^/U-5$D=4QVA^RFRN:#J'V42_<$O!W>0*_`VU1, MYR%X&XS=OP5O3VK!D<9LE8:[\OG?#3HJLC"F2TSRDDNFT@?&B-LUS0Y\I M/\08`N5LUI!+7!?PO;?RL@0RWEZ3$+4R>+5-00#T]IH60N<%-6EK]^^@:401 M)/_;;9"RDL3;\"$.-^$JB'/4\D$U(R_&`D[&/E1=_#!.*) M8'@G@?,,T>D23;!5D\#XA0D,WBU4[9U[A5Z8GAT)C_%X$6K+8GIFU?1>J_N< M'6:JI:6;=/D+!S->'^,T#\+X+@W6M%Z`':IO/4H7I>?K#FKM?E[U=377.KG'*LD_>-[]EE0-EOZCJN+J*]SMN8/-@7'.L M3:,#J&[C%[W7_J5%H'UM2D$!%T4T(/8#@:0YB"\K95&]JN#-"+B'P&04DY-X M8T/:T436W@L'IV5T==7 M;FA"[52F0`^`6E%%YWW021S=/Q]J05S)>^)'O4,87HP!QHB/>,2Z86(R5\_M M7ZV,40X@9NFO!ZCD[6_!M@-5><:P=8**,6*<%YT32\WU1O"#VSQJD44&#\H' M!TPJ%!3`986FDPII<[ARPP&3"J[TT(<110!!/ZM0D7AC1)I9A;R]#V:DS\6; MA[8]FU9,@`(YK[C%#W00N,&[)&5WMFA./4B;`U5;:,3OU%=(VKJOJ%`*TA]_ MR^:&1Q7@3,<\DAI1^F%0AG'5@`SIBJ=IDO1HPYL<+F(71U9G')%H3)92;R1^37#=L MZ(B`\O$93K>KJ=_9:A!:",/35^ MG9"0@/.PK'*ETII/%*QQ!]KSLJNE"T0Z1?=AMLP"E+F2WY,7)1*J6[S&S"%&<\.Z`[9 MB?`[5\N.Y.7^QME)@O8OHBW9L;2?,41=CJAFZ=<`:5D+?$A89NAN5$CP[MHY M>C[O1;MN84;KU45S8F`&-\QU"7VY6DXDU:`[Y1@#]+GZ+[AS3H:Y%,#TX$@@ M=VW)>4P"3K%M<4E484@+?$30!)CPJ*"*$.[(H%XJU6F[9(,:<:8^#MH[(X M@SP+G_&ZO$3#>(JHIP&8`YH":29Y.@*869R95/VE.$I67?#BSQSL$,&H9U`6 M$$'.?\@P6V"2@B8/<4@M\#8@&>S5YD.2K&7OUNF(H.9!)E"Z3H_(5$T8)[R>V$7KE+SA]"E&.`V(EIOO$<.3.-$ M?4(??$DFE:%+5>0+Q#'PVK.,\7)W+],5!QX?78^@Y2ZC5QXD*69?W!N<86*N M=(/_A/PQ2G8T)V*E>L$J-\Y#+3$&2%:MJJ3):*UPA4E[+8INYN(U^]+JVPY0 MW8,_6?1ONM$DY?,J2*,+Y%7*TERT8+IL*VL.?%^'T;*MN"W3!-]@+OA6Q?PYD M`>O^0%,1^S&^M->C\5>=7=4/>YVS2H#P";-B=O76R1A.0!LJXT%WMEF&LW&_ M^3)6QOZ6#'<'(,]K@:[:9^L:?M6!*-_D3P]NZJI$"$K[]WT;U`'0^A1LO93]KJ7A13ZRYH8H=*OFQQQT91_29\81WS%DT<"77P%6M`9MU.>VY MK-ZIDY>CE\L@9S\IO74*(X@*GBF0V[*>,5R`:GW&BZHYB]<_=_2"CEY0S=&5 MI\H+@[YVY)HJ(BCX/F0?RZ<@C*B$9TE**T+:@W%TA2M>A5%8O@@_+!$9RQ8Z M)YFF#G%Z,HXG8*8R16!ETM(P?K5)TE=9T'W!LLL$!P8,@9P@HX2@T&+ M`X,Q&\!8,%!&I?NWO!!EAHB3\\]I^N?P4\%_2"G,/=BXK.W:$21%:/^) MCDDX>*!/TU&J"QP_Y(^4X"[<`B[`M3IJ#A<=%VE*?AKH]3IR:%_MQ1*S!TWLF:ODE2-=LDZ?<'9EEQ;;\W4!+M=,)M#W; M5)78ZFWT`.@;]L17CH6"1]D0ZVE1W4]7=;9`37>(Z\_#P=*%XDCH$:K#KR#$ M[RB72Y'+(G\DT9*D`)_B-4XYI;"]ZJ.7TV>5/L4;?^HH`)TXE]9B;)`]R^H%@,Q.1`3Q.LP MZ$;5Q78;D,D!B8Q5E$5719[18\UA_&!Q"Z3JB`#D(CJ9DE2GH-79U"@.`)L> MXT`VNQW#R&&V.<;(J+*Z3K;"YJ@U)_!]C:\/JGHCPQU>'_*MZJ0'W:#Y1Y(> M%UF>;(EZCEZ:I]:J!]2&3O3&,X;.EZ:J1)P/C>4*F.],$UF9S]0'C.[I/MX_ MZ*'-FCO]5?L(8=T!>&APIYVK5CM'/>UX%#*R,^(_I\]$8W$0-0*2^':1Q`\7 MX5-]I\31RP>2!CC^T:LT&E`5"W&96=)>K7#]%I0HA6"?7!MZ23>T&'+@F+$$6H"8\!@-%EJ M9=PIN:.*/2KYUZO<&=J0M*#I`I5]>!A>9M3154]'C$NC(HO+-GL7V]WA="N: M.@J;`2S`*,1M5ED$;6"64J2"2*\,_%(U1<0.MVX70WP45KV<,5'B!7K!`>2\ M@TA%@D3^0M=V%-%%N,&2(&1$"?1"FSFHSF-L>C+W[ZZ9 MRB2R-T:Y8-L3.4ND&^H%*ND190#TEIH%9+L&&:ZI45$"BP3`7!YZ#W<[,O#^ ME033N\3W;%["S#12O2=W$6- M99R'ZS`JZ/T`;07UZ?,J*M9X39<0Z'9MD5>/<>P?DEYNZ3U\$@59X@T3Z7_'.\^8,/-?=RH8[CSXY<"ZX4*'N!R2WF5%"YX9A4&XXT M''ZI-UCC)$=A7.DIC$DXZ6B)243^@FMMD2P&9;"7%/2@JQ\]ES?WXQ(/U;/D MLK;@UW9H'@[G;K78U>XU\1UPR3H,Z:5\RCB(Z"VO34507KZ'SI:/$G[?7C0C M'L$$8`UG--1FA6QHF]8=RHRW*X??8U@U>M/ MMA!W1C77(:6NV!D-L&7@:RC9AS@LC-34'H>0KH@3/$I6ON5!Y#@,C!8"A@8H M?(5=(@*TI_ROK@3I)M$.Z'U)$\@(UQ"%"A39HP@#-- M<^E4MZGP7+BST[SAEJR`Z@;LPEUT\"Z&`0;PU?-X5^09"SCO+C&]ADNG)A$% ML!_*00B]KM\X\Q$-8$R>6&=8+W@YW@O7].\'Z8 M$[SWR`G>CW&"]QXZ@1I(Z01RN1UNKTFO1FI0T<>LHH0.:K*=A6$\@+;+Q@#M M;(L-8>!^^VNX=/UM+M4M7YUZ6&^A`^`4T9J*A/GC9.YP MR:4ET8=FGFTOO:LHZXX6J.FJNJS1;L[S0ZFEF/6POC/.XN;2F/!>64--26ZW MG+-:U3SM_4UA@Y/KN516PBY:V)'0L7Q8K#C!]WEU.SOYU\]A_AC&5S'^&P[2 M9J8Q>(YBQM2WY8PAJC!;WS#AZ-&"A[FX0\F5?.4U=ECW6,$5;MN67QP]$>D"W>^\D[(4/Q+IAP:/J"+&> M6"C)Y@XEHMCZFY(&E8W-KJD!@3=@:JKC+LHK7>5,5^P\M0^QF$&OU'`6/MD. MQCKVOD=C,_6,"\=JW@<0CTT`6(DU97RIHPWMZI`B\E>O)HLQ>92N!@=E+@8W M<7E#U64E+-N96;?KU7>D*T6=L*@AS`Q8+C(_J^VWKN"5\_9A/]BX5Q9)V5"Z(/1J"#)C4A$!6Q4,7M<9+N MDI1(=93$ZW904KJ1A@;&@XR`\,ZC)'#N-P;2](RKH4&4B,^,8+UE.A8Y`G>> M<5G$X2KUDTU!N+&Q&<0W(?MJN8- M47H#S^"E_#UJWS:@A.#,=IHZI!YM*0GD&KIWM/=L[%&0A8Z/NEJ"N?Y'D>45 M#-]*9&?Z3I*-?A^*M]@>?;O+_T%^MG(@#]]*L!1`S:JL!`P\*J222C?4?GNU M*I05=*29`-#8[<,C:^)3=JN&99CIB'1^F. M2L#)!CU_=>:XW&$0:">HIN=##CZDQZ%)5P9Y@;/L[C&([[[@Z`E?DM:/TLWH MV7OS+=!949Y9/)S4E4=ATP*.62KC:;\H)QVCLF=4=NUSM>(:8R#FTRR-$ MX^:9,VG4>FATFA^/7X;XRM1Y"$DW/V)?I?2I/SSAB,[$W@XMZ392GIVD6]G5 M`27=!CAF&6`ZJ39*4E1V?LV5:&=K%O7VP%EW6909@F*'8^N`^+A9]TC-6H_-GXE:?>AZ?,0\N[Y M7T()OJ=%J^ICP?KD)OES22!@& MD>I`D*`MW/$.J>#[)SIZ#4$.<4BD$)YP8&T7B+1&37.X@QJFDE-QM_.*JW-\ M&XKVQRM_3M)?SN/K-%GA3.N6>XV!_5(HNM`Q.RWA/%,@ALIB:'/ZRF%%`.R< M)L+7$N_$$@.8]UD8A]DC7G](DK76O/<:`YNW4'2A>7=:PIFW0`R5>=?-$6L/ M;-TFLC<"/\PGL/'@,TG9_@P_;%*LPUHU`O;'CJA"/V0MX/R/ZUYE"JP9L+NI M1"W72<*J:0A5"#E*K?XX5GFTAET:K`/8:0KL9`*QA:[&M8-SN)X0D!@/49/Q3:.'R.M!#R4W!`15;>W<'^'"1H]`?E(T?S1 M>7C8ZUFPA$'^#GX?"Y-">4"^TP+P"\N/PW-_AOG*RC/DU7<&/?)N+"7XG2:7 MP7.X+;;J*QNZ;8#N:A`)VKFD@6_@_G:&?N^"#0;6!OHZ!@N2.K1/,H'6VF>W M#9!]B@3MV"??P+U]]GOO?_6R#;1]6I#4X8L_])7QHR"CUQ5L=SC.V&552_J. M^`-[0/;HI6UR';S07RV_!.F:_;^?<):'\<,U3L-D+3MP:[<+H->$9E!3Y^TA MB_S=OU1D7?C^NT:4_M4]98#X3A#7"[I_07R[JB?$>EF4_T%5;ZCL#B9".-!7 M#7,GA#GAJN71LI\^XW059K0\X2)\PONS0]O,`:Y9MJZ:YI)E:YQAKEBV+/X< MP8'K";&NW-ZN_)N&C"Y6GEM-/,9(A/$`\K*F2FR99<5V1ZFRT^<=7N5X?1(^ MA6LJMX'^$N)H5+YH)^R=X`U.4[R^"YX)$$R?T7VN?T?AQ!GN*"9>'^$8 M;\(\$VM.<;?E/%W!!+`M89"N-5BID^J!^@+$]6OU0*6G%A M$J=AZ$B=AAU5:5C5KI.&H:9_5`N`*@D0[DPQ-XY?./I-HW[-V:>IM29Z%0A4 M$0E4X7AJ?Z_7R/V^1J[JM+Y!HZ1[R'A/GZFQ1L\?:4+)!2=;4L=^FRV+_#%)Z:6?G^(U3F]IK50YG[\F MD.HM*'R=ABO,3G5?)%]P6OX4;D-9^>2\7?J4QME5HSY_L].?)XF;33#&0:TJ MF(]5RMSR'6=[.MC!'K'K%>%XA)4/X#,1E\RM5FU2IKD-$UNZYF MLEHI0G4<:+#[M-NY#G:]+K^"8"=1XVS!;J^_PPYV0C!.@QV3X"L+=F9:502[ M4BE?4[#[6-#;)JXVW`Y]M;/CXH.H>O\*0J!>N;-%0WG7AQT8=;B<-IK+R=\5>J<$)4_OLH(#Q6\ZRDEA_@-@_2_+=/(/@$1_@A MC..YOX+;M&&P_BL=74TK59MS27ND)OH:$)_$*$D:6ZA,8=@B.)2(/BV;PWXF M_4([C'R>+,U#@G<:\H6!OG>PK$OK:B0P3XA^^W[#OA_1*1WE9[P5;4@N]=O7 M&^M]\W[#D?MP7GT]C3)_+;E;<[J6/@^8!JN\""*ZX2E[]=D;Z7X-&9OVX\`E M:U+1OO(\38/;PT&BO1:`$]F[&@U?OE>C/K':+OPH\U@]XG41X:N-MH0OD]7P MW='#QK)/9(\_4)BVK:!.H+7%W'VHM"MY/]A5_&GZ:5)HEBDKS=!GUMS5MYUB^PJLFG?!GPIWQN!W:1W! M;U:G#CT,7LF%Z!'J:,0Q.-9PKY!OT>9N9D MK%";>92VTX/+J@P1S1IZ.1G8RP:<%!X$8R`%T\VH,`X$2=AAY)J^XD[R(/(1 MMW.'6J`[JHO#'5*Y!115X<_\RSWJW@]S>!VHW)F6DE5=']Q0.PB7NV7G@05O M![D>/4+?/;54E3>"RMBO9^%Z1CT=P@JWM+A!N'XVQZ!C4P)/!Q[[2AXT^-CK MWK\!R#8VQROK$"/1]'G0[$J'7XN?JH)F;14R=`X4XD"CYRA56PV@@R0XO!@Z M`I[K?8NO-9+:4/VO82L!8#5DHDR>!EL7'\+I]L1AA>+YT?JP"GN8L1K@VWSU M.P-?A;U.V%:0/,?U$>=7.TPEB1\NDBP[PVOR+^$#-M*F`,]A:<1NGK.2M(-Y MCDHI3/]J&YRCI&Z.(M)^@38EA=L7H&83VZ+9WN;]IR]4#3TPV8[(4H-EK?PP M5TX4HZ^>Y7,]LF!LJE9$=C=Y.2[2E'R1RL'N@F=ZTWF.]R8S2N3L-$:MG<#5Q,QZ5Y#[YDQ5\'@Q/M2B= MP##.L\Q8P/K7$)@B+S.A!_,U<^'D'K<_A/GK>1;0@H]H$K'I34)A7+#+BG"U MY";1QB`.,+XW`B3O>@/(G7O>8-EZIJCRKP5J&:&6$\QJMS6H.8&Z2Y.G,"-M M9\'RA-/[1!U$W*`!""0WF'ID&(5,>`G,93V=IN&O("*]M/3R]W@M]P$=U>%LIL8X&"=H&JZ9`G@7LAUX7:*$)<*85HXM/KV]=L M\;=4`^PCX1+\XA0-:W,94RY>A1`=6(,@(6/A2QA0RS?$T>73#`QTEX8=R"6N ML,D-Z+M@,=VUV32AZ[X,`A9W%B6BG^!UL6(IS`GYJ,.\;>)V9_57I`K]\?49 M-=)`W7:@KF?]ZM)X[A%0^R']LHC#5;BC(Q%1`!%F`'@!K3]!6@I,%XU[A%Z% M78ET0X)*PP+5/+R(H@>`;%I0-`78H@CG_#ZCXIT]#.!3R:O\$:?-K^('U:W9 MPUAX-8E4PC2800KI?9D^*H0;$C<8&\3Q*:^P]FK:.`0J:PN\J._R0]FO"*_W M\X@0RRS#>?93L"J+\5>KM!"7ANMI`+(C4R!-5J0C@,F&S*22;T)38RH)%Z@F M116MV^SGX)"H\X21%)OS58 MF8E,%#,O:(A@JT>,031_1T0>G#Z-VF4Q';=.\"[%J]`\L'8)?!BQ1!#DPQ7? MVI.QJB^2F6'S=,"#E+<0!HY.1CCD(MOT3'8]<>^P9[N@:(1'S\0'#S:%*O=J M'0=//-U,3#/78;Q$!V];=L!!X6M`.S!^C(3,HUOQZ-92="`9\$48W)-Y=1[B M[%.X'>+5T7*6NCSH8'LP+/G4?`EN?4@7I"9]PA! MU2[-,5R@EB5B/!$Q^HHK:ME"7;UM60T[9\:#J-JQJ#!R6!Z,KI/&L)/Y7GQ##+`&9JI%2>F+D8C-+>NR3PAB^2Q\0#T+<^6F2'A=9GFQ)A#AZN<&[),W9V/?`;@LT M>ZE\`F?H-\HG*T7\.OEHMH#ODD^46?DB><617I/%>**&Z8+^KN&+:L;P#Y#W MU-%1QH7FE7%C:A@'&`B.-W)#4N>&/$BNGK%6-(L]\_3D/6\UMFM,U!CGP8,L M4IN3^VB-?7CFYMC2>F:/^X+U+]%EY*\H/9(8YP*U7&"F#1,QM@VX,0+.RZI+ M&^DEDM=ILL)XG9T1.[U(@IC>)GF!@TRZYF=("^-?@X#QSF5$Z-RS!DC5-[F* M%FV((WU;DR.JK^\0XU">H&(\8&8?SN!)BL:LH#0X+SX%)_LCVE4\T@ MD_:LH%>[7H9QN"VV-;Z3`E>W/4D4,90)3!`9!Y6/)L,X.`\K8\3KKXTU5TG6 M/E;R014CU'CH"1W0*V8PH[<5P,0Q?N^]_YW'=U^2O^$@E0W?(_AX[85]P",< ML67BJR_N2SC>'1?4'^D5W(0A8AR]]DDM<.(O?S@$MR2]8CN.R7'RW35[H,_YX`$YZ1G1HQ4>V=71!O>23@>AG=J MH!.W^0^+Q>G&:4OB^&6;E36%&4YT\XE>?,UJ7&$01HI)E*&B(W(Z* M,POO\#`*/05^@W=$,X\!?74[>4B#[0W>!L0?XX<65]MFN4T*:>74!'Y`!T^F M*J!SW&0L,_>'3*9)*KY-`+6-4<5Q@1J>J&7*-RS9PJQ]V]8"AW"5;+=)C#*F M%UK[F38L0`]JAC&])R+.T_"^H*'YF@`XW>ZBY`6GET&^>B2X.W\O*\(E"IS" M$.QXYT05[)W\',D-XE#H)%%%YT4I0\13(,IR@6JFJ.;::=2Z`KG>!106`08Z^"P0B5&`2%`5Q] M"0Z#11X2)"KFJ.2^UX+X3]V!G^%BNFJZ86,7I#F[GIQ,?G^'LB`*^I='.H\5 MU5->%"\/,3MZJ:.E6FDF]*">;PY0X.!Z8B@_-I5,ZJX5@\I3.SSHZ?":"ZA' MC@9YZNL(3>8?.YSF+Q12OHS7I_\LPAU=1#EZH:L,R^=0>MC1A!+HJ*,YJ,Y! M1SV9^V..IC+U8WU%N6`>E;,C?PWU`E%J])G2`QYIEZ*CTITD=$X\5"\\I6?6 MUP=E9'TMF3_6MR^3U/HJXUORQE?97DG?LSXW`7TZ,J5?2;"Y\ZS+@`XS.'WA ML5WB[;TT?U)2P'B2`0C>@Q3-G7N.5I;^6T$UQ9ZS?"ZI@/QD"H[`"(<[GS@K MTCBD&W\$RUGX3'_*E"ZA(H#Q"#T$WB'DK9W[@TZ4GADU!,P=:A)@;YB`(C!! MX[-'G";`=!-@A M9H?ASB.67X)TK9GS[K6!L7JAH+R==QHXMVQ![_U-2]K&CRDHJY+H766_3%,B M;VF;1R]MFZI6B,G?`HW7="KP,=BJYZSS=`54PS"CVCKE#3/TX[[R8380XJ(? M=-1_0(+O#1V](+YAU2,JW9)S3IIZT6X1[1=XQNY0B7QX`I_)LX*1JQU;)U8F M:**&@`5.0I%[E4N=5C`E20(1)+5&54O@G,M8:)VX[FSXYX"ZJ7K]::\-C.4* M!>6-MM/`N;T*>N]]]:H-L)$.D-0'`Q4/+F4%;5MA]RE>XY1S/SJ8T+V_9YRN M0EK+%Z[P#1V.%%.(67KR*0>THC1]"CBI&T\R0`L8^CO-56/$6B/6W--)EA'\ M/O@1^F49LF]9-T"&G@&-,EG>P8]-)/G6OP;<"R]U&U1KD(AJ=\-Q],[*F4-?*J.61+"77*7I- M`N1I!R&][J*7>2&X+#3E7P=4+'R*&D*5EP\IPB^ MWD=W6*\V'?&5JW:*]C`FH@7`6XJTL7.#T4C2?ZV6;NM?;7KO'8*N18T"D1B# MF)"NU+SE*,EE6"RYRK'>18P]R"CT0'H&(VLL7NC44O2KQ,HVZ.N\<`6 M28R#L###,-0%,KQZ_9`\$9,IXCQ]*3V@^L>^\5>__CN1J@N-_X-;<^Z+1.VV M_:TS`]WOLO<9/Z'/MXXM3B]3'.9XC5@DGE8_*\E63PMZS8$\5>W^'2!/%0G8 M)*G\'V$RU+X$_4I-U@0H-?5$/G5..EW("1ZPS,)`;O_\7P&LOR]<8_OMGV`L M?[___NDJT@#(ZCV036WQTP1T^,!#_DBFBBE>A_D)3L,G8@U/FLLTU"1`3SD8 MP.B\WZ!H[_[1!JTP_5UD2H)*&L01`1\6FAM)]?,%Z9K\F_R+_$`KD,D__C]0 M2P,$%`````@`YH.A0CGCO7CF+@``B#D#`!4`'`!N=F5C+3(P,3,P,S,Q7W!R M92YX;6Q55`D``X][@5&/>X%1=7@+``$$)0X```0Y`0``[7U=<^.VDO;]5KW_ M@>_L34[5F1GYVTXENR5_S7&M/5+9GLR>JQ1-01(2BE1`TF/EUR\`DA(I$B1` M$@((N5*5L22@@>Y^`#0:C<8O__VV<*U7@`+H>[]^./@T^&`!S_$GT)O]^B$* M/MJ!`^&'__ZO__#P^-/`VL>ALN?/W_^\>/')T3*!DG1 M3XZ_^/@Q:>W2#C!U7(\V>_CI8/W+5=*R[_UL'7\^&GP^'!P<66<_#P8_GPRL MX<.ZX`/F9`IK2[K0^_,%MV9A:7C!KQ\RW7M[0>XG'\UPQ<'1Y[3@A[CDSV\! MS)7^<926/?C\OP_W3\X<+.R/T`M"VW,VM0B9LGH'%Q<7G^FON&@`?PYH_7O? ML4.JG]I^6?WH+)!RP#R_H%^2YX!%.+=N#G<+4$ MOWX(X&+IDH[3[^8(3'_]X+T"YR.1X^`HKO^?UPDDTG^'WN3&"V&XNO.F/EK0 MWG^P"/UOCW.$,Q9`I(]EM>7T[C"5M:53^<$;/F+8JZ23M<8?`3+ M"#ES#*,Q-G#$`;A=OU/TK?4T#)[]&US;7X&XV7'2Z)/]BH5#Y/0$%]"U$>F% M*%B;-[/SU8K^RV.V-"6\R:PO8Q5."4M>YQKTOXJ,G#6O02=+:DM?_YI@ MH9*0U+6G26^91':S#C7H,@>UG<\97VV$L/1>\28BM*$K8_8H-K%S+HFG:Q*Y M8#3]#N!L'H+)\!4@>P:^1HL7@))=:"!/!J(=D+WK:<)I-2'):T,KG/(1E,S! M6GRC:=G/EZL'.R1_K[KB4+Q!R1(8+GP4PK_)^A(0[^EPN43^&\2S]P9;07EG MNY))%UV0+*4OY*CBFX>`[9*.WN-/@*P7V?X1BR*(5Y++U>;#%69CYJ,5+GT/ MO%DX'TV?X:*S(2.Q9W)LM2:,EU67;JVU6X4Y24KG8K/($30DV\`@6E#/9+/% MM4T[\OE-E_Y1W/(H"LE)&CF=[)!9CD9VQRG].>D)'LO?"<@:FA,M6Y+CFVLU M$"OIR.GO9BBLOQPC_Q4&34><,&W9?#T"Q\=;)!?:\?F&3#Y%VI+-]S68`H3` M!'^-)S=`MXSWT'[!O6MJ$+5J1^K^/ZL"O/Q&@!BG?_CH*@I"W&74;()IT]+ M!`*L44KJ'K.:,$S::QN!DQ4G>`N!-P&3];U6_AR]!B&PG3`FY]@MP8TJ<]3X+=3&1 M,0W#"H#S:>:_?IX`2"+0#LD?I/N''P<'21#6?^*OUOUXQF2W^KG]\^^G1R># MPXO!X>#XXNC\_/#TY"C3PZSVARC?6QLY*6W\9P$0^;BQI,3G)0TC^NC,H;O6 M]13Y"R$!)KWP.;GQT02@7S\[[S%[CSQSU313T[B2X.%>@B96@,$/0Q3Y-K.ZP:';ER_=<-/UN)CHX4ZN@6 MKV2V&W?U%G\75.BI4-8<7?&QENCK6+F^_@ULQ*>M=4G3=%7-6**I$P6:BODA M>PG"AA=^M1=EDU]9L?[KB)NK1$&GRA1TA3E#MGN';>&W_P$KIH:VRIFB(AZV M$AV=*=#15810;JBSK0A6T?YK2HBS1%GGR@;4+70!2D^UF,,I5ZK_*N)E*M'. MA;KISE\L?(^Z)>+`BLRI"7ONJZB48Q/_W5*BUCBH[J6$H5H\)9 M$??P-]^-L"A1/)6SQ])6.5,4Q,-6JB05WHJXE]^!Z_Z/Y__PGH`=^!Z8W`5! M!!!368SRIBA-A+U4>2S7Q2^?MX\?6AQ*L*[=`EE2C97)# MEYP1XW_(7>)7VZ6GQN&5C=`*FTLT2I&A?*ZZ>>$=8N&=JL4$AVZ+@&C.:D07HQ5\C98F@3^*0J0=3!6S*@ET32YL!EHH:9D!$E$'F`5SS"60#BR-%:T9\ MC2-X!`[`@P3+XBL(JW%15<4,8`ASR#SVZS$RTB#Q%>:=@81L$3,T7\L1\\"P MQYH>(["TX>3FC40H`[QHCL(Y0+'\JJ<"CIIFX*(IH\Q3RQ[#A0<8!D*`6]G% M$U!!9?NA[>JB[#'REP"%*Q+@2#T:V)9>DOT9GB!K=IH\5>Q/9X> M'FPL7@_0>W!K0=!K=Y2%2&%*QD>+R"5Y M:J\!YL.)[[SAOUU`%>M-DKOR]'NFU-A^D$[(FXQ$J3*2NA?7;:9C>V&JJN3E M=F04MH3Y[FHS7CK''>OCUO_J>XZP9W]323O,=.;F6?_'%P+=4CHVA622^[/P)JLF>$6PV6VGJFXZ:9`$P,*,CD M6N&&3V4=TZ$CSKR)T0;<6-D_@(BAHK4W1"PGQ=):1!VNW4ULQ+\-C M+,.SGJ.D(<\F&JV98PH:V%7RRAC)!/P5A*,IMM/J#X1XJ!B(J`X$8*)Q^T@2 MPWE@9,?47S0-209Q,#QIF?_]T$\>[@=N[6J[-9]550JHYL1&AH=W8;WSQMS77IMP+WNS;\"`=(2K0"=W_ MCP&BF7#J'2*LFL;`I2FOAAP!%W(C#:-PCA>GOS>+`1L0XZEB+A3JF)1PFB)SG[#^(TC??^'< M'QP64OEL2%G^U$J(*;FM3EI>]Z9F(\`LK<8[2-\MJ4OX[7MY,C*LC#_H06:4"8"ZN^6*F MZ)Z++ZGGBHIN9Z3RJIG23=%S)3]2;Q@J&]=!N'YXC#FH,V6TT[3`HEW/B"%. M$GI+=HS\*?-<-E.BSQJM8T/"D%6AS]$2D(=*O5F2OJ?.TF:6[[.NQ9@RQ,'Q M!%Q,<_8%>)AYEUPVGBR@1U\R(0_7)J)@6>-L6X&CF5=8P#C#BW)H80%J3(N[@8AP<^#DW<#JPYW\0ZUJ%@ M4S(OI5,LI?/^&1H";]W'IZ*\#=,;W-Y\3YK7(BGKF*J M%%N3&W#?8K'%CW1'&/0)^GTON`13/_<&_0/TZ)24B@>OD7DJ<23:`PCG_F0C M4]:TL<,>]!N<:L7455I'Y=-<(IYD(;_$6P*V3X11NO\XXF-)0O(8%3K_"L): MXR57IL_ZK6=$0NH8)7D=DKL4:8C;I1U`AZ'=TK)]UC(_0^R'`/LUB+'IT.C@\&9QK38(J:`Z*.6S$-NKL0 MC[10-_D&#C7G2O-!U-@WQS7V39:PE5!6>^&_03Y`CKH8$,>GI_A_@Z/#\X.S MLX,#14;2NK?/!+]U+-%"VHSU]A(O"46K9[7":$KW&JJ5&;-.)C'?(T-K^`99 M%G!E'7U5S59/A4ZY6>10\8'R^[,/@&RQV>M[OIR^JN362NDRS<&E(;L<1O+$ M2AA4UC$2$N(<&W*%A",38C54>.N;"9M6W!N2G6,[#V(E7LH+&PD.`58-N<6R M):QK?X$%P#K,+RN;%\ZY&3C@YU1:=@Y%&XI[#/\[_&?M+F)=4%\`--HZ5//% M-"'T2.':H=^P&^+Z@J-:SV4`D2:/CK8M2^H[QPRB4)<FMZ_4>( M'!'HE=E>#$CQ6.D027P$S892"QF8F.V>Y\F(6'#X>P3L`%R#^-^Z?`ZM"?)S4D8&LFB`74D05!7RTNT&0:OT92V#]O8):_5B,#&_G0'A4?L$TET( M4FI>#T5W%8:3/Z+DOO>SSSC3I,;\"];)A$@9BY@BZ!'\%>%U)`1/`+U"!\1J M?`2./_,HE:J'*F4WJ]U`:&S5*I&4A*P6RFU>'D&2^_#3*7!"DA8AO5&;EVH+ M0'-0WR_<-A5(5TDH=()G[TY3+@Y/3P<]!:=$>724+"/VK-]X$UWLX59G*;W& M2AU7'272X-#X#FX4VL'\UO5_K+?$-7'V)W7W"#$]*R:H-KQ^S1A_5'U)%46> M"M*3,?)?(5;!Y>H;7B+OO'5>NJ$3PM?8KU/-FC@A?0=QA4*W7!==L&Q(8&]+ MGY<&^N](GT(^+GD84&YSYFQTLC'T'.B"G"R>_6XF'QE-[0\\=R8]$],77P/< M>0=6[=ZS1;1#U@=B.U&9 M&.ZV?9:;D6WB^:]_Q)230%:FQX/!7L.OI=1,#'0KBF3H.'[DD?<:'0!?*Y)1 M\%35#GTM(<"#*4XIM/67Z+F$%L5!$N9[N#6VG5=99Q\15,=^VPU$#70N=('. M&(&E#2>IU9`8"T,OOAD^#`)0]5I&`V+["+;&E\/K979#(GK^(Y M#HIPEZ']`MVJ'6PS8ON(PL9RD;H]T`:#Z>BL?FZXMMX^(HM'!%(M>T4@XC]K M:7T"D67.@I">;#1 MGX#&LFYN`?*"K*SN'N.+6QR2O1B*'&!8P@X`$_INY)--=S(/=DCDL!I-16`F M2F>/(->):/1*R;%K6ZRU#;8_<&LIDZX<%*4VOUY[RUOHV9[3@J]>#OE%86*X-G^< M4XG46P>AE=#<'Q!V+R83HR3YQ=]ZO=P?Z+64B52?[)FBW"Q8'GA71/XA[IU7 MO$DB9VNE>4082!,AH1W61&VRULQ*,/+UP,HN72I6*SW51L=][41XM8=S67S?EJYZ1X MB*5X=M@OK+3A4T*N%T4Q+_&5`!"0%#CL")=L*?T4WT*1I<$LM=SN9A_?:6*- M:Q@XKA]$"-M4@8,@[?)H>AD%T`,!7V:-@P'^S_IH;6B1#QMR)+?&FJ"*!+)H M9GOP;RJ8*]\+?!=.8@AXDW%&:*-ILD^QW4UBD+J-CF0C+:F'I,GD*5HL;+0: M39_@S(-3Z)#XACBLE*:ME0W1"OK:#=24'9OBW/5M2%;% M+M6,R./BB-Q0LS+D%$"YC*V:\5A=1 MY`H@\I+F,[))2L_XDM=&/W5#659S^7%RI'X6X`%'?L.^0\'T;0(IN0A<,V^< M%.>-+!%%`XTTO]ITJC930T4-57/%5H=XQCNKBG9CED-%VT-6B+>^#3L:`L3, M\U4S`D]+ML&$WD=*T,I15)&P9]TQ&O"4R>Q/'Q"_\H,PV.3^3T/5:T9L6Z)* M,A?Q]ODRV^>Z<=^2JG930S=PR24TDB"AODTPF5,*SEGEK&Q=)T2LF(K*XR>! MA;VBAM(3-)&%G5U%N]'+H:+2PS-C%W8P([-)YGB1<_B=ERSJ,2TK2TR%#SCN MQB-8DD?B/Q27WXBE(0]'[AO5=K!O98D3R@^`8 M#X)CM8.\D:JW7AULRW_?)@&Z/\93782<.3;ZR35[OL%_,&!LMJT--8N2T^+U MK:]^6#?*ZRKI\8P8Z9/`6LU;7[O!S*?"ZE?`1'CMV\#-QND%S_[-8NGZ*Q"/ MYW$R_I[L5SR!D;GL"2Z@:R,R'CD7]X.2B+5,FY8=6*%OIU21GV;M_CBWNB_*ZZ9ZA#+X[!Y])OU M4]S6/][#X+J[ND(%WB%:/!D>)3LDWOV.+R<%R M0++DCV%!?26)>0A%K%S+%YL8+3X&!7R(OI!(OII`\( M:+B%;V`2!Q9S6P=U=7JJW.:\)"#I4X/1](OO3U@IIZHK]10*+9A+L'!A'A8`>H4.".B9;4#\J0*0*-8U#QF< M/*9^IH%N2T&1I4>L!"Q`XE"[QC^Z/DT$3SWT6"S'<]]BW(K.\L7&O7'Q5%?FH1&Z0#O.!L-UOSQQ?G9V<7I\=G9TS%%LSFI$U"7A296)(+-U&-M\\!&P7_HT[[@?!R,ND M>A)$'C0/(@0$8(^B`1]N;-<)TMPWGU7:& MU7:Z#SC?@1"5;\<8;J2-=S\SOH?>)`FXK9YL&U`P&&%=2:-O.ZMB&C0A^^V\ MQ'XK)D-3:KKU.RO:>L)+@N2(-_,/'UU%0>@O,$@N5^N>)CT7-;&:$M9N,A#* MJ2:'?>.,I$0Z]'7T&SP)(,S-6D9X9KSWO=D]?$WO!%RNO@!_ANSE'#JV.R0O MOC9#8V<-FH52N6*19N;L/F&@T")V45S$*M,&*EW.]B1_X`;ZMU%(#K"A!Q?1 MXI'`Q4T-N5L?C9:`W$7&Z">O2XO.-BUH:S>QM,XV*$\L?8N6X(N:^DIV!21$ M]!J$-G3Y9IOC=F_C63^M6_V']5/2\'LP5<-+N_%KD!3`K*DB5TB[,2]\+;>. MF8J1FKYJ>ZA&76/DXWDG7!$7#GD8B*0OHN'^EZMGW/;P#;*"5#EJ:J=8#E45 M]=N4T1XJG?!S[2]LZ(DJ?5-3.Z4WU9\`$FJX-V3_^F!C*7L`K;*L/P`2X\D, M`V36Z`],:I1;A(DHUX;`XS9"'B06+LU<]$;^"BK1P:Z0%].Y2>`09%KY&4DW MV*![&I*T^6ZQ1/YK_-)M)3@J:AB,#E&NE6>'ZWC3@'>5X`[_R3(ZBP6U`T,C M&Y.3+^9LT,FYYU9>H6>`%F6'FR7%]%5"M3RW#BIY.9.P8&_V!$>:[0F^!6`: MN?=PRMK,<]3L/S[:,BMA'=]`1OC^3%?WY.%R";W9OVQOXI(S%V_RC`=.0(Y@ MJ#)IH`!K)N>J;`YP6O#;T2+_"M"+K\^$,_1".(%N1)RNF\C]FS?'C29@0D[D M2.A)%"8I4;>&>,L8$^@U ML?#`I#"/BJU!+"JF0*E+]KNR?GT,Z5T$X*P3.CP`FWRFWF4QP_6H&&9#J%J4 MK)6EJ];J7+.ZZ6I=)$U5E1RHSDZ.CP:#GH;77&#HGJD=N<*"%HNY23C4-_QB MS?_E:OWGOR">AI`S7]V3C)L583=\E;73.8?"2LY*F_/*H?T#Q=K/3I9%]BK# M<(1H:(>%%FJMP$AC49@2?I'R?.HH*J.C8S5FNK02LYMU?"9"0U]55VNM MY)BL-=M2`T..)7L'RA*I-;R,J"XSD\WVT7(X&?9IP M$C5U:<.D`M#@<%TVGJ[!2Y@,9OSI.PSGT!MYX-_`1FLI"0.,A^A^(:ZQ1)3O MGQF'][RL#J>X:5Q`%WBCS":,W^(- M5<>`JR:_WXAK(!L)@;,[M]N'"Y)KZ>\X(>#0FPR72^2_T7>>ULP'Y3:]J"7/ M^TK*NDL6Z9.%.V5E>I4)50B8EK[!UOWQP>E`6>!"+A%W-J<^RZG,K-#?R295 M0(FK68Q;?8,;-MVOR1]2+*B=7@654M0J)X_Z!BOD&;C"<^B,I`"F2J@\,JRO MJ)VV.955IV5N7@TY3K[RT=)'F.E+WYMLYK]*=%36T1P8W/HM`D6<;4,P\A!Y MT(%+VR6,5T.CK*BYB.#F5KE+1*(56!M>4%E).W"TMAH:\-N3$(3D>=]\=HG"FCN MM4^XW0.OO09Z%52*N->^9]J4Z+770-NI\<<9*]]MH!@UN_K;SV M9F&D4Z^]28C@YO;=:\^WY],`'*VMA@;\]L1K7W=5Y1X$P?/<]IY_`/<5/.#2 M36^@&K:E2(>#ZZ%]9^G2+PRN_@,):=]$MQ=0T:#O#=R*OMLESC9E9] MU5-XELC.#B-$'CT%+2["M&K-<'SO0%@2+C/T>`)/YX54=M(G\+H�?X;N35 M]B#'M`EI8*)L'\2$&\85Z_[*(U,O/I/CX-.2(8>>-D>_@#7T= M"G*%389!/:.&G#"L.;Z%'@SP6OG%]R>U.,@5-AD']8PJ3V'0,0YHO%B=_FDA MD_7.9E#:TP.*]#V<_!$E9G&=UC-%3=9]'9MMMYBE/A"E&/@*:NU97,1DG;/8 M:[LUV_5#(_1YIDL[(+>5%DO@!910PV2BI\6M&:7_D39@95O0)Y_HIKNC:;:' MC\`EPXT^]DD?F7DA3(SM%1WH-=NZMD3[^&")#B.\&V5ROE_"L<-3'%XZ_&&C M24V<<*Z,=@KE$'^)^ZV6)0Z5*7ILEZ*S,"$/R5MI,Y#<#=F421!,&=YP[4W( MH]=?[06H?)M$1E/:`:@>"R5C?E>",<0WE'WCL3+XM%A0.[SL3/=E2PV7=`P! M3?+^8R5>SJ/3`=U-QH'>7DBWD6I\19LSE&>/:'DPF,.S.VX>3.N[*7,+3= MC>\J[]WZ*X(!#,$30*_0`6.`[8')(W#\F4>I5$8<2FY67T!58Z/$K:1"4E(> M^=#?RU6Y<_H-!"'T9K$46NFS"'`Q+EXI>Z<<8SS4TEL+-&T`.#,A*=`]? MP?:RVBWQ_J-N!_*0>HFF;[/C.M1]&`31(O8DWKPM@1."R35\A1/@31ZQ#KN> M,GG;[3^BU8I*PELDRL%^G?3\V7[#(@'D*O];^AT1C!>`G(B]R27PP!0F![D% M'50DK)71E#F0WIETNKIRHZ>)\`B('Q];2=\!G,WQJ!YBV]N>@=QJ-BU]YDEV MF_W'JCHQ=178I=/46[Y9+0KR95N0HW3=6LOMS@L1]`+HT+6M*O`B[MIOKVLMK[/CP]'S09U3O3$0)J,_U M`'77%D8BDB\D`B"X\V)O3.7[D9*:ZC\\=RZ=!)D75=.DL>8?#G+0+$N`$8SN&N_%EE M[6HW`4J(?UH M?%WB7>7<4E'N+*M4.2Y2-\XS9=[5+B`74SQ(75W6TP$NC0Q;/KZT>H.KTW%Q M[_\`*/X++B#+$R"S27V!5(T)R;8ECY1,?(:K4R%^6RYWC>ZM)M_1W5A*>EWG MTQ#=7R-BGXRF&3=TXIG>!=#9K;]CO@N!F?A$5_DY;T-Y%N58?K$8+`>08O\_OL-E7K!F!+\T/0*1FVP1&O"^N%QQ^:W)!'V((ZC M45Z2^&BI:SBRVM$/G7+0TB$LA439D>FVI#E!GD(;A5IE_>HLW4G5\[\26GJ' MO6QA2HWX4`5Y8GG?!4$$)M<16F>PCO=Q6;,\/8.95&UPA`CM,6"[D55;0[?T M]>0-(D_Z.0G?^F@*8!B18T6/I&>%B%)8#W!)4W)MNWN,=R6B;1LS8>;PT,DL M?\=_I[+L*(HA-LQOO"+D>VJ69\17%8DE?R!4M?Z^.J@0<$>YJ_NXEV4ZPDIW M13(&3G<]>!\\JH0L-4EV7X=.*C:EHT>H$^\#2*&;DUG4,M=WR*;#D6O4I MK_DSK/G#]Q&F2.R[237>KP'7PTW2^R#:C8#3`[^!?,>"I"L2=Q[^$CS;;R#X M2N)'0O@*Q"Y`G`T.MB]`Q$0M2M7Z:4U7\<6&-:N;OM;<6JBLH>MSS[B[-],I M<,);/![+!P^\'P2W` M_23]*D;\,HKV5>O"/'5TUNU*U!Z]BHH^#&G-_F+\B9^;_WE M&/FO,(#"[^2<%=_)R2_4V;=Q-K]8F_;>%_"V+%Q%B*`_F5_(*A(_DIJ\BLI@ MHZ967P=P&_:4+Z2=XH'.6G@+?X];$D5%=5U#L-&`24.N1*2O*2>C8RT^+HCP M5;"^:DG1GB#XWEOQVB_DY6\(A+?6 MA4=2V5OKM&6ZE8[;IDE),ZWO\[::83\4]/6;[<1CS'%05!X_45>GKP.Y.7.& M;$T+O-]AD7AD=U[C#MV`&0]/P1+'U$ MPKUK=O_LXFH?$[GQL'I6W^$$,%1\N5KW.>$AX'M&I#%E[>:*.E67/PW2+?_Z M/A.19ZKB99!B0?TT+4E[19QP"D-?M9.$X*-ICHW*)SZ8Y;4#`:=JBCH58U&Y MGY'AD4B[SGYE(U]"._V)J6'+N<#!F^Z*NZS7W*7)JJMB3E??;MKWJWK=79FL MNRKFE+MPNUDX"Y9%3F3W-8]"<-;6#AV[LZS:2$BKAQVJ&1D#Y!`=SE@[,=[J M.4$<#]1#I8T"1>%0(P8)2_WNDJEP^7.^`'^&[.4<.H]@1D]-Q#PZA4O<(AZ= M3>-6W/J[3Z?-"P')@\^5[IE<(>V&OI"GI9X5?7?/Z\YOAH#M5OA.F.7U4V&] M6BITR<6>QFJ-\9OEHOK=4U9Y?=7*I:$2#0MQJGR+G85#`)Q/,__UL^-'7HA6 M,1J2#]M`2+[^_=O3EL8W/^BG6B'5;%1;PY)R'3*VVC<1\I>`O<_._FZ,KO@X MT]4[,@R@S5;8YE>SU%7#ER'N$!I/<85["\-K@.`KS_!+_ MT;%D_]&5OUC`.//HT)O$5Y]FP'.$K_Y<%.-^,K0MVYM8.>IJG4!5;//>]1&D MH6*H)KFG2=;V,?(=`"8!R1Y[[]L>O><%[(`YCKGJYH?$`1X2QVH'>2/%9@=[ M<[:ES`1*K+5U=E/*[&U$TOT_0`\NHD4JGNL()'GR6/:;$!'S<-0!_\IW:CN% MTYWW_,/_-[`1:T(2IK.WH*H1@2F;2FYAX%9!-\A:4]IG;%4+P9"M*;@U$A`PM.' M&MLS[8P8-=O0*XNWO')'W'(UA&R)EC;L>N+1:%>C`HN5=,:%H;HA:A MJCBXE'1I[KM8.\'-7Q$,5U_]L.X@H:Z2DE=B,+I)NE[<,_K67#",PKF/2)J, MBN,01@WMQBZ?FG*/P@ARISPPJG,8C&TT0O0,=?*;[49@#!"51#T<6#7S@COL M.2R$N%3NVF>8B#&V1].AZS[CRNQ17U.ZQZIMPIF,A_X4+%R9]1F12*;%(R!! M3"1&?\W_ILQP06)#J]:T)O1ZC!PYO$OSITO+,KN^$S0,GOV;Q=+U5R`V`,<) MNT_V*Q8$L9N?X`*Z-B*6FUC`R<%!V2/0F^M(=F"%OI6VGMB*:?O_M)(>_)-F MG$TZ0>U'Q8$IUV`*/4"W$PB^1(25,?#(&S.XHS1,<.QCY($0(AK+%`N.-V2E M,^J*+,\AYT6VNR62="YJ!$H!PN_@;"TMY>9YIR!-\MH3P61E$5RNTD%X%1=7@+``$$ M)0X```0Y`0``[5U;4^,X%G[?JOT/VCSU5$U(PF5FH&"F`C1=5$%#`7/9IRG% M5A)MVU)&D@/97[]'DAT[L2W;":FPNWZ!Q#[W[^CB(UDY_^4M#-"<"$DYN^@, M#OH=1)C'?J MINA*<"G'5!`T6J`G.B<*/?.Q>L5P)9:/3@Y.#@:'QP=]-%5J=M;KO;Z^'@A- M*V/2`X^'W6ZL[1)+D`Y\1NWAP6!YYRK6S-D9.NX=]7N'_<$1^O&LWS\[Z:/A M_9+P'CP9TTI*Z4U)B!'$@LF+3L:XUZ,#+B;`U!_T_KB_>S9T'4MX]C82`5TA MUU<2AJ,>95)AYI&$/J#LFX-DH&S&CR<=9=\)"`Z16ZX M"*_)&$>!NNC\%>'`@-%!6"E!1Y$B*P01RY#$FN?$J^63ML=72])L9$]Z]F8' MD$;H'#/&%5:0C^:[OC*;43;F\5>XH$-[)GA`7L`QI#_\^G1;:(:^UWL&<<;= M2QQHO)^G!#*Z@ZA_T2FYM]25://)F#)JK()6^=9UU< M!"WG@?UL/L\$D2#%N'P'%V+NF,3%Z>'`BX(-&%/+ROGBJTF8MX_^\H-\&-]" M'Q:2-0@*"-PX'.9P2$4@/D962(M&%1I7/`2WIX1)Z.LKH2FB=N-T5('3BL06 MM;JH83F]"?CK>D]63.-&Z*0*(9"#C*`6EPPNUU1Z`9>1(,]1&&*Q>!@_TPF# M(=+#3`T]CT=,P53MD0?4HT3J^8D?!>1A_#NADRE,D88P]\(3\C4*1T0`]Q0F M6?*:*$R#&-<=ZW#EQ3'TL(>0"ZD).C&L%3HK,G:@U!"46((^);:@AS%*K$&Q M.29>)$`_40.0RX4_3?QK[A40^8/ M9S/!WV@(K?<&4_$;#B("'4$1:TF:[4B+.]&.^T?KB98*0ZDT]&EI"M*V(#`& M9:Q!VAQD[=&I52BDS;1-,NV+?H+\E<&C7:##?P??(#&8GTV`6Y`GE1DV+A?I MERM`9L+%`JCO")NHZ6/^;F,E86,AM792GH'I7K:)K@1X$_$X\RC`35N M;)T`#<15)41NSE&>$*M:VQ1YWQ2Y)F,B!/'A\A!&3:6']CN*1Q!OQTQU&U%5 MJ9$;]LM3(]%H4L'JM.-WJK5-BZJTN.)A2.V<"&)WQ.?HU.-P@G^8' M]XQ,A)E^Q,A(;3$LQC!>;TK^`QB?(6H*IN!C+D)C?8Q='4IWH0I`TY@E2UR9 MCQHN*PUEQ+5(52Z$/&(!EZ9$47#"M2JR2EBU1'+B7")!GU:DM2VJLMQKBF13 M'OA$R,]_19#GCKIO`;$;K^.*`G!6(+(26\@*![)K(CU!9W9N>AE)RHC,C5W% M1"Z(!M"D4-9(G-@,^B6C"4JE("VFQ:1D*%GV,$/YPC^'LX`OB,7A,8[? M,YY#:NM&\TQ#&F"AXUDP\FPLR8UP01$AHPMAB11'B;H8_$3A]RA6^;U9WHBU MFH1H6^DV)0?S?[%9X2'F=:%^N.TV/JNCK=%N@_&+?DC=L+@4\[HP/@*,0E:971NI'XJ0"K_A-Z"M/&C>C%:U0QNV$[SL%5L MEFD!W'[6^!4+`2[-R[;*;RC%!?7Q=HN5Z--26[OI;:,ES!*HG;1N0.LO:+:( M;?`@4-5(:_&X$:R[]-FVOBVQ7+:RXI?9+A?W6.G/BP98-Y99E0NY8DY)+F0: M>=FKNP\LH-%OM2M_/ MWD)4%?CY^FTI^-E7$Y8J449GFQ0;)D4RV7ZP<7R(E#Y`2)_%U"PCJN54I4/N M[11'.L13=\B&6!_**&QS8^ZYRV?Q&\GK"HK3C;*"KO(E^2& M7ME+]+;)T6#S4-4LP$7J!K9B]+4SK;Z<:A78V#RK14F>;$N^2$E\(GP@\FU+OB4R`9)ND*)-5E1;Y M.6"#M$B5(JNU38P-MEBYAO5B2B>HM3=F@HPO.OJHTFYR+.F?H/O@+0P2$BW? MM,>_(Z:M4 M2Z'KY[WLF;_P;?5,X'/PG`N%6.&QRF6'/-M#I.^X9P0Y6/2W;L+7U9>Z@\/N MT>#@3?J)C4U,2(/0S(2$K[$)1I8DWL&$SZ';HOHTYL-N?]#5YS&7V%#(HS]T M4^8-`E!\_'2=.&0YOUI&'8A3'8C!#YMA<6J3G)&)/IZ\GAV!$"M5+OI19$A\T;B97NG/ZTW7V MQW`DE<">ZAC+T_-"*FAI$.A5K8N.$A$T,ML[FL/?SX`&YDFWBH1Z]@#N11UOYH MV,TR7$E][_,;$1Z5.B.MXUO*<`0DY`RFAV)1.R2N$-A[(WNPQT7'$\2GJG%D M[.FO6X:FMA!7LA@9[Q*9LA!<<8@4M!=#]C!^HO*;/L22,H@@Q<$M##K"I'R\ MK]_^?2%OZC(`UY(@;"^F,`SV=P3.5$*WTU#8S,)T:0JX7,/-@,_,6:2\>H9SR,5[R+1 MAT6/%1$/C+Q,0>]D"O\(^2?D;[H1)O'_727N=M2SSP,J-^CY9.0:\QIY:/R* M?;RA\_<(6J7(#QFU1\']R%-QYD.G)L+$^^);#B^2O-YITZA:P35[H7,=?6.N M_??H3YA-"+3$>Z(/[U^.6.M778;Z/,1TMW`8>UY>>8&5V:L?PDK=0(OL7+F^ M9TMM:MK!2<]%Q)SXJS8[*?9L_7+E??4,WVNB.Q+=Y*[A-BCU[C&+QC"A,L\5 MR]N9P7I+,1_TN:S$L?N(48_.].,$#"3@644@BN@_J,>Y,X)_P[;@,?0\$>E3 M,.,"1#7=AQP_)?L:5GN?W-4]]SB)/9?%9EY^-#NO MBNV\^BAV?H[TDL*JD6O7]FSA4%*\:M_*E;V/WT23L,D=P9+(FTCI5Q4HHV$4 M/N*%?94H(K?LF;Z9)X1T6&_.N)]^HZK+K^^)KKYL&(0LZW]Y&#[K7^O:+`PK MK!\S#':B^C`>!H$6)(>1FG*A?[9G^6SFHMAO'>8K42D67,H;XL.WY:2E_/:' M'-'7S37G3I?YDMS\D)Z8E,EM[A[J9_F)/4U]D9+$+6;XBH4?KT]HC^[HG,B5 M''PG@?NND.1FF\5;X=.GJ=)I:@W&_ZWT>")Z@@`M8.T''5=0'I.MLZ:^GGTG MT\8NQC6V+Z:\=LOLVF&NPKH[\7MZ'J[(3-<+JHOT]=3B(N:FS/NO91;\D/'Z M#@0WR?XV'ISW[$8-^/@?4$L!`AX#%`````@`YH.A0GX@9/2H@@``,A<%`!$` M&````````0```*2!`````&YV96,M,C`Q,S`S,S$N>&UL550%``./>X%1=7@+ M``$$)0X```0Y`0``4$L!`AX#%`````@`YH.A0@;R$279#P``C>$``!4`&``` M`````0```*2!\X(``&YV96,M,C`Q,S`S,S%?8V%L+GAM;%54!0`#CWN!475X M"P`!!"4.```$.0$``%!+`0(>`Q0````(`.:#H4("@PIF_A```*('`0`5`!@` M``````$```"D@1N3``!N=F5C+3(P,3,P,S,Q7V1E9BYX;6Q55`4``X][@5%U M>`L``00E#@``!#D!``!02P$"'@,4````"`#F@Z%"Q:C_9C]%``"B5P0`%0`8 M```````!````I(%HI```;G9E8RTR,#$S,#,S,5]L86(N>&UL550%``./>X%1 M=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`YH.A0CGCO7CF+@``B#D#`!4` M&````````0```*2!]ND``&YV96,M,C`Q,S`S,S%?<')E+GAM;%54!0`#CWN! M475X"P`!!"4.```$.0$``%!+`0(>`Q0````(`.:#H4(;JW4Q5`P``".````1 M`!@```````$```"D@2L9`0!N=F5C+3(P,3,P,S,Q+GAS9%54!0`#CWN!475X C"P`!!"4.```$.0$``%!+!08`````!@`&`!H"``#*)0$````` ` end XML 32 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes (Schedule Of Reconciliation Of Income Tax Provisions) (Details) (USD $)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Income Taxes [Abstract]      
Tax expense at U.S. statutory rate $ 6,046,264 $ 5,700,630 $ 6,809,003
State income taxes, net of Federal benefit 244,691 252,881 345,213
Domestic manufacturing deduction (460,723) (467,053) (549,123)
Municipal interest (118,282) (235,470) (239,636)
Other 15,669 (8,844) (35,206)
Income tax provision $ 5,727,619 $ 5,242,144 $ 6,330,251
XML 33 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Balance Sheets (USD $)
Mar. 31, 2013
Mar. 31, 2012
ASSETS    
Cash and cash equivalents $ 2,509,683 $ 1,544,536
Marketable securities, short term 9,711,029 17,551,629
Accounts receivable, net of allowance for uncollectible accounts of $15,000 2,521,395 2,684,840
Inventories 3,336,592 3,229,376
Prepaid expenses and other assets 958,147 1,159,852
Total current assets 19,036,846 26,170,233
Fixed assets    
Machinery and equipment 8,417,061 7,488,211
Leasehold improvements 1,499,454 720,882
Gross fixed assets 9,916,515 8,209,093
Less accumulated depreciation 6,228,122 5,697,861
Net fixed assets 3,688,393 2,511,232
Marketable securities, long term 73,040,257 54,445,298
Total assets 95,765,496 83,126,763
LIABILITIES AND SHAREHOLDERS' EQUITY    
Accounts payable 422,092 663,702
Accrued payroll and other 918,060 867,331
Deferred taxes 440,736 136,872
Total current liabilities 1,780,888 1,667,905
Shareholders' equity    
Common stock, $0.01 par value, 6,000,000 shares authorized; 4,862,436 issued and outstanding as of March 31, 2013 and 4,824,745 issued and outstanding as of March 31, 2012 48,624 48,247
Additional paid-in capital 21,200,742 20,974,477
Accumulated other comprehensive income 1,557,726 1,087,456
Retained earnings 71,177,516 59,348,678
Total shareholders' equity 93,984,608 81,458,858
Total liabilities and shareholders' equity $ 95,765,496 $ 83,126,763
XML 34 R45.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Repurchase Plan (Details) (USD $)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Stock Repurchase Plan [Abstract]    
Common stock, shares authorized 6,000,000 6,000,000
Common stock par value $ 0.01 $ 0.01
Shares of all types authorized 10,000,000  
Authorized common stock for repurchase $ 2,500,000  
XML 35 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Statements of Shareholders Equity (USD $)
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Retained Earnings [Member]
Total
Balance at Mar. 31, 2010 $ 47,006 $ 20,169,924 $ 1,129,726 $ 34,606,638 $ 55,953,294
Balance, shares at Mar. 31, 2010 4,700,583        
Exercise of stock options and warrants 756 417,949 0 0 418,705
Exercise of stock options and warrants, shares 75,615        
Comprehensive income:          
Unrealized (loss) on marketable securities, net of tax 0 0 (69,288) 0 (69,288)
Net income       13,360,945 13,360,945
Comprehensive income         13,291,657
Stock-based compensation 0 76,720 0 0 76,720
Tax benefit of stock-based compensation   230,173     230,173
Balance at Mar. 31, 2011 47,762 20,894,766 1,060,438 47,967,583 69,970,549
Balance, Shares at Mar. 31, 2011 4,776,198        
Exercise of stock options and warrants 485 (449) 0 0 36
Exercise of stock options and warrants, shares 48,547        
Comprehensive income:          
Unrealized (loss) on marketable securities, net of tax 0 0 27,018   27,018
Net income 0 0 0 11,381,095 11,381,095
Comprehensive income         11,408,113
Stock-based compensation   80,160     80,160
Balance at Mar. 31, 2012 48,247 20,974,477 1,087,456 59,348,678 81,458,858
Balance, Shares at Mar. 31, 2012 4,824,745        
Exercise of stock options and warrants 377 143,811 0 0 144,188
Exercise of stock options and warrants, shares 37,691        
Comprehensive income:          
Unrealized (loss) on marketable securities, net of tax 0 0 470,270   470,270
Net income 0 0 0 11,828,838 11,828,838
Comprehensive income         12,299,108
Stock-based compensation   66,720     66,720
Tax benefit of stock-based compensation   15,734     15,734
Balance at Mar. 31, 2013 $ 48,624 $ 21,200,742 $ 1,557,726 $ 71,177,516 $ 93,984,608
Balance, Shares at Mar. 31, 2013 4,862,436        
XML 36 R35.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Schedule Of Valuation Assumptions) (Details)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Stock-Based Compensation [Abstract]      
Risk-free interest rate 0.70% 1.00% 1.60%
Expected volatility 38.00% 42.00% 56.00%
Expected life (years) 4 years 1 month 6 days 4 years 1 month 6 days 4 years 2 months 12 days
Dividend yield 0.00% 0.00% 0.00%
XML 37 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
Inventories (Tables)
 12 Months Ended
Mar. 31, 2013
Inventories [Abstract]  
Schedule Of Inventories
March 31
2013 2012
Raw materials $ 1,312,011 $ 1,285,106
Work in process 1,533,951 1,658,467
Finished goods 775,630   585,803  
3,621,592 3,529,376
Less inventory reserve (285,000 ) (300,000 )
Total inventories $ 3,336,592   $ 3,229,376  
XML 38 R36.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Summary Of Options Outstanding) (Details) (USD $)
 12 Months Ended
Mar. 31, 2013
Number Outstanding 49,000
Weighted Average Exercise Price $ 30.27
Weighted Remaining Contractual Life (years) 4 years 7 months 6 days
Range One [Member]
  
Ranges of Exercise Prices, Lower Limit $ 15.08
Ranges of Exercise Prices, Upper Limit $ 16.33
Number Outstanding 27,000
Weighted Average Exercise Price $ 16.24
Weighted Remaining Contractual Life (years) 2 years 9 months 18 days
Range Two [Member]
  
Ranges of Exercise Prices, Lower Limit $ 31.27
Ranges of Exercise Prices, Upper Limit $ 42.45
Number Outstanding 9,000
Weighted Average Exercise Price $ 37.00
Weighted Remaining Contractual Life (years) 6 years
Range Three [Member]
  
Ranges of Exercise Prices, Lower Limit $ 51.04
Ranges of Exercise Prices, Upper Limit $ 58.27
Number Outstanding 13,000
Weighted Average Exercise Price $ 54.76
Weighted Remaining Contractual Life (years) 7 years 6 months
XML 39 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information (Tables)
 12 Months Ended
Mar. 31, 2013
Segment Information [Abstract]  
Schedule Of Revenue By Major Customers
% of Revenue for Year Ended March 31
2013 2012 2011
Customer A 16% 16% 14%
Customer B 15% 14% 11%
Customer C 14% * 11%
   
 
*Less than 10%
Schedule Of Revenue By Geographic Region
Year Ended March 31
2013 2012 2011
United States $ 12,006,493 $ 13,334,563 $ 14,169,952
Europe 10,666,338 10,798,146 12,009,294
Asia 3,979,862 4,130,930 4,576,270
Other 380,726 315,581 441,547
Total Revenue $ 27,033,419 $ 28,579,220 $ 31,197,063
XML 40 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 41 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Statements of Cash Flows (USD $)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
OPERATING ACTIVITIES      
Net income $ 11,828,838 $ 11,381,095 $ 13,360,945
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 647,163 500,121 411,547
Stock-based compensation 66,720 80,160 76,720
Excess tax benefits (15,734) 0 (230,173)
Deferred income taxes 51,262 (12,850) 294,384
Changes in operating assets and liabilities:      
Accounts receivable 163,445 911,399 625,325
Inventories (107,216) 114,481 (1,637,430)
Prepaid expenses and other assets 201,705 25,454 (404,012)
Accounts payable and accrued expenses (190,881) (187,950) 332,334
Deferred revenue 0 0 (20,833)
Net cash provided by operating activities 12,645,302 12,811,910 12,808,807
INVESTING ACTIVITIES      
Purchases of fixed assets (1,824,324) (1,480,237) (732,800)
Purchases of marketable securities (27,209,753) (18,501,362) (14,742,032)
Proceeds from maturities and sales of marketable securities 17,194,000 7,761,980 1,580,068
Net cash used in investing activities (11,840,077) (12,219,619) (13,894,764)
FINANCING ACTIVITIES      
Net proceeds from sale of common stock 144,188 36 418,705
Excess tax benefits 15,734 0 230,173
Net cash provided by financing activities 159,922 36 648,878
Increase (decrease) in cash and cash equivalents 965,147 592,327 (437,079)
Cash and cash equivalents at beginning of period 1,544,536 952,209 1,389,288
Cash and cash equivalents at end of period 2,509,683 1,544,536 952,209
Supplemental disclosures of cash flow information:      
Cash (refunded) paid during the period for income taxes $ 5,202,616 $ 5,207,565 $ 6,303,598
XML 42 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Balance Sheets (Parenthetical) (USD $)
Mar. 31, 2013
Mar. 31, 2012
Balance Sheets    
Accounts receivable, allowance for uncollectible accounts $ 15,000 $ 15,000
Common stock par value $ 0.01 $ 0.01
Common stock, shares authorized 6,000,000 6,000,000
Common stock shares, issued 4,862,436 4,824,745
Common stock shares, outstanding 4,862,436 4,824,745
XML 43 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Repurchase Plan
 12 Months Ended
Mar. 31, 2013
Stock Repurchase Plan [Abstract]  
Stock Repurchase Plan

NOTE 10. STOCK REPURCHASE PLAN
     Our authorized stock is stated as six million shares of common stock, $0.01 par value, and ten million shares of all types. Our Board may designate any series and fix any relative rights and preferences to authorized but undesignated stock. We have an outstanding authorization from our Board to purchase up to $2,500,000 of our common stock, all of which remained available as of March 31, 2013.
XML 44 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information (USD $)
In Millions, except Share data, unless otherwise specified
 12 Months Ended
Mar. 31, 2013
Apr. 26, 2013
Sep. 28, 2012
Document and Entity Information [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Mar. 31, 2013    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2013    
Entity Registrant Name NVE CORP /NEW/    
Entity Central Index Key 0000724910    
Current Fiscal Year End Date --03-31    
Entity Filer Category Accelerated Filer    
Entity Common Stock, Shares Outstanding   4,862,436  
Entity Current Reporting Status Yes    
Entity Public Float     $ 176
Entity Voluntary Filers No    
Entity Well-known Seasoned Issuer No    
XML 45 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Information as to Employee Stock Purchase, Savings, And Similar Plans
 12 Months Ended
Mar. 31, 2013
Information as to Employee Stock Purchase, Savings, And Similar Plans [Abstract]  
Information As To Employee Stock Purchase, Savings, And Similar Plans

NOTE 11. INFORMATION AS TO EMPLOYEE STOCK PURCHASE, SAVINGS, AND SIMILAR PLANS
     All of our employees are eligible to participate in our 401(k) savings plan the first quarter after reaching age 21. Employees may contribute up to the Internal Revenue Code maximum. We make matching contributions of 100% of the first 3% of participants' salary deferral contributions. Our matching contributions were $105,370 for fiscal 2013, $109,126 for fiscal 2012, and $110,268 for fiscal 2011.
 
XML 46 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Statements of Income (USD $)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Revenue      
Product sales $ 24,434,823 $ 25,151,822 $ 26,024,823
Contract research and development 2,598,596 3,427,398 5,172,240
Total revenue 27,033,419 28,579,220 31,197,063
Cost of sales 7,025,181 9,325,511 9,783,698
Gross profit 20,008,238 19,253,709 21,413,365
Expenses      
Selling, general , and administrative 2,240,563 2,380,603 2,474,468
Research and development 2,570,821 2,600,058 1,269,127
Total expenses 4,811,384 4,980,661 3,743,595
Income from operations 15,196,854 14,273,048 17,669,770
Interest income 2,359,603 2,350,191 2,021,426
Income before taxes 17,556,457 16,623,239 19,691,196
Provision for income taxes 5,727,619 5,242,144 6,330,251
Net income $ 11,828,838 $ 11,381,095 $ 13,360,945
Net income per share - basic $ 2.44 $ 2.37 $ 2.83
Net income per share - diluted $ 2.43 $ 2.34 $ 2.76
Weighted average shares outstanding      
Basic 4,839,810 4,796,227 4,729,035
Diluted 4,863,546 4,863,471 4,844,266
XML 47 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Inventories
 12 Months Ended
Mar. 31, 2013
Inventories [Abstract]  
Inventories
NOTE 5. INVENTORIES
     Inventories consisted of the following:
 
March 31
2013 2012
Raw materials $ 1,312,011 $ 1,285,106
Work in process 1,533,951 1,658,467
Finished goods 775,630   585,803  
3,621,592 3,529,376
Less inventory reserve (285,000 ) (300,000 )
Total inventories $ 3,336,592   $ 3,229,376  
XML 48 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Marketable Securities
 12 Months Ended
Mar. 31, 2013
Marketable Securities [Abstract]  
Marketable Securities
NOTE 4. MARKETABLE SECURITIES
     Marketable securities with remaining maturities less than one year are classified as short-term, and those with remaining maturities greater than one year are classified as long-term. The fair value of our marketable securities as of March 31, 2013, by maturity, were as follows:
Total <1 Year 1–3 Years 3–5 Years
$ 82,751,286 $ 9,711,029 $ 34,310,566 $ 38,729,691
 
     As of March 31, 2013 and 2012 our marketable securities were as follows:
As of March 31, 2013 As of March 31, 2012

Adjusted
Cost		 Gross
Unrealized
Gains		 Gross
Unrealized
Losses		 Fair
Market
Value
Adjusted
Cost		 Gross
Unrealized
Gains		 Gross
Unrealized
Losses		 Fair
Market
Value
Corporate bonds $ 72,923,502    $ 2,378,845    $ (4,187 )    $ 75,298,160    $ 50,513,389    $ 1,481,604    $ (76,434 )    $ 51,918,559
Municipal bonds   7,381,223   81,058
   (9,155 )   7,453,126 19,775,582   334,793
   (32,007 ) 20,078,368
Total $ 80,304,725   $ 2,459,903   $ (13,342 )   $ 82,751,286 $ 70,288,971   $ 1,816,397   $ (108,441 )   $ 71,996,927

     The following table shows the gross unrealized losses and fair value of our investments with unrealized losses, aggregated by investment category and length of time that individual securities had been in a continuous unrealized loss position as of March 31, 2013 and 2012:
Less Than 12 Months 12 Months or Greater Total
Fair
Market
Value		 Gross
Unrealized
Losses		 Fair
Market
Value		 Gross
Unrealized
Losses		 Fair
Market
Value		 Gross
Unrealized
Losses
As of March 31, 2013
  Corporate bonds $ 1,171,976   $ (4,187 )   $ -   $ -     $ 1,171,976   $ (4,187 )
  Municipal bonds   508,607 (9,155 ) - -   508,607 (9,155 )
  Total $ 1,680,583 $ (13,342 ) $ - $ -   $ 1,680,583 $ (13,342 )
As of March 31, 2012
Corporate bonds $ 10,387,955 $ (76,434 )     -     -     $ 10,387,955   $ (76,434 )
Municipal bonds - -   908,550 (32,007 ) 908,550 (32,007 )
Total $ 10,387,955 $ (76,434 ) $ 908,550 $ (32,007 ) $ 11,296,505 $ (108,441 )
 
     Gross unrealized losses totaled $13,342 as of March 31, 2013, and were attributed to one corporate bond and two municipal bonds out of a portfolio of 43 bonds. The gross unrealized losses were due to market-price decreases and rating downgrades after the bonds were purchased, and none had been in a continuous unrealized loss position for 12 months or greater. A substantial majority of the bonds we held were rated by Moody's or Standard and Poor's and had investment-grade credit ratings. For each bond with an unrealized loss, we expect to recover the entire cost basis of each security based on our consideration of factors including their credit ratings, the underlying ratings of insured bonds, and historical default rates for securities of comparable credit rating. Because we expect to recover the entire cost basis of the securities, and because we do not intend to sell the securities and it is not more likely than not that we will be required to sell the securities before recovery of the cost basis, which may be maturity, we did not consider any of our marketable securities to be other-than-temporarily impaired at March 31, 2013.
XML 49 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Tables)
 12 Months Ended
Mar. 31, 2013
Stock-Based Compensation [Abstract]  
Schedule Of Valuation Assumptions
Year Ended March 31
2013 2012 2011
Risk-free interest rate 0.7 % 1.0 % 1.6 %
Expected volatility 38 % 42 % 56 %
Expected life (years) 4.1   4.1   4.2  
Dividend yield 0 % 0 % 0 %
Summary Of Options Outstanding
Ranges of
Exercise Prices		      Number
Outstanding		      Weighted Average
Exercise Price		      Weighted Remaining
Contractual Life (years)
$  15.08 - 16.33 27,000 $ 16.24 2.8
31.27 - 42.45 9,000 37.00 6.0
51.04 - 58.27 13,000 54.76 7.5
49,000 $ 30.27 4.6
Summary Of Stock Options And Warrants
Option Shares
Reserved		       Options
Outstanding		       Weighted Average
Option Exercise Price		       Warrants
Outstanding		       Weighted Average
Warrant Exercise Price
At March 31, 2010     170,230     254,500     $ 17.28   10,000     $ 16.28
Granted
 (4,000 ) 4,000 $ 42.45 - -
Exercised
 -   (83,500 ) $ 9.56 -   -
At March 31, 2011     166,230   175,000   $ 21.54 10,000   $ 16.28
Granted
 (4,000 ) 4,000 $ 58.25 -       -
Exercised
 -   (70,000 ) $ 16.93 -     -
At March 31, 2012    162,230   109,000   $ 25.85 10,000   $ 16.28
Granted
 (4,000 ) 4,000 $ 54.11 - -
Exercised
 -   (64,000 ) $ 24.23 - -
Terminated
 -   -   $ - (6,000 )     7.35
At March 31, 2013    158,230   49,000   $ 30.27 4,000   $ 29.69
XML 50 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Policy)
 12 Months Ended
Mar. 31, 2013
Summary of Significant Accounting Policies [Abstract]  
Cash And Cash Equivalents
Cash and Cash Equivalents
     We consider all highly liquid investments with maturities of three months or less when purchased to be cash equivalents.
Fair Value Of Financial Instruments
Fair Value of Financial Instruments
     The carrying amount of cash and cash equivalents, accounts receivable, and accounts payable approximates fair value because of the short maturity of these instruments. Fair values of marketable securities are based on quoted market prices.
Marketable Securities
Marketable Securities
     We classify securities with original maturities greater than three months and remaining maturities one year or less as short-term marketable securities and securities with remaining maturities greater than one year as long-term marketable securities. Securities not due at a single maturity date are classified by their average life. We classify all of our marketable securities as available-for-sale, thus securities are recorded at fair value and any associated unrealized gain or loss, net of tax, is included as a separate component of shareholders' equity, "Accumulated other comprehensive income (loss)." We use a specific-identification cost basis to determine gains and losses. The amortized cost of marketable securities is adjusted for amortization of premiums and accretion of discounts to maturity, both of which are included in interest income.

     We consider an other-than-temporary impairment of our marketable securities to exist if we determine it is probable that we will be unable to collect all amounts due according to the contractual terms of a debt security. If we judged a decline in fair value for any security to be other than temporary, the cost basis of the individual security would be written down and a charge recognized in net income. We consider a number of factors in determining whether other-than-temporary impairment exists, including: credit market conditions; the credit ratings of the securities; historical default rates for securities of comparable credit rating; the presence of insurance of the securities and, if insured, the credit rating and financial condition of the insurer; the effect of market interest rates on the value of the securities; and the duration and extent of any unrealized losses. We also consider the likelihood that we will be required to sell the securities prior to maturity based on our financial condition and anticipated cash flows. We determined that no write-downs for other-than-temporary impairment were required on available-for-sale securities during fiscal 2013, 2012, or 2011.
Concentration Of Risk And Financial Instruments
Concentration of Risk and Financial Instruments
     Financial instruments potentially subject to significant concentrations of credit risk consist principally of cash equivalents, marketable securities, and accounts receivable.

     We have invested our excess cash in corporate-backed and municipal-backed bonds and other money market instruments. Our investment policy prescribes purchases of only high-grade securities, and limits the amount of credit exposure to any one issuer.

     Our customers are throughout the world. We generally do not require collateral from our customers, but we perform ongoing credit evaluations of their financial condition. More information on accounts receivable is contained in the paragraph titled "Accounts Receivable and Allowance for Doubtful Accounts" of this note.

     Additionally, we are dependent on critical suppliers including our packaging vendors and suppliers of certain raw silicon and semiconductor wafers that are incorporated in our products.
Accounts Receivable And Allowance For Doubtful Accounts
Accounts Receivable and Allowance for Doubtful Accounts
     Accounts receivable are recorded net of an allowance for doubtful accounts. We make estimates of the uncollectibility of accounts receivable. We specifically analyze accounts receivable, historical bad debts, and customer creditworthiness when evaluating the adequacy of the allowance. We had no charges or provisions to our allowance for doubtful accounts in fiscal 2013, 2012, or 2011.
Inventories
Inventories
     Inventories are stated at the lower of cost or net realizable value. Cost is determined by the first in, first out method. We record inventory reserves when we determine certain inventory is unlikely to be sold based on sales trends, turnover, competition, and other market factors.
Product Warranty
Product Warranty
     In general we warrant our products to be free from defects in material and workmanship for one year.
Fixed Assets
Fixed Assets
     Fixed assets are stated at cost. Depreciation of machinery and equipment, and furniture and fixtures is recorded over the estimated useful lives of the assets, generally five years, using the straight-line method. Amortization of leasehold improvements is recorded using the straight-line method over the lesser of the lease term or five-year useful life. We record losses on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets' carrying amount. We have not identified any indicators of impairment during fiscal 2013, 2012, or 2011.
Revenue Recognition
Revenue Recognition
Product Revenue Recognition
     We recognize product revenue on shipment because the terms of our sales are FOB shipping point, meaning that our customers (end users and distributors) take title and assume the risks and rewards of ownership on shipment. Our customers may return defective products for refund or replacement under warranty, and have other very limited rights of return.

     Shipping charges billed to customers are included in product sales and the related shipping costs are included in selling, general, and administrative expense. Such shipping costs were $27,386 for fiscal 2013, $40,185 for fiscal 2012, and $39,427 for fiscal 2011.

     Payments from our distributors are not contingent on resale or any other matter other than the passage of time, and delivery of products is not dependent on the number of units resold to the ultimate customer. There are no other significant acceptance criteria, pricing or payment terms that would affect revenue recognition.
Accounting For Commissions And Discounts
Accounting for Commissions and Discounts
     We sometimes utilize independent sales representatives that provide services relating to promoting our products and facilitating product sales but do not purchase our products. We pay commissions to sales representatives based on the amount of revenue facilitated, and such commissions are recorded as selling, general, and administrative expenses.

     Our stocking distributors take title and assume the risks and rewards of product ownership. We presume consideration given to a customer is a reduction in revenue unless both of the following conditions are met: (i) we receive an identifiable benefit in exchange for the consideration and the identifiable benefit is sufficiently separable from the customer's purchase of our products such that we could have purchased the products or services from a third party; and (ii) we can reasonably estimate the fair value of the benefit received. We recognize discounts provided to our distributors as reductions in revenue. Under certain limited circumstances, our distributors may earn commissions for activities unrelated to their purchases of our products, such as for facilitating the sale of custom products or research and development contracts with third parties. We recognize any such commissions as selling, general, and administrative expenses.
Research And Development Contract Revenue Recognition
Research and Development Contract Revenue Recognition
     We recognize contract revenues pro-rata as work progresses. Our research and development contracts do not contain post-shipment obligations. Contracts may be either firm-fixed-price or cost-plus-fixed-fee. Firm-fixed-price contracts provide for a price that is not subject to any adjustment based on our cost in performing the contract.

     Cost-plus-fixed-fee contracts are cost-reimbursement contracts that also provide for payment to us of a negotiated fee that is fixed at the inception of the contract. The costs for which we earn reimbursement are the actual costs incurred and are recorded in the period in which they are incurred. We recognize the contract fees pro-rata as work progresses.
Income Taxes
Income Taxes
     We account for income taxes using the liability method. Deferred income taxes are provided for temporary differences between the financial reporting and tax bases of assets and liabilities. We provide valuation allowances against deferred tax assets if we determine that it is less likely than not that we will be able to utilize the deferred tax assets.
Research And Development Expense Recognition
Research and Development Expense Recognition
     Research and development costs are expensed as they are incurred.
Stock-Based Compensation
Stock-Based Compensation
     We measure stock-based compensation cost at the grant date based on the fair value of the award and recognize the compensation expense over the requisite service period, which is generally the vesting period. We estimate pre-vesting option forfeitures at the time of grant by analyzing historical data and revise those estimates in subsequent periods if actual forfeitures differ from those estimates. Ultimately, the total expense recognized over the vesting period will only be for those awards that vest.
Net Income Per Share
Net Income Per Share
     Net income per basic share is computed based on the weighted-average number of common shares issued and outstanding during each year. Net income per diluted share amounts assume conversion, exercise or issuance of all potential common stock instruments (stock options and warrants). Stock options and warrants totaling 5,000 for fiscal 2013; 5,000 for fiscal 2012; and 1,000 for fiscal 2011 were not included in the computation of diluted earnings per share because the exercise prices were greater than the market price of the common stock. The following table reflects the components of common shares outstanding:

Year Ended March 31
2013 2012 2011
Weighted average common shares outstanding – basic 4,839,810 4,796,227 4,729,035
Effect of dilutive securities:
Stock options
 21,934 60,075 108,121
Warrants
 1,802 7,169 7,110
Shares used in computing net income per share – diluted 4,863,546 4,863,471 4,844,266
 
Use Of Estimates
Use of Estimates
     The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
XML 51 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Information
 12 Months Ended
Mar. 31, 2013
Segment Information [Abstract]  
Segment Information
NOTE 8. SEGMENT INFORMATION
     We operate in one reportable segment. We manufacture and sell spintronic products, and conduct contract research and development activities.

     The following table summarizes customers comprising 10% or more of revenue for fiscal 2013, 2012, and 2011:
 
% of Revenue for Year Ended March 31
2013 2012 2011
Customer A 16% 16% 14%
Customer B 15% 14% 11%
Customer C 14% * 11%
   
 
*Less than 10%
 
     Revenue by geographic region was as follows:
 
Year Ended March 31
2013 2012 2011
United States $ 12,006,493 $ 13,334,563 $ 14,169,952
Europe 10,666,338 10,798,146 12,009,294
Asia 3,979,862 4,130,930 4,576,270
Other 380,726 315,581 441,547
Total Revenue $ 27,033,419 $ 28,579,220 $ 31,197,063
XML 52 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation
 12 Months Ended
Mar. 31, 2013
Stock-Based Compensation [Abstract]  
Stock-Based Compensation
NOTE 6. STOCK-BASED COMPENSATION
Stock Option Plan
     Our 2000 Stock Option Plan, as amended, provides for issuance to employees, directors, and certain service providers of incentive stock options and nonstatutory stock options. Generally, the options may be exercised at any time prior to expiration, subject to vesting based on terms of employment. The period ranges from immediate vesting to vesting over a five-year period. The options have exercisable lives ranging from one year to ten years from the date of grant, and are generally not eligible to vest early in the event of retirement, death, disability, or change in control. Exercise prices are not less than fair market value of the underlying Common Stock at the date the options are granted. Stock-based compensation expense was $66,720 in fiscal 2013; $80,160 in fiscal 2012; and $76,720 in fiscal 2011.

Valuation assumptions
     We use the Black-Scholes standard option-pricing model to determine the fair value of stock options. The following assumptions were used to estimate the fair value of options granted:
Year Ended March 31
2013 2012 2011
Risk-free interest rate 0.7 % 1.0 % 1.6 %
Expected volatility 38 % 42 % 56 %
Expected life (years) 4.1   4.1   4.2  
Dividend yield 0 % 0 % 0 %
 
     The determination of the fair value of the awards on the date of grant using the Black-Scholes model is affected by our stock price as well as assumptions of other variables, including projected stock option exercise behaviors, risk-free interest rate, and expected volatility of our stock price in future periods. Our estimates and assumptions affect the amounts reported in the financial statements and accompanying notes.

Expected life
     We analyze historical exercise and termination data to estimate the expected life assumption. We believe historical data currently represents the best estimate of the expected life of a new option. We examined the historical pattern of option exercises to determine if there was a discernible pattern as to how different classes of optionees exercised their options. Our analysis showed that officers and directors held their stock options for a longer period of time before exercising compared to the rest of our employee population. Therefore we use different expected lives for officers and directors than we use for our general employee population for determining the fair value of options.

Risk-free interest rate
     The risk-free rate is based on the yield of U.S. Treasury securities on the grant date for maturities similar to the expected lives of the options.

Volatility
     We use historical volatility to estimate the expected volatility of our common stock.

Dividend yield
     We assume a dividend yield of zero because we do not anticipate paying dividends in the foreseeable future.

Tax effects of stock-based compensation
     Stock-based compensation increased deferred tax assets by $24,239 for fiscal 2013 and $29,122 for fiscal 2012.
 
General stock option information
     We had no nonvested shares as of March 31, 2013 or 2012.
 
     The following table summarizes information about options outstanding at March 31, 2013, all of which were exercisable:
Ranges of
Exercise Prices		      Number
Outstanding		      Weighted Average
Exercise Price		      Weighted Remaining
Contractual Life (years)
$  15.08 - 16.33 27,000 $ 16.24 2.8
31.27 - 42.45 9,000 37.00 6.0
51.04 - 58.27 13,000 54.76 7.5
49,000 $ 30.27 4.6
 
     Our 2000 Stock Option Plan, as amended, provides for issuance to employees, directors, and certain service providers of incentive stock options and nonstatutory stock options. Generally, the options may be exercised at any time prior to expiration, subject to vesting based on terms of employment. The period ranges from immediate vesting to vesting over a five-year period. The options have exercisable lives ranging from one year to ten years from the date of grant. Exercise prices are not less than fair market value as determined by our Board at the date the options are granted.

     A summary of our stock options and warrants are shown in the following table:
 
Option Shares
Reserved		       Options
Outstanding		       Weighted Average
Option Exercise Price		       Warrants
Outstanding		       Weighted Average
Warrant Exercise Price
At March 31, 2010     170,230     254,500     $ 17.28   10,000     $ 16.28
Granted
 (4,000 ) 4,000 $ 42.45 - -
Exercised
 -   (83,500 ) $ 9.56 -   -
At March 31, 2011     166,230   175,000   $ 21.54 10,000   $ 16.28
Granted
 (4,000 ) 4,000 $ 58.25 -       -
Exercised
 -   (70,000 ) $ 16.93 -     -
At March 31, 2012    162,230   109,000   $ 25.85 10,000   $ 16.28
Granted
 (4,000 ) 4,000 $ 54.11 - -
Exercised
 -   (64,000 ) $ 24.23 - -
Terminated
 -   -   $ - (6,000 )     7.35
At March 31, 2013    158,230   49,000   $ 30.27 4,000   $ 29.69
 
     The remaining weighted-average exercisable life was 4.6 years at March 31, 2013; 3.7 years at March 31, 2012; and 4.3 years at March 31, 2011. All outstanding options were exercisable as of March 31, 2013, 2012, and 2011. The total intrinsic value of options exercised during fiscal 2013 was $1,881,138 based on the difference between the exercise price and stock price at the time of exercise for in-the-money options. The total intrinsic value of options outstanding March 31, 2013, based on our closing stock price for that day, was $1,290,440 all of which were exercisable. The total fair value of option grants was $66,720 in fiscal 2013. There was no unrecognized stock-based compensation at March 31, 2013.

     No warrants were issued in the past three fiscal years. Remaining weighted-average exercisable warrant life was 0.9 years at March 31, 2013; 0.9 years at March 31, 2012; and 1.9 years at March 31, 2011.
XML 53 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes
 12 Months Ended
Mar. 31, 2013
Income Taxes [Abstract]  
Income Taxes
NOTE 7. INCOME TAXES
     Income tax provisions for fiscal 2011 through 2013 consisted of the following:
Year Ended March 31
2013 2012 2011
Current taxes
Federal
 $ 5,314,876 $ 4,847,082 $ 5,761,632
State
 377,215 407,913 504,408
Deferred taxes
Federal
 34,718   (17,233 ) 56,996  
State
 810   4,382   7,215  
Income tax provision $ 5,727,619   $ 5,242,144   $ 6,330,251  
 
     A reconciliation of income tax provisions at the U.S. statutory rate for fiscal 2011 through 2013 is as follows:
 
Year Ended March 31
2013 2012 2011
Tax expense at U.S. statutory rate $ 6,046,264   $ 5,700,630   $ 6,809,003
State income taxes, net of Federal benefit 244,691   252,881   345,213
Domestic manufacturing deduction (460,723 ) (467,053 ) (549,123 )
Municipal interest (118,282 ) (235,470 ) (239,636 )
Other   15,669     (8,844 )   (35,206 )
Income tax provision $ 5,727,619   $ 5,242,144   $ 6,330,251  

     Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax assets and liabilities as of March 31, 2013 and 2012 were as follows:
 
March 31
2013 2012
Vacation accrual $ 134,214   $ 126,453  
Inventory reserve 103,540   108,990  
Depreciation (4,756 )   9,245  
Stock-based compensation deductions 145,592   145,418  
Unrealized gain on marketable securities (888,836 )   (620,500 )
Other 69,510   93,522  
Net deferred tax liabilities $ (440,736 ) $ (136,872 )

     Realizations of stock-based compensation deductions are credited to "Additional paid-in capital" and included in "Tax benefit of stock-based compensation" on our statements of shareholders' equity. Credits of $15,734 in fiscal 2013 and $230,173 in fiscal 2011 were attributed to stock-based compensation deductions. The "Additional paid-in capital" credits also included the tax benefit of stock-based compensation deductions in those years.

     The amounts credited to "Additional paid-in capital" were the tax benefits of the deductions to the extent they exceeded the corresponding compensation expense recognized for financial reporting purposes. "Tax benefit of stock-based compensation" represented the tax benefits of deductions for stock-based compensation to the extent they exceeded the corresponding compensation expense recognized for financial reporting purposes. Cash we received from the exercise of stock options related to excess tax benefits is included in "Net proceeds from sale of common stock" in the statement of cash flows for the year in which the option was exercised and cash received.

     We had $95,184 of Federal net operating losses and $142,775 of state net operating losses at March 31, 2013, compared to $149,284 of Federal net operating losses and $155,681 of state net operating losses at March 31, 2012. These net operating losses expire in fiscal 2020 and are subject to limitation including limitation under the Internal Revenue Code.

     We had no unrecognized tax benefits as of March 31, 2013, and we do not expect any significant unrecognized tax benefits within 12 months of the reporting date. We recognize interest and penalties related to income tax matters in income tax expense. As of March 31, 2013 we had no accrued interest related to uncertain tax positions. The tax years 1999 through 2012 remain open to examination by the major taxing jurisdictions to which we are subject.
XML 54 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Commitments and Contingencies
 12 Months Ended
Mar. 31, 2013
Commitments and Contingencies [Abstract]  
Commitments and Contingencies
NOTE 9. COMMITMENTS AND CONTINGENCIES
     Lease payments were $259,823 for fiscal 2013, $253,740 for fiscal 2012, and $245,220 for fiscal 2011. The operating lease for our facility expires December 31, 2020. We pay operating expenses including maintenance, utilities, real estate taxes, and insurance in addition to rental payments. We also lease a piece of office equipment under an operating lease expiring July 2014 with payments due quarterly. Our future minimum lease payments are shown in the following table:
 
Year Ending March 31
2014 2015 2016 2017 2018 2019 2020 2021 Total
$ 266,496 $ 269,269 $ 271,938 $ 272,953 $ 277,012 281,124 $ 285,396 $ 216,451 $ 2,140,639

    On February 24, 2012, Everspin filed a patent infringement lawsuit against us in the U.S. District Court for the Minnesota District alleging certain NVE products infringe on two patents purported to be owned by Everspin. The lawsuit seeks an injunction and compensation. While the ultimate results of this matter cannot be predicted with certainty, we do not expect it to have a material adverse effect on our financial statements.
XML 55 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Narrative) (Details) (USD $)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Stock-based compensation expense $ 66,720 $ 80,160 $ 76,720
Vesting period 5 years    
Dividend yield 0.00% 0.00% 0.00%
Deferred tax assets increased from stock-based compensation 24,239 29,122  
Intrinsic value of options exercised 1,881,138    
Intrinsic value of options outstanding 1,290,440    
Fair value of option grants $ 66,720    
Maximum [Member]
      
Exercisable lives 10 years    
Minimum [Member]
      
Exercisable lives 1 year    
Options [Member]
      
Weighted-average exercisable life 4 years 7 months 6 days 3 years 8 months 12 days 4 years 3 months 18 days
Warrants [Member]
      
Weighted-average exercisable life 10 months 24 days 10 months 24 days 1 year 10 months 24 days
XML 56 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Marketable Securities (Tables)
 12 Months Ended
Mar. 31, 2013
Marketable Securities [Abstract]  
Fair Value Of Marketable Security By Maturity
Total <1 Year 1–3 Years 3–5 Years
$ 82,751,286 $ 9,711,029 $ 34,310,566 $ 38,729,691
Amortized Cost And Approximate Fair Values Of Marketable Securities
As of March 31, 2013 As of March 31, 2012

Adjusted
Cost		 Gross
Unrealized
Gains		 Gross
Unrealized
Losses		 Fair
Market
Value
Adjusted
Cost		 Gross
Unrealized
Gains		 Gross
Unrealized
Losses		 Fair
Market
Value
Corporate bonds $ 72,923,502    $ 2,378,845    $ (4,187 )    $ 75,298,160    $ 50,513,389    $ 1,481,604    $ (76,434 )    $ 51,918,559
Municipal bonds   7,381,223   81,058
   (9,155 )   7,453,126 19,775,582   334,793
   (32,007 ) 20,078,368
Total $ 80,304,725   $ 2,459,903   $ (13,342 )   $ 82,751,286 $ 70,288,971   $ 1,816,397   $ (108,441 )   $ 71,996,927
Gross Unrealized Losses And Fair Values Of Investments By Investment Category And Length Of Time
Less Than 12 Months 12 Months or Greater Total
Fair
Market
Value		 Gross
Unrealized
Losses		 Fair
Market
Value		 Gross
Unrealized
Losses		 Fair
Market
Value		 Gross
Unrealized
Losses
As of March 31, 2013
  Corporate bonds $ 1,171,976   $ (4,187 )   $ -   $ -     $ 1,171,976   $ (4,187 )
  Municipal bonds   508,607 (9,155 ) - -   508,607 (9,155 )
  Total $ 1,680,583 $ (13,342 ) $ - $ -   $ 1,680,583 $ (13,342 )
As of March 31, 2012
Corporate bonds $ 10,387,955 $ (76,434 )     -     -     $ 10,387,955   $ (76,434 )
Municipal bonds - -   908,550 (32,007 ) 908,550 (32,007 )
Total $ 10,387,955 $ (76,434 ) $ 908,550 $ (32,007 ) $ 11,296,505 $ (108,441 )
XML 57 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Narrative) (Details) (USD $)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Product warranty term, years 1 year    
Shipping costs $ 27,386 $ 40,185 $ 39,427
Stock options and warrants not included in computation of diluted earnings per share 5,000 5,000 1,000
Machinery and Equipment [Member]
      
Property, plant and equipment useful life 5 years    
Furniture and Fixtures [Member]
      
Property, plant and equipment useful life 5 years    
Leasehold Improvements [Member]
      
Property, plant and equipment useful life 5 years    
XML 58 R41.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes (Schedule Of Deferred Tax Assets And Liabilities) (Details) (USD $)
Mar. 31, 2013
Mar. 31, 2012
Income Taxes [Abstract]    
Vacation accrual $ 134,214 $ 126,453
Inventory reserve 103,540 108,990
Depreciation (4,756) 9,245
Stock-based compensation deductions 145,592 145,418
Unrealized gain on marketable securities (888,836) (620,500)
Other 69,510 93,522
Net deferred tax liabilities $ (440,736) $ (136,872)
XML 59 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Statements of Comprehensive Income (USD $)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Comprehensive Income [Abstract]      
Net income $ 11,828,838 $ 11,381,095 $ 13,360,945
Unrealized (gain) loss from marketable securities, net of tax 470,270 27,018 (69,288)
Comprehensive income $ 12,299,108 $ 11,408,113 $ 13,291,657
XML 60 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measurements
 12 Months Ended
Mar. 31, 2013
Fair Value Measurements [Abstract]  
Fair Value Measurements

NOTE 3. FAIR VALUE MEASUREMENTS
     Generally accepted accounting principles establish a framework for measuring fair value, provide a definition of fair value and prescribe required disclosures about fair-value measurements. Generally accepted accounting principles define fair value as the price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement that should be determined using assumptions that market participants would use in pricing an asset or liability. Generally accepted accounting principles utilize a valuation hierarchy for disclosure of fair value measurements. The categorization within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The categories within the valuation hierarchy are described as follows:

     Level 1 – Financial instruments with quoted prices in active markets for identical assets or liabilities. Our Level 1 financial instruments consist of publicly-traded marketable corporate debt securities, which are classified as available-for-sale. On the balance sheets, these securities are included in "Marketable securities, short term" and "Marketable securities, long term." The fair value of our Level 1 marketable securities was $75,298,160 at March 31, 2013 and $51,918,559 at March 31, 2012.

     Level 2 – Financial instruments with quoted prices in active markets for similar assets or liabilities. Level 2 fair value measurements are determined using either prices for similar instruments or inputs that are either directly or indirectly observable, such as interest rates. Our Level 2 financial instruments consist of municipal debt securities, which are classified as available-for-sale. On the balance sheets, these securities are included in "Marketable securities, short term" and "Marketable securities, long term." The fair value of our Level 2 marketable securities was $7,453,126 at March 31, 2013 and $20,078,368 at March 31, 2012. The classification of municipal debt securities as Level 2 at March 31, 2012 has been revised to conform with the current-year classification, consistent with the Level 2 measurement principles applied to securities in all periods presented.

     Level 3 – Inputs to the fair value measurement are unobservable inputs or valuation techniques. We do not have any financial assets or liabilities being measured at fair value that are classified as Level 3 financial instruments.
XML 61 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Schedule Of Weighted Average Number Of Shares) (Details)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2011
Net Income per Share [Abstract]      
Weighted average common shares outstanding - basic 4,839,810 4,796,227 4,729,035
Stock options 21,934 60,075 108,121
Warrants 1,802 7,169 7,110
Shares used in computing net income per share - diluted 4,863,546 4,863,471 4,844,266
XML 62 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 98 207 1 true 26 0 false 4 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.nve.com/role/DocumentDocumentAndEntityInformation Document and Entity Information true false R2.htm 00100 - Statement - Balance Sheets Sheet http://www.nve.com/role/StatementBalanceSheets Balance Sheets false false R3.htm 00105 - Statement - Balance Sheets (Parenthetical) Sheet http://www.nve.com/role/StatementBalanceSheetsParenthetical Balance Sheets (Parenthetical) false false R4.htm 00200 - Statement - Statements of Income Sheet http://www.nve.com/role/StatementStatementsOfIncome Statements of Income false false R5.htm 00300 - Statement - Statements of Comprehensive Income Sheet http://www.nve.com/role/StatementStatementsOfComprehensiveIncome Statements of Comprehensive Income false false R6.htm 00400 - Statement - Statements of Shareholders Equity Sheet http://www.nve.com/role/StatementStatementsOfShareholdersEquity Statements of Shareholders Equity false false R7.htm 00500 - Statement - Statements of Cash Flows Sheet http://www.nve.com/role/StatementStatementsOfCashFlows Statements of Cash Flows false false R8.htm 10101 - Disclosure - Description of Business Sheet http://www.nve.com/role/DisclosureDescriptionOfBusiness Description of Business false false R9.htm 10201 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.nve.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R10.htm 10301 - Disclosure - Fair Value Measurements Sheet http://www.nve.com/role/DisclosureFairValueMeasurements Fair Value Measurements false false R11.htm 10401 - Disclosure - Marketable Securities Sheet http://www.nve.com/role/DisclosureMarketableSecurities Marketable Securities false false R12.htm 10501 - Disclosure - Inventories Sheet http://www.nve.com/role/DisclosureInventories Inventories false false R13.htm 10601 - Disclosure - Stock-Based Compensation Sheet http://www.nve.com/role/DisclosureStockBasedCompensation Stock-Based Compensation false false R14.htm 10701 - Disclosure - Income Taxes Sheet http://www.nve.com/role/DisclosureIncomeTaxes Income Taxes false false R15.htm 10801 - Disclosure - Segment Information Sheet http://www.nve.com/role/DisclosureSegmentInformation Segment Information false false R16.htm 10901 - Disclosure - Commitments and Contingencies Sheet http://www.nve.com/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies false false R17.htm 11001 - Disclosure - Stock Repurchase Plan Sheet http://www.nve.com/role/DisclosureStockRepurchasePlan Stock Repurchase Plan false false R18.htm 11101 - Disclosure - Information as to Employee Stock Purchase, Savings, And Similar Plans Sheet http://www.nve.com/role/DisclosureInformationAsToEmployeeStockPurchaseSavingsAndSimilarPlans Information as to Employee Stock Purchase, Savings, And Similar Plans false false R19.htm 20202 - Disclosure - Summary of Significant Accounting Policies (Policy) Sheet http://www.nve.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicy Summary of Significant Accounting Policies (Policy) false false R20.htm 30203 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.nve.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) false false R21.htm 30403 - Disclosure - Marketable Securities (Tables) Sheet http://www.nve.com/role/DisclosureMarketableSecuritiesTables Marketable Securities (Tables) false false R22.htm 30503 - Disclosure - Inventories (Tables) Sheet http://www.nve.com/role/DisclosureInventoriesTables Inventories (Tables) false false R23.htm 30603 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.nve.com/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) false false R24.htm 30803 - Disclosure - Segment Information (Tables) Sheet http://www.nve.com/role/DisclosureSegmentInformationTables Segment Information (Tables) false false R25.htm 30903 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.nve.com/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) false false R26.htm 40201 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details) Sheet http://www.nve.com/role/DisclosureSummaryOfSignificantAccountingPoliciesNarrativeDetails Summary of Significant Accounting Policies (Narrative) (Details) false false R27.htm 40202 - Disclosure - Summary of Significant Accounting Policies (Schedule Of Weighted Average Number Of Shares) (Details) Sheet http://www.nve.com/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfWeightedAverageNumberOfSharesDetails Summary of Significant Accounting Policies (Schedule Of Weighted Average Number Of Shares) (Details) false false R28.htm 40301 - Disclosure - Fair Value Measurements (Details) Sheet http://www.nve.com/role/DisclosureFairValueMeasurementsDetails Fair Value Measurements (Details) false false R29.htm 40401 - Disclosure - Marketable Securities (Narrative) (Details) Sheet http://www.nve.com/role/DisclosureMarketableSecuritiesNarrativeDetails Marketable Securities (Narrative) (Details) false false R30.htm 40402 - Disclosure - Marketable Securities (Fair Value Of Marketable Securities By Maturity) (Details) Sheet http://www.nve.com/role/DisclosureMarketableSecuritiesFairValueOfMarketableSecuritiesByMaturityDetails Marketable Securities (Fair Value Of Marketable Securities By Maturity) (Details) false false R31.htm 40403 - Disclosure - Marketable Securities (Amortized Cost And Approximate Fair Values Of Marketable Securities) (Details) Sheet http://www.nve.com/role/DisclosureMarketableSecuritiesAmortizedCostAndApproximateFairValuesOfMarketableSecuritiesDetails Marketable Securities (Amortized Cost And Approximate Fair Values Of Marketable Securities) (Details) false false R32.htm 40404 - Disclosure - Marketable Securities (Gross Unrealized Losses And Fair Values Of Investments By Investment Category And Length Of Time) (Details) Sheet http://www.nve.com/role/DisclosureMarketableSecuritiesGrossUnrealizedLossesAndFairValuesOfInvestmentsByInvestmentCategoryAndLengthOfTimeDetails Marketable Securities (Gross Unrealized Losses And Fair Values Of Investments By Investment Category And Length Of Time) (Details) false false R33.htm 40501 - Disclosure - Inventories (Details) Sheet http://www.nve.com/role/DisclosureInventoriesDetails Inventories (Details) false false R34.htm 40601 - Disclosure - Stock-Based Compensation (Narrative) (Details) Sheet http://www.nve.com/role/DisclosureStockBasedCompensationNarrativeDetails Stock-Based Compensation (Narrative) (Details) false false R35.htm 40602 - Disclosure - Stock-Based Compensation (Schedule Of Valuation Assumptions) (Details) Sheet http://www.nve.com/role/DisclosureStockBasedCompensationScheduleOfValuationAssumptionsDetails Stock-Based Compensation (Schedule Of Valuation Assumptions) (Details) false false R36.htm 40604 - Disclosure - Stock-Based Compensation (Summary Of Options Outstanding) (Details) Sheet http://www.nve.com/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingDetails Stock-Based Compensation (Summary Of Options Outstanding) (Details) false false R37.htm 40605 - Disclosure - Stock-Based Compensation (Summary Of Stock Options And Warrants) (Details) Sheet http://www.nve.com/role/DisclosureStockBasedCompensationSummaryOfStockOptionsAndWarrantsDetails Stock-Based Compensation (Summary Of Stock Options And Warrants) (Details) false false R38.htm 40701 - Disclosure - Income Taxes (Narrative) (Details) Sheet http://www.nve.com/role/DisclosureIncomeTaxesNarrativeDetails Income Taxes (Narrative) (Details) false false R39.htm 40702 - Disclosure - Income Taxes (Schedule Of Income Tax Provisions) (Details) Sheet http://www.nve.com/role/DisclosureIncomeTaxesScheduleOfIncomeTaxProvisionsDetails Income Taxes (Schedule Of Income Tax Provisions) (Details) false false R40.htm 40703 - Disclosure - Income Taxes (Schedule Of Reconciliation Of Income Tax Provisions) (Details) Sheet http://www.nve.com/role/DisclosureIncomeTaxesScheduleOfReconciliationOfIncomeTaxProvisionsDetails Income Taxes (Schedule Of Reconciliation Of Income Tax Provisions) (Details) false false R41.htm 40704 - Disclosure - Income Taxes (Schedule Of Deferred Tax Assets And Liabilities) (Details) Sheet http://www.nve.com/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails Income Taxes (Schedule Of Deferred Tax Assets And Liabilities) (Details) false false R42.htm 40801 - Disclosure - Segment Information (Schedule Of Revenue By Major Customers) (Details) Sheet http://www.nve.com/role/DisclosureSegmentInformationScheduleOfRevenueByMajorCustomersDetails Segment Information (Schedule Of Revenue By Major Customers) (Details) false false R43.htm 40802 - Disclosure - Segment Information (Schedule Of Revenue By Geographic Region) (Details) Sheet http://www.nve.com/role/DisclosureSegmentInformationScheduleOfRevenueByGeographicRegionDetails Segment Information (Schedule Of Revenue By Geographic Region) (Details) false false R44.htm 40901 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.nve.com/role/DisclosureCommitmentsAndContingenciesDetails Commitments and Contingencies (Details) false false R45.htm 41001 - Disclosure - Stock Repurchase Plan (Details) Sheet http://www.nve.com/role/DisclosureStockRepurchasePlanDetails Stock Repurchase Plan (Details) false false R46.htm 41101 - Disclosure - Information as to Employee Stock Purchase, Savings, And Similar Plans (Details) Sheet http://www.nve.com/role/DisclosureInformationAsToEmployeeStockPurchaseSavingsAndSimilarPlansDetails Information as to Employee Stock Purchase, Savings, And Similar Plans (Details) false false All Reports Book All Reports Process Flow-Through: 00100 - Statement - Balance Sheets Process Flow-Through: Removing column 'Mar. 31, 2011' Process Flow-Through: Removing column 'Mar. 31, 2010' Process Flow-Through: 00105 - Statement - Balance Sheets (Parenthetical) Process Flow-Through: 00200 - Statement - Statements of Income Process Flow-Through: 00300 - Statement - Statements of Comprehensive Income Process Flow-Through: 00500 - Statement - Statements of Cash Flows nvec-20130331.xml nvec-20130331.xsd nvec-20130331_cal.xml nvec-20130331_def.xml nvec-20130331_lab.xml nvec-20130331_pre.xml true true XML 63 R38.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes (Narrative) (Details) (USD $)
 12 Months Ended
Mar. 31, 2013
Mar. 31, 2011
Mar. 31, 2012
Income Taxes [Abstract]      
Tax benefit of stock-based compensation $ 15,734 $ 230,173  
Net operating loss, federal 95,184   149,284
Net operating loss, state $ 142,775   $ 155,681
XML 64 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Mar. 31, 2013
Summary of Significant Accounting Policies [Abstract]  
Schedule Of Weighted Average Number Of Shares
Year Ended March 31
2013 2012 2011
Weighted average common shares outstanding – basic 4,839,810 4,796,227 4,729,035
Effect of dilutive securities:
Stock options
 21,934 60,075 108,121
Warrants
 1,802 7,169 7,110
Shares used in computing net income per share – diluted 4,863,546 4,863,471 4,844,266